CPDD 78th Annual Scientific Meeting Program

CPDD 78th Annual 

Scientific Meeting Program 

June 11-16, 2016 

La Quinta Resort and Club 

Palm Springs, California

MEETING FACILITIES 

THE 

STUDIO 

FOUNTAIN 

ROOM 

SANTA ROSA 

ROOM 

CALIFORNIA 

LIFESTYLE 

REALTY 

DIEGO ROOM 

LOLLIPOPS 

THE BUNGALOW 

SHOP 

PLAZA GROUND LEVEL 

TWENTY6 RESTAURANT 

DIEGO ROOM 

THE STUDIO 

GRETA’S 

POLO RALPH LAUREN 

TUMBLEWEEDS 

AUDREY’S 

COFFEE MARKET/ 

GIFT SHOP 

SHOPS ON THE PLAZA 

LOLLIPOPS 

THE BUNGALOW SHOP 

COFFEE MARKET/GIFT 

SHOP 

AUDREY’S 

GRETA'S 

TUMBLEWEEDS 

POLO RALPH LAUREN 

PLAZA UPPER LEVEL 

ADOBE GRILL 

LAS BRISAS 

EXECUTIVE OFFICES 

MARKETING 

SALES 

HUMAN RESOURCES 

ACCOUNTING 

LAS 

BRISAS

BOARD OF DIRECTORS 

Sandra D. Comer, PhD, President 

Eric C. Strain, MD, Past-President 

Leonard L. Howell, PhD, President-Elect 

Linda B. Cottler, PhD, MPH, Treasurer 

Patrick M. Beardsley, PhD 

Kathleen M. Carroll, PhD 

Marilyn E. Carroll, PhD 

Howard D. Chilcoat, ScD 

Timothy P. Condon, PhD 

Linda P. Dwoskin, PhD 

Toby K. Eisenstein, PhD 

Margaret Haney, PhD 

Carl L. Hart, PhD 

Sarah H. Heil, PhD 

Stephen T. Higgins, PhD 

Marc J. Kaufman, PhD 

Gregory M. Miller, PhD 

Charles O’Keeffe, MBA 

Thomas E. Prisinzano, PhD 

Jennifer Tidey, PhD 

EXECUTIVE OFFICER 

Loretta P. Finnegan, MD 

DIRECTOR, EXECUTIVE OFFICE 

Ellen B. Geller, MA 

SCIENTIFIC PROGRAM COMMITTEE 

Elise Weerts, PhD, Chair 

William W. Stoops, Chair-Elect 

Michael Bardo, PhD 

Howard Chilcoat, ScD 

Ziva Cooper, PhD 

Linda Cottler, PhD, MPH 

Kelly Dunn, PhD 

Linda P. Dwoskin, PhD 

Michael Kuhar, PhD 

Matthew Johnson, PhD 

Kathryn McHugh, PhD 

F. Gerald Moeller, MD 

Danielle Ramo, PhD 

Loretta P. Finnegan, MD, ex officio 

Ellen B. Geller, MA, ex officio

PRE-MEETING SATELLITES 

Ninth Annual International Women’s and Children’s Health 

and Gender Group Conference 

Chaired by Wendee Wechsberg 

Flores 1-4 

June 10 

The 2016 NIDA International Forum: Global 

Developments in Drug Trends 

Chaired by Steven Gust 

Fiesta 14 

June 10 

Fiesta 6/8 

June 11 

The International Study Group Investigating 

Drugs as Reinforcers (ISGIDAR) 

Chaired by Mark Smith 

Fiesta 12 

June 11 

CPDD REGISTRATION 

La Cita 

Saturday, June 11 

1:30 PM - 5:30 PM 

Sunday, June 12 - Wednesday, June 15 

7:30 AM - 5:00 PM 

Thursday, June 16 

7:30 AM - 3:00 PM 

OPENING RECEPTION 

(Cash Bar) 

CAPRA/LAWN 

Saturday, June 11 

7:00 PM - 9:00 PM 

(Pre-registrants can pick up 

badges only)

June 12, 2016 

June 12, 2016 Fiesta 

Sunday, June 12, 2016 

Plenary Program Sunday, 

Fiesta Ballroom 

8:30 - 11:30 AM 

8:30 Welcome 

CPDD President Sandra Comer 

8:40 Report from the National Institute on Drug Abuse, 

Nora Volkow, Director 

9:10 Report from the National Institute on Alcohol Abuse and Alcoholism, Title of Talk: 

The role of stress in addiction: An NIAAA perspective 

George Koob, Director 

9:40 Presentation of the Stephen G. Holtzman Travel Award for Preclinical Investigators to Jae Kim 

Introduction by Martin W. Adler 

9:45 Presentation of the CPDD/Media Award to Bess O’Brien 

Introduction by Bertha Madras 

10:00 Presentation of the J. Michael Morrison Award to Minda Lynch 

Introduction by Marilyn Carroll 

10:10 Presentation of the Joseph Cochin Young Investigator Award to Jun-Xu Li 

Introduction by Charles France 

10:20 Presentation of the Mentorship Award to Kenner Rice 

Introduction by Thomas Prisinzano 

10:30 Presentation of the Nathan B. Eddy Award to Warren K. Bickel 

Introduction by Stephen Higgins 

10:45 Nathan B. Eddy Lecture: The Addictionomics of Self Control 

Warren Kurt Bickel, Virginia Tech Carilion Research Institute, Roanoke, VA 

CPDD Early Career Travel Awards Luncheon Sunday, 

(By Invitation Only) 

President’s Symposium 

Sunday, 

WHERE THERE’S SMOKE: U.S., AUSTRALASIAN, 

AND EUROPEAN CANNABIS POLICIES AND USE 

11:45 - 1:00 PM 

June 12, 2016 Morgan’s 

6/8 

1:30 - 2:30 PM 

President: Sandra Comer, Columbia University and NYSPI 

Deborah Hasin, Columbia University; New York State Psychiatric Institute 

Alison Ritter, University of New South Wales 

Marc Auriacombe, University of Bordeaux (France) 

1




Symposium I Sunday, 

DEVELOPING INNOVATIVE BRAIN STIMULATION 

TREATMENT OPTIONS FOR SUBSTANCE-DEPENDENT 

INDIVIDUALS: TRANSLATING BASIC SCIENCE 

KNOWLEDGE OF NEURAL CIRCUITS TO OUR CLINICS 

6/8 

3:00 - 5:00 PM 

Chairs: Colleen A. Hanlon and Nora Volkow 

3:00 Developing innovative brain stimulation treatment options for substance dependentindividuals: 

Translating basic science knowledge of neural circuits to our clinics 

Colleen A Hanlon, Medical University of South Carolina, Charleston, SC 

3:25 Theta burst TMS as a tool to change smoking behavior 

Warren Kurt Bickel, Virginia Tech Carilion Research Institute, Roanoke, VA 

3:50 10 Hz TMS as a tool to decrease pain and opioid use among prescription opiate-dependent 

individuals: A single-blind sham controlled MRI & TMS study 

Gregory Sahlem, Medical University of South Carolina, Charleston, SC 

4:15 From optogenetics to a potential rTMS treatment against cocaine use disorders 

Nora Volkow, National Institute of Drug Abuse, Baltimore, MD 

4:40 DISCUSSANT: Dr. Hanlon and Dr. Bonci will lead an interactive discussion with the panel 

members and soliciting questions from the audience 

Colleen A Hanlon, Medical University of South Carolina, Charleston, SC 

Symposium II Sunday, 

INFLUENCE OF METABOLIC HORMONES ON REWARD 

PROCESSING AND ADDICTION 

10/14 

3:00 - 5:00 PM 

Chairs: Arbi Nazarian and Minda Lynch 

3:00 Insulin signaling and diabetes: What do we know about the rewarding effects of nicotine in the 

diabetic brain? 

Arbi Nazarian, Western University of Health Sciences, Pomona, CA 

3:24 Leptin signaling in the ventral tegmental area regulates food intake and brain reward function 

Adriaan Bruijnzeel, University of Florida, Gainesville, FL 

3:48 Ghrelin and GLP-1: Seeking the yin and yang in alcoholism 

Lorenzo Leggio, NIAAA and NIDA, Bethesda, MD 

4:12 The role of central glucagon-like peptide-1 receptors in cocaine addiction 

Heath Schmidt, University of Pennsylvania, Philadelphia, PA 

4:36 DISCUSSANT: What do metabolic hormones in the brain teach us about reward and addiction? 

Minda Lynch, NIDA, Bethesda, MD 

2



Oral Communications 1 Sunday, 

RUSH: STIMULANTS-PRECLINICAL STUDIES 

12 

3:00 - 5:00 PM 

Chairs: Wendy J. Lynch and Jae K. Kim 

3:00 Effect of a dopamine D3 receptor partial agonist on cocaine-induced locomotion and 

self-administration 

J. Bonadonna 1 , G. Powell 1 , A. K. Carlson 1 , R. Mendoza 1 , R. H. Mach 2 , R. R. Luedtke 3 , 

J. L. Neisewander 1 , 1 School of Life Sciences, Arizona State University, Tempe, AZ, 2 Perelman 

School of Medicine, University of Pennsylvania, Philadelphia, PA, 3 Health Science Center, 

University of North Texas, Fort Worth, TX 

3:15 CXCR4 antagonist Plerixafor attenuates cue-and cue/drug-induced relapse to cocaine seeking 

and expression and development of cocaine-induced conditioned place preference 

J. K. Kim 1 , S. Rawls 1,2 , 1 Pharmacology, Lewis Katz School of Medicine at Temple University, 

Philadelphia, PA, 2 Center for Substance Abuse Research, Lewis Katz School of Medicine at 

Temple University, Philadelphia, PA 

3:30 Kappa opioid receptor agonist 16-ethynyl salvinorin A attenuates the rewarding effects of 

cocaine in the progressive ratio model in rats with fewer side-effects 

B. M. Kivell 1 , D. Young 1 , A. Culverhouse 1 , T. Prisinzano 2 , 1 School of Biological Sciences, 

Victoria University of Wellington, Wellington, New Zealand, 2 Department of Medicinal 

Chemistry, University of Kansas, Lawrence, KS 

3:45 Effects of chronic amphetamine on abuse-related behavioral and neurochemical effects of 

cocaine in rats 

A. Johnson, S. S. Negus, Virginia Commonwealth University, Richmond, VA 

4:00 Long-term blockade of cocaine use and locomotor activation in rats by an adenoviral vectordelivered 

cocaine hydrolase 

J. R. Smethells 2 , N. Swalve 2 , S. Brimijoin 1 , R. Parks 4 , M. E. Carroll 2 , 1 Molecular 

Pharmacology, Mayo Clinic, Rochester, MN, 2 University of Minnesota, St. Paul, MN, 4 Ottawa 

Hospital Research Institute, Ottawa, ON, Canada 

4:15 Exercise during early, but not late, abstinence attenuates subsequent relapse vulnerability in a 

rat model 

W. J. Lynch, R. M. Beiter, A. B. Peterson, J. Abel, Psychiatry and Neurobehavioral Sciences, 

University of Virginia, Charlottesville, VA 

4:30 New generation tamoxifen analogs as potential treatments for amphetamine abuse 

C. A. Carpenter 1 , R. Altshuler 1 , A. Zestos 2 , R. Sorenson 3 , E. M. Jutkiewicz 1 , R. Kennedy 2 , 

H. Showalter 3 , M. Gnegy 1 , 1 Pharmacology, University of Michigan, Ann Arbor, MI, 

2 

Chemistry, University of Michigan, Ann Arbor, MI, 3 Vahlteich Medicinal Chemistry Core, 

University of Michigan, Ann Arbor, MI 

4:45 Enantiomers of (±)GZ-888 potently and selectively inhibit vesicular monoamine transporter-2 

function and methamphetamine-stimulated locomotor activity 

N. Lee 1 , G. Zheng 3 , S. M. Mayfield 2 , E. D. Denehy 2 , J. R. Nickell 1 , Z. Cao 1 , P. A. Crooks 3 , 

M. T. Bardo 2 , L. P. Dwoskin 1 , 1 Pharmaceutical Sciences, University of Kentucky, 

Lexington, KY, 2 Psychology, University of Kentucky, Lexington, KY, 3 Pharmaceutical 

Sciences, University of Arkansas for Medical Sciences, Fayetteville, AR 

3



Oral Communications 2 Sunday, 

DAZED AND CONFUSED: POLYDRUG ABUSE 

4 

3:00 - 5:00 PM 

Chairs: Kimberly C. Kirby and J. Aaron A. Johnson 

3:00 Gender and age bias in drug and alcohol screening 

J. A. Johnson 2 , R. Howell 2 , P. Seale 1 , 1 Navicent Health, Macon, GA, 2 Augusta University, 

Augusta, GA 

3:15 Addressing unmet addiction need in an urban hospital 

K. Ahamad 2 , S. Nolan 3 , E. Wood 1 , 1 Urban Health Research Initiative, BC Centre for 

Excellence in HIV/AIDS, Vancouver, BC, Canada, 2 University of British Columbia, 

Vancouver, BC, Canada, 3 Department of Medicine, University of British Columbia, 

Vancouver, BC, Canada 

3:30 Longitudinal health service patterns of patients with alcohol, cannabis, and opioid use disorders 

A. L. Bahorik 2 , D. Satre 2,1 , A. H. Kline-Simon 1 , K. C. Young-Wolff 1,2 , C. Weisner 2,1 , 

C. Campbell 1,2 , 1 Division of Research, Kaiser Permanente Northern California, Oakland, CA, 

2 

Psychiatry, University of California, San Francisco, San Francisco, CA 

3:45 Expanded brief intervention for substance use in primary care 

A. C. Brooks 1 , C. M. Carpenedo 1 , J. Lauby 2 , D. Metzger 1,5 , E. Byrne 1 , K. Favor 3 , 

K. C. Kirby 1,4 , 1 Treatment Research Institute, Philadelphia, PA, 2 Public Health Management 

Corporation, Philadelphia, PA, 3 Lincoln University, Lincoln University, PA, 4 Rowan 

University, Glassboro, NJ, 5 University of Pennsylvania, Philadelphia, PA 

4:00 The computer-based drug and alcohol training assessment in Kenya 

V. Clair 1,2 , V. Mutiso 3 , A. Musau 3 , E. Frank 1 , D. Ndetei 3 , 1 University of British Columbia, 

Vancouver, BC, Canada, 2 Urban Health Research Initiative, British Columbia Centre for 

Excellence in HIV/AIDS, Vancouver, BC, Canada, 3 Africa Mental Health Foundation, 

Nairobi, Kenya 

4:15 Who says yes?: Sample representativeness in a clinical trial of SBIRT 

S. S. Kelpin 2 , S. J. Ondersma 3 , D. Svikis 1 , 1 Virginia Commonwealth Univ., Richmond, VA, 

2 

Psychology, Virginia Commonwealth University, Richmond, VA, 3 Wayne State University, 

Detroit, MI 

4:30 Mortality rates among substance use disorder participants in clinical trials: Pooled analysis of 

22 NIDA CTN studies 

P. VanVeldhuisen 1 , L. Hu 1 , R. Lindblad 1 , N. Oden 1 , P. Wakim 2 , C. Rosa 3 , 1 Emmes, 

Rockville, MD, 2 NIH, Bethesda, MD, 3 NIDA, Rockville, MD 

4:45 A brief substance use screening and assessment for general medical settings: Validation of the 

tobacco, alcohol, prescription medication, and other substance use tool 

J. McNeely 1 , L. T. Wu 2 , G. Subramaniam 3 , G. Sharma 4 , R. P. Schwartz 5 , 1 NYU School of 

Med, NYC, NY, 2 Duke U School of Med, Durham, NC, 3 NIDA, Bethesda, MD, 4 Emmes 

Corp, Rockville, MD, 5 Friends Research Inst, Baltimore, MD 

4




June 12, 2016 


Primm-Singleton Awardees Reception Sunday, 

Workshop I Sunday, 

NAVIGATING KEY STAGES OF A CAREER IN ADDICTION 

SCIENCE: GRADUATE SCHOOL, POST-DOC 

AND EARLY-CAREER 

The Studios 

5:00 - 6:00 PM 

10/14 

6:00 - 8:00 PM 

Chairs: Teresa Franklin and Denise C. Vidot 

Navigating the Pre-doctoral stage: Achieving the impossible! 

Qiana Brown, Columbia University Mailman School of Public Health, New York, NY 

Navigating the Post-doctoral stage: I made it! Now what? 

Teresa Franklin, Perelman School of Medicine at the University of Pennsylvania, 

Philadelphia, PA 

Navigating the early career stage: How do I obtain NIH funding? 

Cristina B Bares, The University of Michigan School of Social Work, Ann Arbor, MI 

Workshop II Sunday, 

THE LANDMARK ADOLESCENT BRAIN COGNITIVE 

DEVELOPMENT STUDY (ABCD): A DETAILED 

DISCUSSION OF THE STUDY GOALS, METHODOLOGIES, 

AND PROJECT START-UP 

6/8 

7:00 - 9:00 PM 

Chairs: Susan Weiss and Margaret Murray 

The NIH Vision for ABCD 

Gaya Dowling, National Institute on Drug Abuse, Rockville, MD 

Design, sampling strategy, and organization of ABCD 

Sandra A Brown, University of California, San Diego, La Jolla, CA 

Assessment domains and technologies applied in ABCD 

Susan Tapert, University of California, San Diego, La Jolla, CA 

ABCD neuroimaging and data sharing 

Anders Dale, University of California, San Diego, La Jolla, CA 

Current status of the study 

Terry Jernigan, University of California, San Diego, La Jolla, CA 

Workshop III Sunday, 

EMERGING TECHNOLOGY FOR HUMAN 

SUBJECTS RESEARCH 

12 

7:00 - 9:00 PM 

Chairs: Jonathan J. Stoltman and Edward V. Nunes 

Using Amazon’s Mechanical Turk (mTurk) to sample substance using populations 

Justin C Strickland, Department of Psychology, University of Kentucky, Lexington, KY 

5




HIPAA, quasi-anonymity, and other ethical issues with electronic screening and brief 

intervention in health care settings 

Steven J. Ondersma, Department of Psychiatry & Behavioral Neurosciences, Wayne State 

University, Detroit, MI 

Using Facebook to recruit young adult tobacco users 

Danielle Ramo, Department of Psychiatry, University of California, San Francisco, 

San Francisco, CA 

The remote monitoring of smoking among adolescents and emerging adults: Attitudes, 

acceptability, and feasibility 

Erin A McClure, Department of Psychiatry and Behavioral Sciences, Medical University 

of South Carolina, Charleston, SC 

Crossing the bridge between the laboratory and the natural environment in addictions research 

Jin H. Yoon, University of Texas Health Science Center at Houston, Houston, TX 

DISCUSSANT: 

Edward V Nunes, NYS Psychiatric Institute, New York, NY 

Workshop IV Sunday, 

INTERNATIONAL EMERGENCE AND ABUSE OF NEW 

PSYCHOTROPIC SUBSTANCES (NPS), THEIR TOXICITY 

AND THE CURRENT REGULATORY RESPONSE 

4 

7:00 - 9:00 PM 

Chairs: Patrick Beardsley and Jane C. Maxwell 

Introduction to the NPS issues and the status of the International Regulatory Response 

Patrick Beardsley, Virginia Commonwealth University, Richmond, VA 

Detection, identification, exposure assessment and pharmacological evaluation of new 

psychotropic substances of abuse 

B. F. Thomas, Research Triangle Institute, Research Triangle Park, NC 

NPS situation in Europe 

Paul Griffiths, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, Portugal 

NPS situation in Australasia 

Raimondo Bruno, University of Tasmania, Hobart Tasmania, TAS, Australia 

NPS situation in North America 

Jane C. Maxwell, University of Texas Addiction Research Institute, Austin, TX 

General Discussion: 

Co- Chairs 

Workshop V Sunday, 

EPIDEMIOLOGY AND PUBLIC HEALTH 

RESEARCH METHODS 

10/14 

8:00 - 10:00 PM 

Chairs: James C. Anthony and Jan Copeland 

Introduction to the Workshop 

Jan Copeland, National Cannabis Prevention Medicine, University of NSW, 

New South Wales, NSW, Australia 

6


Introduction to the Workshop 

James C. Anthony, Michigan State University, East Lansing, MI 

Overview of NIDA Epidemiology and DESPR Program Announcements and NIDA-supported 

resources for research 

Marsha Lopez, National Institute on Drug Abuse, Bethesda, MD 

Estimating causal effects with observational data when there is more than one treatment 

Rajeev Ramchand, Rand Corporation, Arlington, VA 

Please be advised that no photographing of presentations or data is permitted. 

Badges must be worn at all times and are required for admission into all events and sessions. 

7




Monday, June 13, 2016 

Town Hall Monday, 

FROM DISCOVERY TO TRANSLATION: NAVIGATING 

THE ENTREPRENEURSHIP JUNGLE 

6/8 

8:00 - 10:00 AM 

Chairs: Beatriz Rocha and Marco Pravetoni 

Start-ups from an academic view 

Andrew Coop, University of Maryland School of Pharmacy, Baltimore, MD 

How to spin off small pharmaceutical business 

Elena Koustova, National Institute on Drug Abuse, Bethesda, MD 

Starting your own spin-off focusing on med development for drug addiction 

Paul Kenny, Department of Pharmacology & Systems Therapeutics, Icahn School of Medicine 

at Mount Sinai, New York, NY 

Media Forum Monday, 

WHAT’S HOT: PIVOTAL RESEARCH REPORTED 

AT CPDD 2016 

10/14 

8:00 - 10:00 AM 

Chairs: Bertha Madras and Anna R. Childress 

Introduction to media: How to shape an effective and short presentation 

Bertha Madras, Harvard Medical School, Belmont, MD 

Introduction to each speaker 

Anna Rose Childress, University of Pennsylvania, Philadelphia, PA 

Symposium III Monday, 

IDENTIFYING SYSTEM-LEVEL BIOMARKERS 

OF SUBSTANCE ABUSE USING FUNCTIONAL 

CONNECTIVITY OF THE BRAIN 

10/14 

10:15 - 12:15 PM 

Chairs: Yihong Yang and Elliot Stein 

10:15 Imbalanced striatal-frontal functional connectivity predicts compulsive and impulsive behaviors 

in cocaine addiction 

Yihong Yang, National Institute on Drug Abuse, Intramural Research Program, 

Baltimore, MD 

10:40 Graph-theoretical modeling of brain connectivity in long-term, heavy cannabis users 

Francesca Filbey, University of Texas at Dallas, Dallas, TX 

11:05 Alcohol and brain connectivity: Neuroimaging of humans and animal models 

Adolf Pfefferbaum, Center for Health Sciences, SRI International, Menlo Park, CA 

11:30 Towards a biomarker of nicotine dependence 

Elliot Stein, National Institute on Drug Abuse, Intramural Research Program, Baltimore, MD 

11:55 DISCUSSANT: Addiction: Unbalanced neurocircuitry 

Nora Volkow, National Institute on Drug Abuse, Rockville, MD 

8




Symposium IV Monday, 

COGNITIVE FUNCTION AS A NOVEL TREATMENT 

TARGET FOR DRUG ADDICTION 

6/8 

10:15 - 12:15 PM 

Chairs: Mehmet Sofuoglu and Kathleen Carroll 

10:15 Psychostimulants as cognitive enhancers in cocaine addiction 

Muhammad A. Parvaz, Icahn School of Medicine at Mount Sinai, New York, NY 

10:40 Use of compensatory strategies in technological enhancement treatment for substance abusers 

Efrat Aharonovich, Columbia University, New York, NY 

11:05 Smart phones for smoking cessation: Cognitive bias modification for addiction 

Andrew Waters, Uniformed Services University of the Health Sciences, Bethesda, MD 

11:30 A placebo controlled trial of galantamine and CBT4CBT as a cognitive enhancement strategy 

Kathleen Carroll, Yale University, West Haven, CT 

11:55 DISCUSSANT: The promise of cognitive enhancement as a treatment for addictions 

Mehmet Sofuoglu, Yale University School of Medicine, West Haven, CT 

Oral Communications 3 Monday, 

THE MAN WITH THE GOLDEN ARM: OPIOID TREATMENT 

12 

10:15 - 12:15 PM 

Chairs: Charles Gorodetzky and Kelly E. Dunn 

10:15 Pain severity and subsequent opioid use during buprenorphine-naloxone treatment of 

prescription opioid- dependent patients with chronic pain 

R. Weiss 1 , M. L. Griffin 3 , K. McDermott 2 , K. McHugh 4 , S. L. Karakula 2 , G. Fitzmaurice 4 , 

1 

Harvard Medical School, Belmont, MA, 2 Alcohol and Drug Abuse Clinical Research 

Program, McLean Hospital, Brookline, MA, 3 McLean Hospital/HMS, Belmont, MA, 4 McLean 

Hospital/Harvard Medical School, Belmont, MA 

10:30 The role of genetic polymorphisms on patient response to opioid use disorder therapy with 

naltrexone and guanfacine 

E. Blokhina 1 , E. Krupitsky 1,4 , A. Kibitov 3 , E. Verbitskaya 1 , T. Kosten 2 , D. A. Nielsen 2 , 

E. Zvartau 1 , 1 First Pavlov State Medical University, St. Petersburg, Russian Federation, 

2 

Baylor College of Medicine, Houston, TX, 3 Serbsky Federal Medical Research Centre 

of Psychiatry and Narcology, Moscow, Russian Federation, 4 Bekhterev Research 

Psychoneurological Institute, St. Petersburg, Russian Federation 

10:45 Optimal minimum length of treatment in opioid-dependence with buprenorphine 

V. Zah 1 , N. Matveev 1 , C. Chen 2 , J. Ruby 3 , 1 Health Economics, ZRx Outcomes Research 

Inc., Mississauga, ON, Canada, 2 College of Pharmacy, University of New Mexico, 

Albuquerque, NM, 3 Medical Affairs / HEOR, Indivior, Inc., Richmond, VA 

11:00 Optimal prevention of relapse among opioid users: A 12-week randomized controlled trial of 

extended-release naltrexone injections versus daily buprenorphine-naloxone 

L. H. Tanum 1,3 , A. Opheim 2 , K. Solli 3 , K. Sharma-Haase 3 , Z. Latif 1 , N. Kunoe 3 , 1 R&D mental 

health, Akershus University Hospital, Lorenskog (Oslo), Norway, 2 Department of addiction 

medicine, Haukeland University Hospital, Bergen, Norway, 3 University of Oslo, Norwegian 

Centre for Addiction Research, Oslo, Norway 

9



11:15 Randomized controlled evaluation of tramadol for opioid detoxification 

K. E. Dunn, D. A. Tompkins, G. Bigelow, E. C. Strain, Johns Hopkins University, 

Baltimore, MD 

11:30 A phase III, randomized, double-blind, placebo-controlled study of the safety and efficacy of 

lofexidine for relief of symptoms in adults undergoing inpatient opioid detoxification 

C. Gorodetzky 1 , S. L. Walsh 2 , K. Gullo 3 , 1 USWM (Cons.), Kansas City, MO, 2 Univ. KY, 

Lexington, KY, 3 USWM, Louisville, KY 

11:45 Interim buprenorphine treatment for reducing illicit opioid use during treatment delays 

S. C. Sigmon 1 , T. A. Ochalek 2 , B. Hruska 1 , S. H. Heil 1 , S. Higgins 1 , G. Rose 1 , B. A. Moore 3 , 

1 

Psychiatry, The University of Vermont, Burlington, VT, 2 Psychology, University of Vermont, 

Burlington, VT, 3 Psychiatry, Yale University School of Medicine, New Haven, CT 

12:00 Unobserved home induction onto buprenorphine: Outcomes at year 7 

J. D. Lee 2 , E. Patterson Bhatraju 2 , B. Tofighi 2 , M. Flannery 2 , A. Kermack 2 , M. Gourevitch 2 , 

A. Garment 3 , K. Goldfeld 2 , J. McNeely 1 , E. Grossman 3 , 1 Population Health, NYU School 

of Medicine, New York, NY, 2 Population Health, New York University, New York, NY, 

3 

Medicine, New York University, New York, NY 


MRS. DOUBTFIRE: SEX/GENDER 

4 

10:15 - 12:15 PM 

Chairs: Eduardo Butelman and Logan Dowdle 

10:15 Oxytocin reduced motivation to take cocaine in female rats and reduced reinstated drug seeking 

in male and females 

K. Leong, A. Hand, S. M. Ghee, C. M. Reichel, Neuroscience, Medical University of South 

Carolina, Charleston, SC 

10:30 Methamphetamine addiction vulnerability, the marked sex differences in the propensity to select 

methamphetamine over food reinforcement 

M. Purpura, P. Viera, Psychological and Brain Sciences, University of California Santa 

Barbara, Santa Barbara, CA 

10:45 Sex differences in a mood-based impulsivity model as a predictor for amphetamine CPP in rats 

D. B. Vazquez Sanroman 2 , M. T. Bardo 1,2 , 1 Psychology, University of Kentucky, 

Lexington, KY, 2 Psychology, Center for Drug Abuse Research Translation, Lexington, KY 

11:00 Taurine’s effects on cocaine–induced behavioral sensitization in male and female rats 

K. Y. Salas-Ramirez, M. Muritala, S. Singh, S. Ayo, R. Liang, T. Adebowale, K. Chauhan, 

A. Elzanie, CUNY School of Medicine, New York, NY 

11:15 Examining frontal-striatal circuit integrity in male and female cocaine users with TMS 

L. T. Dowdle, W. DeVries, M. Canterberry, C. A. Hanlon, Medical University of South 

Carolina, Charleston, SC 

11:30 Gender differences in cannabis use disorder treatment: Change readiness and taking steps 

predict worse outcomes for women 

B. J. Sherman 1 , N. Baker 2 , A. McRae-Clark 1 , 1 Psychiatry, Medical University of South 

Carolina, Charleston, SC, 2 Medical University of South Carolina, Charleston, SC 

10


11:45 Sex differences in smoking withdrawal, urge, and cessation after stroke-induced insular cortex 

damage 

A. Abdolahi 1,2 , G. Williams 2 , C. Benesch 2 , H. Wang 2 , E. Spitzer 3 , B. Scott 3 , R. Block 2 , 

E. van Wijngaarden 2 , 1 Acute Care Solutions, Philips Research, Cambridge, MA, 2 University of 

Rochester, Rochester, NY, 3 Rochester General Hospital, Rochester, NY 

12:00 Addictive diseases and depression comorbidity: Age trajectory and gender comparison 

E. Butelman 1 , S. Bacciardi 2 , A. G. Maremmani 2 , M. Darst-Campbell 1 , B. M. Ray 1 , E. Ducat 1 , 

M. Kreek 1 , 1 Laboratory on the Biology of Addictive Diseases, The Rockefeller University, 

New York, NY, 2 “VP Dole” Dual Diagnosis Unit, Santa Chiara University Hospital of Pisa, 

Pisa, Italy 

Poster Session I 

(Lunch) 

Odd-numbered posters manned first hour; 

Even-numbered, second hour 

Flores 

12:15 - 2:15 PM 

Set-up time begins Sunday, 1 PM 

Must be removed by Monday 2:30 PM 

IMMUNE/HIV 

1 Preliminary findings: HIV/STD risk among crack cocaine-dependent patients in treatment in 

Brazil’s ‘Crackland’ 

S. McPherson 2 , C. S. Madruga 1 , A. Q. Miguel 1 , M. G. McDonell 2 , A. Ribeiro 1 , 1 Psychiatry, 

UNIFESP, Sao Paulo, Brazil, 2 Washington State University, Spokane, WA 

2 Rates and correlates of syphilis reinfection among men who have sex with men in San Francisco 

J. P. Jain 1 , G. Santos 2 , S. Scheer 3 , S. Gibson 4 , P. Crouch 4 , R. Kohn 3 , W. Chang 1 , A. Carrico 1 , 

1 

CHS, UCSF, San Francisco, CA, 2 Community Health Systems, University of California San 

Francisco, San Francisco, CA, 3 SFDPH, San Francisco, CA, 4 SFAF, San Francisco, CA 

3 HIV, overdose mortality and the impact of anti-retroviral therapy adherence 

A. Caudarella 2 , H. Dong 1 , K. Hayashi 1 , T. Kerr 1 , E. Wood 1 , M. Milloy 1 , 1 Urban Health 

Research Initiative, BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada, 

2 

University of British Columbia, Toronto, ON, Canada 

4 Food insecurity and HIV progression among Russians with heavy alcohol consumption 

B. Idrisov 2 , K. Lunze 2 , D. M. Cheng 2 , E. Blokhina 1 , N. Gnatienko 2 , G. Patts 2 , C. Bridden 2 , 

C. Chaisson 2 , S. D. Weiser 4 , E. Krupitsky 1 , J. H. Samet 2 , 1 First St. Petersburg Pavlov State 

Medical University, St. Petersburg, Russian Federation, 2 Boston University, Boston, MA, 

4 

UCSF School of Medicine, San Francisco, CA 

5 Predictors of skin infections among hospitalized injection drug users in Boston 

K. T. Phillips 2 , B. J. Anderson 3,4 , J. M. Liebschutz 1 , M. Stein 3,4 , 1 Medicine, Boston University 

School of Medicine, Boston, MA, 2 University of Northern Colorado, Greeley, CO, 3 General 

Internal Medicine, Butler Hospital, Providence, RI, 4 Brown University, Providence, RI 

6 CD8+ lymphocytes and CD14 high 

CD16 low 

monocytes in chronic marijuana-using HIV patients 

J. Panee, L. Chang, University of Hawaii, Honolulu, HI 

11


7 Marijuana use frequency is associated with viral load suppression and biobehavioral outcomes 

in HIV+ patients 

L. H. Lundahl 1 , C. L. Arfken 1 , J. A. Cohn 2 , M. Greenwald 1 , 1 Psychiatry and Behavioral 

Neuroscience, Wayne State University School of Medicine, Detroit, MI, 2 Internal Med, Wayne 

State University, Detroit, MI 

8 Effects of HIV infection and cocaine dependence on laboratory-based decision making task 

performance 

S. L. Towe, A. L. Hobkirk, C. S. Meade, Psychiatry & Behavioral Sciences, Duke University, 

Durham, NC 

9 The interaction between cocaine dependence and HIV infection on risky decision making and its 

neural substrates 

M. Addicott, A. L. Hobkirk, D. Cordero, C. S. Meade, Psychiatry & Behavioral Sciences, 

Duke University, Durham, NC 

10 Is TAAR1 a potential therapeutic target for immune dysregulation in drug addiction? 

L. M. Fleischer, N. Tamashunas, G. M. Miller, Pharmaceutical Sciences, Northeastern 

University, Boston, MA 

11 Development of a combination heroin-HIV vaccine 

G. R. Matyas 1 , O. Torres 2 , R. Jalah 2 , J. Antoline 3,4 , K. K. Peachman 2 , M. Rao 1 , A. Jacobson 3,4 , 

C. Alving 1 , K. Rice 3,4 , 1 US Military HIV Research Program, Walter Reed Army Institute 

of Research, Silver Spring, MD, 2 US Military HIV Research Program, Henry M. Jackson 

Foundation, Silver Spring, MD, 3 NIDA, NIH, Bethesda, MD, 4 NIAAA, NIH, Bethesda, MD 

12 HIV-1 Tat-protein elevates forebrain glutathione levels and increases morphine drug-seeking 

and depression-like behaviors in mice 

J. P. McLaughlin 2 , S. Eans 2 , J. Medina 2 , K. Hymel 2 , A. Rock 3 , D. Mintzopoulos 3 , 

M. J. Kaufman 1 , 1 Brain Imaging Center, McLean Hospital, Belmont, MA, 

2 

Pharmacodynamics, University of Florida, Gainesville, FL, 3 McLean Imaging Center, 

McLean Hospital, Belmont, MA 

PRECLINICAL STUDIES 

13 Search for novel TLR4 antagonists for the treatment of neuropathic pain and drug abuse 

M. Wang, A. E. Jacobson, Molecular Targets and Medications Discovery Branch, National 

Institute of Drug Abuse and National Institute on Alcohol Abuse and Alcoholism, National 

Institutes of Health, Bethesda, MD 

14 Morphine-induced analgesia in the sensory and affective components of inflammatory pain 

A. Armendariz, A. Nazarian, Pharmaceutical Sciences, Western University of Health 

Sciences, Pomona, CA 

15 Partial kappa opioid receptor agonist effects in vivo in mice: Biased versus unbiased 

C. Guariglia, A. Dunn, K. Windisch, E. Butelman, B. Reed, M. Kreek, The Rockefeller 

University, New York, NY 

16 Abuse-related effects of the biased mu opioid receptor agonist TRV130 on intracranial 

self-stimulation in rats 

A. Altarifi 1 , B. Blough 3 , S. S. Negus 2 , 1 Pharmacology, Jordan University of Science & 

Technology, Irbid, Jordan, 2 Virginia Commonwealth University, Richmond, VA, 3 Research 

Triangle Institute, Research Triangle Park, NC 

12


17 Chronic administration of nandrolone increases the liability to morphine dependence with no 

correlation with LVV-hemorphin 7 in rats 

E. Huang 1 , Y. Chen 3 , T. Huang 1 , L. Chow 2 , 1 Pharmacology, National Defense Medical Center, 

Taiwan, Taipei, Taiwan, 2 Anesthesiology Department, Taipei Veterans General Hospital, 

Taipei, Taiwan, 3 Department of Neurological Surgery, Tri-Service General Hospital, Taipei, 

Taiwan 

18 Anxiolytic-like and discriminative stimulus effects of benzodiazepine+neuroactive steroid 

combinations in rats 

B. W. Gunter 2,1 , S. A. Jones 1 , D. Platt 1 , J. K. Rowlett 1 , 1 University of Mississippi Medical 

Center, Jackson, MS, 2 Vanderbilt University, Pegram, TN 

19 Novel environment response as a predictor of midazolam self-administration in rats 

J. E. Cook 1 , S. L. Huskinson 1 , B. W. Gunter 2 , K. Freeman 1 , J. K. Rowlett 1 , 1 University of 

Mississippi Medical Center, Jackson, MS, 2 Vanderbilt University, Pegram, TN 

20 Emerging role of microRNAs in regulation of nicotine dependence: A Caenorhabditis elegans 

model 

X. Pan, J. R. Polli, Biology, East Carolina University, Greenville, NC 

21 The role of the α7 and α4β2 nicotinic receptors in nicotine sensitization and neural plasticity 

of adolescent rats neonatally treated with quinpirole: Effects on mTOR and nicotinic receptor 

density 

D. J. Peterson 1,2 , J. Wherry 2 , E. D. Cummins 3 , D. Hoover 2 , R. W. Brown 2 , 1 Psychology, East 

Tennessee State University, Johnson City, TN, 2 Biomedical Sciences, East Tennessee State 

University, Johnson City Tennessee, TN, 3 Psychology, University of Nebraska, Lincoln, NE 

22 Silencing giant cholinergic interneurons in the nucleus accumbens with DREADDs reduces 

nicotine self-administration in rats 

E. A. Williams, C. A. Bradley, M. I. Palmatier, Psychology, East Tennessee State University, 

Johnson City, TN 

23 Role of accumbens nicotinic acetylcholine receptors in cue-induced nicotine seeking and 

synaptic plasticity 

A. del Franco 1,2 , G. Powell 1,2 , B. Pagni 1 , J. Goenaga 1 , M. Scofield 3 , C. Gipson-Reichardt 1 , 

1 

Psychology, Arizona State University, Tempe, AZ, 2 School of Life Sciences, Arizona 

State University, Tempe, AZ, 3 Neurosciences, Medical University of South Carolina, 

Charleston, SC 

24 Vulnerability to glutamate excitotoxicity is sexually dimorphic in rats exposed to chronic social 

defeat stress: Relevance to astrocytic glutamate-glutamine cycle 

V. Rappeneau 1 , A. BLAKER 2 , J. PETRO 1 , B. Yamamoto 2 , A. Shimamoto 1 , 1 Neuroscience 

and Pharmacology, Meharry Medical College, Nashville, TN, 2 Department of Pharmacology 

and Toxicology, Indiana University School of Medicine, Indianapolis, IN 

25 Expression of the cannabinoid CB1 receptor in Chinese hamster ovary cells: A specific cellular 

model to investigate the acute and chronic effects of synthetic cannabinoids 

M. Funada, K. Tomiyama, Drug Dependence Research, NIMH, NCNP, Kodaira, Japan 

26 In vivo and in vitro cannabinoid effects of three synthetic compounds 

M. J. Forster, M. B. Gatch, Center for Neuroscience Discovery, UNT Health Science Center, 

Fort Worth, TX 

13


27 Physiological and pharmacokinetic effects of e-cigarette-type exposure 

to delta9-tetrahydrocannabinol in rats 

J. D. Nguyen 1 , S. M. Aarde 1 , S. Vandewater 1 , Y. Grant 1 , D. G. Stouffer 1 , M. Cole 2 , 

L. Parsons 1 , M. A. Taffe 1 , 1 CNAD, The Scripps Research Institute, San Diego, CA, 2 La Jolla 

Alcohol Research, Inc., La Jolla, CA 

28 Real-time, continuous electrochemical monitoring of drugs in vivo 

P. Vieira 1 , N. Arroyo Currás 2 , J. Somerson 2 , K. Ploense 1 , K. Plaxco 2 , T. E. Kippin 1 , 

1 

Psychological & Brain Sciences, University of California Santa Barbara, Goleta, CA, 

2 

Chemistry, University of California Santa Barbara, Santa Barbara, CA 

IMAGING 

29 Fractional anisotropy increase in long-term anabolic-androgenic steroid users 

M. J. Kaufman 2 , J. Seitz 1 , A. E. Lyall 1 , G. Kanayama 2 , N. Makris 1,2 , J. I. Hudson 2 , 

M. Kubicki 1 , H. G. Pope, Jr. 2 , 1 Brigham & Women’s Hospital, Boston, MA, 2 McLean 

Hospital, Belmont, MA 

30 Alexithymia and addiction: A review and preliminary data suggesting neurobiological links to 

reward/loss processing 

K. P. Morie 1 , S. W. Yip 2 , C. Nich 3 , K. Hunkele 3 , K. Carroll 2 , M. N. Potenza 2 , 1 Diagnostic 

Radiology, Yale University, New Haven, CT, 2 Psychiatry, Yale University, New Haven, CT, 

3 

Connecticut Mental Health Center, New Haven, CT 

31 A brain imaging study of dopamine receptor D 2 

availability in cannabis-dependent users 

after recovery from cannabis-induced psychosis using [ 123 I] IBZM in Single Photon Emission 

Tomography 

A. M. Weinstein 1,2 , H. Lerman 2 , M. Greemland 2 , O. Frisch 3 , E. Even-Sapir 2 , 1 Behavioral 

Sciences, University of Ariel, Ariel, Israel, 2 Nuclear Medicine, Tel Aviv Sourasky Medical 

Center, Tel Aviv, Israel, 3 Kfar Izun Treatment Center, Ceasaria, Israel 

32 Psilocybin in long-term meditators: Effects on default mode network functional connectivity 

and retrospective ratings of qualitative experience 

F. S. Barrett 1 , M. W. Johnson 1 , R. R. Griffiths 1,2 , 1 Psychiatry and Behavioral Sciences, Johns 

Hopkins University School of Medicine, Baltimore, MD, 2 Neuroscience, Johns Hopkins 

University School of Medicine, Baltimore, MD 

33 Altered resting state fMRI response in young adult marijuana users and heavy drinkers 

A. D. Dager 1 , S. Meda 2 , H. Tennen 3 , S. Raskin 4 , C. Austad 5 , R. Wood 5 , C. Fallahi 5 , 

G. Pearlson 1,2 , 1 Yale, New Haven, CT, 2 Olin Neuropsych Res Ctr, Hartford, CT, 3 Univ of CT 

Health Ctr, Farmington, CT, 4 Trinity College, Hartford, CT, 5 Central CT State Univ, New 

Britain, CT 

34 Striatal responses to d-amphetamine differentiates young adults at “high-risk” of drug abuse 

M. J. Wesley 1 , J. A. Lile 1 , C. E. Emurian 1 , C. Martin 2 , J. Joseph 3 , T. H. Kelly 1 , 1 Behavioral 

Science, University of Kentucky, Lexington, KY, 2 Psychiatry, University of Kentucky 

College of Medicine, Lexington, KY, 3 Neurosciences, Medical University of South Carolina, 


35 Psychological intervention with working memory training increases basal ganglia volume: 

A VBM study of inpatient treatment for methamphetamine dependence 

S. J. Brooks, D. J. Stein, L. Van Nunen, Psychiatry and Mental Health, University of Cape 

Town, Cape Town, South Africa 

14


36 Methamphetamine dependence linked to interoceptive processing deficits during aversive 

breathing load 

A. C. May 1 , J. L. Stewart 4 , P. Davenport 2 , S. Tapert 1 , M. P. Paulus 3 , 1 UC San Diego, 

San Diego, CA, 2 Physiological Sciences, University of Florida, Gainesville, FL, 3 Laureate 

Institute for Brain Research, Tulsa, OK, 4 Queens College, City University of New York, 

Flushing, NY 

37 The effects of naltrexone on neural responses to methamphetamine cues 

K. E. Courtney 1 , D. Ghahremani 2 , L. Ray 3 , 1 Psychology, University of California, 

Los Angeles, San Diego, CA, 2 Psychiatry and Biobehavioral Science, University of 

California, Los Angeles, Los Angeles, CA, 3 Psychology, University of California, 

Los Angeles, Los Angeles, CA 

38 Structural analysis of the limbic system in substance dependence 

M. F. Regner, R. Rosello, J. Honce, D. Yamamoto, M. Dalwani, J. Sakai, J. Tanabe, UCD, 

Aurora, CO 

39 Effective connectivity of attentional bias in cocaine dependence 

F. Moeller 7,8,3 , L. Ma 7,9 , J. Steinberg 7,3 , J. Bjork 7,3 , S. D. Lane 2 , P. A. Narayana 10 , T. Kosten 1 , 

A. Bechara 11 , J. Schmitz 4 , A. E. Price 6 , K. A. Cunningham 5 , 1 Psychiatry, Baylor, Houston, TX, 

2 

Psychiatry & Behavioral Sciences, UT Health Science Center, Houston, TX, 3 Psychiatry and 

Pharmacology, VCU, Richmond, VA, 4 UT, Houston, TX, 5 Center for Addiction Research, 

UT Medical Branch, Galveston, TX, 6 Neuroscience Graduate Program, UT Medical Branch, 

League City, TX, 7 Institute for Drug and Alcohol Studies, VCU, Richmond, VA, 8 Center 

for Clinical and Translational Research, Richmond, VA, 9 Radiology, VCU, Richmond, VA, 

10 

Radiology, UT Houston Medical School, Houston, TX, 11 Psychology, USC Brain and 

Creativity Institute, Los Angeles, CA 

40 When bigger isn’t better: Widespread brain activation during attempted inhibition of the 

response to 6-sec cocaine video cues predicts poor drug use outcome 

A. R. Childress, K. Jagannathan, P. Regier, J. Suh, Z. Monge, T. Franklin, R. Wetherill, 

K. A. Young, S. Darnley, M. Gawrysiak, D. Langleben, K. M. Kampman, C. P. O’Brien, 

University of Pennsylvania, Philadelphia, PA 

41 Transition to problem stimulant use marked by amplified insular responding to pleasant 

interoceptive stimuli 

E. Ramirez-Coombs 1 , A. C. May 3 , J. L. Stewart 1,4 , S. Tapert 5,3 , M. P. Paulus 6,3 , 1 Psychology, 

CUNY Graduate Center, New York, NY, 3 Psychiatry, UC San Diego, San Diego, CA, 

4 

Psychology, CUNY Queens College, Flushing, NY, 5 Psychiatry Service, Veterans Affairs San 

Diego Healthcare System, San Diego, CA, 6 Laureate Institute of Brain Research, Tulsa, OK 

42 Resting state functional connectivity among cocaine users 

A. L. Hobkirk 1 , R. P. Bell 2 , A. V. Utevsky 3 , C. S. Meade 1 , 1 Psychiatry & Behavioral Sciences, 

Duke University, Durham, NC, 2 Psychology, University of North Carolina, Chapel Hill, NC, 

3 

Psychology and Neuroscience, Duke University, Durham, NC 

43 Hemispheric associations of behavioral inhibition and approach in substance dependence 

D. Yamamoto 1 , M. T. Banich 5 , M. F. Regner 3 , J. Sakai 1 , J. Tanabe 1 , 1 Department of Psychiatry 

and Radiology, University of Colorado Denver, Aurora, CO, 3 Departments of Radiology and 

Bioengineering, University of Colorado Denver, Denver, CO, 5 Institute of Cognitive Science, 

University of Colorado Boulder, Boulder, CO 

15


44 Neural effects of treatment in a trial of behavioral therapies and disulfiram for cocaine 

dependence 

E. E. DeVito 1 , G. Dong 2,1 , H. Kober 1 , J. Xu 1 , K. Carroll 1 , M. N. Potenza 1 , 1 Psychiatry, Yale 

University School of Medicine, New Haven, CT, 2 Psychology, Zhejiang Normal University, 

Jinhua, China 

45 Poorer working memory performance among cocaine users accounted for by increased 

activation in the middle frontal gyrus 

J. Y. Yi 1 , R. P. Bell 1 , T. Ross 2 , E. Stein 2 , S. B. Daughters 1 , 1 Department of Psychology and 

Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, 2 Neuroimaging 

Research Branch, National Institute on Drug Abuse, National Institutes of Health, 

Baltimore, MD 

46 Distress tolerance among substance users associated with connectivity between the MFG 

and vmPFC/sgACC during a distress tolerance task 

E. D. Reese 1 , R. P. Bell 1 , J. Y. Yi 1 , T. Ross 2 , E. Stein 2 , S. B. Daughters 1 , 1 Department of 

Psychology and Neuroscience, University of North Carolina at Chapel Hill, Chapel Hill, NC, 

2 

Neuroimaging Research Branch, National Institute on Drug Abuse, National Institutes of 

Health, Baltimore, MD 

47 The “little brain” steps up: Cerebellar activity during successful inhibition predicts treatment 

outcome in cocaine patients 

P. S. Regier, K. Jagannathan, J. Suh, M. Goldman, K. M. Kampman, T. Franklin, 

C. P. O’Brien, A. R. Childress, Psychiatry, University of Pennsylvania, Philadelphia, PA 

48 Switching gears: Shifts in reward function associated with age of onset of MJ use 

N. Hager 1 , K. Jagannathan 1 , R. Wetherill 1 , P. Regier 1 , Y. Mashhoon 2 , H. Pater 1 , C. P. O’Brien 1 , 

A. R. Childress 1 , T. Franklin 1 , 1 Psychiatry, University of Pennsylvania, Philadelphia, PA, 

2 

Psychiatry, Harvard, Belmont, MA 

49 Losing balance: Time course of smoking cue-elicited neural activity 

T. Franklin, K. Jagannathan, N. Hager, R. Wetherill, H. Rao, H. Pater, A. R. Childress, 

Psychiatry, University of Pennsylvania, Philadelphia, PA 

50 Right inferior frontal gyrus structure and function predict smoking (re)lapse in real-world 

and laboratory contexts 

B. Froeliger 1,2 , P. McConnell 1 , S. Bell 1 , C. Eichberg 1 , M. Sweitzer 3 , K. M. Gray 2 , 

J. McClernon 3 , 1 Neuroscience, MUSC, Charleston, SC, 2 Psychiatry, MUSC, Charleston, SC, 

3 

Psychiatry, Duke, Durham, NC 

51 Insula reactivity to negative stimuli is associated with daily cigarette use: A preliminary 

investigation using the human connectome database 

A. L. Peechatka 1,2 , N. Dias 3 , A. Janes 3 , 1 McLean Imaging Center, McLean Hospital, 

Belmont, MA, 2 Psychology, Suffolk University, Boston, MA, 3 McLean Imaging Center, 

McLean Hospital/ Harvard Medical School, Belmont, MA 

ABUSE LIABILITY 

52 Impact of smoking reduced nicotine content cigarettes on sensitivity to cigarette price: Results 

from a multi-site clinical trial 

E. Donny 1 , T. T. Smith 1 , R. Cassidy 2 , J. W. Tidey 2 , X. Luo 3 , C. Le 3 , D. Hatsukami 4 , 

1 

Psychology, University of Pittsburgh, Pittsburgh, PA, 2 Brown University, Providence, RI, 

3 

University of Minnesota, Minneapolis, MN, 4 University of Minnesota Medical School, 

Minneapolis, MN 

16


53 Interactions between alcohol and mephedrone in humans 

M. Farré 1,2,3 , E. Papaseit 2,1,3 , C. Pérez-Mañà 2,3 , E. de Souza Fernandes 4 , 

J. F. Mateus 2 , E. Olesti 2,6 , K. Kuypers 4 , E. Theunisen 4 , F. Fonseca 5,3 , M. Torrens 5,3 , 

J. Ramaekers 4 , R. F. de la Torre 2,6 , 1 Clinical Pharmacology, Hospital Universitari Germans 

Trias i Pujol-IGTP, Badalona, Spain, 2 Pharmacology, Hospital del Mar Medical Research 

Institute-IMIM, Barcelona, Spain, 3 Universitat Autonoma de Barcelona-UAB, Barcelona, 

Spain, 4 Faculty of Psychology and Neuroscience, Maastricht University, Maastrich, 

Netherlands, 5 Institut de Neuropsiquiatria i Addiccions, Hospital del Mar-IMIM-PSMAR, 

Barcelona, Spain, 6 Universitat Pompeu Fabra, Barcelona, Spain 

54 Select characteristics of recreational of opioid users undergoing a human abuse potential study 

M. D. Smith, L. R. Webster, PRA Health Sciences, Salt Lake City, UT 

55 Abuse liability of buprenorphine vs. buprenorphine/naloxone: Importance of absolute amount 

J. D. Jones 4 , J. M. Manubay 3 , S. Mogali 4 , V. Metz 1 , S. Comer 4 , 1 Columbia University NYSPI, 

New York, NY, 3 Family Medicine/Psychiatry, NYSPI/Columbia University, New York, NY, 

4 

Division on Substance Abuse, New York State Psychiatric Institute/ Columbia University 

College of Physicians and Surgeons, New York, NY 

56 Monitoring Internet postings for mentions of an extended-release hydrocodone formulation with 

abuse-deterrent properties 

A. DeVeaugh-Geiss 1 , H. Chilcoat 1 , P. Coplan 1 , V. Harikrishnan 1 , A. C. Besharat 2 , J. L. Green 2 , 

1 

Purdue Pharma LP, Stamford, CT, 2 Denver Health RADARS System, Denver, CO 

57 Correlating viscosity and in vitro dissolution to in vivo pharmacokinetic profiles of proprietary 

injected-molded tablet formulations with abuse-deterrent characteristics 

T. Elhauge, N. Skak, M. J. Øvergård, K. Lindhardt, Egalet Corporation, Værløse, Denmark 

58 Moderate TBI increases susceptibility to rewarding effects of a subthreshold dose of cocaine in 

mice 

L. Cannella 1 , S. Merkel 1,2 , R. Razmpour 1 , C. S. Tallarida 2,3 , S. Rawls 2,3 , S. Ramirez 1,2,4 , 

1 

Pathology, TUSM, Philadelphia, PA, 2 CSAR, TUSM, Philadelphia, PA, 3 Pharmacology, 

TUSM, Philadelphia, PA, 4 Shriner’s, Philadelphia, PA 

59 Evaluation of human abuse liability of JZP-110 

L. P. Carter 1,5 , E. Sellers 2 , J. Henningfield 3,6 , G. Wang 1 , Y. Lu 1 , D. Kelsh 4 , B. Vince 4 , 1 Jazz 

Pharmaceuticals, Palo Alto, CA, 2 University of Toronto, Toronto, ON, Canada, 3 Pinney 

Associates, Bethesda, MD, 4 Vince & Associates Clinical Research, Overland Park, KS, 

5 

University of Arkansas for Medical Sciences, Little Rock, AR, 6 Johns Hopkins School of 

Medicine, Baltimore, MD 

ETHIC DIFFERENCES/HEALTH DISPARITIES 

60 A mixed methods assessment of familism’s (Familismo) influence on the initiation, cessation, 

and treatment of injection heroin use 

D. V. Flores 1 , L. Torres 1 , J. Burnett 3 , R. Xia 3 , P. Bordnick 1 , 1 University of Houston, 

Houston, TX, 3 University of Texas Medical School, Houston, TX 

61 A multi-component brief intervention for risky drug use among Latino patients of a federally 

qualified health center in East Los Angeles: A randomized controlled trial of the QUIT Using 

Drugs Intervention Trial (QUIT) brief intervention 

L. Gelberg 1 , R. Andersen 1 , M. Vahidi 1 , M. Rico 1 , S. Baumeister, 2 , B. Leake 1 , 1 UCLA, 

Los Angeles, CA, 2 University of Regensburg, Regensburg, Germany 

17


62 Subjective happiness moderates the effects of nicotine dependence on acute tobacco withdrawal 

in African-American smokers 

M. M. Liautaud 1 , R. Pang 1 , A. Leventhal 1,2 , 1 Preventive Medicine, University of Southern 

California, Los Angeles, CA, 2 Psychology, University of Southern California, 

Los Angeles, CA 

63 Smoking and trauma in Syrian refugees 

H. Jefee-Bahloul 1,2 , M. Jaafar 3 , 1 Psychiatry- Division of Substance Use, University of 

Massachusetts Medical School, Boston, MA, 2 Psychiatry, Yale School of Medicine, 

New Haven, CT, 3 Union of Syrian Medical Relief Organizations, Reyhanli, Turkey 

64 Sport involvement and marijuana use during adolescence: The significance of level of contact 

and race/ethnicity 

K. Rigg 2 , J. A. Ford 1 , 1 Sociology, University of Central Florida, Orlando, FL, 2 Mental Health 

Law & Policy, University of South Florida, Tampa, FL 

65 Perceived racial discrimination and motivations for illicit substance use among Black college 

student drug users 

D. Lanaway, Psychology, University of Cincinnati, Cincinnati, OH 

66 The gap in marijuana prevalence between Black and White adolescents has disappeared since 

2011: The role of perceived risk of marijuana use 

R. Miech 1 , P. O’Malley 1 , L. A. Johnston 1 , J. Wallace 4 , 1 University of Michigan, Ann 

Arbor, MI, 4 University of Pittsburgh, Pittsburgh, PA 

67 US trends in past-year marijuana use and perceived risk of regular use, 2002-2013, by race/ 

ethnicity 

D. Shmulewitz, Q. Brown, R. Rahim-Juwel, S. S. Martins, M. M. Wall, P. M. Mauro, 

H. Carliner, A. L. Sarvet, D. Hasin, Columbia University, New York, NY 

68 The interactive effects of race, community support, and neighborhood environment in predicting 

adolescent marijuana use trajectories 

A. Rowe 3 , C. M. Risco 3 , J. W. Felton 2 , C. W. Lejuez 3 , L. MacPherson 3 , 2 University of 

Maryland, College Park, MD, 3 Psychology, University of Maryland, College Park, MD 

69 Racial discrimination and risk taking propensity among African American young adults 

C. M. Risco 2 , D. Iwamoto 1 , A. Rowe 1 , F. Fonseca 1 , M. Benner 1 , T. Mbonu 1 , I. Espinoza 1 , 

C. W. Lejuez 2 , 1 University of Maryland, College Park, MD, 2 Psychology, University of 

Maryland, College Park, College Park, MD 

70 Interpersonal predictors of short-term treatment outcomes among African-American women 

in MMT 

J. J. Lister 1 , S. Xuan 1 , M. Greenwald 2 , D. M. Ledgerwood 2 , 1 Social Work, Wayne State 

University, Detroit, MI, 2 Psychiatry, Wayne State University, Detroit, MI 

71 Does perceived racial discrimination and degree of ethnic identity predict changes in substance 

use over time? An examination of Black emerging adults 

A. Saint-Fleur, D. M. Anglin, City College of New York, Hempstead, NY 

EPIDEMIOLOGY 

72 Perceived harmfulness of marijuana and risk for adolescent use: Individual and collective 

beliefs 

A. L. Sarvet 1 , M. Wall 1 , K. Keyes 1 , M. Cerda 2 , J. Schulenberg 3 , D. Hasin 1 , 1 Columbia 

University, New York, NY, 2 University of California, Davis, CA, 3 University of Michigan, 

Ann Arbor, MI 

18


73 Age differences in adult past-year marijuana use and risk perceptions in the U.S., 2002-2013 

P. M. Mauro, D. Shmulewitz, D. Hasin, A. L. Sarvet, R. Rahim-Juwel, Q. Brown, H. Carliner, 

M. Wall, S. S. Martins, Columbia University, New York, NY 

74 Male-female differences in cannabis use onset among U.S. adolescents and young adults in the 

21 st century 

C. Lopez-Quintero 1 , J. C. Anthony 2 , 1 Epidemiology and Biostatistics, Michigan State 

University, East Lansing, MI, 2 Michigan State University, East Lansing, MI 

75 Toward a patient registry for cannabis use: An exploratory study 

K. Hoffman 2,3 , J. Ponce-Terashima 3 , D. McCarty 1 , J. Muench 4 , 1 CB 669 PHPM, Oregon 

Health & Science University, Portland, OR, 2 School of Public Health, Oregon Health & 

Science University, Portland, OR, 3 INCAAS, Lima, Peru, 4 Family Medicine, Oregon Health & 

Science University, Portland, OR 

76 Characterizing therapeutic users of cannabis in Ontario, Canada 

B. Brands 1,2,4 , H. Hamilton 2,3 , A. Ialomiteanu 2 , R. Mann 2,3 , 1 Health Canada, Toronto, ON, 

Canada, 2 Centre for Addiction and Mental Health, Toronto, ON, Canada, 3 DLSPH, University 

of Toronto, Toronto, ON, Canada, 4 Pharmacology, University of Toronto, Toronto, ON, 

Canada 

77 Is cannabis use associated with an increased risk of onset and persistence of alcohol use 

disorders? A three-year prospective study among adults in the United States 

A. H. Weinberger 2 , J. Platt 3 , R. Goodwin 1,3 , 1 Queens College, City University of New York, 

Flushing, NY, 2 Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, 

3 

Department of Epidemiology, Columbia University, New York, NY 

78 Using MyChart® to assess patient attitudes toward cannabis use 

D. McCarty 1 , R. Leed 1 , M. Payment 1 , L. Kunkel 1 , T. Korthuis 5 , T. Burdick 3 , 1 School of Public 

Health, Oregon Health & Science University, Portland, OR, 3 Family Medicine, OHSU, 

Portland, OR, 5 Internal Medicine, OHSU, Portland, OR 

79 Monetary payment for research participation: What do marijuana users think? 

K. Vaddiparti, C. W. Striley, E. Kwiatkowski, L. Cottler, Epidemiology, University of Florida, 

Gainesville, FL 

80 Cannabis use data collected via social media: A methodological comparison 

J. Borodovsky, D. C. Lee, B. S. Crosier, A. J. Budney, Geisel School of Medicine at 

Dartmouth, Lebanon, NH 

81 Physical activity and marijuana use among United States adults: Results from the national 

health and nutrition examination surveys 2007-2012 

D. C. Vidot 1 , W. Hlaing 1 , G. Prado 1 , A. Acheampong 2 , S. Messiah 1 , 1 University of Miami, 

Miami, FL, 2 University of Florida, Gainesville, FL 

82 Hypertension medication use among past 30-day marijuana users in a community sample from 

Northeast Florida 

H. R. Crooke, L. Cottler, E. Kwiatkowski, C. W. Striley, Epidemiology, University of Florida, 


83 DSM-5 cannabis use disorders in the United States, 2012-2013 

D. S. Hasin 1,2 , B. F. Grant 3 , 1 Columbia University, New York, NY, 2 New York State 

Psychiatric Institute, New York, NY, 3 National Institute on Alcohol Abuse and Alcoholism, 

Rockville, MD 

19


84 Marijuana use problems predict post-college employment outcomes 

K. M. Caldeira 1 , K. E. O’Grady 2 , B. A. Bugbee 1 , K. B. Vincent 1 , A. M. Arria 1 , 1 School 

of Public Health, University of Maryland, College Park, MD, 2 Psychology, University of 

Maryland, College Park, MD 

85 Is risk of cannabis dependence lower for ‘cannabis only’ users? 

K. Alcover, C. Lopez-Quintero, J. C. Anthony, Epidemiology & Biostatistics, Michigan State 

University, East Lansing, MI 

86 Elevated cotinine levels in recently active cannabis users absent recent cigarette or other 

tobacco exposure: Unmeasured blunt or environmental sources? 

B. J. Fairman 1 , O. Alshaarawy 2 , 1 Mental Health, Johns Hopkins Bloomberg School of Public 

Health, Baltimore, MD, 2 Epidemiology and Biostatistics, Michigan State University, East 

Lansing, MI 

87 Perceived nicotine content and its association with perceived disease risks of Spectrum research 

cigarettes 

L. Pacek 3 , F. J. McClernon 3 , R. Denlinger 1 , M. Mercincavage 5 , A. Strasser 5 , R. Vandrey 4 , 

N. Nardone 8 , D. Hatsukami 7 , E. Donny 6 , 1 Brown University, Providence, RI, 3 Psychiatry 

and Behavioral Sciences, Duke University Medical Center, Durham, NC, 4 Johns Hopkins 

University, Baltimore, MD, 5 Psychiatry, University of Pennsylvania Perelman School 

of Medicine, Philadelphia, PA, 6 Psychology, University of Pittsburgh, Pittsburgh, PA, 

7 

University of Minnesota Medical School, Minneapolis, MN, 8 University of California San 

Francisco, San Francisco, CA 

88 Has nicotine dependence increased among smokers in the United States? A new test of the 

hardening hypothesis 

R. Goodwin 1,2 , M. Wall 3 , S. Galea 5 , M. J. Zvolensky 4 , M. Gbedemah 1 , M. Hu 6 , D. S. Hasin 2 , 

1 

Psychology, City University of New York, Queens, NY, 2 Epidemiology, Columbia 

University, New York, NY, 3 Biostatistics, Columbia University, New York, NY, 4 Psychology, 

University of Houston, Houston, TX, 5 Epidemiology, Boston University, Boston, MA, 

6 

Sociomedical Sciences, Columbia University, New York, NY 

89 Some context for understanding the place of the GED in the relationship between educational 

attainment and smoking prevalence 

A. N. Kurti 2,1 , E. Klemperer 1,2,3 , I. A. Zvorsky 1,2,3 , R. Redner 1,2 , J. Priest 5,2 , S. Higgins 1,2,3 , 

1 

Vermont Center on Behavior and Health, Burlington, VT, 2 Psychiatry, University 

of Vermont, South Burlington, VT, 3 Psychological Science, University of Vermont, 

Burlington, VT, 5 Biostatistics, University of Vermont, Burlington, VT 

90 Energy drink use trajectories predict substance use outcomes 

A. M. Arria 1 , K. M. Caldeira 1 , B. A. Bugbee 1 , K. B. Vincent 1 , K. E. O’Grady 2 , 1 School 

of Public Health, University of Maryland, College Park, MD, 2 Psychology, University of 

Maryland, College Park, MD 

91 The transition to recovery: Key predictors and how they relate to aging 

M. L. Dennis 1 , C. K. Scott 1 , J. G. Csernansky 2 , H. C. Breiter 2 , 1 Lighthouse Inst., Chestnut 

Health Systems, Normal & Chicago, IL, 2 Department of Psychology and Behavioral Science, 

Northwestern University School of Medicine, Chicago, IL 

92 Life chaos among drug users and non-drug users 

S. O. Lasopa, K. Vaddiparti, C. W. Striley, L. Cottler, Epidemiology, University of Florida, 


20


93 Executive functioning and DSM-5 criteria for substance use disorder among addicted inpatients 

D. R. Lima, P. D. Goncalves, M. Ometto, A. Malbergier, R. Amaral, S. Nicastri, A. Andrade, 

P. J. Cunha, Interdisciplinary Group of Studies on Alcohol and Drugs, Institute of Psychiatry, 

São Paulo, Brazil 

POLICY 

94 Does perceived availability of marijuana explain changes in marijuana use after medical 

marijuana law implementation among U.S. adults? 

C. Mauro 1 , J. Santaella 2 , J. H. Kim 2 , M. M. Wall 1 , S. S. Martins 2 , 1 Biostatistics, Columbia 

University, NY, NY, 2 Epidemiology, Columbia University, NY, NY 

95 Medical marijuana dispensaries in Los Angeles: Access and service among young adults 

A. Kioumarsi, M. Reed, S. Lankenau, Drexel University, Philadelphia, PA 

96 Attitudes and practices of cannabis dispensary staff 

N. A. Haug 1 , D. Kieschnick 1 , J. E. Sottile 1 , R. Vandrey 2 , K. Babson 3 , M. O. Bonn-Miller 3 , 

1 

Palo Alto University, Palo Alto, CA, 2 Johns Hopkins University, Baltimore, MD, 3 VA Palo 

Alto Health Care System, Menlo Park, CA 

97 Nonmedical use of prescription opioids and medical marijuana laws in the U.S. from 2004-2013 

J. H. Kim, J. Santaella, P. M. Mauro, J. A. Cisewski, C. Mauro, M. M. Wall, S. S. Martins, 

Columbia University, New York, NY 

98 Smoking cessation assistance pre- and post-implementation of stage 1 meaningful use 

S. R. Bailey 2 , M. J. Hoopes 3 , J. Puro 3 , J. E. DeVoe 2,3 , T. Burdick 4 , D. J. Cohen 4 , J. Heintzman 2 , 

M. Marino 4 , J. Irvine 3 , D. McCarty 1 , S. P. Fortmann 5 , 1 CB 669 PHPM, Oregon Health 

& Science Univ, Portland, OR, 2 Family Medicine, Oregon Health & Science University, 

Portland, OR, 3 Research, OCHIN, Portland, OR, 4 Family Medicine, OHSU, Portland, OR, 

5 

Center for Health Research, Kaiser Permanente Northwest, Portland, OR 

99 Impact of recovery interventions on opioid users. A simulation study 

G. Bobashev 1 , B. Eggleston 1 , R. J. Morris 1 , C. Barbosa 1 , W. Dowd 1 , M. L. Dennis 2 , 

C. K. Scott 2 , 1 RTI International, Durham, NC, 2 Chestnut, Chicago, IL 

100 Benzodiazepine dependence among young adults in the club scene: Data from a second cohort 

S. P. Kurtz 1 , M. E. Buttram 1 , M. Pagano 3 , 1 ARSH: Center for Research on Substance Use and 

Health Disparities, Nova Southeastern University, Miami, FL, 3 Department of Psychiatry, 

Division of Child Psychiatry, Case Western Reserve University, Cleveland, OH 

101 Potential opioid misuse in the social security healthcare system of Peru 

J. Ponce Terashima 1 , K. Hoffman 1 , F. Fiestas 3 , V. Dongo 3 , D. McCarty 2 , 1 International Center 

for Advanced Research and Applied Science, Lima, Peru, 2 Oregon Health & Science Univ, 

Portland, OR, 3 EsSalud, Lima, Peru 

102 Impact of the opioid safety initiative on opioid prescribing practices in the Veterans Healthcare 

Administration 

L. A. Lin 1 , A. S. Bohnert 1,2 , M. llgen 1,2 , 1 Department of Psychiatry, University of Michigan, 

Ann Arbor, MI, 2 Department of Veterans Affairs Healthcare System, Serious Mental Illness 

Treatment Resource and Evaluation Center, Ann Arbor, MI 

103 Naloxone access laws and implementation of overdose prevention programs at Veteran 

Affairs hospitals 

M. E. Niculete 2,1 , A. Peckham 3 , D. Boggs 3,1 , H. Steinberg 2,1 , 1 Psychiatry, Yale University, 

New Haven, CT, 2 Psychology, VA Connecticut Healthcare System, West Haven, CT, 

3 

Pharmacy, VA Connecticut Healthcare System, West Haven, CT 

21


104 State-level opioid antagonist access laws: The emergence of three distinct strategies, 2001–2015 

S. Burris 1 , S. K. Johnson 3 , J. Ibrahim 2 , E. Platt 3 , L. Allen 3 , 1 Temple University Beasley School 

of Law, Philadelphia, PA, 2 College of Public Health, Temple University, Philadelphia, PA, 

3 

Legal Science, LLC, Philadelphia, PA 

105 Naloxone uptake and use among people who inject drugs in the Seattle area, 2009-2015 

S. N. Glick 1 , J. Tsui 1 , M. Hanrahan 2 , C. J. Banta-Green 1 , H. Thiede 2 , 1 University of 

Washington, Seattle, WA, 2 Public Health-Seattle & King County, Seattle, WA 

106 Change in abuse diagnoses in patients prescribed oxycontin after its reformulation with abusedeterrent 

properties 

A. Kadakia 2 , P. Coplan 1 , R. Singh 2 , A. DeVeaugh-Geiss 1 , 1 Risk Management and 

Epidemiology, Purdue Pharma, Stamford, CT, 2 Purdue, Stamford, CT 

107 Diversion of controlled substances at the pharmacy level: Findings from RxPATROL since 

introduction of opioids with abuse-deterrent properties 

J. G. Erensen, J. D. Haddox, L. N. Bauza, Purdue Pharma L.P., Stamford, CT 

108 Drug users’ advice on enrollment and retention in health research 

A. Zulich, A. Elliott, C. W. Striley, L. Cottler, Epidemiology, University of Florida, 


109 Drug users and non-drug users both favor uncommon informed consent practices 

A. Elliott, A. Zulich, L. Cottler, C. W. Striley, Epidemiology, University of Florida, 


110 Increased drug use and the timing of social assistance receipt among people who use illicit 

drugs 

L. Wang, E. Krebs, M. Olding, K. DeBeck, K. Hayashi, M. Milloy, L. Richardson, B. Nosyk, 

BC Centre for Excellence in HIV/AIDS, Vancouver, BC, Canada 

111 Meta-analysis as a form of evidence: An examination of the Cochrane reviews for behavioral 

health 

S. Magura, M. J. Lee, S. Means, Western Michigan University, Kalamazoo, MI 

112 A summary of addiction services in a Canadian city: Preliminary results from an Internet-based 

scoping study 

E. Knight, St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship, BC Centre for 

Excellence in HIV/AIDS, Vancouver, BC, Canada 

113 Using residential in-patient detoxification units to facilitate effectiveness of therapeutic 

community rehabilitation: A comparative follow-up pilot study 

S. Rabinovitz, School of Criminology, University of Haifa, Haifa, Israel 

22





Marian W. Fischman Monday, 

Memorial Award Lecture 

Presentation of the Marian W. Fishman Award to Marilyn Huestis 

6/8 

2:15 - 3:15 PM 

Introduction by Jack Henningfield 

Lecture: The Great US Cannabis Experiment: Research & Education 

to Enable Informed Public Decisions 

Marilyn Huestis 

Symposium V Monday, 

INTRACELLULAR SIGNALING MOLECULES AS 

TARGETS FOR STIMULANT ABUSE TREATMENT 

10/14 

3:30 - 5:30 PM 

Chairs: Margaret Gnegy and John Traynor 

3:30 A tonic-phasic model explains the effect of deltaFosB on addiction-related behaviors 

Thomas Green, University of Texas Medical Branch, Galveston, TX 

3:55 RGS2 signaling and implication for drug addiction 

Rong Chen, Wake Forest School of Medicine, Winston Salem, SC 

4:20 Trace amine-associated receptor 1 as a target for stimulant abuse treatment 

Jun-Xu Li, University at Buffalo, New York, NY 

4:40 PKCbeta as a target for amphetamine abuse 

Margaret Gnegy, University of Michigan School of Medicine, Ann Arbor, MI 

5:10 DISCUSSANT: 

John Traynor, University of Michigan Medical School, Ann Arbor, MI 

Symposium VI Monday, 

IS TWO BETTER THAN ONE? NEW INSIGHTS ON 

POLYSUBSTANCE USE FROM EPIDEMIOLOGICAL, 

CLINICAL, AND BASIC RESEARCH 

6/8 

3:30 - 5:30 PM 

Chairs: Heather Kimmel and Paul W. Czoty 

3:30 Epidemiology of polysubstance use in the United States: Findings from national cross-sectional 

and longitudinal studies 

Sean McCabe, University of Michigan, Ann Arbor, MI 

3:55 Early adolescent polysubstance use and young adult substance use disorders 

Howard Moss, University of California at Riverside School of Medicine, La Jolla, CA 

4:20 Polysubstance users versus alcohol users: Do different cognitive and neurobiological deficits 

ask for different treatment? 

Dieter Meyerhoff, School of Medicine UCSF, San Francisco, CA 

4:45 The toxic effects of serial exposure to alcohol and methamphetamine 

Bryan K Yamamoto, Indiana University School of Medicine, Indianapolis, IN 

5:10 DISCUSSANT: Translational studies of polysubstance abuse: Enhancing translation 

Paul W. Czoty, Wake Forest School of Medicine, Winston-Salem, NC 

23




STUDIO 54: CLUB DRUGS 

4 

3:30 - 5:30 PM 

Chairs: Leonard Howell and Matthew W. Johnson 

3:30 Ketamine-induced changes in resting state functional connectivity in conscious nonhuman 

primates: Implications for drug abuse 

E. A. Maltbie 1 , K. Gopinath 2 , L. Howell 1 , 1 Yerkes National Primate Research Center, Emory 

University, Atlanta, GA, 2 Department of Radiology and Imaging Sciences, Emory University, 

Atlanta, GA 

3:45 Juvenile ketamine exposure alters sensitivity to reward-related stimuli in adulthood 

S. D. Iniguez 1,2 , L. M. Riggs 2 , A. R. Zavala 3 , 1 Psychology, University of Texas at El Paso, 

El Paso, TX, 2 Psychology, California State University, San Bernardino, San Bernardino, CA, 

3 

Psychology, California State University, Long Beach, Long Beach, CA 

4:00 Alterations in brain neurotransmitter levels after single and repeated inhalation of toluene 

in rats 

A. A. Elkoussi, Pharmacology, Assiut College of Medicine, Assiut, Egypt 

4:15 MDMA increases affiliative behaviors and vocalizations in nonhuman primates in a 5-HT 2A 

receptor-dependent manner 

E. G. Pitts, A. R. Minerva, E. B. Oliver, L. Howell, Yerkes National Primate Research Center, 

Emory University, Atlanta, GA 

4:30 S-Mephedrone: Preclinical investigation against behavioral effects of the synthetic cathinone 

MDPV 

H. Philogene 1 , S. Rawls 1 , A. Reitz 2 , 1 Center for Substance Abuse Research, Lewis Katz School 

of Medicine at Temple University, Philadelphia, PA, 2 Fox Chase Chemical Diversity Center, 

Doylestown, PA 

4:45 3,4-Methylenedioxy-N-ethylcathinone and its analogs differentially affect dopamine and 5-HT 

systems in rat brain 

H. M. Walters 1 , O. Dillon-Carter 1 , J. S. Partilla 1 , F. Sakloth 2 , R. A. Glennon 2 , 

C. W. Schindler 3 , M. H. Baumann 1 , 1 Designer Drug Research Unit, IRP, NIDA, NIH, 

Baltimore, MD, 2 Department of Medicinal Chemistry, VCU School of Pharmacy, 

Richmond, VA, 3 Preclinical Pharmacology Section, IRP, NIDA, NIH, Baltimore, MD 

5:00 Pharmacological mechanisms underlying cardiovascular effects of 

3,4-methylenedioxypyrovalerone 

C. W. Schindler 1 , E. Thorndike 1 , M. Suzuki 4 , K. Rice 4 , M. Baumann 5 , 1 Preclinical 

Pharmacology Section, NIH/NIDA Intramural Research, Baltimore, MD, 4 Drug Design and 

Synthesis Section, NIH/NIDA Intramural Research, Baltimore, MD, 5 Designer Drug Unit, 

NIH/NIDA Intramural Research, Baltimore, MD 

5:15 Commuting distance to Miami’s club scene and binge substance use and related problems 

among young adults 

M. E. Buttram 1 , M. Pagano 2 , S. P. Kurtz 1 , 1 Center for Applied Research on Substance Use 

and Health Disparities, Nova Southeastern University, Miami, FL, 2 Department of Psychiatry, 

Division of Child Psychiatry, Case Western Reserve University, Cleveland, OH 

24




A STREET CAR NAMED DESIRE: REWARD/ 

REINFORCEMENT 

12 

3:30 - 5:30 PM 

Chairs: Adam Leventhal and Sally L. Huskinson 

3:30 Caffeine self-administration in rats 

C. A. Bradley, E. M. Sanders, E. A. Williams, M. I. Palmatier, Psychology, East Tennessee 

State University, Johnson City, TN 

3:45 Variable availability as a determinant of cocaine choice in rhesus monkeys 

S. L. Huskinson 1 , K. Freeman 1 , N. Petry 2 , J. K. Rowlett 1,3 , 1 University of Mississippi Medical 

Center, Jackson, MS, 2 University of Connecticut School of Medicine, Farmington, CT, 

3 

Tulane National Primate Research Center, Covington, LA 

4:00 Increasing nicotine cost and decreasing nicotine dose are not equivalent manipulations: 

A behavioral economics analysis 

T. T. Smith 2 , L. E. Rupprecht 1 , A. F. Sved 1,2 , E. Donny 2 , 1 Center for Neuroscience, University 

of Pittsburgh, Pittsburgh, PA, 2 Psychology, University of Pittsburgh, Pittsburgh, PA 

4:15 Influence of cocaine cues on monetary choice in cocaine users 

J. C. Strickland 1 , C. R. Rush 1,2,3 , W. W. Stoops 1,2,3 , 1 Psychology, University of Kentucky, 

Lexington, KY, 2 Behavioral Science, University of Kentucky, Lexington, KY, 3 Psychiatry, 

University of Kentucky, Lexington, KY 

4:30 Physical activity enjoyment predicts sensitivity to the acute subjective effects of amphetamine in 

healthy volunteers 

M. Pester, M. Kirkpatrick, A. Leventhal, Preventive Medicine, University of Southern 

California, Los Angeles, CA 

4:45 Neural responses to risk and reward predict transition to problem stimulant use 

J. L. Stewart 2,3 , A. C. May 1 , M. Reske 4 , S. Tapert 1,5 , M. P. Paulus 6,1 , 1 Psychiatry, UC San 

Diego, La Jolla, CA, 2 Psychology, CUNY Graduate Center, New York, NY, 3 Psychology, 

CUNY Queens College, Flushing, NY, 4 Institute of Neuroscience and Medicine-4, Medical 

Imaging Physics, Forschungszentrum Jülich GmbH, Jülich, Germany, 5 Psychiatry Service, 

Veterans Affairs San Diego Healthcare System, San Diego, CA, 6 Laureate Institute of Brain 

Research, Tulsa, OK 

5:00 Activity based reward processing among opiate users: Validation of the behavioral incentive 

delay task 

R. P. Bell, J. Y. Yi, Y. Chen, A. Petruzzella, I. Jiang, K. A. Johnson, E. D. Reese, 

S. B. Daughters, Department of Psychology and Neuroscience, University of North Carolina at 

Chapel Hill, Chapel Hill, NC 

5:15 Differences in delay discounting between heroin and prescription opioid users 

S. L. Karakula 1 , M. L. Griffin 2 , R. Weiss 2 , K. McHugh 2 , 1 McLean Hospital, Belmont, MA, 

2 

McLean Hospital/Harvard Medical School, Belmont, MA 

25




June 13, 2016 


Pre- and Post-Doctoral Trainees Monday, 

Networking Event 

Workshop VI Monday, 

22ND ANNUAL CONTINGENCY MANAGEMENT 

WORKING GROUP 

CAPRA 

5:45 - 7:00 PM 

10/14 

7:00 - 9:00 PM 

Chairs: Diann Gaalema and Kelly E. Dunn 

Workshop VII Monday, 

INTRODUCING THE NATIONAL DRUG EARLY 

WARNING SYSTEM (NDEWS) 

4 

7:00 - 9:00 PM 

Chairs: Eric Wish and Moira O’Brien 

Building a national drug early warning system: Introducing the NDEWS model and new drug 

use trends and patterns from 12 sentinel community sites 

Erin Artigiani, University of Maryland, Center for Substance Abuse Research (CESAR), 

College Park, MD 

Emerging patterns and trends in the use of heroin, prescription opioids, and other drugs in San 

Francisco 

Phillip Coffin, San Francisco Department of Public Health, San Francisco, CA 

Screening and reporting synthetic cannabinoid use in an urban emergency department 

J Richardson, University of Maryland, African-American Studies Department, College 

Park, MD 

Analyzing drug trends on social media 

Jennifer Golbeck, University of Maryland, College of Information Studies, College Park, MD 

Discussant: NIDA’s new epidemiology 

Linda Cottler, University of Florida, Department of Epidemiology, Gainesville, FL 

Workshop VIII Monday, 

A GENDER LENS TO ADDRESSING ADOLESCENT 

SUBSTANCE USE DISORDERS AND TRAUMA 

WITH SYSTEMS LEVEL APPROACH / SASATE 

BUSINESS MEETING 

12 

7:00 - 9:00 PM 

Chairs: Michael L. Dennis and Sally Stevens 

Substance use disorders and trauma symptoms in national data from adolescents entering 

substance abuse treatment by sex and sexual identity 

Michael L Dennis, Chestnut Health Systems, Normal, IL 

The impact of a system of care approach in treating substance use disorders among 

adolescent girls 

Sally Stevens, University of Arizona – Southwest Institute for Research on Women, 

Tucson, AZ 

26



Outcomes of a trauma responsive system of care for LGBT youth 

Claudia Powell, University of Arizona – Southwest Institute for Research on Women, 

Tucson, AZ 

Empowering female adolescent drug users in Cape Town: A government response 

Felicia Browne, RTI International, Durham, NC 

Workshop IX Monday, 

MARIJUANA LAWS: THE CHANGING LEGAL LANDSCAPE 

AND ITS CONSEQUENCES 

6/8 

7:00 - 9:00 PM 

Chairs: Marsha Lopez and Andrew Freedman 

Do patterns of medical marijuana use correspond to overall health levels? 

Bridget Freisthler, Luskin School of Public Affairs, University of California, Los Angeles, CA 

Tracking emerging cannabis use trends with social media 

Raminta Daniulaityte, Boonshoft School of Medicine, Wright State University, Kettering, OH 

Adolescent marijuana-related attitudes and behaviors in the context of non-medical marijuana 

legalization in Washington State: Implications for prevention 

Walter Mason, Boys Town National Research Institute for Child and Family Studies, Boys 

Town, NE 

Public health effects of medical marijuana legalization in Colorado 

Karen F Corsi, Univ. of Colorado School of Medicine, Denver, CO 

DISCUSSANT: 

Andrew Freedman, Governor’s Office of Marijuana Coordination, Denver, CO 



27


2016 NIDA International Forum Abstracts Flores 

7:00 to 9:00 PM 

Basic Science 

100 The impact of lifestyle on mental health in the Gilgel Gibe Field Research Center, Ethiopia: 

Khat abuse as a risk factor for the development of psychotic symptoms 

K. Adorjan 1 , M. Tesfaye 2 , M. Widmann 3 , F. Tessema 4 , M. Odenwald 3 , S. Toennes 5 , S. 

Papiol 1 , E. Susser 6 , M. Soboka 2 , Z. Mekonnen 7 , M. Rietschel 8 , S. Suleman 7 , T.G. Schulze 1 . 

1 Institute of Psychiatric Phenomics and Genomics, Germany; 2 Department of Psychiatry, 

Jimma University, Ethiopia; 3 Department of Psychology, University of Konstanz, Germany; 

4 Department of Epidemiology, Jimma University, Ethiopia; 5 Toxicology, University of 

Frankfurt, Germany; 6 Department of Epidemiology, Columbia University, United States; 

7 Drug Laboratory, Jimma University, Ethiopia; 8 Department of Genetic Epidemiology in 

Psychiatry, Germany 

101 Haemodynamic responses to tobacco smoke inhalation in male adolescents in Lusaka, Zambia 

T. Chikopela 1 , F.M. Goma 2 . 1 Lusaka Apex Medical University, Zambia; 2 School of 

Medicine, The University of Zambia, Zambia 

102 Alterations in brain neurotransmitter levels after single and repeated inhalation of toluene in 

rats 

A. Elkoussi, Department of Pharmacology, College of Medicine, University of Assiut, Egypt 

103 Cognitive dysfunction and altered cerebral functional connectivity in chronic ketamine users 

C. Hung 1,2,3 , C-S.R. Li 4,5 , S. Zhang 4 , S. Hu 4 , J.R. Duann 6 , T. S-H. Lee 7 . 1 Bali Psychiatric 

Center, Ministry of Health and Welfare, Taiwan; 2 Institute of Brain Science, National Yang- 

Ming University, Taiwan; 3 Brain Connectivity Laboratory, Institute of Neuroscience, 

National Yang-Ming University, Taiwan; 4 Department of Psychiatry, Yale School of 

Medicine, United States; 5 Department of Neuroscience, Yale School of Medicine, United 

States; 6 Biomedical Engineering Research and Development Center, China Medical 

University, China; 7 Department of Health Promotion and Education, National Taiwan 

Normal University, Taiwan 

104 Attenuation of morphine withdrawal by kappa agonist nalbuphine: Involvement of adenosine 

3':5'-cyclic monophosphate system 

R. Jain 1 , R. Raghav 1 , T.S. Roy 2 , A. Dhawan 1 , P. Kumar 1 . 1 Department of Psychiatry, 

National Drug Dependence Treatment Centre, India; 2 Department of Anatomy, All India 

Institute of Medical Sciences, India 

105 The effects of recreational marijuana and ecstasy use on brain activation during visual-motor 

associative learning 

A. Kustubayeva 1,2 , B. Lewis 1 , M. Smith 1 , M. Smith 1 , J. Eliassen 1 . 1 University of Cincinnati, 

United States; 2 Kazakh National University, Kazakhstan 

106 Effects of short periods of maternal separation on social behavior and drug reward on the 

adolescent rat 

A. Magalhães 1,2 , M. Nogueira 3 , J. Bravo 1 , C.J. Alves 1 , A. Mesquita 3 , T. Summavielle 1 , L. De 

Sousa 2 . 1 Instituto de Investigação e Inovação em Saúde, Portugal; 2 Instituto de Ciências 

Biomédicas Abel Salazar, Universidade do Porto, Portugal; 3 Centro de investigação em 

Psicologia, Universidade do Minho, Portugal 

28


107 Survival meta-analysis of age at onset of cannabis use based on the International Cannabis 

Consortium sample of 24,222 individuals 

C.C. Minica 1 , K.J.H. Verweij 1 , P. van der Moost 2 , H. Mbarek 1 , International Cannabis 

Consortium, D.I. Boomsma 1 , J.M. Vink 3 , N.A. Gillespie 4 , E.M. Derks 5 . 1 Department of 

Biological Psychology, Vrije Universiteit Amsterdam, The Netherlands; 2 Department of 

Epidemiology, University of Groningen, University Medical Center, The Netherlands; 

3 Behavioural Science Institute, Radboud University, The Netherlands; 4 Department of 

Psychiatry, Virginia Institute for Psychiatric and Behavior Genetics, Virginia 

Commonwealth University, United States; 5 Department of Psychiatry, Academic Medical 

Centre, The Netherlands 

108 Reduced insula and prefrontal cortex volumes in chronic methamphetamine users with 

psychosis 

C. Qi, Y.H. Liao, Q.X. Wu, T.Q. Liu, W. Hao. Mental Health Institute, The Second Xiangya 

Hospital, Central South University, China 

109 Effect of nalbuphine on opiate withdrawal and changes in dopaminergic and serotoninergic 

expressions in rat brain 

R. Raghav 1 , R. Jain 1 , T.S. Roy 2 , A. Dhawan 1 , P. Kumar 2 . 1 National Drug Dependence 

Treatment Centre, All India Institute of Medical Sciences, India; 2 Department of Anatomy, 

All India Institute of Medical Sciences, India 

110 Abused drugs regulate dopamine release in the striatum throughout presynaptic nicotinic 

receptors 

F.R. Rizzo, M. Federici, N.B. Mercuri. IRCCS Fondazione Santa Lucia and Università Tor 

Vergata, Italy 

111 No association between crack cocaine addiction and COMT Val/Met polymorphism 

T. Roman 1,2 , A.R. Stolf 3 , J.B. Schuch 1,2 , D. Müller 1,2 , G.C. Akutagava-Martins 1,2 , C.M. 

Szobot 3,4 , F. Pechansky 3 , F.H.P. Kessler 3 . 1 Post Graduate Program in Genetics and Molecular 

Biology, Federal University of Rio Grande do Sul (UFRGS), Brazil; 2 Department of 

Genetics, UFRGS, Brazil; 3 Center for Drug and Alcohol Research, Hospital de Clínicas de 

Porto Alegre (HCPA), UFRGS, Brazil; 4 Child and Adolescent Psychiatric Service, HCPA, 

UFRGS, Brazil 

112 Accumbens volumes are reduced among crack cocaine users 

S.B. Schuch-Goi 1 , P.D. Goi 2 , R. Massuda 2 , M. Bermudez 1 , L.S. Fara 1 , F.P. Kessler 1 , L. von 

Diemen 1 , C.S. Gama 2 , F. Pechansky 1 . 1 Center for Drug and Alcohol Research, Hospital de 

Clínicas de Porto Alegre (HCPA), Universidade Federal do Rio Grande do Sul (UFRGS); 

2 Laboratory of Molecular Psychiatry, HCPA, UFRGS, Brazil 

113 Role of the dopaminergic system on crack cocaine addiction: DRD2 and DRD4 genes, 

individual and interaction effects 

A.R. Stolf, J.B. Schuch 2,3 , D. Müller 2,3 , G.C. Akutagava-Martins 2,3 , C.M. Szobot 1,4 , F. 

Pechansky, F.H.P. Kessler, T. Roman 2,3 . 1 Center for Drug and Alcohol Research, Hospital 

de Clínicas de Porto Alegre (HCPA), Federal University of Rio Grande do Sul (UFRGS), 

Brazil; 2 Post Graduate Program in Genetics and Molecular Biology, UFRGS, Brazil; 

3 Department of Genetics, UFRGS, Brazil; 4 Child and Adolescent Psychiatric Service, HCPA, 

UFRGS, Brazil 

29


114 TAAR1 modulates context-dependent Pavlovian conditioning to amphetamine 

I.M. Sukhanov 1,2 , L. Caffino 3 , E.V. Efimova 4,5 , S. Espinoza 2 , T.D. Sotnikova 2,5 , L. Cervo 6 , F. 

Fumagalli 3 , R.R. Gainetdinov 2,4,5 , .. Zvartau 1 . 1 First Pavlov State Medical University, 

Russia; 2 Department of Neuroscience and Brain Technologies, Istituto Italiano di 

Tecnologia, Italy; 3 Dipartimento di Scienze Farmacologiche e Biomolecolari, Università 

degli Studi di Milano, Italy; 4 Skolkovo Institute of Science and Technology, Russia; 

5 Institute of Translational Biomedicine, Faculty of Biology, St. Petersburg State University, 

Russia; 6 IRCCS–Istituto di Ricerche Farmacologiche Mario Negri, Experimental 

Psychopharmacology, Italy 

115 TBARS and BDNF changes in newborns exposed to crack cocaine during pregnancy—a 

comparative study 

C. Szobot 1,2,3 , L.A. Rohde 1,2,4,5 , K.M. Mendes Ceresér 2,6 , C. de Moura Gubert 6 , E. Galvão da 

Silva 6 , F. Xavier 7 , R. Porcianello 2 , L.M. Röhsig 8 , F. Pechansky 2,3,8 , V. Mardini 1 . 1 Child and 

Adolescent Psychiatry Service, Hospital de Clínicas de Porto Alegre (HCPA), Universidade 

Federal do Rio Grande do Sul (UFRGS), Brazil; 2 Graduate Program in Medicine–Psychiatry, 

UFRGS, Brazil; 3 Center for Drug and Alcohol Research, HCPA, UFRGS, Brazil; 4 Instituto 

Nacional de Psiquiatria do Desenvolvimento, Brazil; 5 Department of Psychiatry, UFRGS, 

Brazil; 6 Laboratory of Molecular Psychiatry and Instituto Nacional de Ciência e Tecnologia 

Translacional em Medicina, HCPA, UFRGS, Brazil; 7 Undergraduate Program in Bimedical 

Sciences, Centro Universitário Metodista–IPA, Brazil; 8 Cord Blood Bank and Cryobiology 

Unit, HCPA, UFRGS, Brazil 

116 Case control association β-arrestin 2 gene (ARRB2) with opioid and cocaine dependence 

M. Vaswani 1,2 , L. Ambrose 1 , T. Clarke 1 , W. Berrettini 1 . 1 University of Pennsylvania, United 

States; 2 All India Institute of Medical Sciences, India 

117 Evaluation of oxidative stress markers among adolescent inhalant users seeking treatment at a 

tertiary care center in North India 

A. Verma 1 , R. Jain 1 , A. Dhawan 1 , R. Lakshmy 2 . 1 National Drug Dependence Treatment 

Centre, All India Institute of Medical Sciences, India; 2 Department of Cardiac Biochemistry, 

All India Institute of Medical Sciences, India 

118 Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)- 

naloxone as toll-like receptor 4 antagonists 

X. Wang. Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, China 

Epidemiology 

200 Nonproblematic and problematic Internet use among undergraduate students of medical 

colleges in Zagazig, Egypt 

M. Abdelghani 1,2 , G.S. El-Deen 1 . 1 Department of Psychiatry, Zagazig University, Egypt; 

2 Hubert H. Humphrey Fellowship Program, Virginia Commonwealth University, United 

States 

201 Cannabis use among road transport workers: The roles of life orientation and resilience 

G.E. Abikoye 1,2 , E.B. Edet 1 . 1 Department of Psychology, University of Uyo, Nigeria; 2 Center 

for Research and Information on Substance Abuse, Nigeria 

202 Reasons for the change in drug use patterns toward psychoactive drugs in Gaza Strip and the 

level of satisfaction 

M. AlAfifi 1 , M. Sakka 2 , R. Afifi 1 . 1 Substance Abuse Research Center, Palestine; 2 Al-Azhar 

University, Palestine 

30


203 Perceived community-level violence and prevalence of sexually transmitted infections among 

Mexican female sex workers who inject drugs 

N.A. Alamillo 1 , S.M. Kiene 2 , G. Rangel 3 , G. Martinez 4 , A. Vera 5 , S. Manian 6 , S.A. 

Strathdee 5 . 1 Joint Doctoral Program in Public Health, San Diego State University/University 

of California, San Diego, United States; 2 Division of Epidemiology and Biostatistics, 

Graduate School of Public Health, San Diego State University, United States; 3 El Colegio de 

la Frontera del Norte, Mexico; 4 Community Health and Development of Ciudad Juarez and 

the Mexican Federation of Private Associations, Mexico; 5 Division of Global Health, 

University of California, San Diego (UCSD), United States; 6 Department of Economics, 

UCSD, United States 

204 Introducing a new research method for evaluating alcohol and other drug use among fatally 

injured victims in Latin America 

G. Andreuccetti 1,2 , V. Leyton 1 , I.D. Miziara 1,3 , N.P. Lemos 4 , D.R. Munoz 1 , C.J. Cherpitel 2 , 

H.B. Carvalho 1 . 1 University of São Paulo Medical School, Brazil; 2 Alcohol Research Group, 

United States; 3 Technical-Scientific Police Superintendency of the State of São Paulo, Brazil; 

4 Office of Chief Medical Examiner-San Francisco, United States 

205 Examining the impact of the government’s attempt to regulate the novel psychoactive substance 

market 

M. Beltgens. Department of Criminology, University of Leicester, United Kingdom 

206 Understanding the increase in prescription opioids in Peru: Protocol for an exploration of 

practitioner knowledge 

J. Beltran 1 , K. Hoffman 2,3 , J. Ponce-Terashima 2,4 , F. Fiestas 5 , D. McCarty 3 , V. Dongo 5 . 


States; 2 International Center for Advanced Research and Applied Science, Peru; 3 Oregon 

Health & Science University, United States; 4 George Washington University, United States; 

5 Peruvian Social Security System, Peru 

207 Composition of party drugs in Belgium: Not what you might expect 

P. Blanckaert 1 , K. Maudens 2 , E. Deconinck 3 , P. Calle 4 . 1 Belgian Early Warning System 

Drugs, Scientific Institute of Public Health, Belgium; 2 Toxicological Centre, University of 

Antwerp, Belgium; 3 Section of Medicines, Scientific Institute of Public Health, Belgium; 

4 Department of Internal Medicine, Ghent University, Belgium 

208 Challenges and limitations in the implementation of research findings: The case of the “largest 

open drug scene” in Israel 

H. Bonny-Noach 1,2,3 , S. Toys 1 . 1 Department of Criminology, Ariel University and Beit Berl 

College, Israel; 2 Prevention and Education Divison, Israel Anti-Drug Authority, Israel; 

3 Israeli Society of Addiction Medicine, Israel 

209 Incarceration patterns and risk of HIV infection among people who inject drugs in Tijuana, 

Mexico 

A. Borquez 1 , D. Abramovitz 1 , G. Rangel 2 , L. Beletsky 1 , N. Martin 1 , S. Strathdee 1 . 1 Division 

of Global Public Health, University of California, San Diego, United States; 2 Comisión de 

Salud Fronteriza, Mexican Ministry of Health, Mexico 

210 The prevalence of adult attention deficit/hyperactivity disorder among treatment-seeking 

problem gamblers 

L. Brandt 1 , G. Fischer 1,2 . 1 Center for Public Health, Medical University of Vienna, Austria; 

2 Department of Psychiatry and Psychotherapy, Medical University of Vienna, Austria 

31


211 Drug consumption, knowledge of the consequences of consumption, and the relationship with 

academic performance among undergraduate students in St. Joseph, Trinidad 

N. Brathwaite. Department of Research and Graduate Studies, University of the Southern 

Caribbean, Trinidad and Tobago 

212 Development and validation of a scale for amotivational syndrome in chronic cannabis users 

G.A. Castaño Pérez 1 , E. Becoña Iglesias 2 , S.M. Restrepo Escobar 3 , O.S. Diaz-Granados 4 , 

L.A. Rojas-Bernal 1 . 1 Mental Health Research Group, CES University, Colombia; 2 University 

of Santiago de Compostela, Spain; 3 FUNLAM University, Colombia; 4 Drug Abuse Project, 

the Ministry of Health and Social Protection, Colombia 

213 HIV, overdose mortality, and the impact of antiretroviral therapy 

A. Caudarella 1 , K. Hayashi 1 , H. Dong 1 , M.J. Milloy 1,2 , T. Kerr 1,2 , E. Wood 1,2 . 1 British 

Columbia Centre for Excellence in HIV/AIDS, St. Paul’s Hospital, Canada; 2 Department of 

Medicine, University of British Columbia, Canada 

214 Gender and the role of alcohol on HIV risk behavior among drug users in Costa Rica 

M. Chacón-Ortiz 1 , R. Achí 1 , M. Comerford 2 , K. Barrantes 1 , C. McCoy 2 . 1 Instituto de 

Investigaciones en Salud, Universidad de Costa Rica, Costa Rica; 2 Comprehensive Drug 

Research Center, University of Miami, United States 

215 Chronic pain not associated with occupational status among a predominantly 

dextropropoxyphene-abusing population: Cross-sectional study from Sikkim, North East India 

A. Chakrabarti 1 , D. Datta 2 , S. Pandey 2 , Y. Verma 3 , S. Dutta 4 . 1 Regional Occupational Health 

Centre-Eastern, National Institute of Occupational Health, Indian Council of Medical 

Research, India; 2 Department of Pharmacology, Sikkim Manipal Institute of Medical 

Sciences (SMIMS), India; 3 Department of Pathology, SMIMS, India; 4 Department of 

Psychiatry, SMIMS, India 

216 High prevalence of major depression among treatment-seeking ketamine-dependent patients 

L-Y. Chen 1 , X. Ke 2 , C-K. Chen 3 , M-C. Huang 1,4 . 1 Department of Psychiatry, Taipei City 

Hospital and Psychiatric Center, Taiwan; 2 Department of Psychiatry, Yale School of 

Medicine, United States; 3 Department of Psychiatry, Chang Gung Memorial Hospital, 

Taiwan; 4 Department of Psychiatry, School of Medicine, Taipei Medical University, Taiwan 

217 Substance abuse and HIV risks among the youth of urban Nepal 

M.B.P. Chhetri. Nepal Center for Disaster Management, Nepal 

218 Patients in mental health crisis admitted to hospital and use of combined drugs 

J. Da Silva 1 , E. Ferreira 2 . 1 Anna Nery School of Nursing, Federal University of Rio de 

Janeiro, Brazil; 2 Institute of Psychiatry, Federal University of Rio de Janeiro, Brazil 

219 Drug use in relation to tobacco and alcohol use in Iraqi men 

R.M. Dabbagh 1 , N.J. Al-Hemiary 2 , J.J. Al-Diwan 3 , A.L. Hasson 4 , R.R. Rawson 4 . 

1 Department of Epidemiology, Fielding School of Public Health, University of California, 

Los Angeles (UCLA), United States; 2 Unit of Psychiatry, Department of Medicine, College 

of Medicine, Baghdad University, Iraq; 3 Unit of Mental Health, Department of Community 

Medicine, College of Medicine, Baghdad University, Iraq; 4 Integrated Substance Abuse 

Programs, Semel Institute for Neuroscience and Human Behavior, UCLA, United States 

32


220 Attitudes toward people with problematic drug use in the city of Loja, Ecuador 

A. Delgado 1 , R. Mann 2 , H. Hamilton 2 , B. Brands 2,3 , F. Cumsille 4 , M. Wright 4 , A. Khenti 2 . 

1 National Council for Control of Narcotic and Psychotropic Substances, Ecuador; 2 Center for 

Addiction and Mental Health, University of Toronto, Canada; 3 Office of Research and 

Surveillance, Controlled Substance and Tobacco Directorate, Health Canada, Canada; 4 Inter- 

American Drug Abuse Control Commission, Organization of American States, United States 

221 Impact of harm reduction and medically assisted treatment on HIV incidence among people 

who inject drugs in Ukraine: Results of a prospective cohort study 

K. Dumchev 1 , M. Samko 2 , J. Barska 2 . 1 Ukrainian Institute on Public Health Policy, Ukraine; 

2 Alliance for Public Health, Ukraine 

222 Is khat use disorder a valid diagnostic entity? 

S. Duresso, A. Matthews, S. Ferguson, R. Bruno. School of Medicine, University of 

Tasmania, Australia 

223 A national survey of U.S. primary care physicians’ knowledge and practices regarding e- 

cigarettes 

O. El-Shahawy 1 , J.E. Lafata 2 , S. Sherman 1 . 1 Section on Tobacco, Alcohol, and Drug Use, 

Department of Population Health, School of Medicine, New York University, United States; 

2 Department of Health Behavior and Policy, School of Medicine, Virginia Commonwealth 

University, United States 

224 Family-related factors and concurrent heroin use in methadone maintenance treatment: Report 

from China 

N. Feng 1 , C. Lin 1 , K. Rou 2 , L. Li 1 . 1 Semel Institute for Neuroscience and Human Behavior, 

University of California, Los Angeles, United States; 2 National Center for AIDS/STD 

Control and Prevention, Chinese Center for Disease Control and Prevention, China 

225 Patterns of prescription drug use and misuse in Spain: The European Opioid Treatment Patient 

Survey 

F. Fonseca 1,2,3 , M. Torrens 1,2,3 , M. Farré 2,3,4 , K.E. McBride 5 , I. Maremmani 6,7 , M. Guareschi 7 , 

D. Touzeau 8 , P. Villeger 9 , A. Benyamina 10 , O. D’Agnone 11 , L. Somaini 12 , R.C. 

Dart 5,13 . 1 Institut de Neuropsiquiatria i Addiccions, Hospital del Mar, Spain; 2 Institut Hospital 

del Mar d’Investigacions Mèdiques, Spain; 3 Universitat Autònoma de Barcelona, Spain; 

4 Hospital Universitari Germans Trias i Pujol-IGTP, Spain; 5 Denver Health Rocky Mountain 

Poison and Drug Center, United States; 6 Department of Neurosciences, Santa Chiara 

University Hospital, Italy; 7 Associazione per l’Utilizzo delle Conoscenze Neuroscientifiche a 

fini Sociali, Italy; 8 Clinique Liberté, France; 9 Laboratoire de Toxicologie, Centre Hospitalier 

Universitaire, France; 10 Centre d’Enseignement, de Recherche et de Traitement des 

Addictions, Hôpital Paul Brousse, France; 11 Crime Reduction Initiative, United Kingdom; 

12 Addiction Treatment Centre, Local Health Unit, Italy; 13 School of Medicine, University of 

Colorado-Denver, United States 

226 Khat use prevalence and causes, and its effect on mental health among Bahir-Dar University 

students, North West Ethiopia 

A.G. Gebiresilus. Addis Ababa University, Ethiopia 

33


227 Gender differences among people who inject drugs with regard to HIV transmission risk in St. 

Petersburg, Russia 

N. Gnatienko 1 , J.I. Tsui 2 , J.A. Wagman 3 , D.M. Cheng 4 , A. Raj 3 , E. Blokhina 5 , O. Toussova 5 , 

L. Forman 4 , D. Lioznov 5 , J.H. Samet 1,4 . 1 Boston Medical Center, United States; 2 University 

of Washington, United States; 3 University of California, San Diego, United States; 4 Boston 

University, United States; 5 First St. Petersburg Pavlov State Medical University, Russia 

228 WITHDRAWN An evaluation of opioid substitution treatment (OST) in prison on risk of mortlity 

in period immediately after prison: Does leaving prison on OST reduce the risk of death? 

M. Hickman 1 , G. Stillwell 2 , H. Jones 1 , J. Shaw 3 , M. Farrell 4 , J. Marsden 2 . 1 School of Social 

and Community Medicine, University of Bristol, United Kingdom; 2 National Addiction 

Centre, Institute of Psychiatry, Kings College London, United Kingdom; 3 Institute of Brain, 

Behaviour and Mental Health, University of Manchester, United Kingdom; 4 National Drug 

and Alcohol Research Centre, University of New South Wales, Australia 

229 Prevalence of marijuana use among university students in Bolivia, Colombia, Ecuador, and 

Peru 

M. Hynes 1 , M. Demarco 1 , J.C. Araneda 2 , F. Cumsille 1 . 1 Inter-American Observatory on 

Drugs, Inter-American Drug Abuse Control Commission, Organization of American States, 

United States; 2 Global SMART Programme-Latin America, United Nations Office on Drugs 

and Crime, United States 

230 Abstinence from injecting drugs associated with decline in inflammatory markers but not with 

monocyte activation markers 

S. Islam 1,2 , J. Astemborski 2 , H. Li 3 , S.X. Leng 3 , D. Piggott 2 , S.H. Mehta 2 , G.D. Kirk 2 . 

1 Department of Microbiology, Jahangirnagar University, Bangladesh; 2 Department of 

Epidemiology, School of Public Health, Johns Hopkins University, United States; 

3 Department of Medicine, School of Medicine, Johns Hopkins University, United States 

231 Psychosocial factors associated with relapse to drug addiction among women in Bangladesh 

S.M.S. Islam, M.M. Rahman. International Center for Diarrheal Disease Research, 

Bangladesh 

232 Hepatitis C virus subtype distribution and evolution characteristic among drug users, men who 

have sex with men, and the general population in Beijing 

Y. Jiao 1,2 , C. Wang 2 , S. Li 2 , L. Li 2 , J. Liu 2 , K.J. Bar 3 , H. Wei 1 , Y. Hu 2 , P. Huang 2 , Z. Zeng 2 , 

S. Jiang 2 , J. Du 4 , D. Metzger 3,5 , Y. Shao 1 , X. Zhang 2 , L. Ma* 1 . 1 State Key Laboratory for 

Infection Disease Prevention and Control, National Center for AIDS/STD Control and 

Prevention, Collaborative Innovation Center for Diagnosis and Treatment of Infectious 

Diseases, Chinese Center for Disease Control and Prevention, China; 2 Beijing Chaoyang 

District Centre for Disease Control and Prevention, China; 3 Perelman School of Medicine, 

University of Pennsylvania, United States; 4 National Institutes for Food and Drug Control, 

China; 5 The Treatment Research Center, United States 

233 Trends and patterns of emerging drugs in Mombasa and Nairobi counties, Kenya 

R. Kahuthia-Gathu 1 , R. Gakunju 2 , J. Thungu 3 , P. Okwarah 2 . 1 Kenyatta University, Kenya; 

2 Movement Against Substance Abuse in Africa, Kenya; 3 Thogoto Teachers Training 

College, Kenya 

234 Prevalence of smoking behavior in a tobacco-growing Southeastern Province in Turkey 

I. Kayi 1,2 , S. Abes 3 , G. Yakan 3 , M. Teke 3 , O.B. Akici 3 , A. Bozlak 3 , M. Kutlu 3 . 1 Hubert H. 

Humphrey Fellowship Program, Virginia Commonwealth University, United States; 2 School 

of Medicine, Koc University, Turkey; 3 Adiyaman Public Health Directorate, Turkey 

34


235 Preliminary results of the first nationwide general population survey on drugs in the Republic 

of Georgia 

I. Kirtadze 1 , D. Otiashvili 1 , M. Tabatadze 1 , G. Kamkamidze 2 , L. Sturua 3 , T. Zabransky 4 , B. 

Sopko 5,6 , M-S. Martens 7 , J.C. Anthony 8 . 1 Addiction Research Center, Alternative Georgia, 

Georgia; 2 Health Research Union, Georgia; 3 National Center of Disease Control and Public 

Health, Georgia; 4 ResAd, Czech Republic; 5 National Monitoring Centre for Drugs and Drug 

Addiction, Czech Republic; 6 Department of Medical Chemistry and Clinical Biochemistry, 

2nd Faculty of Medicine, Charles University and Motol University Hospital, Czech 

Republic; 7 Center of Interdisciplinary Addiction Research, University of Hamburg, 

Germany; 8 Michigan State University, United States 

236 The impact of enrollment in methadone maintenance therapy on initiation of heavy drinking 

among people who use heroin 

J. Klimas 1,2 , E. Wood 1,3 , P. Nguyen 1 , H. Dong 1 , M-J. Milloy 1,3 , T. Kerr 1,3 , K. Hayashi 1,3 . 

1 British Columbia Centre for Excellence in HIV/AIDS, Canada; 2 University College Dublin, 

Coombe Healthcare Centre, Ireland; 3 University of British Columbia, Canada 

237 Electronic cigarette use among youth in the Russian Federation 

G. Kong 1 , B. Idrisov 2,3 , A. Galimov 3 , R. Masagutov 3 , S. Sussman 4 . 1 Yale School of 

Medicine, United States; 2 Boston University, United States; 3 Bashkir State Medical 

University, Russia; 4 University of Southern California, United States 

238 Systematic review and meta-analysis of injecting-related injury and disease in people who inject 

drugs 

S. Larney 1 , A. Peacock 2 , B.M. Mathers 3 , L. Degenhardt 1 . 1 National Drug and Alcohol 

Research Centre, University of New South Wales (UNSW), Australia; 2 School of Medicine, 

University of Tasmania, Australia; 3 The Kirby Institute for Infection and Immunity in 

Society, UNSW, Australia 

239 The prevalence of ketamine abuse among vocational school adolescents in Taiwan 

T.S.H. Lee 1 , S-F. Tang 1 , C-C. Hung 2 . 1 Department of Health Promotion and Health 

Education, National Taiwan Normal University, Taiwan; 2 Bali Psychiatric Hospital, Taiwan 

240 Risks of other substance use among kratom users: Findings from a 2011 Thailand national 

household survey 

S. Likhitsathian 1 , A. Aramrattana 2,3,4 , S. Assanangkornchai 5 , C. Angkurawaranon 2 , 

K.Thaikla 3 , M. Srisurapanont 1 . 1 Department of Psychiatry, Chiang Mai University, Thailand; 

2 Department of Family Medicine, Chiang Mai University, Thailand; 3 Research Institute for 

Health Sciences, Chiang Mai University, Thailand; 4 Northern Substance Abuse Center, 

Chiang Mai University, Thailand; 5 Epidemiology Unit, Prince of Songkla University, 

Thailand 

241 Psychoactive substance use and sexual risk among methadone maintenance therapy clients in 

China 

S. Luo 1 , C. Lin 1 , X. Cao 2 , L. Li 1 . 1 Semel Institute for Neuroscience and Human Behavior, 


Control and Prevention, Chinese Center for Disease Control and Prevention, China 

242 The roles of depression and binge drinking in the association between crack cocaine use and 

urban violence in Brazil 

C.S. Madruga 1,2 , C.A. Miguel 1,2 , S. McPherson 3 , M.G. McDonell 3 , R. Caetano 1,2 , R. 

Laranjeira 1,2 . 1 National Institute of Alcohol and Drug Policies, Brazil; 2 Federal University of 

São Paulo, Brazil; 3 Washington State University, United States 

35


243 What works and what does not work in measures against new psychoactive substances (NPS)? 

Similarities and differences in changing NPS market brought by new regulatory approaches in 

Eastern and Central European states 

A. Malczewski 1 , A. Zile-Veisberga 2 . 1 Reitox National Focal Point, National Bureau for Drug 

Prevention, Poland; 2 Ministry of the Interior, Latvia 

244 Drug abuse among street children in Dhaka City 

J.H.B. Masud. Center for Telehealth Services, Bangladesh 

245 Risky sexual behavior formation in the context of drug abuse: A study with Iranian women 

E. Merghati-Khoei 1 , M. Jamshidimanesh 2 , S.A. Mousavi 3 , A. Keramat 2 , M.H. Emamian 4 , K. 

Dolan 5 . 1 Iranian National Center of Addiction Studies, Tehran University of Medical 

Sciences, Iran; 2 Department of Reproductive Health, Shahroud University of Medical 

Sciences, Iran; 3 Psychiatry Center for Health-Related Social and Behavioral Sciences 

Research, Shahroud University of Medical Sciences, Iran; 4 Shahroud University of Medical 

Sciences, Iran; 5 Program of International Research and Training, National Drug and Alcohol 

Research Centre, University of New South Wales, Australia 

246 Global positioning system technology to survey injecting drug users’ movements and social 

interactions 

A. Mirzazadeh 1,2 , M. Grasso 1 , K. Johnson 1 , A. Briceno 1 , S. Navadeh 2,3 , W. McFarland 1 , K. 

Page 4 . 1 Department of Epidemiology and Biostatistics, University of California, San 

Francisco, United States; 2 Regional Knowledge Hub and World Health Organization 

Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman 

University of Medical Sciences, Iran; 3 Department of Epidemiology and Biostatistics, School 

of Public Health, Tehran University of Medical Sciences, Iran; 4 Department of Internal 

Medicine; Division of Epidemiology, Biostatistics and Preventive Medicine, University of 

New Mexico Health Sciences Center, United States 

247 Ambivalent attitudes toward drug users in Guyana: A preliminary study 

P.M. Mohamed 1 , D. Renville 2 . 1 Faculties of Social Science and Health Sciences, University 

of Guyana-Turkeyen Campus, Guyana; 2 Faculty of Natural Sciences, Department of 

Mathematics, University of Guyana-Turkeyen Campus, Guyana 

248 Impact of HIV/HCV co-infection in middle-aged/older patients with substance use disorder 

R. Muga 1,2 , A. Sanvisens 1 , F. Bolao 3,4 , F. Fonseca 2,5 , P. Zuluaga 1,2 , M. Torrens 2,5 , D. 

Fuster 1,2 , J. Tor 1,2 . 1 Hospital Universitari Germans Trias i Pujol, Spain; 2 Universitat 

Autònoma de Barcelona, Spain; 3 Hospital Universitari de Bellvitge, L’Hospitalet de 

Llobregat, Spain; 4 Universitat de Barcelona, Spain; 5 Parc de Salut Mar, Spain 

249 Are energy drinks associated with increased frequency of antisocial behaviors among those 

with alcohol use disorders? 

E. Ngjelina 1 , K. Polak 1 , A. Edwards 2 , K. Kendler 2 , D. Svikis 1 . 1 Department of Psychology, 

Virginia Commonwealth University (VCU), United States; 2 Psychiatry Department, VCU, 

United States 

250 Influence of awareness of HIV status on risky behavior among people who inject drugs in 

Ukraine 

Y. Novak, I. Sazonova. International Alliance for Public Health, Ukraine 

36


251 Psychological factors and risk perception as predictors of tobacco smoking behavior among 

undergraduates of University of Calabar 

U.C. Onukogu 1 , U. Owoidoho 2 , J.B. Okegbe 1 , C.A. Anya 3 , E.E. Ekpe 1 , B. Edet 1 . 1 Federal 

Neuro Psychiatric Hospital-Calabar, Nigeria; 2 University of Calabar, Nigeria; 3 Federal 

University Guso, Nigeria 

252 High prevalence of physical and sexual abuse among socially vulnerable women crack users in 

Brazil 

F. Ornell, J.N. Scherer, S. Halpern, J. Narvaez, V.S. Roglio, F. Pechansky, F.H.P. Kessler, L. 

von Diemen. Collaborating Center on Alcohol and Drugs, Center for Drug and Alcohol 

Research, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, 

Brazil 

253 Crack cocaine users with high family/social problems show more psychiatric symptoms and 

violent behavior 

M.P. Pachado 1,2 , J.N. Scherer 1 , N. Marchi 1 , R.M.M. De Almeida 2 , F. Pechansky 1 , F.H.P. 

Kessler 1 . 1 Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre, 

Federal University of Rio Grande do Sul (UFRGS), Brazil. 2 Psychology Institute, UFRGS, 

Brazil 

254 Cocaine use in trauma patients admitted to intensive care medicine: Clinical and 

epidemiological characterization. 

A. Pascale 1 , F. Verga 2 , J. Gil 3 , A França 2 , I. Alvez 2 , E. Echavarría 2 , H. Bagnulo 2 . 1 Red 

Latinoamericana de Investigadores en Drogas Network (REDLA), Uruguay; 2 Intensive Care 

Unit, Hospital Maciel, Montevideo, Uruguay; 3 Statistics Department, Hospital de Clínicas, 

Montevideo, Uruguay 

255 Gender differences in drug dependence, anxiety, and depressive symptoms among residents of 

therapeutic communities in Peru 

M. Piazza 1,2 , D. Blitchtein-Winicki 1,2 , C. Gómez Restrepo 3 . 1 Universidad Peruana Cayetano 

Heredia, Peru; 2 National Institute of Health, Peru; 3 Pontificia Universidad Javeriana, 

Colombia 

256 Potential opioid misuse in the social security health care system of Peru, January 2014 to 

March 2015 

J. Ponce 1 , F. Fiestas 2 , V. Dongo 2 , K. Hoffman 1 , D. McCarty 3 . 1 International Center for 

Advanced Research and Applied Science, Perú; 2 Seguro Social de Salud, Perú; 3 Oregon 

Health & Science University, United States 

257 First experience of medication-assisted therapy provision by family physicians in Ukraine 

I. Pykalo 1 , O. Morozova 2 , S. Dvoryak 1 . 1 Ukrainian Institute on Public Health Policy, 

Ukraine; 2 Yale School of Public Health, United States 

258 Methamphetamine use among Iranian patients in methadone maintenance treatment: Is this a 

threat? 

S.R. Radfar 1 , U.S. Warda 2 , R. Rawson 2 . 1 Substance Abuse and Dependence Research Center, 

University of Social Welfare and Rehabilitation Sciences, Iran; 2 Integrated Substance Abuse 

Programs, University of California, Los Angeles, United States 

259 Drug use, economic vulnerability, and experiences of sexual violence among female sex 

workers in Tijuana, Mexico 

E. Reed 1 , J.G. Silverman 1 , B.S. West 1 , M. Salazar 1 , M.G.R. Gómez 2,3 , K.C. Brouwer 1 . 

1 University of California, San Diego; United States; 2 U.S.–Mexico Border Health 

Commission, Mexico; 3 El Colegio de la Frontera Norte, Mexico 

37


260 Characteristics and pharmacological treatment of patients with severe cannabis use disorder in 

Badalona, Spain 

I. Rivas 1 , A. Sanvisens 2 , M. Rodriguez 3 , D. Fuster 2 , P. Caballería 3 , R. Muga 2 . 1 Municipal 

Center for Substance Abuse Treatment, Institut Municipal De Serveis Personals, Spain; 

2 Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Spain; 

3 Management of Pharmacy, Metropolitan Areas of Health Regions Barcelona, Catalan 

Health Service, Spain 

261 Health impacts of kratom (Mitragyna speciosa Korth) use in Thailand 

D. Saingam, S. Assanangkornchai, A.F. Geater. Epidemiology Unit, Faculty of Medicine, 

Prince of Songkla University, Thailand 

262 Factors associated with hepatitis C among people who inject drugs in Ukraine 

T. Saliuk, Y. Sazonova. Alliance for Public Health, Ukraine 

263 High prevalence of driving under the influence, and legal and psychiatric problems, among 

crack cocaine drivers 

J.N. Scherer, R. Silvestrin, F. Ornell, T.R.V. Sousa, L. Von Diemen, F.H.P. Kessler, F. 

Pechansky. Center for Drug and Alcohol Research, Hospital de Clínicas de Porto Alegre, 

Federal University of Rio Grande do Sul, Brazil 

264 High prevalence of suicide risk and brain-derived neurotrophic factor serum levels in crack 

cocaine users during early abstinence 

L. Schwanck, J. Scherer, F. Ornell, R. Silvestrin, J. Narvaez, F. Kessler, F. Pechansky, L. 

Von Diemen. Center for Drug and Alcohol Research, Hospital de Clinicas de Porto Alegre, 

Federal University of Rio Grande do Sul, Brazil 

265 Correlates of needle sharing in Iranian drug-injecting dyads: The results of cross-classified 

modeling of personal networks 

A. Shahesmaeili 1,2 , A.A. Haghdoost 2 , H. Soori 3 . 1 Regional Knowledge Hub and World 

Health Organization Collaborating Centre for HIV Surveillance, Institute for Futures Studies 

in Health, Kerman University of Medical Sciences, Iran; 2 Epidemiology Department, School 

of Public Health, Shahid Beheshti University of Medical Sciences, Iran; 3 Safety Promotion 

and Injury Prevention, School of Public Health, Shahid Beheshti University of Medical 

Sciences, Iran 

266 Pattern of uterus bleeding in methamphetamine users differs from heroin users during longterm 

abstinence 

W. Shen, Y. Zhang, L. Li, W. Zhou. Ningbo Addiction Research and Treatment Center, 

China 

267 Smokeless tobacco used as traditional medicine during pregnancy contributes to habituation in 

Southeast Asia 

P.N. Singh 1 , D. Yel 2 , T. Rathavy 3 , S. Vong 3 , K. Somsamouth 4 , R. Paulino 1 , S. Tonstad 1 , J.S. 

Job 1 . 1 Center for Health Research, Loma Linda University, United States; 2 World Health 

Organization, Cambodia; 3 National Center for Maternal and Child Health, Ministry of 

Health, Cambodia; 4 Ministry of Health, Laos 

268 Predictors of hepatitis C virus/human immunodeficiency virus/sexually transmitted diseases 

among drug users in Rio de Janeiro, Brazil 

P. Telles-Dias. Nucleus of Study and Research on Drug Use, State University of Rio de 

Janeiro, Brazil; Epidemiology Department, Federal Fluminense University, Brazil 

38


269 Relationship of determinants for risk behavior and the use of new psychoactive substances 

A. Vreeker 1 , B.G. van der Burg 1 , M. van Laar 1 , T.M. Brunt 1,2 . 1 Netherlands Institute of 

Mental Health and Addiction (Trimbos Institute), Drug Information and Monitoring System, 

Department of Drug Monitoring, The Netherlands; 2 Department of Psychiatry, Academic 

Medical Centre, University of Amsterdam, The Netherlands 

270 Characteristics of community heroin users in Taiwan: A social network approach 

S-C. Wang 1,2 , N.Y. Wang 1 , T-T. Ting 3 . 1 Center for Neuropsychiatric Research, National 

Health Research Institutes, Taiwan; 2 Department of Psychiatry, Far Eastern Memorial 

Hospital, Taiwan; 3 Institute of Sociology, Academia Sinica, Taiwan 

271 Delay discounting among smokers, e-cigarette users, and nondependent controls 

S. Weidberg, A. González-Roz, V. Martínez-Loredo, C. López-Núñez, I. Pericot-Valverde, 

R. Secades-Villa. Department of Psychology, University of Oviedo, Spain 

272 Effects of synthetic cannabinoids on executive function in regular users in Israel and Hungary 

A. Weinstein 1 , K. Cohen 1,2 , P. Rosca 3 , Z. Demetrovics 2 . 1 Department of Behavioral Science, 

Ariel University, Israel; 2 Institute of Psychology, Eötvös Loránd University, Hungary; 

3 Department for the Treatment of Substance Abuse, Ministry of Health, Israel 

273 Systematic literature review on synthetic cathinone (“bath salts”) use and HIV risk and 

transmission 

A.V. Williams 1 , F. Hariga 2 . 1 King’s College London, Addictions Department, Institute of 

Psychiatry, Psychology and Neuroscience, United Kingdom; 2 United Nations Office on 

Drugs and Crime, Austria 

274 What is the relationship between selected sociodemographic variables, knowledge of 

consequences, and drug consumption at a faith-based university in Jamaica? 

F. Williams. Interdisciplinary Department, Lakehead University-Orillia Campus, Canada 

275 Implementing a large multisite experimental study in Ukraine 

O. Zeziulin 1 , K. Dumchev 1 , O. Denisyuk 2 , S. Dvoriak 1 , T. Kiryazova 1 , Y. Sereda 1 , P. 

Smyrnov 2 . 1 Ukrainian Institute on Public Health Policy, Ukraine; 2 Alliance for Public 

Health, Ukraine 

276 Gender differences and correlated factors of heroin use among heroin users in China 

X. Zhou 1 , Z. Yi 1 , X. Yang 1 , Z. Wang 1 , X. Lyu 2 , J. Li 1 . 1 Department of Psychiatry, West 

China Hospital, Sichuan University, China; 2 National Surveillance Center on Drug Abuse, 

China 

Other 

300 The Khat Research Program (KRP): Progress and achievements 

M. al’Absi. University of Minnesota Medical School, United States 

301 Global developments in professional development: Engagement with free online course, 

“Management of Addiction,” by University of Adelaide 

F. Buisman-Pijlman 1 , L. Gowing 1,2 , A. Salem 1 , R. Ali 1,2 . 1 Discipline of Pharmacology, 

School of Medicine, University of Adelaide, Australia; 2 Drug and Alcohol Services South 

Australia, World Health Organization Collaborative Centre, Australia 

302 Review of the evaluation processes for the International Programme in Addiction Studies 

A. Coetzer-Liversage 1 , M. Loos 2 , L. Cathers 2 , F. Buisman-Pijlman 3 , A. Williams 4 . 1 Hubert 

H. Humphrey Fellowship, Virginia Commonwealth University, United States; 2 Virginia 

Commonwealth University, United States; 3 University of Adelaide, Australia; 4 Kings 

College London, United Kingdom 

39


303 The Hubert H. Humphrey Fellowship Program at Virginia Commonwealth University 

J.R. Koch, R.L. Balster, A. Breland, L.D. Hedges. Virginia Commonwealth University, 

United States 

304 Enhancing forensic investigations of narcotic drugs and suspected murder cases in Sierra 

Leone 

J. Lahai. Criminal Investigations Department, Sierra Leone Police Force, Sierre Leone; 

Hubert H. Humphrey Fellowship, Virginia Commonwealth University, United States 

305 The Virginia Commonwealth University Hubert H. Humphrey Fellowship in Substance Abuse 

Prevention, Treatment, and Policy: One-year follow-up 

O. Leonchuk 1 , J.R. Koch 2 , R.L. Balster 2 , A. Breland 2 . 1 North Carolina State University, 

United States; 2 Virginia Commonwealth University, United States 

306 Quarter century of drug decriminalization in the Czech Republic: Tremendous success, pathetic 

failure? 

T. Zabransky 1,2 , J. Radimecky 2,3 . 1 ResAD Institute, Czech Republic; 2 Charles University in 

Prague, First Medical Faculty, Clinic of Addictology, Czech Republic; 3 White Light Non- 

Governmental Organization, Czech Republic 

Prevention 

400 Impact of “class smoke-free” pledge on nicotine dependence in male adolescents: A cluster 

randomized controlled trial 

N.A. Al-sheyab 1 , M.A. Alomari 1 , S. Shah 2 , R. Gallagher 2 . 1 Jordan University of Science and 

Technology, Jordan; 2 The University of Sydney, Australia 

401 Knowledge of smoking in university to prevent students’ tobacco consumption 

F. Bautista-Pérez. Universidad Evangélica de El Salvador, El Salvador 

402 Hepatitis C and HIV in injecting drug users in Armenia, Colombia 

D. Berbesi-Fernández, Á. Segura-Cardona, L. Montoya-Vélez, G. Castaño. CES University, 

Colombia 

403 Influence of cannabis perceptions on consumption behaviors among users in Togo 

M. Bohm 1,2 , N. Djassoa 3 , K. Gbati 3 , K. Dassa 4 . 1 Comité National Anti-Drogue, Togo; 


States; 3 Institut National des Sciences de l’Education, Filière de Psychologie Appliquée, 

Université de Lomé, Togo; 4 Université de Lomé, Togo 

404 The specific needs of female heroin users in Taiwan: Using quantitative and qualitative 

approaches 

Y-L. Chien 1,2 , W-L. Huang 1,3 , S-T. Lee 3 . 1 Department of Psychiatry, National Taiwan 

University Hospital, Taiwan; 2 Department of Psychiatry, University of California, San 

Francisco, United States; 3 Department of Psychiatry, National Taiwan University Hospital 

Yunlin Branch, Taiwan 

405 Outreach case management and community support for improved treatment uptake in HIVpositive 

people who are injectable drug users in Ukraine 

O. Denisiuk, P. Smyrnov, A.Tyshkevych. ICF Alliance for Public Health, Ukraine 

406 Substance use and sexual risk for HIV among women in Russia 

D. Diakonova-Curtis 1 , A. Shaboltas 1 , T. Balachova 2 . 1 Department of Psychology, St. 

Petersburg State University, Russia; 2 Department of Pediatrics, University of Oklahoma 

Health Sciences Center, United States 

40


407 A novel family-based motivational interviewing approach in reducing/eliminating drug abuse: 

A focus on individuals from Mexican descent 

A. Diallo. University of Texas-Rio Grande Valley, United States 

408 Egyptian Humphrey Fellows’ initiative to train dentistry students on screening, brief 

intervention, and referral to treatment model 

W. Hassan 1,2 , A.H. Elrasheed 1,2 , M. Elhamshary 2,3 . 1 Institute of Psychiatry, Ain Shams 

University, Egypt; 2 Hubert H. Humphrey Fellowship Program, Virginia Commonwealth 

University, United States; 3 Psychological Medicine Hospital, Egypt 

409 Food insecurity and HIV progression among Russians with heavy alcohol consumption 

B. Idrisov 1,2 , K. Lunze 2 , D.M. Cheng 2 , E. Blokhina 3 , N. Gnatienko 2 , G. Patts 2 , C. Bridden 2 , 

C.E. Chaisson 2 , S.D. Weiser 4 , E. Krupitsky 3 , J.H. Samet 2 . 1 Bashkir State Medical University, 

Russia; 2 Boston University, United States; 3 First St. Petersburg Pavlov State Medical 

University, Russia; 4 School of Medicine, University of California, San Francisco, United 

States 

410 Feasibility of a multimedia family-based intervention for prevention of drug use among at-risk 

adolescents in Central Asia 

L. Ismayilova 1 , A. Terlikbayeva 2 , Y. Rozental 2 , E. Gaveras 1 . 1 University of Chicago, United 

States; 2 Global Health Research Center of Central Asia, Kazakhstan 

411 Immediate trauma response as a tool to prevent substance abuse among traumatized children 

L. Juríeková. Four Leaf NGO, Slovakia; Hubert H. Humphrey Fellowship Program, 

Virginia Commonwealth University, United States 

412 Social connections among women who use drugs in the aftermath of child loss to Child 

Protective Services 

K.S. Kenny 1 , C. Barrington 2 . 1 Department of Maternal and Child Health, The Gillings 

School of Global Public Health, University of North Carolina (UNC) at Chapel Hill, United 

States; 2 Department of Health Behavior, The Gillings School of Global Public Health, UNC 

at Chapel Hill, United States 

413 History of injecting drugs mediates effect of project START intervention on sex behavior of 

males released from prison in Ukraine 

T. Kiriazova 1 , Y. Sereda 2 , O. Neduzhko 1 , O. Postnov 1 , S. Dvoriak 1 . 1 Ukrainian Institute on 

Public Health Policy, Ukraine; 2 Institute for Social Research After Olexander Yaremenko, 

Ukraine 

414 HIV antiretroviral drugs for recreational substance use and implications for HIV pre-exposure 

prophylaxis in South Africa 

C. Kuo 1,2,3 , D. Operario 1,2 , J. Hoare 3 , K. Underhill 4 , D. Giovenco 1 , L. Brown 2,5 . 1 Department 

of Behavioral and Social Sciences, Center for Alcohol and Addiction Studies, School of 

Public Health, Brown University, United States; 2 Lifespan/Tufts/Brown Center for AIDS 

Research, United States; 3 Department of Psychiatry and Mental Health, University of Cape 

Town, South Africa; 4 Center for Interdisciplinary Research on AIDS, Yale University, and 

Yale Law School, United States; 5 Department of Psychiatry and Mental Health, Alpert 

Medical School, Brown University, United States 

415 Assessing commune health workers’ knowledge of methadone maintenance therapy in Vietnam 

C. Lin 1 , N.A. Tuan 2 , L. Li 1 . 1 Semel Institute for Neuroscience and Human Behavior, Center 

for Community Health, University of California, Los Angeles, United States; 2 National 

Institute of Hygiene and Epidemiology, Vietnam 

41


416 Intimate violence partner, alcohol, and drugs in Uruguay 

R. Magri. Hospital Pereira Rossell, Uruguay 

417 Playing with fire: Nonmedical pharmaceutical opioid use among young people in Sydney, 

Australia 

L. Maher, G. Dertadian. The Kirby Institute for Infection and Immunity in Society, 

University of New South Wales, Australia 

418 Translating and adapting efficacious prevention interventions in partnership with Latin 

American collaborators 

F.F. Marsiglia, S. Kulis. Arizona State University, United States 

420 Evaluation of a brief intervention based on motivational interviewing in Colombia 

J. Mejia-Trujillo. Corporacion Nuevos Rumbos, Colombia 

421 Index of HIV policy environments regarding people who inject drugs across the European 

region 

P. Meylakhs. Laboratory for Comparative Social Research, National Research University 

Higher School of Economics, Russia 

422 HPTN 074: Density-based analysis to identify spatial aggregation of eligible people who inject 

drugs in Jakarta 

M. Muslim 1,2 , H. Susami 1,3 , Z. Djoerban 1,3 , S. Djauzi 1,3 , R. Sarasvita 1,3 , D. Imran 1 , S. 

Suyitno 1 , S. Rose 4 , D. Metzger 5,6 . 1 HPTN 074 Indonesia Site, Cipto Mangunkusumo 

Hospital, Indonesia; 2 Climate Change Research Center, University of Technology-Sumbawa, 

Indonesia; 3 Abhipraya Foundation, Indonesia; 4 FHI 360 International, United States; 

5 University of Pennsylvania, United States; 6 The Treatment Research Institute, United States 

423 A geospatial approach for participant recruitment of HPTN 074 study in Jakarta, Indonesia 

M. Muslim 1 , H. Susami* 1 , Z. Djoerban 1 , S. Djauzi 1 , R. Sarasvita 1 , D. Imran 1 , T. Hadi 1 , S. 

Rose 2 , D. Metzger 3,4 . 1 HPTN 074 Indonesia Site, Cipto Mangunkusumo Hospital, Indonesia; 

2 FHI 360 International, United States; 3 University of Pennsylvania, United States; 4 The 

Treatment Research Institute, United States 

424 Alcohol marketing and early alcohol use among young people: An exploratory study in Uganda 

R. Mutaawe. Uganda Youth Development Link, Uganda; Hubert H. Humphrey Fellowship 

Program, Virginia Commonwealth University, United States 

425 Mobile society and drug use associated with transmission of HIV/AIDS among women and girls 

in Burma (Myanmar) 

R. Myint 1 , L.A. Swe 2 . 1 Myanmar Anti-Narcotics Association, Burma (Myanmar); 

2 Community-Based Self-Help Group, Burma (Myanmar) 

426 Prevalence of substance use and psychological problems among adolescents: A community 

survey 

F. Naveed. Drug Free Pakistan Foundation, Pakistan 

427 Motivations and reasons for drug use in Armenia 

S.R. Nazinyan 1 , A.A. Bazarchyan 1 , A.I. Hovhanisyan 2 , A.H. Karamyan 1 , M.R. Kostandyan 1 . 

1 National Institute of Health After S. Avdalbekyan, Ministry of Health, Armenia; 2 Ministry 

of Justice, Armenia 

428 Training of village health teams in community-based integration of prevention measures of 

substance use among youth and women in West Nile region of Uganda 

R. Nerima. WellShare International, Uganda 

42


429 Community pharmacists’ knowledge, attitudes, and confidence regarding naloxone for overdose 

reversal 

S. Nielsen 1,2 , N. Menon 1 , S. Larney 1 , M. Farrell 1 , L. Degenhardt 1 . 1 National Drug and 

Alcohol Research Centre, University of New South Wales, Australia; 2 South Eastern Sydney 

Local Health District Drug and Alcohol Services, Australia 

430 Policing, massive street drug testing, and polysubstance use chaos in Georgia: A policy case 

study 

D. Otiashvili 1 , M. Tabatadze 1,2 , N. Balanchivadze 3 , I. Kirtadze 1,2 . 1 Addiction Research 

Centre–Alternative Georgia, Georgia; 2 Business School, Ilia State University, Georgia; 

3 National Centre for Commercial Law, Free University, Georgia 

431 Personality profile of adolescents with substance use disorders 

R. Racheva. Department of Psychology, Bulgarian Academy of Sciences, Bulgaria 

432 Risk and protective factors for recreational and hard drug use among adolescents and emerging 

adults in Malaysia 

M. Razali 1 , W. Kliewer 2 . 1 Sultan Idris Education University, Malaysia; 2 Virginia 

Commonwealth University, United States 

433 Quit Using Drugs Intervention Trial: A brief intervention for risky drug use among federally 

qualified health centers in East Los Angeles 

M. Rico 1 , L. Gelberg 1 , R.M. Andersen 1 , M. Vahidi 1 , S. Baumeister 2 , B. Leake 1 . 1 Department 

of Family Medicine, University of California, Los Angeles, United States; 2 University of 

Regensburg, Germany 

434 Evaluation of CHOICE-8 effect on girls and boys, who took part in the substance abuse 

prevention program 

V. Ryabukha. Prevention Center “Choice,” Ukraine 

435 Family members affected by a relative’s substance misuse looking for social support: Who are 

they? 

H.M.T. Sakiyama 1,2 , M. de Fatima Rato Padin 1,2 , M. Canfield 3 , R. Laranjeira 1,2 , S.S. 

Mitsuhiro 1,2 . 1 National Institute of Public Policy for Alcohol and Other Drugs, Brazil; 

2 Federal University of São Paulo, Brazil; 3 University of Roehampton, United Kingdom 

436 Substance use among female sex workers in two U.S.–Mexico border cities: Associations with 

age of entry 

M. Salazar, K. Brouwer, S. Boyce, J. Silverman. Division of Global Public Health, 

University of California, San Diego, United States 

437 HIV trends among people who inject drugs in the biggest cities of Ukraine 

I. Sazonova, Y. Novak, T. Saluik. ICF Alliance for Public Health, Ukraine 

438 Motherhood, substance abuse, and HIV risk among sex workers in the U.S.–Mexico border 

region: Implications for interventions 

A.E. Servin-Aguirre 1,2 , E. Reed 2 , J.G. Silverman 2 , C. Magis-Rodriguez 3 , S. Boyce 2 , S.A. 

Strathdee 2 , K.C. Brouwer 2 . 1 School of Medicine, Universidad Xochicalco, Campus Tijuana, 

Mexico; 2 Division of Global Public Health, School of Medicine, University of California, 

San Diego, United States; 3 Centro Nacional para la Prevención y el Control del VIH/SIDA, 

Mexico 

43


439 A critical analysis of the falling age of initiation among adolescent injecting drug users and the 

programmatic response in Manipur, India 

K. Shimray 1 , P. Batsen 2 . 1 National Health Mission, India; 2 Royal Tropical Institute (KIT), 

The Netherlands 

440 Cigarette gifting between Chinese smokers and nonsmokers 

J. Tang 1,2 , Y. Liao 1,2 . 1 Mental Health Institute, the Second Xiangya Hospital of Central South 

University, China; 2 Department of Psychiatry and Biobehavioral Sciences, University of 

California, Los Angeles, United States 

Treatment 

500 Use of marijuana among former opioid substitution treatment clients in Nepal 

S.L. Acharya 1 , J. Howard 2,3 , R. Shrestha 4 , K. Lama 4 , S. Paudel 5 . 1 Master’s Program, 

Tribhuvan University, Nepal; 2 National Cannabis Prevention and Information Centre, 

University of New South Wales (UNSW), Australia; 3 National Drugs and Alcohol Research 

Centre, UNSW, Australia; 4 Saarathi Nepal Non-Governmental Organization, Nepal; 5 HIV 

and Human Rights Consultant, Nepal 

501 Improvements in general health and methamphetamine use treatment: A study of the efficacy of 

cognitive-behavioral therapy 

Z. Alam-Mehrjerdi 1 , P. Clare 2 , N. Ezard 3 , K. Dolan 1 . 1 Program of International Research and 

Training, Faculty of Public Health and Community Medicine, National Drug and Alcohol 

Research Centre (NDARC), University of New South Wales (UNSW), Australia; 2 Faculty of 

Public Health and Community Medicine, NDARC, UNSW, Australia; 3 Alcohol and Drug 

Service, St. Vincent’s Hospital, Australia 

502 The creation of a female-friendly women’s drug treatment and rehabilitation center in Pakistan 

A. Ashraf. Sunny Trust International, Addiction Treatment and Rehabilitation Center, 

Pakistan; Hubert H. Humphrey Fellowship Program, Virginia Commonwealth University, 

United States 

503 Accessibility of harm reduction services at drop-in centers in Burma (Myanmar) 

T.M. Aung, Z.N. Soe. John Snow Inc., Burma (Myanmar) 

504 Addiction medicine course for medical residents at the National Institute of Neurology and 

Neurosurgery in Mexico City 

M. Azcarraga. National Institute of Neurology and Neurosurgery, Mexico; Hubert H. 

Humphrey Fellowship Program, Virginia Commonwealth University, United States 

505 Emerging substance use patterns among children in India 

S. Bhattacharjee 1 , R. Kumar 1 , A. Agrawal 2 , K.E. O’Grady 3 , H.E. Jones 4 . 1 Society for 

Promotion of Youth and Masses, India; 2 National Drug Dependency Treatment Centre, All 

India Institute of Medical Sciences, India; 3 University of Maryland-College Park, United 

States; 4 University of North Carolina, United States 

506 Feasibility and acceptability of a Short Message Service (SMS) smoking cessation program for 

young adults in Lima: Pilot study results 

D. Blitchtein-Winicki 1 , K. Zevallos 1 , R. Samolski, D. Requena 1 , Ch. Velarde 1 , M. Ybarra 3 , 

J.C. Anthony 2 . 1 Universidad Peruana Cayetano Heredia, Peru; 2 Department of Epidemiology, 

Michigan State University, United States; 3 Center for Innovative Public Health Research, 

United States 

44


507 The role of genetic polymorphisms on patient response to opioid use disorder therapy with 

naltrexone and guanfacine 

. Blokhina 1 , . Krupitsky 1,2 , . Kibitov 3 , . Verbitskaya 1 , V. Brodyansky 3 , V. Palatkin 1 , . 

Kosten 4 , D. Nielsen 4 , E. Zvartau 1 . 1 First Pavlov State Medical University of St. Petersburg, 

Russia; 2 Bekhterev Research Psychoneurological Institute, Russia; 3 Serbsky Federal Medical 

Research Centre of Psychiatry and Narcology, Russia; 4 Baylor College of Medicine, United 

States 

508 In-house outreach: Strategies to promote and advertise a smoking cessation program in a 

Mexican university hospital 

O. Campollo 1,2 , O.P. Torres 1 . 1 Center of Alcoholism and Addictions, University of 

Guadalajara, Mexico; 2 Molecular Biology Department, Hospital Civil de Guadalajara “Fray 

Antonio Alcalde,” Mexico 

509 Effects of eye movement desensitization and reprocessing on reducing craving and anxiety: A 

randomized trial 

J. Chen 1 , L. Yang 1 , D. Yan 1,2 , S. Teng 1 , J. Cao 1,2 , Y. Zhao 1 , Z. Wang 1,2 . 1 Department of 

Epidemiology and Health Statistics, School of Public Health, Tongji Medical College, 

Huazhong University of Science and Technology, China; 2 Mental Health Center, Tongji 

Medical College, Huazhong University of Science and Technology, China 

510 Screening, brief intervention, and referral to treatment implementation in primary care centers 

in Brazil: Successful initiative beyond drug issues 

F. de Conto, R. de Cerqueira Campos. Florianopolis Department of Mental Health and 

Primary Care, Brazil 

511 Treatment retention and adherence in an integrated treatment program for opiate addiction and 

HIV in Ho Chi Minh City, Vietnam 

C. Denis 1 , D. Metzger 1 , L. Huang 2 , V. Trias 2 , M. Auriacombe 1,3 , A. Voisin 4 , T. Doan 2 , H. 

Tran 2 , L. Nguyen 2 , G. Raguin 2 , S. Mai Thi Hoai 5 , G. Le Truong 5 , J-P. Daulouède 2,3,4 , C. 

O’Brien 1 . 1 Center for Studies of Addiction, University of Pennsylvania, United States; 

2 Expertise France, France; 3 CNRS USR 3413 SANPsy, University of Bordeaux, France; 

4 Bizia Addiction Clinic, France; 5 HCMC AIDS Committee, Vietnam 

512 Addiction treatment human resources and training needs during Vietnam’s rapid scale-up of 

methadone treatment 

N.B. Diep 1 , N.T. Trang 1 , N.T.M. Tam 2 , P.Q. Loc 1 , S. Larkins 3 , L.M. Giang 1 . 1 Hanoi Medical 

University, Vietnam; 2 Vietnam Administration of HIV/AIDS Control, Vietnam; 3 University 

of Los Angeles, California, United States 

513 Time variant dynamic top-down regulation in fronto-amygdalar network during drug cue 

exposure in heroin dependents 

H. Ekhtiari 1,2,3 , A.Z. Sadeghi 2 , A. Shahbabaei 1,3 , M.A. Oghabian 2 . 1 Iranian National Center 

for Addiction Studies, Tehran University of Medical Sciences, Iran; 2 Neuroimaging and 

Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of 

Medical Sciences, Iran; 3 Translational Neuroscience Program, Institute for Cognitive Science 

Studies, Iran 

45


514 Methylphenidate substitution for methamphetamine addiction and implications for future 

randomized clinical trials: A case series 

R. Gabrhelík 1 , J. Minařík 1 , R. Malcolm 2 , A. Pavlovská 1 , P. Miller 2 . 1 Department of 

Addictology, First Faculty of Medicine, Charles University in Prague and General University 

Hospital in Prague, Czech Republic; 2 Department of Psychiatry and Behavioral Sciences, 

Addiction Sciences Division, Medical University of South Carolina, United States 

515 Histopathological alterations in liver structures of cocaine-addicted rats fed a nutritionally 

supplemented rat diet 

N. Gardner 1 , A. Wheatley 1 , B. Hanchard 2 , T. Gibson 2 , W. De La Haye 3 , K. Luke 4 , P. 

Bahadosingh 4 , L. Dilworth 2 , A. Salako 5 , H. Lowe 6 , H. Asemota 1,4 . 1 Biotechnology Centre, 

University of the West Indies-Mona Campus, Jamaica; 2 Department of Pathology, University 

of the West Indies-Mona Campus, Jamaica; 3 Department of Community Health and 

Psychiatry, University of the West Indies-Mona Campus, Jamaica; 4 Department of Basic 

Medical Sciences, University of the West Indies-Mona Campus, Jamaica; 5 Awele 

Foundation International, United States; 6 Environmental Health Foundation, Jamaica 

516 Informing drug treatment development through science: International standards on the 

treatment of drug use disorders 

G. Gerra 1 , V. Poznyak 2 , E. Sáenz 1 , A. Busse 1 , N. Clark 2 . 1 United Nations Office on Drugs 

and Crime, Italy; 2 World Health Organization, Switzerland 

517 Executive functioning and outpatient treatment adherence after intensive inpatient care for 

cocaine dependence: A 6-month follow-up study 

P.D. Gonçalves 1,2 , M. Ometto 1 , A. Malbergier 1 , P.A. Martins 1 , L. Beraldo 1 , B. dos Santos 1 , 

S. Nicastri 1 , A.G. Andrade 1 , P.J. Cunha 1 . 1 Institute of Psychiatry, School of Medicine, 

University of São Paulo, Brazil; 2 University of California, San Diego, United States 

518 Assessment of cognitive functions in tramadol-dependent patients: A case control study 

S. Hassaan, A. Darwish, H. Khalifa, S. Mostafa. Department of Psychiatry, Assiut 

University, Egypt 

519 A summary of addiction services in a Canadian city: Results from an Internet-based scoping 

study 

E. Knight. St. Paul’s Hospital Goldcorp Addiction Medicine Fellowship, BC Centre for 

Excellence in HIV/AIDS, Canada 

520 Pregabalin for opioid detoxification: Interim results 

E.M. Krupitsky 1 , R.D. Ilyuk 1 , A.D. Mikhailov 1 , K.A. Kazankov 2 , K.V. Rybakova 1 , O.G. 

Grishina 1 , I.A. Zaplatkin 1 , D.D. Langleben 3 , G. Woody 3 . 1 St. Petersburg Bekhterev 

Psychoneurological Institute, Russia; 2 Murmansk Regional Addiction Hospital, Russia; 

3 School of Medicine, University of Pennsylvania, United States 

521 Extended-release Naltrexone for discontinuation of opioid maintenance treatment: A 

randomized prospective study 

N. Kunøe 1 , K.K. Solli 1,2 , A. Opheim 3 , L. Tanum 1,2 . 1 Norwegian Centre for Addiction 

Research, University of Oslo, Norway; 2 Vestfold Hospital Trust, Norway; 3 Haukeland 

University Hospital, Norway; 3 Akershus University Hospital, Norway 

522 Relationship between anger and psychoactive substance use: A systematic review 

H.V. Laitano, F.H.P. Kessler, T.C. Hartmann, P.T. Souza Filho, A. Ely. Center for Drug and 

Alcohol Research, Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio 

Grande do Sul, Brazil 

46


523 Adherence to methadone maintenance treatment protocol among service providers in China 

C-W. Lan 1 , C. Lin 1 , X. Cao 2 , L. Li 1 . 1 Semel Institute for Neuroscience and Human Behavior, 


Control and Prevention, Chinese Centers for Disease Control and Prevention, China 

524 Comparing psychiatric symptoms in subjects with chronic ketamine use and methamphetamine 

use 

Y. Liao 1,2 , J. Tang 1,2 , C. Qi 1 , Q. Wu 1 . 1 Mental Health Institute, the Second Xiangya Hospital 

of Central South University, China; 2 Department of Psychiatry and Biobehavioral Sciences, 

University of California, Los Angeles, United States 

525 How synthetic cannabinoid users differ from intravenous drug users in their attitudes toward 

Narcotics Anonymous in Russia 

B. Lobodov 1 , L. Rod 2 , E. Chernyckii 2 , P. Strogonov 2 . 1 Medical Center “Semya,” Russia; 

2 Voronezh State Regional Narcological Dispensary, Russia 

526 Impulsivity, sensation seeking, and substance use among adolescents: A longitudinal research 

study 

C. López-Núñez, V. Martínez Loredo, S. Fernández-Artamendi, J.R. Fernández-Hermida, I. 

Pericot-Valverde, S. Weidberg, R. Secades-Villa. University of Oviedo, Spain 

527 Child protection experts’ initiatives in Tehran for treatment of street children with substance 

use disorder 

M. Maarefvand 1 , R. Daneshmand 1 , S. Shariati-Rad 1,2 , A. Noroozi 1 , O. Massah 1 , E. Salari 1 , H. 

Bahari 1 , N. Habibi 1 , N. Dodangi 1 , M. Sadeghi 1 , M. Firoozhoohi 1 , R. Radfar 1 , L. Lundgren 3 , 

A. Farhoudian 1 . 1 Substance Abuse and Dependence Research Center, University of Social 

Welfare and Rehabilitation Sciences, Iran; 2 Students Research Center of International 

Campus, Tehran University of Medical Sciences, Iran; 3 Center for Addictions Research and 

Services, School of Social Work, Boston University, United States 

528 Correlates of lifetime addiction treatment experience among people who inject drugs in four 

Ukrainian cities 

A. Mazhnaya 1 , S.D. Phillips 2 , O. Filippova 3 , R. Aleksanyan 4 , T. Zub 3 , P. Alpatova 3 , J. 

Owczarzak 5 . 1 ICF Alliance for Public Health, Ukraine; 2 Department of Anthropology, 

Indiana University, United States; 3 Department of Sociology, V.N. Karazin Kharkiv National 

University, Ukraine; 4 Center for AIDS Intervention Research, Medical College of 

Wisconsin, United States; 5 Department of Health, Behavior, and Society, School of Public 

Health, Johns Hopkins University, United States 

529 Publications related to methadone maintenance treatment in China, 2005–2014: A bibliometric 

analysis 

X. Mei 1 , W. Zhou 2 , X. Tan 1 , P. Liu 2 , L. Luo 2 , C. Liu 2 , M. Chawarski 3 . 1 School of Public 

Health, Wuhan University, China; 2 Wuhan Centers for Disease Prevention and Control, 

China; 3 Yale School of Medicine, United States 

530 Demographic, temporal, and geographical features of suspected opiate overdoses attended by 

the London Ambulance Service, 2005–2007 

I. Miftari. Insight Advantage Inc., Canada 

47


531 Improving the lives of children who use drugs in Afghanistan 

A.S. Momand 1 , E. Mattfeld 2 , G. Gerra 2 , B. Moralis 3 , T. Brown 3 , K. O’Grady 4 , H.E. Jones 5 . 

1 United Nations Office on Drugs and Crime (UNODC), Afghanistan; 2 UNODC, Austria; 

3 Bureau of International Narcotics and Law Enforcement, U.S. Department of State, United 

States; 4 Department of Psychology, University of Maryland-College Park, United States; 

5 University of North Carolina (UNC) Horizons, Department of Obstetrics and Gynecology, 

UNC at Chapel Hill, United States 

532 Nicotine dependence as a mediator of Project EX’s effects to reduce tobacco use in high-risk 

youth 

A. Morales, M.T. Gonzálvez, M. Orgilés, J.P. Espada. Miguel Hernández University, Spain 

533 “Not on the agenda”: A qualitative study of health services’ use among poor young women who 

use drugs in Cape Town, South Africa 

B. Myers 1 , T. Carney 1 , W.M. Wechsberg 2 . 1 Alcohol, Tobacco and Other Research Unit, 

South African Medical Research Council, South Africa; 2 RTI International, United States 

534 Retraumatization: Sexual abuse, post-traumatic stress disorder, and sexual risk behavior 

among club drug users 

J.C.M. Narvaez 1 , L. Remy 1 , J. Scherer 1 , F. Ornell 1 , R. Silvestrin 1 , H. Surratt 2 , S. Kurtz 2 , F. 

Pechansky 1 . 1 Collaborating Center on Alcohol and Drugs, Center for Drug and Alcohol 

Research, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, 

Brazil; 2 Center for Drug and Alcohol Research, Nova Southeastern University, United States 

535 A stepped-wedge cluster randomized trial of behavioral interventions targeting amphetaminetype 

stimulant use and sexual risk among female entertainment and sex workers in Cambodia: 

Design of implementation science protocol 

K. Page 1 , E.S. Stein 2 , A.W. Carrico 3 , J.L. Evans 2 , M. Sokunny 4 , E. Nil 4 , S. Ngak 4 , C. 

Sophal 5 , C. McCulloch 2 , L. Maher 6 . 1 Division of Epidemiology, Biostatistics and Preventive 

Medicine, Department of Internal Medicine, University of New Mexico Health Sciences 

Center, United States; 2 Department of Epidemiology and Biostatistics, University of 

California, San Francisco, United States; 3 Department of Community Health Systems, 

School of Nursing, University of California, San Francisco, United States; 4 FHI360 

Cambodia, Cambodia; 5 Department of Mental Health and Substance Abuse, Ministry of 

Health, Cambodia; 6 The Kirby Institute for Infection and Immunity, University of New 

South Wales, Australia 

536 Codeine misuse/dependence: Best practice and future innovations in addressing risk, harm, and 

successful treatment 

C.D.H. Parry 1 , M.C. van Hout 2 , I. Norman 3 . 1 Alcohol, Tobacco, and Other Drug Research 

Unit, Medical Research Council, South Africa; 2 School of Health Sciences, Waterford 

Institute of Technology, Ireland; 3 Florence Nightingale Faculty of Nursing and Midwifery, 

Kings College London, United Kingdom 

537 Validation of a purchase task for assessing the relative reinforcing efficacy of e-cigarettes 

I. Pericot-Valverde, S. Fernández-Artamendi, A. González-Roz, C. López-Núñez, S. 

Weidberg, R. Secades-Villa. University of Oviedo, Spain 

538 What does addiction mean? A qualitative study to assess patients’ understanding about 

addiction and its treatment 

S. Prakash, R. Rao, P. Ramshankar, V. Krishnan, A. Ambekar, A. Dhawan. National Drug 

Dependence Treatment Centre, All India Institute of Medical Sciences, India 

48


539 Retention and drop out of opioid substitution therapy program due to drug diversion in Ukraine 

T. Prokhorova, V.P. Kolomiets. ICF Alliance for Public Health, Ukraine 

540 Detoxification unit within a residential substance abuse treatment facility: A gateway to better 

outcomes? 

S. Rabinovitz. School of Criminology, Unit for Excellence in Research & Study of 

Addiction, University of Haifa, Israel 

541 Quality of life in patients attending substance abuse treatment: A study in Songkhla Province, 

Thailand 

P. Rattanakornpreeda, S. Paileeklee. Khon Kaen University, Thailand 

542 Preliminary findings: Suicidal ideation among crack cocaine-dependent patients receiving 

treatment in São Paulo, Brazil’s “Crackland” and its association with HIV/STD 

A. Ribeiro 1,2 , C. Madruga 2,3 , A. Miguel 2,3 , S. McPherson 4 , M. Ribeiro 1,2 . 1 Reference Centre 

of Drug Addiction Treatment, Brazil; 2 Federal University of São Paulo, Brazil; 3 National 

Institute of Alcohol and Drug Policies, Brazil; 4 Washington State University, United States 

543 Substance use: Recruitment and control tools for forced entry into sex work in two U.S.–Mexico 

border cities 

T. Rocha-Jimenez, K. Brouwer, S. Boyce, M. Salazar, J. Silverman. University of California, 

San Diego, United States 

544 Linking infectious and narcology care: A strengths-based case management intervention to link 

HIV-infected people who inject drugs in Russia to HIV care: Randomized controlled trial 

results 

J.H. Samet 1,2 , E. Blokhina 3 , D.M. Cheng 1 , A.Y. Walley 1,2 , D. Lioznov 3 , C.E. Chaisson 1 , C. 

Bridden 2 , E. Quinn 1 , N. Gnatienko 2 , O. Toussova 3 , A. Gifford 1 , E. Krupitsky 3 , A. Raj 4 . 

1 Boston University, United States; 2 Boston Medical Center, United States; 3 First St. 

Petersburg Pavlov State Medical University, Russia; 4 University of California, San Diego, 

United States 

545 A retrospective chart review of treatment completers versus noncompleters among those seeking 

in-patient treatment at a tertiary care drug dependence treatment center 

S. Sarkar, Y.P.S. Balhara, N. Gautam, J. Singh. Department of Psychiatry, National Drug 

Dependence Treatment Centre, All India Institute of Medical Sciences, India 

546 Improvement in the treatment of substance use disorders through adopting evidence-based 

practices in Pakistan 

U. Shamim. Hubert H. Humphrey Fellowship Program, Virginia Commonwealth University, 

United States 

547 Gender differences among Russian addicts in their attitude toward long-term nonmedical 

treatment 

E. Smirnova 1 , B. Lobodov 1 , L. Rod 2 . 1 Medical Center “Semya,” Russia; 2 Voronezh State 

Regional Narcological Dispensary, Russia 

548 The percentage of patients on high methadone doses in Ho Chi Minh City and related factors 

M.T.H. Son, T.T.T. Van. Ho Chi Minh City AIDS Preventive Center, Vietnam 

549 Acute tryptophan depletion response in cocaine-dependent subjects with comorbid depression 

M. Torrens 1,2,3 , J.I. Mestre-Pintó 1 , C. Pérez-Mañá 1,3 , E. Papaseit 1,3 , F. Fonseca 1,2,3 , M. 

Farré 1,3,4 . 1 Institut Hospital del Mar d’Investigacions Mèdiques, Spain; 2 Institut de 

Neuropsiquiatria i Addiccions, Spain; 3 Universidad Autónoma de Barcelona, Spain; 

4 Hospital Universitari Germans Trias i Pujol-IGTP, Spain 

49


550 Antiretroviral therapy initiation and adherence in people who inject drugs: Community-based 

approach 

A. Tyshkevych, O. Denisiuk, P. Smyrnov. ICF Alliance for Public Health, Ukraine 

551 Initial results of integrated antiretroviral and methadone treatment in District Preventive 

Medicine Centers in Ho Chi Minh City, 2013–2015 

T.T.T. Van, N.T.T. Nga, D.Q. Thong, L.T.N. Diep, M.T.H. Son, N.T.T. Thao, V. Hung, N.T. 

Hoa. Ho Chi Minh City Provincial AIDS Committee, Vietnam 

552 Fatal overdose in recently detoxified HIV-infected individuals who inject drugs in St. 

Petersburg, Russia: Role of Naltrexone 

T. Yaroslavtseva 1 , E. Blokhina 1 , E. Krupitsky 1,2 , D.M. Cheng 3 , N. Gnatienko 4 , A.Y. Walley 3 , 

E. Verbitskaya 1 , E. Zvartau 1 , S. Poole 5 , R. Gross 5 , G. Woody 5 , J.H. Samet 3,4 . 1 First Pavlov 

State Medical University of St. Petersburg, Russia; 2 Bekhterev Research Psychoneurological 

Institute, Russia; 3 Boston University, United States; 4 Boston Medical Center, United States; 

5 University of Pennsylvania, United States 



50



Tuesday, June 14, 2016 

Policy Forum Tuesday, 

Chairs: Martin Y. Iguchi 

6/8 

8:00 - 10:00 AM 

8:00 Friends of NIDA 

Martin Y. Iguchi 

8:10 Update from Capitol Hill: Implications for NIH/NIDA funding 

Ed Long, Van Scoyoc Associates, Washington, DC 

8:40 Integrated care: Is 42 CFR Part 2 a barrier or a necessity? 

Westley Clark, Santa Clara University Public Health Program, Santa Clara, CA 


Gavin Bart, Division of Addiction Medicine Hennepin County Medical Center, 



Dennis McCarty, OHSU/PSU School of Public Health, Oregon Health & Science University, 

Portland, OR 

Symposium VII Tuesday, 

5HT2A AND 5HT2C LIGANDS AS POTENTIAL 

THERAPEUTICS FOR SUBSTANCE USE DISORDERS 

10/14 

10:15 - 12:15 PM 

Chairs: Jane B. Acri and Leonard Howell 

10:15 Behavioral effects of lorcaserin in rhesus monkeys: Interactions with stimulant drugs 

C. P. France, Dept. of Pharmacology, University of Texas Health Science Center, 

San Antonio, TX 

10:40 Effects of pimavanserin and lorcaserin on drug vs. food choice in rhesus monkeys 

Matt Banks, Dept. of Pharmacology and Toxicology, Virginia Commonwealth University, 

Richmond, VA 

11:05 Effects of 5-HT2C receptor agonist lorcaserin on THC self-administration and reinstatement of 

THC-seeking in squirrel monkeys 

Zuzana Justinova, Preclinical Pharmacology Section, National Institute on Drug Abuse, IRP, 

NIH, Baltimore, MD 

11:25 Modification of the abuse-related effects of cocaine by serotonergic ligands 

Jack Bergman, McLean Hospital, Harvard Medical School, Belmont, MA 

11:50 DISCUSSANT: Targeted 5HT2A/C pharmacotherapy for drug addiction 

Leonard Howell, Yerkes National Primate Research Center, Emory University, Atlanta, GA 

51




Symposium VIII Tuesday, 

NEONATAL ABSTINENCE SYNDROME: CONTEXT 

AND CONSEQUENCES IN 2016 

6/8 

10:15 - 12:15 PM 

Chairs: Karol Kaltenbach and Hendree E. Jones 

10:15 Neonatal abstinence syndrome: How it has been used to drive policies against women using 

substances during pregnancy 

Hendree E Jones, University of North Carolina School of Medicine, Chapel Hill, NC 

10:45 Understanding factors that exacerbate or mitigate severity and duration of neonatal abstinence 

syndrome 

Karol Kaltenbach, Emeritus Professor of Pediatrics, Sidney Kimmel Medical College at 

Thomas Jefferson University, Moorestown, NJ 

11:15 The assessment and treatment of neonatal abstinence syndrome: What do we know? 

Sarah Hughes Heil, University of Vermont, Burlington, VT 

11:45 DISCUSSANT: Neonatal abstinence syndrome in context: Science, family, and society 

Mishka Terplan, Behavioral Health System, Baltimore, MD 

Oral Communications 7 Tuesday, 

GATTACA: GENOTYPE/PHENOTYPE 

4 

10:15 - 12:15 PM 

Chairs: Mehdi Farokhnia and Mark Greenwald 

10:15 Extinction and reinstatement of cocaine-reinforced behavior in rat lines selected for low and 

high levels of intravenous drug self-administration 

K. Grasing, H. Xu, Kansas City VA Medical Center, Kansas City, MO 

10:30 Adrenoceptor variants moderate treatment response of doxazosin for cocaine use disorder 

D. A. Nielsen 2 , D. Shorter 2 , C. Domingo 2 , M. H. Harding 2 , E. M. Nielsen 2 , T. Kosten 1 , 

1 

Psychiatry, Baylor, Houston, TX, 2 Psychiatry and Behavioral Science, Baylor College of 

Medicine, Houston, TX 

10:45 Composition of the N-methyl-D-aspartate receptor protein complex in the medial prefrontal 

cortex associates with individual differences in motor impulsivity 

C. A. Krebs, N. C. Anastasio, UTMB Galveston, Galveston, TX 

11:00 Recent cocaine use behavior differs by GLT1 genotype: A pilot study 

M. Greenwald 1 , E. A. Woodcock 1 , L. H. Lundahl 1 , M. Burmeister 3 , 1 Psychiatry and Behavioral 

Neurosciences, Wayne State University School of Medicine, Detroit, MI, 3 Psychiatry and 

Human Genetics, University of Michigan, Ann Arbor, MI 

11:15 Targeted over-expression of brain-derived neurotrophic factor in the nucleus accumbens 

increases goal tracking and nicotine locomotor sensitization, but reduces nicotine 

self-administration in rats 

R. W. Brown 2 , L. A. Beuttel 1 , S. A. Dean 1 , C. A. Bradley 1 , J. Wherry 2 , S. Kirby 1 , 

M. I. Palmatier 1 , M. Zhu 2 , 1 Psychology, East Tennessee State University, Johnson City, TN, 

2 

Biomedical Sciences, East Tennessee State University, Johnson City, TN 

52



11:30 GABBR2 gene variants affect cigarette smoking pattern in alcohol-dependent individuals: 

A genetic association study 

M. Farokhnia 1 , M. Schwandt 2 , C. Hodgkinson 3 , L. Leggio 1 , 1 Section on Clinical 

Psychoneuroendocrinology and Neuropsychopharmacology, NIAAA and NIDA, 

NIH, Bethesda, MD, 2 Laboratory of Clinical and Translational Studies, NIAAA, NIH, 

Bethesda, MD, 3 Laboratory of Neurogenetics, NIAAA, NIH, Rockville, MD 

11:45 Cannabinoid receptor gene polymorphism (rs2023239) associated with demand for marijuana 

E. R. Aston 1 , V. Knopik 3,4 , J. McGeary 2,3,4 , J. MacKillop 5,1 , J. Metrik 2,1 , 1 Center for Alcohol 

and Addiction Studies, Brown University School of Public Health, Providence, RI, 

2 

Providence Veterans Affairs Medical Center, Providence, RI, 3 Division of Behavioral 

Genetics, Department of Psychiatry, Rhode Island Hospital, Providence, RI, 4 Department of 

Psychiatry and Human Behavior, Alpert Medical School, Brown University, Providence, RI, 

5 

Peter Boris Centre for Addictions Research, McMaster University, Hamilton, ON, Canada 


ALTERED STATES: ABUSE LIABILITY 

12 

10:15 - 12:15 PM 

Chairs: Ziva D. Cooper and Michelle Baladi 

10:15 The experimental tobacco marketplace II: Substitutability in dual e-cigarette and cigarette users 

A. Quisenberry, M. N. Koffarnus, A. Bianco, E. Perry, W. K. Bickel, Addiction Recovery 

Research Center, Virginia Tech Carilion Research Institute, Roanoke, VA 

10:30 Validity of the modified cigarette evaluation questionnaire in predicting the reinforcing effects 

of cigarettes that vary in nicotine content under double-blind conditions 

C. A. Arger 4 , S. H. Heil 4 , S. C. Sigmon 4 , J. W. Tidey 3 , M. Stitzer 4 , D. Gaalema 1 , M. Desarno 1 , 

H. Durand 4 , E. Ruggieri 4 , S. T. Higgins 4 , 1 University of Vermont, Burlington, VT, 3 Psychiatry, 

Brown, Providence, RI, 4 Psychiatry, University of Vermont, Burlington, VT 

10:45 3,4-Methylenedioxypyrovalerone maintains differential patterns of responding in male 

Sprague-Dawley rats 

G. T. Collins 1,2 , B. M. Gannon 1 , K. Rice 3 , 1 Pharmacology, University of Texas Health Science 

Center at San Antonio, San Antonio, TX, 2 South Texas Veterans Health Care System, San 

Antonio, TX, 3 Chemical Biology Research Branch, NIDA/NIAAA, Bethesda, MD 

11:00 Evaluation of the effects of JZP-110 in nonclinical models of abuse liability 

M. Baladi 2 , L. P. Carter 2,3 , J. Black 2 , J. Bergman 1 , 1 McLean Hospital/Harvard Medical School, 

Belmont, MA, 2 Jazz Pharmaceuticals, Palo Alto, CA, 3 University of Arkansas for Medical 

Sciences, Little Rock, AR 

11:15 Assessment of the abuse potential of ABT-126, an α7-selective nicotinic agonist 

T. J. Hudzik, Preclinical Safety, AbbVie, North Chicago, IL 

11:30 Opioid modulation of cannabis-induced analgesia and subjective effects in cannabis smokers 

Z. D. Cooper, S. D. Comer, M. Haney, Psychiatry, Columbia University and NYSPI, 

New York, NY 

53


11:45 Analgesia and abuse liability of high-dose intravenous opioids in patients on methadone or 

buprenorphine 

D. A. Tompkins 1 , M. T. Smith 1 , R. R. Edwards 2 , G. Bigelow 1 , E. C. Strain 1 , 1 Johns Hopkins 

University, Baltimore, MD, 2 Harvard Medical School, Boston, MA 

12:00 No evidence of increased abuse potential of CL-108, a bilayered tablet containing hydrocodone/ 

acetaminophen/promethazine, in recreational opioid users 

N. Levy-Cooperman 1 , M. Shram 1 , L. R. Webster 2 , 1 Altreos Research Partners, Toronto, ON, 

Canada, 2 PRA, Salt Lake City, UT 

Poster Session II 

(Lunch) 



Flores 

12:15 - 2:15 PM 

Set-up time begins Monday, 3 PM 

Must be removed by Tuesday 2:30 PM 

MARIJUANA & CANNABINOIDS: HUMAN STUDIES 

1 Timing of sexual abuse, sexual risk behaviors and substance use among U.S. women 

M. Cook. “Moved to Poster Session IV, #104 on T hursday” 

2 Ethical issues in using text message assessments for sensitive behaviors: A prospective study of 

young adults’ drug use and risky sexual behaviors 

E. E. Bonar 3 , G. P. Koocher 4 , R. Cunningham 2 , R. L. Collins 5 , J. A. Cranford 3 , M. Walton 2 , 

2 

University of Michigan, Ann Arbor, MI, 3 Psychiatry, University of Michigan, Ann Arbor, MI, 

4 

DePaul University, Chicago, IL, 5 University at Buffalo, State University of New York, 

Buffalo, NY 

3 Examining problematic marijuana use among marijuana-using young adults 

C. F. Wong 1 , E. Iverson 1 , S. E. Lankenau 2 , 1 Children’s Hospital Los Angeles/USC, 

Los Angeles, CA, 2 Community Health and Prevention, Drexel University, Philadelphia, PA 

4 Properties of the marijuana motives questionnaire among medical cannabis patients 

K. Bohnert 2,1 , M. Ilgen 2,1 , 1 Psychiatry, University of Michigan, Ann Arbor, MI, 2 VA Center for 

Clinical Management Research, Ann Arbor, MI 

5 Linking animal models to human self-administration practices among medical cannabis 

patients: A daily diary study 

S. P. Novak, N. Peiper, J. Wiley, Behavioral Epidemiology, RTI International, Research 

Triangle Park, NC 

6 High impulsivity correlates with cannabis cue-induced craving in a non-treatment seeking 

cohort of heavy cannabis users 

G. Sahlem 1 , N. Baker 3 , R. J. Malcolm 2 , A. McRae-Clark 1 , 1 Psychiatry, Medical University of 

South Carolina, Charleston, SC, 2 Psychiatry and Behavioral Sciences, Medical University of 

South Carolina, Charleston, SC, 3 Department of Public Health Sciences, Medical University of 

South Carolina, Charleston, SC 

7 Craving and anxiety responses to laboratory stress for individuals seeking treatment for 

cannabis use disorder: A pilot study 

M. Olonoff 2 , M. Pavlicova 3 , S. Evans 2 , J. J. Mariani 2 , J. Choi 3 , D. J. Brooks 1 , A. Mahony 3 , 

F. R. Levin 2 , 1 Substance Abuse, NYSPI, New York, NY, 2 Columbia University, New York 

State Psychiatric Institute, New York, NY, 3 Columbia University, New York, NY 

54


8 Responses to social stress in regular cannabis smokers 

J. Xia, D. N. Patel, G. Bedi, Psychiatry, Columbia University and NYSPI, New York, NY 

9 Single administration of oxytocin attenuates craving to smoke cannabis 

K. J. Hartwell 1,2 , N. Baker 1 , J. R. Walker 1 , A. McRae-Clark 1 , 1 MUSC, Charleston, SC, 

2 

Ralph H Johnson VAMC, Charleston, SC 

10 A dynamic causal modeling study of the reward system in marijuana users 

L. Ma 1,2 , J. Steinberg 1,3 , J. Bjork 1,3 , L. Keyser-Marcus 1,3 , J. Vassileva 1,3 , S. Ferré 4 , F. Moeller 1,3 , 

1 

Institute for Drug and Alcohol Studies, Virginia Commonwealth University, Richmond, VA, 

2 

Department of Radiology, Virginia Commonwealth University, Richmond, VA, 3 Department 

of Psychiatry, Virginia Commonwealth University, Richmond, VA, 4 Integrative Neurobiology 

Section, National Institute on Drug Abuse, Intramural Research Program, National Institutes 

of Health, Baltimore, MD 

11 Chronic cannabis use is associated with impaired discrimination of threat and safety cues in 

Pavlovian conditioning 

S. Papini 4 , L. Ruglass 2 , T. Lopez-Castro 2 , J. Smits 4 , A. Campbell 3 , D. Hien 1 , 1 Psychology, 

Adelphi University, NY, NY, 2 Psychology, The City College of New York, New York, NY, 

3 

Psychiatry, Columbia University Medical Center, New York, NY, 4 Psychology, 

The University of Texas at Austin, Austin, TX 

12 Efforts to diversity research populations can pay dividends 

C. W. Striley, E. Kwiatkowski, L. Cottler, Epidemiology, University of Florida, 


SEX/GENDER DIFFERENCES 

13 Sex differences on cortical brain morphometry and behaviors in adolescent marijuana users 

V. Douet, L. Chang, B. Stoytcheva, T. Ernst, T. PING Consortium, Department of Medicine, 

University of Hawaii, John A. Burns School of Medicine, Honolulu, HI 

14 Are gender differences in the prevalence of past-year marijuana use and risk perception in the 

U.S. narrowing from 2002-2013? 

R. Rahim-Juwel, H. Carliner, D. Shmulewitz, A. L. Sarvet, M. Wall, S. S. Martins, Q. Brown, 

P. M. Mauro, D. Hasin, Columbia University, New York, NY 

15 Gender differences in the effect of childhood adversity on alcohol, drug, and poly-substance use 

disorders 

E. Evans 1,2 , D. Upchurch 1 , C. E. Grella 2 , 1 Fielding School of Public Health, UCLA, 

Los Angeles, CA, 2 UCLA Integrated Substance Abuse Programs, University of California, 


16 Gender differences in the effects of concurrent drug use on the risk of heroin relapse 

A. L. Moskowitz 1,2 , C. E. Grella 2 , 1 Psychology, UCLA, Los Angeles, CA, 2 Integrated 

Substance Abuse Programs, UCLA, Los Angeles, CA 

17 Gender differences in remission from alcohol and marijuana dependence in college students 

B. A. Bugbee 1 , K. M. Caldeira 1 , K. E. O’Grady 2 , K. B. Vincent 1 , A. M. Arria 1 , 1 University of 

Maryland School of Public Health, College Park, MD, 2 Psychology, University of Maryland, 

College Park, MD 

18 Heavy episodic drinking and weight control behavior among college students: Does gender 

matter? 

R. L. Peralta 1 , P. B. Barr 2 , 1 Department of Sociology, The University of Akron, Akron, OH, 

2 

Department of Psychology and African American Studies, Virginia Commonwealth 

University, Richmond, VA 

55


19 Barriers to long-acting reversible contraceptive use among opioid-maintained women 

A. K. Matusiewicz, H. S. Melbostad, S. H. Heil, Department of Psychiatry, University of 

Vermont, Burlington, VT 

20 Health characteristics and sexual risk behaviors among young adult prescription opioid 

misusers in the club scene: Examining the role of gender 

M. A. Levi Minzi, M. E. Buttram, S. P. Kurtz, ARSH: Center for Research on Substance Use 

and Health Disparities, Nova Southeastern University, Miami, FL 

21 What’s in Your medicine cabinet?: Gender differences 

L. Cottler, E. Kwiatkowski, C. W. Striley, Epidemiology, University of Florida, 


22 Male-female differences in making a rapid transition from first heroin use to onset of heroin 

dependence: United States, 2005-2013 

O. J. Santiago Rivera, J. C. Anthony, Epidemiology and Biostatistics, Michigan State 

University, East Lansing, MI 

23 Gender differences among PWID with regard to HIV transmission risk in St. Petersburg, Russia 

N. Gnatienko 5 , J. Tsui 2 , J. A. Wagman 3 , D. M. Cheng 4 , A. Raj 3 , E. Blokhina 1 , O. Toussova 1 , 

L. Forman 4 , D. Lioznov 1 , J. H. Samet 4,5 , 1 First Pavlov State Medical University of 

St. Petersburg, St. Petersburg, Russian Federation, 2 University of Washington, Seattle, WA, 

3 

University of California, San Diego, CA, 4 Boston University, Boston, MA, 5 Boston Medical 

Center, Boston, MA 

24 Working memory is impaired for both male and female HIV+ substance users 

E. Martin 2 , R. Gonzalez 1 , J. Vassileva 4 , P. Maki 3 , L. Rubin 3 , D. Hardy 5 , 1 Psychology, 

Florida International University, Miami, FL, 2 Psychiatry, Rush University Medical 

Center, Chicago, IL, 3 Psychiatry, University of Illinois, Chicago, IL, 4 Psychiatry, Virginia 

Commonwealth University, Richmond, VA, 5 Psychology, Loyola Marymount University, 


25 Sexual violence among patients with substance use disorders in FQHCs 

C. W. Bone 2 , R. Andersen 3 , M. Vahidi 1 , L. Gelberg 1,3 , 1 Family Medicine, UCLA, Woodland 

Hills, CA, 2 Internal Medicine, Yale, New Haven, CT, 3 UCLA School of Public Health, 


26 Predictors of Internet-delivered drug treatment outcomes and acceptability among women 

T. Saraiya 1 , A. Campbell 2 , M. Hu 2 , 1 Adelphi University, New York, NY, 2 Dept of Psychiatry, 


27 Gender and racial/ethnic differences in referral sources for SUD treatment among adolescents 

and young adults in California (2009-2014) 

J. Lim, D. Urada, UCLA Integrated Substance Abuse Programs, Los Angeles, CA 

28 WITHDRAWN 

29 “Sex and the new Kandel-Kandel nicotine gateway evidence”: Initial stepping-stones 

F. A. Wagner 1,3 , K. C. Alcover 3 , O. A. Vsevolozhskaya 2 , J. C. Anthony 3 , 1 PSRC, Morgan 

State University, Baltimore, MD, 2 Biostatistics, University of Kentucky, Lexington, KY, 

3 

Department of Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 

56


30 Mentholated cigarette use among African American women and men: What’s blunt smoking got 

to do with it? 

L. Montgomery, Counseling/Substance Abuse Counseling, University of Cincinnati, 

Cincinnati, OH 

31 Gender discrimination, educational attainment, and illicit drug use among U.S. women 

H. Carliner 1 , A. Sarvet 2 , A. R. Gordon 3 , D. S. Hasin 1,2 , 1 Epidemiology, Columbia University, 

New York, NY, 2 New York State Psychiatric Institute, New York, NY, 3 Pediatrics, Harvard 

Medical School, Boston, MA 

32 Social ties and substance use among reserve soldiers in single and dual military households 

E. M. Anderson Goodell 1 , S. Cercone Heavey 2 , D. Homish 2 , G. G. Homish 2 , 1 Mental Health, 

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2 Community Health and 

Health Behavior, State University of New York at Buffalo, Buffalo, NY 

HIV/HCV 

33 Borderline personality disorder and brief intervention for drug use in HIV primary care 

J. Derri 2 , A. Le 2 , D. S. Hasin 1,2 , E. Aharonovich 1,2 , 1 Psychiatry, Columbia University Medical 

Center, New York, NY, 2 New York State Psychiatric Institute, New York, NY 

34 Modeling a theory-based approach to examine the influence of neurocognitive impairment on 

HIV risk reduction behaviors among drug users in treatment 

R. Shrestha 1,2 , T. B. Huedo-Medina 2,3 , M. Copenhaver 2,3 , 1 Department of Community 

Medicine & Health Care, University of Connecticut Health Center, Farmington, CT, 2 Center 

for Health, Intervention, and Prevention, University of Connecticut, Storrs, CT, 3 Department 

of Allied Health Sciences, University of Connecticut, Storrs, CT 

35 Feasibility, acceptability, tolerability of targeted naltrexone for non-dependent 

methamphetamine-using and binge-drinking men who have sex with men 

G. Santos 1,1 , P. Coffin 1 , D. Santos 1 , S. Huffaker 1 , T. Matheson 1 , J. Euren 1 , A. DeMartini 1 , 

C. Rowe 1 , J. Hahn 3 , D. Vlahov 3 , E. Vittinghoff 3 , S. L. Batki 1 , 1 Community Health Systems, 

University of California San Francisco, San Francisco, CA, 3 University of California San 

Francisco, San Francisco, CA 

36 Health knowledge and sociodemographic predictors of risky behaviors 

B. Peteet 1 , M. Staton-Tindall 2 , 1 Psychology, University of Cincinnati, Cincinnati, OH, 2 Social 

Work, University of Kentucky, Lexington, KY 

37 Gender disparities in HIV prevalence and risk behaviors among people who inject drugs in 

Tajikistan 

W. Zule 1 , D. Otiashvili 2 , A. Latypov 3 , S. Bangel 1 , W. Wechsberg 1 , 1 RTI International, 

Durham, NC, 2 Addiction Research Center, Alternative Georgia, Tbilisi, Georgia, 

3 

Management Sciences for Health, Leadership, Management and Governance, Kiev, Ukraine 

38 Condom barriers among African American substance users: Age and gender differences 

C. L. McCuistian, K. Burlew, Psychology, University of Cincinnati, Cincinnati, OH 

39 Current drug users and women have higher rates of risky sexual behaviors 

K. A. Phillips, L. Moran, S. K. Hertzel, D. H. Epstein, K. L. Preston, Treatment Section, 

NIDA IRP, Baltimore, MD 

40 Racial and ethnic differences in substance use diagnoses, comorbid psychiatric disorders and 

treatment initiation among HIV-positive and HIV-negative women 

E. D. Storholm 1,3,2 , M. Silverberg 2 , D. Satre 2,3 , 1 Rand Corporation, Santa Monica, CA, 2 Kaiser 

Permanente, Oakland, CA, 3 Psychiatry, UCSF, San Francisco, CA 

57


41 Latent classes of polydrug use and associations with HIV risk behaviors and overdose among 

people who inject drugs in Tijuana, Mexico 

M. C. Meacham 1,2,3 , S. Roesch 2 , S. Strathdee 1 , P. Gonzalez-Zuniga 1 , T. Gaines 1 , 1 University of 

California San Diego, La Jolla, CA, 2 San Diego State University, San Diego, CA, 3 University 

of California San Francisco, San Francisco, CA 

42 Used syringes analysis: A new approach to better-know what is injected 

T. Nefau 2,1 , S. Karolak 2 , Y. Levi 2 , V. Thibault 3 , C. Duplessy-Garcon 1 , J. Bara 1 , 1 SAFE 

association, Paris, France, 2 Univ Paris Sud, Châtenay-Malabry, France, 3 Virology Laboratory, 

Hôpital Pitié-Salpêtrière, Paris, France 

43 Syringe-sharing among a prospective cohort of street-involved youth in Vancouver, Canada: 

Implications for structural interventions 

N. Bozinoff 1 , E. Wood 1,2 , L. Richardson 1,3 , H. Dong 1 , T. Kerr 1,3 , K. DeBeck 1,4 , 1 BC Centre for 

Excellence in HIV/AIDS, Vancouver, BC, Canada, 2 Department of Medicine, University of 

British Columbia, Vancouver, BC, Canada, 3 Department of Sociology, University of British 

Columbia, Vancouver, BC, Canada, 4 School of Public Policy, Simon Fraser University, 

Vancouver, BC, Canada 

44 Access to and retention in harm reduction services among persons who inject drugs in 

Washington, DC 

S. T. Allen 1 , M. Ruiz 2 , S. Sherman 1 , 1 Epidemiology, Johns Hopkins University, 

Baltimore, MD, 2 Prevention and Community Health, George Washington University, 

Washington, DC 

45 Provider perspectives on care coordination for people living with HIV who use drugs 

K. Claborn 1,2 , 1 Psychiatry & Human Behavior, Warren Alpert Medical School of Brown 

University, Providence, RI, 2 Medicine, Rhode Island Hospital, Providence, RI 

46 Domestic prevalence of substance use disorders in HIV care settings 

B. Hartzler 1 , D. Donovan 1 , B. Beadnell 9 , H. M. Crane 1 , J. J. Eron 2 , E. H. Geng 3 , 

W. C. Matthews 5 , K. H. Mayer 4 , R. D. Moore 6 , M. Mugavero 7 , S. Napravnik 2 , B. Rodriguez 8 , 

J. C. Dombrowski 1 , 1 University of Washington, Seattle, WA, 2 University of North Carolina- 

Chapel Hill, Chapel Hill, NC, 3 University of California-San Francisco, San Francisco, CA, 

4 

Harvard University, Boston, MA, 5 University of California-San Diego, San Diego, CA, 

6 

Johns Hopkins University, Baltimore, MD, 7 University of Alabama-Birmingham, 

Birmingham, AL, 8 Case Western Reserve University, Cleveland, OH, 9 Prevention Research 

Institute, Louisville, KY 

47 Impact of a strengths-based case management intervention on HIV viral load among people who 

use drugs in Oakland, California 

A. Kral, M. L. Comfort, C. Powers, H. Cheng, A. Lopez, B. Lambdin, J. Lorvick, RTI 

International, San Francisco, CA 

48 Sexual risk and substance use behaviors among partnered and non-partnered HIV-infected 

adults with substance dependence 

A. R. Bazzi 3 , M. Sullivan 6 , M. Drainoni 4 , A. S. Ventura 2 , G. J. Patts 2 , A. Y. Walley 1 , R. Saitz 5 , 

1 

General Internal Medicine, Boston Univ, Boston, MA, 2 Boston University, Boston, MA, 

3 

Community Health Sciences, Boston University School of Public Health, Boston, MA, 

4 

Health Policy and Management, Boston University School of Public Health, Boston, MA, 

5 

Community Health Sciences, Boston University and Boston Medical Center, Boston, MA, 

6 

Boston Medical Center, Boston, MA 

58


49 LINC - A strengths-based case management intervention to link HIV-infected PWID in Russia to 

HIV care – RCT Results 

J. H. Samet 1 , E. Blokhina 2 , D. M. Cheng 1 , A. Y. Walley 1 , D. Lioznov 2 , C. Chaisson 1 , 

C. Bridden 3 , E. Quinn 1 , N. Gnatienko 3 , O. Toussova 2 , A. Gifford 1 , E. Krupitsky 2 , A. Raj 4 , 

1 

Boston University, Boston, MA, 2 First Pavlov State Medical University, St. Petersburg, 

Russian Federation, 3 Boston Medical Center, Boston, MA, 4 University of California, San 

Diego, CA 

50 Daily alcohol use as an independent risk factor for HIV seroconversion among people who 

inject drugs 

S. Young 1 , E. Wood 1,2 , H. Dong 2 , T. Kerr 1,2 , K. Hayashi 2 , 1 Department of Medicine, University 

of British Columbia, Vancouver, BC, Canada, 2 Urban Health Research Initiative, BC Centre 

for Excellence in HIV/AIDS, Vancouver, BC, Canada 

51 Extended-release naltrexone feasibility in HIV clinics: A pilot study 

T. Korthuis 3 , P. J. Lum 5 , P. Vergara-Rodriguez 6 , K. Ahamad 4 , E. Wood 4 , R. Lindblad 1 , 

R. Mandler 2 , J. Sorensen 5 , D. Ha 3 , N. Oden 1 , L. Kunkel 3 , D. McCarty 3 , 1 EMMES, 

Rockville, MD, 2 NIDA, Bethesda, MD, 3 OHSU, Portland, OR, 4 UBC, Vancouver, BC, 

Canada, 5 UCSF, San Francisco, CA, 6 CORE Center, Chicago, IL 

52 Technology-based intervention preferences to enhance self-management of substance use 

disorders, HIV, and hepatitis C among patients in inpatient detoxification 

B. Tofighi 2 , F. Grazioli 1 , A. Thomas 3 , A. Desai 2 , A. Coelho Pinguello 2 , P. Greco 2 , J. D. Lee 2 , 

1 

School of Social Work, New York University, New York, NY, 2 Population Health, New York 

University School of Medicine, New York City, NY, 3 Psychiatry, New York University, 

New York, NY 

53 Sexual and drug use risk behaviors and HIV- and Hepatitis-C transmission knowledge among 

non-treatment-seeking individuals with opioid use disorders in NYC 

V. Metz 1,2 , M. Sullivan 1,2,3 , J. D. Jones 1,2 , E. Evans 1,2 , R. Luba 1,2 , J. Vogelman 1,2 , S. Comer 1,2 , 

1 

New York State Psychiatric Institute, New York, NY, 2 Columbia University Medical Center, 

New York, NY, 3 Alkermes, Inc, Waltham, MA 

54 HCV incidence and treatment in aging Latino injectors 

M. R. Klawans, Y. Villarreal, T. Northrup, A. Stotts, McGovern Medical School, University 

of Texas Health Science Center at Houston, Houston, TX 

55 Hepatitis C virus core antigen reliably diagnoses HCV infection in injection and non-injection 

drug users 

M. Zeremski 2 , Y. Chen 3 , R. Zavala 4 , Y. de Jong 2 , C. Sylvester 1 , G. Cloherty 6 , A. Talal 5 , 

1 

Research & Evaluation, START: Treatment & Recovery Centers, Brooklyn, NY, 2 Weill 

Cornell Medical College, New York, NY, 3 Biostatistics, University at Buffalo (SUNY), 

Buffalo, NY, 4 START: Treatment & Recovery Centers, Brooklyn, NY, 5 Medicine, University 

at Buffalo (SUNY), Buffalo, NY, 6 Abbott Diagnostics, Des Plaines, IL 

ADOLESCENT DRUG ABUSE 

56 Alcohol use during an N-acetylcysteine cannabis cessation trial in adolescents 

L. M. Squeglia, N. Baker, E. A. McClure, K. M. Gray, Medical University of South Carolina, 


57 Adolescent cannabis use disorder: Adaptive treatment for poor responders to initial treatment 

Y. Kaminer, Psychiatry, University of CT School of Medicine, Farmington, CT 

59


58 Male-female differences of antecedent cannabis use among newly incident young alcohol 

drinkers: Does age matter? 

H. G. Cheng 1 , C. Lopez-Quintero 1 , J. C. Anthony 2 , 1 Epidemiology and Biostatistics, Michigan 

State University, East Lansing, MI, 2 Michigan State University, East Lansing, MI 

59 A longitudinal examination of the impact of childhood emotional abuse on cannabis use 

trajectories among community youth 

A. N. Banducci 1,2 , J. W. Felton 2 , M. O. Bonn-Miller 1 , C. W. Lejuez 2 , L. MacPherson 2 , 1 VA 

Palo Alto Health Care System, The National Center for PTSD, Palo Alto, CA, 2 University Of 

Maryland, College Park, College Park, MD 

60 The romantic relationship context of adolescent marijuana use 

P. A. Matson 2 , N. Ialongo 1 , S. Chung 2 , G. Bobashev 3 , J. M. Ellen 4 , 1 Johns Hopkins Bloomberg 

School of Public Health, Baltimore, MD, 2 Johns Hopkins School of Medicine, Baltimore, MD, 

3 

RTI International, Durham, NC, 4 All Children’s Hospital Johns Hopkins Medicine, St. 

Petersburg, FL 

61 Psychometric assessment of the marijuana adolescent problem inventory 

S. F. Babbin, C. Stanger, A. J. Budney, Department of Psychiatry, Geisel School of Medicine 

at Dartmouth, Lebanon, NH 

62 Predictors of cannabis uptake in an adolescent cohort: Associations with tobacco use, drinking, 

and child, peer, and familial factors 

R. P. Mattick 1 , P. Clare 1 , A. Aiken 1 , M. Wadolowski 1,4 , R. Bruno 2 , K. Kypri 4 , J. Najman 5 , 

D. Hutchinson 1 , N. McBride 5 , 1 National Drug and Alcohol Research Centre, University of 

New South Wales, Sydney, NSW, Australia, 2 School of Medicine, University of Tasmania, 

Hobart, TAS, Australia, 4 School of Medicine and Public Health, University of New Castle, 

New Lambton Heights, NSW, Australia, 5 School of Public Health, University of Queensland, 

Brisbane, QLD, Australia 

63 Attitudes towards tobacco use among parents of adolescents 

S. E. Gomez Luna 1 , D. A. Cavallo 2 , S. Krishnan-Sarin 3 , 1 School of Medicine, RAMS/YALE, 

Stamford, CT, 2 Psychiatry, Yale University, New Haven, CT, 3 Psychiatry, Yale School of 

Medicine, New Haven, CT 

64 Cigarillo use patterns among adolescents 

G. Kong 1 , D. A. Cavallo 4 , D. R. Camenga 3 , M. E. Morean 4 , P. Simon 2 , K. M. Gutierrez 4 , 

S. Krishnan-Sarin 4 , 1 Yale School of Medicine, New Haven, CT, 2 Department of Psychiatry, 

Division of Prevention and Community Research, Yale School of Medicine, New Haven, CT, 

3 

Emergency Medicine, Yale School of Medicine, New Haven, CT, 4 Department of Psychiatry, 

Yale University, School of Medicine, New Haven, CT 

65 Greater curiosity about smoking cigarettes among 6th and 12th grade students using alternative 

tobacco-smoking products 

L. E. Segura 1 , A. Maldonado 1 , J. Santaella 1 , C. Storr 2 , S. S. Martins 1 , 1 Epidemiology, 

Columbia University, New York, NY, 2 University of Maryland School of Nursing, 

Baltimore, MD 

66 Longitudinal patterns of e-cigarette and cigarette dual use in adolescents 

D. R. Camenga, K. Bold, G. Kong, D. A. Cavallo, K. M. Gutierrez, P. Simon, S. Krishnan- 

Sarin, Yale School of Medicine, New Haven, CT 

67 Low socioeconomic status is associated with e-cigarette and tobacco product use latent class 

membership among adolescents 

P. Simon 2 , D. R. Camenga 1 , G. Kong 2 , D. A. Cavallo 2 , M. E. Morean 2 , K. M. Gutierrez 2 , 

S. Krishnan-Sarin 2 , 1 Emergency Medicine, Yale University, New Haven, CT, 2 Psychiatry, 

Yale University, New Haven, CT 

60


68 Associations between non-traditional tobacco product use and ADHD symptoms in adolescents 

N. Goldenson 1 , R. Khoddam 2 , A. Leventhal 1,2 , 1 Preventive Medicine, University of 

Southern California, Los Angeles, CA, 2 Psychology, University of Southern California, 


69 Polydrug use among a cohort of adolescent light smokers 

K. McKelvey, D. Ramo, K. Delucchi, M. Rubinstein, UCSF, San Francisco, CA 

70 Intra-individual changes in Stroop-related neural activations linked to cigarette abstinence in 

adolescent smokers 

S. W. Yip, S. Krishnan-Sarin, I. Balodis, K. Carroll, M. N. Potenza, Psychiatry, Yale 

University, New Haven, CT 

71 Classifying youth substance use with non-invasive questions 

A. Mellis 1 , C. Eddy 3 , C. Franck 3 , A. G. Wilson 2 , M. N. Koffarnus 1 , W. K. Bickel 1 , 1 Addiction 

Recovery Research Center, Virginia Tech Carilion Research Institute, Roanoke, VA, 

2 

Department of Psychology, University of Kentucky, Lexington, Lexington, KY, 3 Department 

of Statistics, Virginia Tech, Blacksburg, VA 

72 Persistence of extra-medical prescription pain reliever use among United States adolescents: 

A latent class analysis 

M. A. Parker, J. C. Anthony, Epidemiology & Biostatistics, Michigan State University, East 

Lansing, MI 

73 Parental permission for adolescent alcohol use at home with friends: Associations with 

demographic factors and risky drinking in Ontario, Canada 

H. Hamilton 1,2 , A. Boak 1 , R. Mann 1,2 , 1 Centre for Addiction and Mental Health, Toronto, ON, 

Canada, 2 Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada 

CRIMINAL JUSTICE 

74 Illegal drug use and criminal behavior among Kentucky juvenile offenders 

C. Leukefeld 2,1 , M. F. Dickson 1 , M. Staton-Tindall 1 , M. Webster 1,2 , C. B. Oser 1,3 , 

H. K. Knudsen 2,1 , K. R. Marks 2 , J. R. Havens 1,2 , 1 Center on Drug and Alcohol Research, 

University of Kentucky, Lexington, KY, 2 Behavioral Science, University of Kentucky, 

Lexington, KY, 3 Sociology, University of Kentucky, Lexington, KY 

75 Delivering HIV-prevention services to criminally-involved adolescents in substance abuse 

treatment 

K. L. Dugosh, D. S. Festinger, Law and Ethics, Treatment Research Institute, Philadelphia, PA 

76 Patterns of substance use and arrest among hospitalized people living with HIV: A latent class 

analysis 

K. Shiu 1 , A. M. Brincks 7 , D. J. Feaster 7 , J. A. Frimpong 1 , L. Gooden 1 , A. Nijhawan 8 , 

R. P. Schwartz 2 , L. Haynes 3 , S. Tross 1 , J. Sorensen 4 , M. Drainoni 9 , R. Mandler 5 , C. del Rio 6 , 

L. R. Metsch 1 , 1 Columbia University, New York, NY, 2 Friends Research Institute, 

Baltimore, MD, 3 MUSC, Charleston, SC, 4 University of California, San Francisco, San 

Francisco, CA, 5 NIDA, Bethesda, MD, 6 Emory University, Atlanta, GA, 7 University of Miami, 

Miami, FL, 8 UT Southwestern Medical Center, Dallas, TX, 9 Boston University, Boston, MA 

77 Substance use and HIV care among Puerto Ricans living with HIV on Rikers Island 

T. Pugh 1 , J. Wiersema 2 , P. Teixeira 3 , 1 SMS, Mailman School of Public Health, NYC, NY, 

2 

NYC Correctional Health Services, NYC, NY, 3 Weill Cornell Medicine, NYC, NY 

61


78 Preliminary outcomes of a brief intervention to reduce HIV and HCV risk among rural women 

M. Staton-Tindall 3 , G. Ciciurkaite 1 , J. R. Havens 2 , B. Peteet 4 , M. Webster 2 , C. B. Oser 1 , 

1 

Sociology, University of Kentucky, Lexington, KY, 2 Behavioral Science, University of 

Kentucky, Lexington, KY, 3 Social Work, University of Kentucky, Lexington, KY, 4 University 

of Cincinnati, Cincinnati, OH 

79 Drugged driving and other high-risk behavior among rural drug-involved female offenders 

M. Webster, M. F. Dickson, M. Staton-Tindall, C. B. Oser, C. Leukefeld, Center on Drug and 

Alcohol Research, University of Kentucky, Lexington, KY 

80 The association between religion/spirituality and 30-day crack/cocaine and marijuana use 

among female offenders 

A. Acheampong 1 , D. C. Vidot 3 , C. W. Striley 2 , L. Cottler 2 , 1 University of Florida, 

Gainesville, FL, 2 Epidemiology, University of Florida, Gainesville, FL, 3 University of Miami 

Miller School of Medicine, Miami, FL 

81 Hallucinogen use is associated with a decreased likelihood of positive urine drug screen 

following entry into community corrections supervision 

P. Hendricks 1 , S. Lappan 1 , K. L. Cropsey 2 , 1 Health Behavior, University of Alabama 

at Birmingham, Birmingham, AL, 2 Psychiatry, University of Alabama at Birmingham, 

Birmingham, AL 

82 History of injection drug use mediates the effect of Project START intervention in men who were 

released from prison in Ukraine 

T. Kiriazova 2 , Y. Sereda 1 , 1 Sociology, Institute for Social Research after Olexander 

Yaremenko, Kyiv, Ukraine, 2 Ukrainian Institute on Public Health Policy, Kyiv, Ukraine 

83 Criminal justice involvement and violence in civilians with substance use disorders and 

posttraumatic stress disorder 

T. Lopez-Castro 2 , D. Hien 1 , S. Papini 3 , 1 Psychology, Adelphi University, NY, NY, 2 Dept. 

of Psychology, The City College of New York, New York, NY, 3 Psychology, University of 

Texas, Austin, TX 

84 Substance use disorders, trauma and victimization in a representative sample of Latino prison 

inmates 

M. Vélez Pastrana 3,1 , R. A. Gonzalez 2,1 , A. Alicea-Rodríguez 1,3 , C. Albizu 1 , 1 Center for 

Evaluation and Sociomedical Research, University of Puerto Rico, San Juan, PR, 2 Centre 

for Mental Health, Imperial College London, London, United Kingdom, 3 Carlos Albizu 

University, San Juan, PR 

85 The pathway to substance misuse for young people with ADHD and conduct disorder 

R. A. Gonzalez 1,2 , G. Gudjonsson 3 , K. Wolff 3 , K. Xenitidis 3 , L. Mutch 3 , I. Mallet-Lambert 3 , 

F. R. Levin 4 , S. Young 1 , 1 Centre for Mental Health, Imperial College London, London, 

United Kingdom, 2 Center for Evaluation and Sociomedical Research, University of Puerto 

Rico Medical Sciences Campus, San Juan, PR, 3 IoP, King’s College London, London, 

United Kingdom, 4 Division on Substance Abuse, New York State Psychiatric Institute, 

New York, NY 

86 The effect of treatment for opioid use disorders on the costs of crime 

E. Krebs 1 , D. Y. Huang 4 , E. Evans 2 , D. Urada 4 , Y. Hser 3 , B. Nosyk 1 , 1 BC Centre for 

Excellence in HIV/AIDS, Vancouver, BC, Canada, 2 UCLA, Los Angeles, CA, 3 Department 

of Psychiatry & Behavioral Sciences, UCLA, Los Angeles, CA, 4 Integrated Substance Abuse 

Programs, UCLA, Los Angeles, Los Angeles, CA 

62


87 Methadone patients in patient-centered treatment: One-year arrest data 

S. M. Kelly 1 , K. E. O’Grady 2 , J. Gryczynski 1 , S. G. Mitchell 1 , J. H. Jaffe 1,3 , R. P. Schwartz 1 , 

1 

Friends Research Institute, Baltimore, MD, 2 Univ. of MD, College Park, MD, 3 Univ. of MD, 

School of Medicine, Baltimore, MD 

88 Addictive behaviors and psychiatric comorbidities of incarcerated women in a French overseas 

territory 

L. Techer 3 , J. Alexandre 2 , D. Mété 3 , M. Auriacombe 2 , M. Fatseas 2 , 2 Addiction Psychiatry 

(CNRS USR 3413), Universite Bordeaux, Bordeaux, France, 3 Addiction Treatment Center, 

CHU Ile de la Réunion, Saint Denis, France 

THEORETICAL 

89 The quest to extend health services to vulnerable substance users in Rio de Janeiro, Brazil, in 

the context of an unfolding economic crisis 

N. Krawczyk 3 , D. Kerrigan 2 , F. I. Bastos 1 , 1 ICICT, Oswaldo Cruz Foundation, Rio de 

Janeiro, Brazil, 2 Health Behavior and Society, Johns Hopkins Bloomberg School of Public 

Health, Baltimore, MD, 3 Mental Health, Johns Hopkins Bloomberg School of Public Health, 

Baltimore, MD 

90 Parallel growth modeling to better understand co-addiction: A randomized clinical trial of 

tobacco smoking and stimulant use 

M. Mamey 1 , L. Burns 1 , C. Barbosa-Leiker 2 , C. Parks 1 , S. McPherson 2 , 1 Psychology, 

Washington State University, Pullman, WA, 2 College of Nursing, Washington State 

University, Spokane, WA 

91 Dealing with zero-numerators in estimating drug-dependence chances: A Bayesian approach 

O. A. Vsevolozhskaya 3 , F. A. Wagner 2 , J. C. Anthony 1 , 1 Michigan State University, East 

Lansing, MI, 2 PSRC, Morgan State University, Baltimore, MD, 3 Biostatistics, University of 

Kentucky, Lexington, KY 

92 Statistical assessment of abuse-deterrent opioids 

L. Chen, FDA/CDER, Silver Spring, MD 

93 A theory of social roles in addiction and recovery suitable for dynamic simulation modeling 

E. Stringfellow, Brown School of Social Work, Washington University in St. Louis, St. 

Louis, MO 

94 Driving impairment of CNS prescription and non-prescription drugs 

T. Hopyan 2 , R. Mann 1,3 , C. Wickens 1,3 , 1 Center for Addiction & Mental Health, Toronto, ON, 

Canada, 2 INC Research, Toronto, ON, Canada, 3 University of Toronto, Toronto, ON, Canada 

95 Assessing the abuse potential of botanical substances 

K. Bonson, A. Trachtenberg, M. Klein, Controlled Substance Staff, Food and Drug 

Administration, Silver Spring, MD 

96 Pre-clinical abuse testing applications in drug development 

J. Randall-Thompson, M. Klein, Controlled Substance Staff, Food and Drug Administration, 

Silver Spring, MD 

97 FDA role in the drug scheduling process of a drug under development 

S. N. Calderon, D. Chiapperino, M. Klein, CDER/CSS, Food and Drug Administration, Silver 

Spring, MD 

98 Assessment of the abuse potential and benefits of kratom and its mitragynine alkaloids: 

Implications for regulation 

R. K. Lanier 1 , R. V. Fant 2 , E. Cone 2 , J. Henningfield 2 , 1 US Naturals, Washington, DC, 2 Pinney 

Associates, Bethesda, MD 

63


99 Readiness to change is a predictor of reduced substance use involvement: Findings from a 

randomized controlled trial of patients attending South African emergency departments 

B. Myers 1 , D. J. Stein 2 , K. Sorsdahl 2 , 1 Alcohol, Tobacco and Other Drug Research Unit, South 

African Medical Research Council, Tygerberg, South Africa, 2 University of Cape Town, Cape 

Town, South Africa 

CLUB/DESIGNER DRUGS 

100 Dopaminergic mediation of the discriminative stimulus effects of three cathinone analogs of 

MDMA 

S. Dolan 2 , M. B. Gatch 1 , 1 Pharmacology & Neuroscience, UNT Health Science Center, Fort 

Worth, TX, 2 Institute for Healthy Aging, Center for Neuroscience Discovery, University of 

North Texas Health Science Center, Fort Worth, TX 

101 Entactogenic effects of synthetic cathinones 

M. B. Gatch, M. J. Forster, Center for Neuroscience Discovery, UNT Health Science Center, 

Fort Worth, TX 

102 Comparison of anomalous experiences after ingesting psilocybin mushrooms in research and 

non-research settings 

T. M. Carbonaro, M. W. Johnson, R. R. Griffiths, Johns Hopkins University, Baltimore, MD 

103 Reliability and validity of the Japanese version of the DAST-2 

T. Shimane, T. Matsumoto, Department of Drug Dependence Research, National Institute of 

Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan 

STIMULANTS: ANIMAL STUDIES 

104 Participation of CC-Chemokine ligands in reward system on methamphetamine-induced 

psychological dependence in mice 

S. Kishioka 1 , F. Saika 1 , S. Matsuzaki 1 , M. Ko 2 , N. Kiguchi 1,2 , 1 Pharmacology, Wakayama 

Medical University, Wakayama, Japan, 2 Physiology and Pharmacology, Wake Forest 

University School of Medicine, Winston-Salem, NC 

105 Pharmacological effects of injected or vaporized methamphetamine and alpha-PVP in mice 

J. A. Marusich, T. Lefever, B. Blough, B. F. Thomas, J. Wiley, RTI International, Research 

Triangle Park, NC 

106 Combined effects of a serotonin 5HT2C receptor agonist and a serotonin 5HT2A receptor 

antagonist on methamphetamine-induced sleep disruption evaluated with actigraphy in rhesus 

monkeys 

L. F. Berro, M. Peres Diaz, M. L. Andersen, L. Howell, Emory University, Atlanta, GA 

107 Effects of lorcaserin on cocaine and methamphetamine self-administration and on reinstatement 

of extinguished responding in rhesus monkeys 

L. R. Gerak 1 , G. T. Collins 1,2 , C. P. France 1,3 , 1 Pharmacology, University of Texas Health 

Science Center, San Antonio, TX, 2 South Texas Veterans Health Care System, San 

Antonio, TX, 3 Psychiatry, University of Texas Health Science Center, San Antonio, TX 

108 Cocaine-cue memory extinction is associated with depotentiation at amygdala synapses 

M. T. Rich, T. Cahanap, Y. Huang, M. M. Torregrossa, University of Pittsburgh, Pittsburgh, PA 

109 Regulation of gene expression of the delta opioid receptor, corticotropin-releasing hormone, 

and CRH-1 receptor during withdrawal from chronic cocaine 

K. L. Connelly, E. M. Unterwald, Center for Substance Abuse Research, Temple University 

Lewis Katz School of Medicine, Philadelphia, PA 

110 Crabp2 and Fabp5 mediated retinoic acid signaling is a novel mechanism controlling 

depression- and addiction-related behavior 

Y. Zhang, E. Crofton, S. Koshy, T. Green, University of Texas Medical Branch, Galveston, TX 

64




111 Hyperactivity, but not anxiety-like, behavior is observed in rats receiving chronic cocaine 

followed by exposure to single prolonged stress 

S. A. Perrine, M. J. Lisieski, Psychiatry and Behavioral Neurosciences, Wayne State 

University School of Medicine, Detroit, MI 

112 Disruption of the serotonin 5-HT 2C 

receptor interaction with protein phosphatase and tensin 

homologue regulates the behavioral effects of the selective 5-HT 2C 

R agonist WAY163909 

C. Soto 3 , R. G. Fox 3 , N. C. Anastasio 3,1 , H. C. Du 2 , S. Gilbertson 2 , K. A. Cunningham 3,1 , 

1 

Department of Pharmacy & Toxicology, UTMB, Galveston, TX, 2 Department of Chemistry, 

University of Houston, Houston, TX, 3 Center for Addiction Research, UTMB, Galveston, TX 

113 Crack cocaine users with high family/social problems show more psychiatric symptoms and 

violent behaviors 

M. P. Pachado 1,3 , J. N. Scherer 1,3 , L. S. Guimaraes 1,3 , N. Marchi 1,3 , R. Almeida 3 , 

F. P. Pechansky 2,3 , F. H. Kessler 2,3 , 1 Psychiatric Dept, Center for Drug and Alcohol Research, 

Porto Alegre, Brazil, 2 Psychiatry, Center for Drug and Alcohol Studies at HCPA/UFRGS, 

Porto Alegre, Brazil, 3 Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 

114 Mediational pathways among trait impulsivity, use consequences, and quit attempts in cocaine users 

E. A. Woodcock 1 , J. J. Lister 2 , L. H. Lundahl 1 , M. Greenwald 1 , 1 Psychiatry, Wayne State 

University, Detroit, MI, 2 Social Work, Wayne State University, Detroit, MI 

Symposium IX Tuesday, 

TRANSLATIONAL MARKERS OF SUBSTANCE USE 

VULNERABILITY: RECEPTORS, RISK-PROCESSING, 

AND PSYCHOPATHOLOGY 

6/8 

2:15 - 3:15 PM 

Chairs: Noelle C. Anastasio and Thomas J. Crowley 

2:15 Interrogations into the neuromolecular underpinnings of inherent impulsivity in rodents 

Noelle C Anastasio, University of Texas Medical Branch at Galveston, Galveston, TX 

2:35 Brain-driven vulnerability to substance use disorders: Do brains make drug abusers? 

Thomas J Crowley, University of Colorado School of Medicine, Aurora, CO 

2:55 Interventions targeting endophenotypes of risk for addiction 

Patricia Conrod, University of Montreal, Catherine Montreal, QC, Canada 

Symposium X Tuesday, 

IMAGING THE MALE & FEMALE ADDICTED BRAIN: 

STRUCTURAL AND FUNCTIONAL DIFFERENCES 

AND IMPLICATIONS FOR PRECISION MEDICINE 

10/14 

2:15 - 3:15 PM 

Chairs: Cora Lee Wetherington and Will Aklin 

2:15 Brain structure and function in female compared to male stimulant users with long-term 

abstinence 

Jody Tanabe, University of Colorado Denver School of Medicine, Aurora, CO 

2:35 Imaging the dopamine signature in tobacco smokers 

Kelly Cosgrove, Yale University, New Haven, CT 

2:55 Functional brain connectivity in addictions: The impact of sex and early trauma 

Kathleen T. Brady, Medical University of South Carolina, Charleston, SC 

65





SON OF FLUBBER: CHEMISTRY 

Chairs: Jun Zhu and Linda Dwoskin 

4 

2:15 - 3:15 PM 

2:15 Tyrosine470 and 88 of human dopamine transporter are responsible for the allosteric 

modulatory effect of SRI-30827, SRI-20041 and HIV-1 Tat protein on dopamine transporter 

J. Zhu 1 , W. Sun 2 , S. Ananthan 4 , C. Zhan 5 , 1 Drug Discovery and Biomedical Sciences, South 

Carolina College of Pharmacy, University of South Carolina, Columbia, SC, 2 Drug Discovery 

and Biomedical Sciences, University of South Carolina, Columbia, SC, 4 Organic Chemistry, 

Southern Research Institute, Birmingham, AL 

2:30 Oral JPC-077, a vesicular monoamine transporter-2 inhibitor, reduces methamphetamine 

self-administration across repeated treatments 

A. Wilson 3 , N. Lee 2 , J. R. Nickell 2 , J. P. Culver 2 , V. Janganati 4 , G. Zheng 4 , P. A. Crooks 4 , 

L. P. Dwoskin 2 , M. T. Bardo 3 , 2 Pharmaceutical Sciences, University of Kentucky, 

Lexington, KY, 3 Psychology, University of Kentucky, Lexington, KY, 4 University of 

Arkansas for Medical Sciences, Little Rock, AR 

2:45 Stereoselective differences in the reinforcing effects of “bath salts” constituent 

3,4-methylenedioxypyrovalerone under a progressive ratio schedule of reinforcement in rats 

B. M. Gannon 1 , K. Galindo 1 , K. Rice 2 , G. T. Collins 1,3 , 1 Pharmacology, University of Texas 

Health Science Center at San Antonio, San Antonio, TX, 2 Chemical Biology Research 

Branch, NIDA and NIAAA, Bethesda, MD, 3 South Texas Veterans Health Care System, 


3:00 Investigation of the κ-opioid receptor agonist CR845 and reference comparator, butorphanol, in 

rats trained to discriminate (-) pentazocine from saline 

D. J. Heal 2 , J. Gosden 2 , N. Slater 2 , R. H. Spencer 1 , F. Menzaghi 1 , 1 Cara Therapeutics, 

Shelton, CT, 2 RenaSci Ltd, Nottingham, United Kingdom 


SHAWSHANK REDEMPTION: CRIMINAL JUSTICE 

Chairs: Carlos C. Mahaffey and David S. Festinger 

12 

2:15 - 3:15 PM 

2:15 Attitudes and practices on the use of extended-release naltrexone in criminal justice settings 

D. S. Festinger 1 , K. L. Dugosh 1 , D. R. Gastfriend 3 , C. Sierka 1 , 1 Law and Ethics, Treatment 

Research Institute, Philadelphia, PA, 3 Treatment Research Institute, Philadelphia, PA 

2:30 An evaluation of opioid substitution treatment in prison on risk of mortality in period 

immediately after prison: Does leaving prison on OST reduce the risk of death? 

G. Stillwell 1 , H. Jones 2 , J. Shaw 3 , M. Farrell 4 , J. Marsden 1 , 1 National Addiction Centre, 

Institute of Psychiatry, Kings College London, London, United Kingdom, 2 School of Social 

and Community Medicine, University of Bristol, Bristol, United Kingdom, 3 Institute of Brain, 

Behaviour and Mental Health, University of Manchester, Manchester, United Kingdom, 

4 

National Drug and Alcohol Research Centre, University of New South Wales, Sydney, NSW, 

Australia 

2:45 Alcohol and cocaine use and drug distribution among formerly incarcerated black men 

C. C. Mahaffey 2 , D. Stevens-Watkins 1 , C. Leukefeld 3 , 1 Spalding University, Louisville, KY, 

2 


Lexington, KY 

66




3:00 The Silk Road Health Project: The intersection between criminal justice involvement, substance 

use and HIV risks among migrant and non-migrant workers in Almaty, Kazakhstan 

P. Marotta, N. El-Bassel, Columbia University, New York, NY 

Symposium XI Tuesday, 

NOT YOUR AVERAGE JOINT: ALTERNATIVE METHODS 

OF CANNABIS ADMINISTRATION 

6/8 

3:30 - 5:30 PM 

Chairs: Adam Leventhal and Marcel Bonn-Miller 

3:30 Dose effects of oral cannabis administration 

Ryan Vandrey, Johns Hopkins University School of Medicine, Baltimore, MD 

3:55 Patterns of vaping cannabis among adolescent and adult cannabis users 

Dustin C. Lee, Geisel School of Medicine at Dartmouth, Lebanon, NH 

4:20 Routes of cannabis consumption as a function of clinical status 

Marcel O. Bonn-Miller, VA Palo Alto Health Care System & University of Pennsylvania, 

Menlo Park, CA 

4:45 Prevalence and correlates of cannabis vaping, smoking, and edible use among adolescents 

Adam Leventhal, University of Southern California Keck School of Medicine, 


5:10 DISCUSSANT: Leveraging alternative methods of cannabis administration research to inform 

science, practice, and policy 

Alan J. Budney, Geisel School of Medicine at Dartmouth, Lebanon, NH 


DAYS OF WINE AND ROSES: ALCOHOL 

4 

3:30 - 5:30 PM 

Chairs: Elise M. Weerts and Erica McGrath 

3:30 Regional- and sex-dependent effects of chronic ethanol and cocaine co-administration on adult 

neural stem cell survival and differentiation 

E. McGrath 1,3,4 , P. Wu 3 , K. A. Cunningham 1 , T. Dunn 3 , J. Gao 3 , A. C. Grant 3 , K. Dineley 2 , 

J. Allende-Labastida 6 , B. Kaphalia 7 , 1 Center for Addiction Research, University of Texas 

Medical Branch, Galveston, TX, 2 Neurology, University of Texas Medical Branch, 

Galveston, TX, 3 Neuroscience and Cell Biology, University of Texas Medical Branch, 

Galveston, TX, 4 Institute for Translational Science, University of Texas Medical Branch, 

Galveston, TX, 6 Cell Biology, University of Texas Medical Branch, Galveston, TX, 

7 

Toxicology, University of Texas Medical Branch, Galveston, TX 

3:45 Comparison of the reinforcing efficacy of midazolam, ethanol, and mixtures of the two 

in male rats 

D. Townsend 1 , J. K. Rowlett 1,2 , D. Platt 1 , K. Freeman 1 , 1 University of Mississippi Medical 

Center, Jackson, MS, 2 Comparative Pathology, Tulane National Primate Research Center, 

Covington, LA 

4:00 Naltrexone reduces appetitive and consummatory responses to alcohol in a sex-dependent 

manner in rats 

S. J. Nieto, K. J. Winoske, T. A. Kosten, Psychology, University of Houston, Houston, TX 

67



4:15 The peroxisome proliferator-activated receptor alpha agonist fenofibrate attenuates alcohol 

self-administration in rats 

C. N. Haile 1,2,3 , T. A. Kosten 1,2,3 , 1 Psychiatry, Baylor College of Medicine, Houston, TX, 

2 

Psychology & TIMES, University of Houston, Houston, TX, 3 Michael E. DeBakey VA 

Medical Center, Houston, TX 

4:30 Reduction of alcohol self-administration by 3-ISO-PBC 

E. M. Weerts 1 , V.V.N.P.B. Tiruveedhulaand 2 , J. M. Cook 2 , 1 Psychiatry and Behavioral 

Sciences, Johns Hopkins University, Baltimore, MD, 2 Department of Chemistry & 

Biochemistry, University of Wisconsin Milwaukee, Milwaukee, WI 

4:45 Inhibitory processing predicts increases in binge-drinking behavior: A six-month longitudinal 

design 

A. L. Paz 2 , J. Conniff 1 , D. Ferrato 1 , R. Gonzalez 3 , M. Rosselli 1 , 1 Florida Atlantic University, 

Davie, FL, 2 Neuropsychology, Florida Atlantic University, Miami, FL, 3 Florida International 

University, Miami, FL 

5:00 Rates of homelessness and factors that predict them among homeless, alcohol-dependent adults 

in a therapeutic workplace clinical trial 

A. Holtyn 1 , E. Carlson 1 , B. Jarvis 2 , M. Fingerhood 1 , K. Silverman 2 , 1 Johns Hopkins, 

Baltimore, MD, 2 Johns Hopkins University School of Medicine, Baltimore, MD 

5:15 Treatment for alcohol use disorders in seriously mentally ill adults using the ethyl glucuronide 

biomarker 

M. G. McDonell 1 , E. Leickly 1 , S. McPherson 1 , D. Srebnik 2 , J. M. Roll 1 , R. Ries 2 , J. Skalisky 1 , 

1 

Washington State University, Spokane, WA, 2 University of Washington, Seattle, WA 


DUE DATE: PERINATAL DRUG ABUSE 

12 

3:30 - 5:30 PM 

Chairs: Loretta Finnegan and Qiana Brown 

3:30 Cannabis use during pregnancy for the United States, 2005-2013 

O. Alshaarawy 1,2 , J. C. Anthony 1 , 1 Epidemiology and Biostatistics, Michigan State University, 

East Lansing, MI, 2 Epidemiology and Biostatistics, Indiana University, Bloomington, IN 

3:45 Trends in marijuana use among reproductive age women: 2002-2013 

Q. Brown 1 , D. Shmulewitz 1,2 , S. S. Martins 1 , D. Hasin 1,2 , 1 Columbia University, 

New York, NY, 2 New York State Psychiatric Institute, New York, NY 

4:00 Marijuana doesn’t count: Is objective screening in obstetrics clinics needed to identify and 

assist pregnant marijuana users? 

T. Northrup 1 , M. R. Klawans 1 , Y. Villarreal 1 , P. Berens 2 , A. Stotts 1 , 1 Family and Community 

Medicine, University of Texas Health Science Center at Houston, Houston, TX, 2 OB/GYN, 

University of Texas Health Science Center at Houston, Houston, TX 

4:15 Prevalence of prenatal cigarette smoking and marijuana use in North Delaware State 

Y. Washio, R. Butler, N. D. Goldstein, M. K. Hoffman, Christiana Care Health Services, 

Newark, DE 

68



4:30 Microstructural brain development in infants with prenatal stimulant exposure during first three 

months of age 

L. Chang 1 , K. Oishi 2 , J. Skranes 3 , S. Buchthal 1 , E. Cunningham 1 , C. Jiang 1 , D. Alicata 1 , 

R. Yamakawa 1 , S. Hayama 1 , T. Ernst 1 , 1 University of Hawaii, John A. Burns School of 

Medicine, Honolulu, HI, 2 Johns Hopkins Medicine, Baltimore, MD, 3 Norwegian University 

Science and Technology, Tronheim, Norway 

4:45 Bupropion therapy during pregnancy: Concentrations of the drug and its major metabolites in 

umbilical cord plasma and amniotic fluid 

V. M. Fokina 1 , H. West 1 , C. Oncken 2 , S. Clark 1 , M. S. Ahmed 1 , G. Hankins 1 , T. Nanovskaya 1 , 

1 

OB/GYN Maternal Fetal Medicine, University of Texas Medical Branch, Galveston, TX, 

2 

University of Connecticut Health Center, Farmington, CT 

5:00 Benzodiazepine and other illicit drug use during methadone-maintained pregnancies: 

2002-2011 

D. J. Hand, K. Kaltenbach, V. Short, D. J. Abatemarco, Pediatrics, Thomas Jefferson 

University, Philadelphia, PA 

5:15 WITHDRAWN - Factors associated with cocaine use in pregnancy 

R. M. Nagarajan, X. Cai, C. Hine, B. Merry, K. A. Yonkers, Psychiatry, Yale University, 

New Haven, CT 


MISERY: PAIN 

10/14 

3:30 - 4:30 PM 

Chairs: Launette M. Rieb and Caroline A. Arout 

3:30 Pain as a predictor and consequence of tobacco withdrawal among African-American smokers 

J. F. McBeth 1 , J. Ditre 2 , M. Kirkpatrick 1 , L. Ray 3 , A. Leventhal 4 , 1 Preventive Medicine, 

University of Southern California, Camarillo, CA, 2 Psychology, Syracuse University, 

Syracuse, NY, 3 Psychology, University of California Los Angeles, Los Angeles, CA, 

4 

Preventive Medicine, University of Southern California, Los Angeles, CA 

3:45 Marijuana use in adults with sickle cell disease 

A. Forray 2 , J. Bozzo 3 , J. Cole 3 , J. Spodick 3 , J. D. Roberts 1 , 1 Yale School of Medicine, 

New Haven, CT, 2 Psychiatry, Yale School of Medicine, New Haven, CT, 3 Yale-New Haven 

Hospital, New Haven, CT 

4:00 Healed injury sites can hurt again during opioid withdrawal: A descriptive case series 

L. M. Rieb 2,1 , W. Norman 2 , R. Martin 3 , J. Berkowitz 2,4 , E. Wood 1,5 , M. Miloy 1,5 , 1 BC Centre 

for Excellence in HIV/AIDS, Vancouver, BC, Canada, 2 Family Practice, University of 

British Columbia, Vancouver, BC, Canada, 3 School of Population and Public Health, 

University of British Columbia, Vancouver, BC, Canada, 4 Sauder School of Business, UBC, 

Vancouver, BC, Canada, 5 Medicine, UBC, Vancouver, BC, Canada 

4:15 Rates and correlates of specialized pain clinic use nationally in the Veterans Health 

Administration 

C. A. Arout 2 , M. Sofuoglu 1,3 , R. A. Rosenheck 2,3 , 1 Psychiatry, Yale University, 

West Haven, CT, 2 Psychiatry, Yale University School of Medicine, New Rochelle, NY, 

3 

Mental Illness Research, Education, and Clinical Center, Veterans Health Administration, 

West Haven, CT 

69

June 14, 2016 






CLEAN AND SOBER: WITHDRAWAL 

10/14 

4:45 - 5:45 PM 

Chairs: Scott E. Lukas and Meg Haney 

4:45 Parallel changes in brain GABA levels, sleep and mood state during acute cocaine withdrawal: 

Predictors of “readiness for treatment”? 

S. E. Lukas 2 , C. Zuo 2 , N. Dias 1 , A. Janes 2 , J. Betts 1 , W. Tartarini 1 , M. L. Copersino 2 , 

D. Penetar 2 , 1 McLean Hospital/Harvard Medical School, Belmont, MA, 2 Psychiatry, McLean 

Hospital/Harvard Medical School, Belmont, MA 

5:00 Nicotine withdrawal induces negative correlation in resting connectivity between insula and 

executive control networks in smokers 

A. L. Matous, J. Fedota, K. Slater, B. Salmeron, H. Gu, T. Ross, E. Stein, NIDA-IRP, 

Baltimore, MD 

5:15 Premenstrual symptom severity and tobacco withdrawal, craving, and mood after overnight 

tobacco abstinence 

R. Pang 1 , A. Leventhal 2 , 1 University of Southern California, Los Angeles, CA, 2 Preventive 

Medicine, University of Southern California, Los Angeles, CA 

5:30 Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and relapse 

among non-treatment-seeking cannabis users 

E. S. Herrmann, Z. Cooper, G. Bedi, D. Ramesh, S. C. Reed, S. D. Comer, R. Foltin, 

M. Haney, New York State Psychiatric Institute, New York, NY 

Film Night Tuesday, 

THE HUNGRY HEART 

A documentary about prescription drug abuse 

Produced and directed by Bess O’Brien 

MIT- Town Hall Tuesday, 

Workshop X Tuesday, 

RESEARCH AND EMERGING STRATEGIES FOR PARENTS 

OF SUBSTANCE INVOLVED ADOLESCENTS AND YOUTH: 

RESULTS FROM NIDA’S PARENTS’ TRANSLATIONAL 

RESEARCH CENTER 

CAPRA 

7:00 - 9:00 PM 

4 

5:45 - 6:45 PM 

12 

7:00 - 9:00 PM 

Chairs: Kimberly C. Kirby and Elena Bresani 

Addressing adolescent substance use: Parental perspectives 

Brenda L Curtis, Department of Psychiatry, University of Pennsylvania School of Medicine, 


Quality indicators for adolescent SAT: The consumer guide to adolescent treatment 

Kathleen Meyers, Treatment Research Institute, Philadelphia, PA 

70




Adolescent treatment for substance abuse: What goes on outside of specialty treatment? 

Mary Tabit, Treatment Research Institute, Philadelphia, PA 

Community reinforcement and family training (CRAFT) for parents: Efficacy and online 

training program 

Kimberly C Kirby, Departments of Psychology and Biomedical Sciences, Rowan University, 

Glassboro, NJ 

Discussant: Making sense of needs and quality treatment 

David R Gastfriend, American Society of Addiction Medicine, Newtown Center, ME 

Workshop XI Tuesday, 

ANNUAL CPDD DESIGN AND ANALYSIS WORKSHOP 

10/14 

7:00 - 9:00 PM 

Chairs: Sterling M. McPherson and Susan K. Mikulich-Gilbertson 

Potential peril lurking in substance variables that are ratios 

Susan Kay Mikulich-Gilbertson, University of Colorado Anschutz Medical Center, 

Aurora, CO 

Testing invariance of growth models to examine gender differences in substance use outcomes 

from clinical trials 

Celestina Barbosa-Leiker, Washington State University, College of Nursing, Spokane, WA 

Issues in the measurement and analysis of health-related quality of life in populations with 

substance use disorders 

Bohdan Nosyk, BC Centre for Excellence in HIV/AIDS, Vancouver BC, BC, Canada 

An introduction to machine learning and potential uses in substance use research 

Daniel J. Feaster, University of Miami Miller School of Medicine, Miami, FL 

Toward precision addiction medicine: Applying machine learning techniques to predict and 

model treatment response on an individual level 

Sean Luo, Columbia University, New York, NY 

Workshop XII Tuesday, 

EDUCATION IN DRUG ABUSE 

4 

7:00 - 9:00 PM 

Chairs: Michael Kuhar and Jack Stein 

Online degree programs 

Robert Balster, Virginia Commonwealth University, Richmond, VA 

Those amazing MOOCs 

Michael Kuhar, Emory University, Atlanta, GA 

Available knowledge: What should a physician/scientist in the 21st century know? 

Bertha Madras, Harvard University, Belmont, ME 

Discussant: Discovering NIDA’s research portfolio 

Jack Stein, National Institute on Drug Abuse, Bethesda, MD 

71



Workshop XIII Tuesday, 

REGULATORY AND METHODOLOGICAL CONSIDERATIONS 

IN THE EVALUATION OF DRUG DEPENDENCE IN THE 

PRECLINICAL AND CLINICAL SETTING 

Chairs: Beatrice Setnik and Michael Klein 

6/8 

7:00 - 9:00 PM 

Regulatory and methodological considerations in the assessment of drug dependence and 

withdrawal in humans 

Alicja Lerner, Controlled Substances Staff, FDA, Silver Spring, MD 

Untangling dependence, tolerance, and addiction – An examination of definitions and 

diagnostic criteria 

Jack Henningfield, Pinney Associates, The Johns Hopkins School of Medicine, Bethesda, MD 

An overview of preclinical models to assess physical and psychological dependence and their 

translation to the clinic 

David John Heal, RenaSci, Ltd, BioCity, Nottingham, United Kingdom 

Analyzing and interpreting adverse events related to withdrawal and dependence 

Sian Ratcliffe, Pfizer Inc., Groton, CT 

DISCUSSANT: Practical considerations for the assessment of drug dependence in animal, 

patient and healthy volunteer populations 

Beatrice Setnik, INC Research, Raleigh, NC 

72




Wednesday, June 15, 2016 

Population Neuroscience Wednesday, 

TOWARDS POPULATION NEUROSCIENCE 

6/8 

8:00 - 10:00 AM 

Chairs: Carlos Blanco and A. Roger Little 

Priorities within the division of neuroscience and behavior: Overview and opportunities 

A. Roger Little, NIDA, Bethesda, MD 

Research priorities for epidemiology, services and prevention 

Carlos Blanco, NIDA, Bethesda, MD 

Animal Forum Wednesday, 

STUDYING ADDICTION IN MALE AND FEMALE ANIMALS: 

TRANSLATION TO HUMANS 

4 

8:00 - 10:00 AM 

Chairs: Marilyn E. Carroll and Mark S. Todtenkopf 

8:00 Sex influences on brain and body: An issue whose time has come 

Larry Cahill, UC Irvine, Irvine, CA 

9:00 Sex differences in behavioral dyscontrol, addiction and treatment: Translation from animals 

to humans 

John R. Smethells, University of Minnesota 

9:30 Power analysis for animal studies of sex differences in addiction 

Mark S Todtenkopf, Alkermes, Inc., Waltham, MA 

Symposium XII Wednesday, 

MEDICINAL CHEMISTRY OF NOVEL KAPPA OPIOID 

RECEPTOR LIGANDS 

4 

10:15 - 12:15 PM 

Chairs: F. I. Carroll and Thomas Prisinzano 

10:15 Small changes in macrocyclic tetrapeptide structure have significant impact on opioid activity 

in vivo 

Jane Aldrich, University of Florida, Gainesville, FL 

10:40 Development of neoclerodane-based drug abuse medication 

Thomas Prisinzano, University of Kansas, Lawrence, KS 

11:05 Biased kappa opioid receptor ligands: Chemistry, pharmacology, and physiology 

Jeff Aubé, University of North Carolina, Chapel Hill, NC 

11:30 New JDTic analogs as potential pharmacotherapies for treating substance abuse 

Ivy Carroll, Research Triangle Institute, Research Triangle Park, NC 

11:55 DISCUSSANT: 

Linda P Dwoskin, University of Kentucky, Lexington, KY 

73




Symposium XIII Wednesday, 

BIO-BEHAVIORAL RESEARCH ON HIV AMONG 

PEOPLE WHO USE DRUGS 

6/8 

10:15 - 12:15 PM 

Chairs: Christina S. Meade and Adam Carrico 

10:15 Bio-behavioral outcomes from the women’s health CoOp: The seek, test, treat and retain model 

in Pretoria, South Africa 

Wendee Wechsberg, RTI International, Research Triangle Park, NC 

10:40 Prospects of ending the HIV epidemic among people who inject drugs in Haiphong, Vietnam 

Don Des Jarlais, Icahn School of Medicine at Mount Sinai, New York, NY 

11:05 Impact of HIV infection and cocaine dependence on decision-making processes: Results from a 

functional neuroimaging study 

Christina S Meade, Duke University, Durham, NC 

11:30 Optimizing biomedical approaches to HIV prevention with substance-using men who have sex 

with men 

Adam Carrico, University of California San Francisco, San Francisco, CA 

11:55 DISCUSSANT: NIH and NIDA priorities for HIV/AIDS research 

Shoshana Kahana, National Institute on Drug Abuse, Bethesda, MD 

Oral Communications 15 Wednesday, 

A BEAUTIFUL MIND: CO-MORBIDITIES 

10/14 

10:15 - 12:15 PM 

Chairs: Marc Auriacombe and Cathryn Glanton Holzhauer 

10:15 How psychiatric comorbidity and mood states influence craving and substance use in daily life? 

An ecological momentary assessment study in patients with alcohol, tobacco, cannabis and 

heroin use disorders 

F. Serre 2 , M. Fatseas 2 , J. Swendsen 3 , M. Auriacombe 2 , 2 Addiction Psychiatry (CNRS USR 

3413), Universite Bordeaux, Bordeaux, France, 3 CNRS UMR 5287 - INCIA, Univ. Bordeaux, 

Bordeaux, France 

10:30 Are greater consequences in polysubstance-using women related to anxiety? 

C. Glanton Holzhauer 1 , E. Wulfert 2 , 1 Psychiatry, University of Massachusetts Medical School, 

Worcester, MA, 2 Psychology, University at Albany, SUNY, Albany, NY 

10:45 Prevalence and correlates of hazardous alcohol use and co-occurring mental health problems 

in Nepal following the 2015 earthquakes 

J. C. Kane 1 , N. Luitel 2 , M. J. Jordans 3,4 , B. A. Kohrt 5 , M. Greene 1 , W. A. Tol 1,6 , 1 Mental 

Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2 Transcultural 

Psychosocial Organization, Kathmandu, Nepal, 3 Research and Development, Healthnet 

TPO, Amsterdam, Netherlands, 4 Centre for Global Mental Health, Institute of Psychiatry, 

Psychology and Neuroscience, Kings College, London, United Kingdom, 5 Duke Global Health 

Institute, Duke University, Durham, NC, 6 Peter C. Alderman Foundation, Bedford, NY 

74



11:00 1-Year post-treatment outcomes from a RCT of a behavioral activation treatment for substance 

use and depression 

K. A. Johnson, C. Seitz-Brown, K. Anderson, D. Degeorge, E. Blevins, S. B. Daughters, 

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, 

Chapel Hill, NC 

11:15 Neuropharmacological investigation of withdrawal-induced inhibitory control deficits among 

smokers with ADHD 

F. J. McClernon, S. H. Kollins, R. Kozink, M. Hallyburton, M. Sweitzer, J. Oliver, Psychiatry 

and Behavioral Sciences, Duke Univ. Medical Center, Durham, NC 

11:30 The prevalence of adult attention deficit/hyperactivity disorder among treatment-seeking 

problem gamblers 

L. Brandt 1 , G. Fischer 1,2 , 1 Center for Public Health, Medical University of Vienna, Vienna, 

Austria, 2 Department for Psychiatry and Psychotherapy, Medical University of Vienna, 

Vienna, Austria 

11:45 Internalizing symptoms and conduct problems: Redundant, incremental, or interactive risk 

factors for substance use during the first year of high school? 

R. Khoddam 1 , N. Jackson 1 , A. Leventhal 2 , 1 Psychology, University of Southern California, 

Los Angeles, CA, 2 Preventive Medicine, University of Southern California, Los Angeles, CA 

12:00 Anxiety and depression as predictors of long-term abstinence among stimulant-dependent 

outpatients in a clinical trial of concurrent smoking cessation and substance abuse treatment 

K. Sanchez1,2, 1School of Social Work, University of Texas at Arlington, Arlington, TX, 

2Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 


THE SOCIAL NETWORK 

12 

10:15 - 12:15 PM 

Chairs: Warren K. Bickel and Deena Peyser 

10:15 The effects of social contact on “binge” cocaine self-administration 

A. M. Robinson 3 , R. Lacy 1 , J. C. Strickland 2 , C. P. Magee 3 , M. A. Smith 3 , 1 Psychology, 

Franklin and Marshall, Lancaster, PA, 2 University of Kentucky, Lexington, KY, 3 Psychology, 

Davidson College, Davidson, NC 

10:30 Prosocial effects and neurotoxicity of (–)-3,4-methylenedioxymethamphetamine in mice 

D. Curry, A. Belkoff, L. Howell, Yerkes National Primate Research Center, Emory 

University, Atlanta, GA 

10:45 Social reinstatement: A rat model of peer-induced relapse 

V. G. Weiss 2 , J. R. Yates 1 , M. T. Bardo 3 , 1 Experimental Psychology, University of Kentucky, 

Lexington, KY, 2 Psychology, University of Kentucky, Lexington, KY, 3 University of 

Kentucky, Lexington, KY 

11:00 Social facilitation of alcohol effects predicts self-reported progression of use in adolescents 

M. Kirkpatrick, R. Pang, M. Stone, A. Leventhal, Preventive Medicine, University of Southern 

California, Los Angeles, CA 

11:15 Social networks, support, and alcohol use among late middle-aged and older adults 

S. Kim 1 , S. Spilman 2 , D. Liao 2 , P. Sacco 3 , A. Moore 2 , 1 UCLA Integrated Substance Abuse 

Programs, Los Angeles, CA, 2 University of California, Los Angeles, Los Angeles, CA, 

3 

University of Maryland, Baltimore, MD 

75


11:30 Age- and gender-specific impacts of social influences on last 30-day marijuana use 

J. E. Goldstick, Q. Epstein-Ngo, J. Heinze, H. Hsieh, M. Walton, R. Cunningham, 

M. Zimmerman, University of Michigan, Ann Arbor, MI 

11:45 Do as I say, not as I do: A unique social support network among women, but not men, seeking 

treatment for alcohol and drug use disorders 

D. Peyser, J. Buckman, L. Banu, M. Bates, Psychology, Rutgers University, Piscataway, NJ 

12:00 The social interactome of recovery: Network topology influences social media engagement 

W. K. Bickel 1 , A. Quisenberry 1 , P. Chandrasekar 2 , M. N. Koffarnus 1 , E. A. Fox 2 , C. Franck 2 , 

1 

Addiction Recovery Research Center, Virginia Tech Carilion Research Institute, 

Roanoke, VA, 2 Virginia Tech, Blacksburg, VA 

Poster Session III 

(Lunch) 



Set-up time begins Tuesday, 3 PM 

Must be removed by Wednesday 2:30 PM 

OPIOID TREATMENT 

1 Gender differences in timing of reminder messages for automated, CBT-based treatment for 

methadone 

D. M. Printz 1 , F. D. Buono 1 , D. P. Lloyd 2 , S. Reichin 2 , B. A. Moore 1 , 1 Psychiatry, Yale 

University, New Haven, CT, 2 APT Foundation, New Haven, CT 

2 Predicting craving and mood 90 minute into the future using GPS data 

W. J. Kowalczyk 1 , M. Tyburski 1 , M. Vahabzadeh 1 , J. Lin 1 , K. A. Phillips 1 , A. J. Milam 2 , 

D. M. Furr-Holden 2 , M. Mezghanni 1 , D. H. Epstein 1 , K. L. Preston 1 , 1 NIDA, IRP, 

Baltimore, MD, 2 Johns Hopkins, Baltimore, MD 

3 Evaluation of tailored therapeutic recommendations to improve use of an automated telephonebased 

treatment for methadone 

D. P. Lloyd 1 , D. M. Printz 3 , F. D. Buono 3 , S. Reichin 1 , B. A. Moore 2 , 1 APT Foundation, 

New Haven, CT, 2 Psychiatry, Yale University School of Medicine, New Haven, CT, 

3 

Psychiatry, Yale University, New Haven, CT 

4 Finding a needle in the haystack: Using machine learning to predict overdose in opioid users 

B. S. Crosier 1 , J. Borodovsky 2 , P. Mateu-Gelabert 3 , H. Guarino 4 , 1 Center for Technology and 

Behavioral Health, Dartmouth College, West Windsor, VT, 2 Psychiatry, Dartmouth College, 

Hanover, NH, 3 NDRI, Inc., New York, NY, 4 National Development & Research Institutes, 

New York, NY 

5 Gender differences in methadone dose patterns and length of treatment in outpatient methadone 

maintenance treatment programs 

J. A. Frimpong 1 , K. Shiu 2 , T. D’Aunno 3 , H. Pollack 4 , P. Friedmann 5 , 1 Columbia University, 

New York, NY, 2 Sociomedical Sciences, Columbia University, New York, NY, 

3 

New York University, New York, NY, 4 University of Chicago, Chicago, IL, 

5 

Baystate Health, Springfield, MA 

6 Measuring circadian entrainment during outpatient opioid agonist maintenance 

J. W. Bertz 1 , D. H. Epstein 1 , M. Rea 2 , M. G. Figueiro 2 , G. Ward 2 , K. L. Preston 1 , 1 Clinical 

Pharmacology and Therapeutics Research Branch, NIDA Intramural Research Program, 

Baltimore, MD, 2 Lighting Research Center, Rensselaer Polytechnic Institute, Troy, NY 

76


7 A randomized trial of patient-centered methadone treatment with optional counseling 

R. P. Schwartz 1 , S. M. Kelly 1 , J. Gryczynski 1 , K. O’Grady 2 , D. Gandhi 4 , Y. Olsen 3 , J. H. Jaffe 1 , 

S. G. Mitchell 1 , 1 Friends Research Institute, Baltimore, MD, 2 Univ. of Maryland, College 

Park, MD, 3 IRB REACH, Baltimore, MD, 4 Psychiatry, Univ. of Maryland, Baltimore, MD 

8 Fair hearing outcomes for patients recommended discharge from methadone maintenance 

J. S. Chang, J. Chiu, V. Gruber, J. Sorensen, U.C. San Francisco, San Francisco, CA 

9 A systematic review of opioid agonist treatments for pharmaceutical opioid dependence 

S. Nielsen 3,2 , B. Larance 3 , L. Degenhardt 3 , L. Gowing 1 , N. Lintzeris 2,4 , 1 University of Adelaide, 

Adelaide, SA, Australia, 2 South Eastern Sydney Local Health District, Sydney, NSW, 

Australia, 3 UNSW Australia, Sydney, NSW, Australia, 4 University of Sydney, Sydney, NSW, 

Australia 

10 The impact of psychopharmacotherapy on disenrollment from office-based opioid treatment 

with buprenorphine 

Z. M. Weinstein 1,2 , D. M. Cheng 1 , E. Quinn 1 , D. Hui 1 , H. Kim 1 , G. Gryczynski 1,2 , C. Labelle 1,2 , 

J. H. Samet 1,2 , 1 Boston University, Boston, MA, 2 Boston Medical Center, Boston, MA 

11 Urine drug testing for patients on buprenorphine: Informative beyond self-reported cocaine and 

opioid use? 

S. M. Bagley 2 , D. M. Cheng 4 , M. R. Winter 4 , D. Alford 3 , C. Labelle 3 , A. Y. Walley 1 , 

J. H. Samet 3 , 1 General Internal Medicine, Boston Univ, Boston, MA, 2 Medicine, Boston 

University School of Medicine, Boston, MA, 3 Boston University Medical Center/Boston 

Medical Center, Boston, MA, 4 Boston University School of Public Health, Boston, MA 

12 Within-subject evaluation of interim buprenorphine vs. waitlist on illicit opioid use 

T. A. Ochalek 5 , J. D. Pusey 5 , B. Hruska 1 , S. H. Heil 1 , S. Higgins 1 , G. Rose 1 , B. A. Moore 4 , 

S. C. Sigmon 1 , 1 Psychiatry, The University of Vermont, Burlington, VT, 4 Psychiatry, Yale 

University School of Medicine, New Haven, CT, 5 Psychology, University of Vermont, 

Burlington, VT 

13 Safety of combination buprenorphine/naloxone and extended-release naltrexone 

R. Lindblad 1 , A. Saxon 3 , P. VanVeldhuisen 1 , L. Lu 1 , L. Hu 1 , A. Hasson 2 , C. Thomas 2 , 

S. Sparenborg 4 , L. Mooney 2 , W. Ling 2 , 1 EMMES, Rockville, MD, 2 UCLA, Los Angeles, CA, 

3 

VA, Seattle, WA, 4 NIDA, Rockville, MD 

14 “The devil I know is better than the devil I don’t know”: Enrollment in a pilot trial of opioid 

dose escalation vs. buprenorphine/naloxone for pain 

A. Manhapra, D. A. Fiellin, W. Becker, Yale University, New Haven, CT 

15 Improving buprenorphine treatment outcomes with the L-type calcium channel blocker 

isradipine 

A. Oliveto 1 , J. McGaugh 1 , J. B. Guise 1 , J. D. Thostenson 2 , M. J. Mancino 1 , 1 Psychiatry, 

University of Arkansas for Medical Sciences, Little Rock, AR, 2 Biostatistics, University of 


16 Sensitivity analysis of a comparative trial of 6-month buprenorphine implants (Probuphine) and 

sublingual buprenorphine in stable opioid-dependent patients 

R. Rosenthal 2 , M. R. Lofwall 1 , S. Kim 3 , M. Chen 4 , K. Beebe 5 , F. Vocci 6 , 1 University of 

Kentucky, Lexington, KY, 2 Psychiatry, Icahn School of Medicine, New York, NY, 3 Braeburn 

Pharmaceuticals, Princeton, NJ, 4 TCM Groups, Berkeley Heights, NJ, 5 Titan Pharmaceuticals, 

South San Francisco, CA, 6 Friends Research Institute, Baltimore, MD 

77


17 Pregabalin for opioid detoxification: Interim results 

E. Krupitsky 1 , R. Ilyuk 1 , A. Mikhailov 1 , K. Kazankov 1 , K. Rybakova 1 , O. Grishina 1 , 

I. Zaplatkin 4 , D. Langelben 3 , G. E. Woody 3 , 1 St. Petersburg VM Bekhterev Research 

Psychoneurological Institute, St. Petersburg, Russian Federation, 3 Psychiatry, University of 

Pennsylvania Perelman School of Medicine, Philadelphia, PA, 4 Murmansk Regional Addiction 

Hospital, Murmansk, Russian Federation 

18 The effect of substance use disorders on the association between guideline-concordant longterm 

opioid therapy and all-cause mortality 

J. R. Gaither 1,2 , J. Goulet 1,2 , W. Becker 1,2 , S. Crystal 3 , E. J. Edelman 1 , K. S. Gordon 2 , 

R. Kerns 1,2 , D. Rimland 4 , M. Skanderson 2 , A. Justice 1,2 , D. A. Fiellin 1 , 1 Yale, New Haven, CT, 

2 

VA, West Haven, CT, 3 Rutgers, New Brunswick, NJ, 4 Emory, Atlanta, GA 

19 Increasing medication use for alcohol and opioid disorders through organizational change 

J. H. Ford 2 , A. Abraham 4 , N. Lupulescu-Mann 5 , R. Croff 3 , K. Johnson 2 , M. Chalk 6 , 

L. Schmidt 7 , D. McCarty 1 , 1 CB 669 PHPM, Oregon Health & Science Univ, Portland, OR, 

2 

University of Wisconsin-Madison, Madison, WI, 3 Public Health & Preventive Medicine, 

Oregon Health & Science University, Portland, OR, 4 University of Georgia, Athens, GA, 

5 

OHSU, Portland, OR, 6 TRI, Philadelphia, PA, 7 UCSF, San Francisco, CA 

20 Pay for performance and treatment outcome in medication-assisted treatment 

E. Loscalzo, A. Levit, R. Sterling, S. Weinstein, Psychiatry and Human Behavior, Thomas 

Jefferson University, Philadelphia, PA 

21 Injection heroin use and methadone maintenance treatment outcomes 

D. M. Ledgerwood 1 , J. J. Lister 2 , B. V. LaLiberte 1 , M. Greenwald 1 , 1 Psychiatry, Wayne State 

School of Medicine, Detroit, MI, 2 Wayne State University, Detroit, MI 

22 Comparison of risk behavior, addiction severity, and history of overdose between active and 

agonist-maintained heroin users 

B. Todhunter 1,3 , K. Wehmeyer 1 , J. D. Jones 3 , S. D. Comer 2 , 1 Psychology, Columbia 

University, Teachers College, New York, NY, 2 Psychiatry, Columbia University and NYSPI, 

New York, NY, 3 Division of Substance Abuse, New York Psychiatric Institute, Columbia 

Medical School, New York, NY 

23 Modeling heroin careers over 40 years: Social costs 

A. Ritter 1 , V. Hoang 1 , V. Cao 3 , M. Shanahan 1 , N. Shukla 3 , P. Perez 3 , M. Farrell 2 , 1 Drug Policy 

Modelling Program, University of New South Wales, Sydney, NSW, Australia, 2 NDARC, 

UNSW, Sydney, NSW, Australia, 3 SMART Infrastructure Facility, University of Wollongong, 

Wollongong, NSW, Australia 

24 Baseline predictors of outpatient induction onto extended-release naltrexone 

V. A. Barbieri 2 , K. Mishlen 1 , M. Sullivan 4,3 , A. Bisaga 2 , 1 Substance Abuse, Columbia 

University, New York, NY, 2 Substance Abuse, Columbia University/ New York State 

Psychiatric Institute, New York, NY, 3 Columbia University, New York, NY, 4 Alkermes, Inc., 

Waltham, MA 

25 Opioid use following an outpatient detoxification and induction onto XR-NTX: Testing the 

blockade as a predictor of retention in treatment 

K. Mishlen 1 , V. A. Barbieri 1 , M. A. Sullivan 2,3 , A. Bisaga 1 , 1 Substance Abuse, Columbia 

University/ New York State Psychiatric Institute, New York, NY, 2 Alkermes, Inc., 

Waltham, MA, 3 Columbia University, New York, NY 

26 Employment-based reinforcement of naltrexone adherence in unemployed heroin users: Effects 

on opiate use 

B. Jarvis, A. Holtyn, A. DeFulio, A. Umbricht, M. Fingerhood, G. Bigelow, K. Silverman, 

Johns Hopkins University School of Medicine, Baltimore, MD 

78


27 Developing home-based continuing care: Exploring feasibility and acceptance with parents and 

young adults 

K. Zentgraf 1 , D. Zaslav 1 , E. Bresani 1 , K. Meyers 1 , M. Tabit 1 , K. C. Kirby 1,2,3 , 1 Treatment 

Research Institute, Philadelphia, PA, 2 Psychology, Rowan University, Glassboro, NJ, 

3 

Psychiatry, University of Pennsylvania, Philadelphia, PA 

28 A pilot trial of two models of clinical supervision of integrated cognitive behavioral therapy for 

PTSD and substance use disorders 

A. Meier 1 , M. P. McGovern 2 , C. Lambert-Harris 1 , B. McLeman 4 , E. Saunders 4 , 1 Psychiatry, 

Geisel School of Medicine at Dartmouth, Lebanon, NH, 2 Psychiatry and Community & 

Family Medicine, Geisel School of Medicine at Dartmouth, Lebanon, NH, 4 Psychiatric 

Research Center, Geisel School of Medicine at Dartmouth, Lebanon, NH 

GENETICS 

29 Gene variants of the dopaminergic system are associated with non-dependent heroin use and 

heroin dependence 

M. Randesi 1 , O. Levran 1 , J. Ott 1 , P. Blanken 2 , W. van den Brink 2 , J. M. van Ree 2 , M. Kreek 1 , 

1 

The Rockefeller University, New York, NY, 2 Central Committee on the Treatment of Heroin 

Addicts, Utrecht, Netherlands 

30 RNA-seq analysis: Differential transcriptome in the dorsal and ventral striatum in male 

C57BL/6J mice after chronic oxycodone self-administration 

Y. Zhang 1 , Y. Liang 2 , M. Randesi 1 , O. Levran 1 , V. Yuferov 1 , M. Kreek 1 , 1 The Laboratory of 

the Biology of the Addictive Diseases, The Rockefeller University, New York, NY, 2 Hospital 

Informatics, The Rockefeller University, New York, NY 

31 Unbiased gene profiling of the rhesus macaque mesolimbic system following long-term cocaine 

self-administration 

E. J. Vallender 1,2,3 , D. Goswami 3 , N. M. Shinday 3 , S. Westmoreland 3 , W. D. Yao 3 , 

J. K. Rowlett 1,2,3 , 1 University of Mississippi Medical Center, Jackson, MS, 2 Tulane National 

Primate Research Center, Covington, LA, 3 Harvard Medical School, Southborough, MA 

32 The role of dopaminergic system on crack-cocaine addiction: DRD2 and DRD4 genes and their 

individual and interaction effects 

A. R. Stolf 2 , J. B. Schuch 1 , D. Muller 1 , G. C. Akutagava-Martins 1 , C. Szobot 3 , 

F. P. Pechansky 2 , F. P. Kessler 2 , T. Roman 1 , 1 Post Graduate Program in Genetics and 

Molecular Biology / Department of Genetics, Federal University of Rio Grande do Sul, Porto 

Alegre, Brazil, 2 Center for Drug and Alcohol Research, HCPA/UFRGS, Porto Alegre, Brazil, 

3 

Child and Adolescent Psychiatric Service / Hospital de Clínicas de Porto Alegre, Federal 

University of Rio Grande do Sul, Porto Alegre, Brazil 

33 No association between crack-cocaine addiction and COMT Val/Met polymorphism 

T. Roman 3 , A. R. Stolf 2 , J. B. Schuch 3 , D. Muller 3 , G. C. Akutagava-Martins 3 , C. Szobot 1 , 

F. P. Pechansky 2 , F. P. Kessler 2 , 1 Child and Adolescent Psychiatric Service / Hospital de 

Clínicas de Porto Alegre, UFRGS, Porto Alegre, Brazil, 2 Center for Drug and Alcohol 

Research / HCPA, UFRGS, Porto Alegre, Brazil, 3 Post Graduate Program in Genetics and 

Molecular Biology / Department of Genetics, Federal University of Rio Grande do Sul, Porto 

Alegre, Brazil 

REWARD & PUNISHMENT 

34 Cocaine increases permeability of blood-brain-barrier in the hippocampus and striatum: 

Implications for drug use and abuse 

A. L. Riley 1 , D. Kearns 2 , S. Hargrave 1 , T. Davidson 1 , 1 Psychology, American University, 

Washington, DC, 2 Psychology, American University, Washington, MD 

79


35 Measuring sign-tracking in humans: The promise and pitfalls of translation 

M. Wardle 1 , S. Flagel 2 , P. Lopez-Gamundi 1 , C. Amador 1 , 1 Psychiatry and Behavioral Science, 

University of Texas Health Science Center at Houston, Houston, TX, 2 Psychiatry, University 

of Michigan, Ann Arbor, MI 

36 Age-related differences in licking microstructural indices of incentive motivation and hedonic 

impact in rats 

I. A. Mendez 1 , N. Murphy 1 , S. Ostlund 3 , N. Maidment 1 , 1 Psychiatry and Biobehavioral 

Sciences, UCLA, Los Angeles, CA, 3 Anesthesiology and Perioperative Care, UCI, Irvine, CA 

37 Extended vs. brief intermittent access to palatable food differently promote binge-like intake and 

rejection of less preferred food in female rats 

A. Kreisler, E. Zorrilla, Committee on the Neurobiology of Addictive Disorders, The Scripps 

Research Institute, San Diego, CA 

38 The highly selective 5-HT 2C 

receptor agonist WAY163909 reduces compulsive behavior and 

food intake in female rhesus monkeys 

M. Perez Diaz 2 , L. Howell 2,1 , M. Wilson 2,3 , 1 Neuropharmacology and Neurologic Diseases, 

Emory University, Atlanta, GA, 2 Yerkes National Primate Research Center, Emory University, 

Atlanta, GA, 3 Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA 

39 Comparison of the effects of psychostimulant drugs of abuse on brain endothelial barrier 

integrity and extracellular microvesicle production 

A. M. Andrews 1,2 , S. Merkel 1,2 , E. Lutton 1 , C. Hicks 2 , S. Rawls 2 , S. Ramirez 1,2,3 , 1 Pathology 

and Laboratory Medicine, Temple University, Philadelphia, PA, 2 Center for Substance Abuse 

Research, Temple University, Philadelphia, PA, 3 The Shriners Hospitals Pediatric Research 

Center, Philadelphia, PA 

40 PPARγ agonism to treat white matter damage in cocaine use disorder 

A. Dimet 1,3 , L. Denner 1 , R. Miller 1,3 , K. A. Cunningham 1,3 , M. Huentelman 4 , S. D. Lane 2 , 

K. Dineley 1,3 , 1 UTMB, Galveston, TX, 2 Psychiatry & Behavioral Sciences, University of 

Texas Health Science Center - Houston, Houston, TX, 3 Center for Addiction Research, 

University of Texas Medical Branch, Galveston, TX, 4 Translational Genomics Research 

Institute, Phoenix, AZ 

41 The effects of repeated cocaine administration on the surface expression of glutamate receptor 

subunits in the medial prefrontal cortex 

J. D. Steketee, K. C. Summers, Pharmacology, University of Tennessee Health Science 

Center, Memphis, TN 

42 Combining multiple schedules of reinforcement with glutamate biosensors to examine the effects 

of cocaine and food on prelimbic glutamatergic signaling in freely moving rats 

S. R. Batten, J. S. Beckmann, Psychology, University of Kentucky, Lexington, KY 

43 DREADD-induced activation of agranular insular cortex decreases cue reactivity associated 

with self-administration of high fat pellets 

A. E. Price 1 , S. J. Stutz 1 , H. Neelakantan 1 , N. C. Anastasio 1,2 , K. A. Cunningham 1,2 , 1 Center for 

Addiction Research, UTMB, Galveston, TX, 2 Department of Pharmacology & Toxicology, 

UTMB, Galveston, TX 

44 Estradiol increases choice of cocaine over food in male rats: The effect of estradiol on cocaine 

choice generalizes to both sexes 

J. R. Bagley, T. E. Kippin, Psychological and Brain Sciences, University of California at Santa 

Barbara, Santa Barbara, CA 

80


45 Comparative analysis of transcriptomics and proteomics of environmental enrichment and 

cocaine 

E. Crofton, Y. Zhang, F. Kong, B. Luxon, H. Spratt, C. F. Lichti, T. Green, University of 

Texas Medical Branch, Galveston, TX 

46 Preexposure attenuates methylphenidate-induced taste avoidance, but enhances BDNF/TrkB 

activity in the insular cortex of the rat 

B. B. Wetzell 2 , M. Muller 3 , S. M. Flax 3 , H. E. King 3 , K. DeCicco-Skinner 4 , A. L. Riley, 

2 

Psychopharmacology Laboratory, American University, Washington, DC, 3 Psychology 

Department, American University in Washington DC, Washington, DC, 4 Biology, American 

University, Washington, DC 

47 Across time and space: Independent component analysis reveals spatial and temporal 

differences in functional brain networks between cocaine and alcohol users 

T. Kearney-Ramos, L. T. Dowdle, O. Mithoefer, C. Mullins, W. DeVries, M. George, 

C. A. Hanlon, Medical University of South Carolina, Charleston, SC 

48 An analysis of the rewarding and aversive associative effects of nicotine in the neonatal 

quinpirole model of schizophrenia: Underlying mechanisms and the effects of antipsychotics 

S. Kirby 1 , A. R. Denton 1 , D. J. Peterson 1 , E. D. Cummins 1 , J. M. Dose 3 , R. W. Brown 2 , 

1 

Psychology, East Tennessee State University, Johnson City, TN, 2 Biomedical Sciences, East 

Tennessee State University, Johnson City, TN, 3 Psychology, St. Norbert College, De Pere, WI 

ALCOHOL 

49 Evaluation of CERC-501, a selective kappa opioid antagonist in preclinical models of 

alcoholism 

D. R. Gehlert 2,1 , L. Rorick-Kehn 3 , A. Thorsell 4 , B. Paterson 1 , M. Heilig 4 , 1 Cerecor, 

Baltimore, MD, 2 Matrix Pharma Consulting, Boulder, CO, 3 Lilly Research Laboratories, 

Indianapolis, IN, 4 Linkoping University, Linkoping, Sweden 

50 Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care 

J. Chen 1 , R. D. McDonald 1 , R. Obi 1 , S. Wong 1 , M. Flannery 1 , B. Tofighi 1 , A. Kermack 1 , 

J. Rotrosen 2 , M. Gourevitch 1 , J. D. Lee 1 , 1 Population Health, New York University, 

New York, NY, 2 Psychiatry, New York University, New York, NY 

51 Alexithymia in alcohol-dependent patients is mediated by stress, anxiety and loss of self-control 

over drinking 

F. A. Thorberg 1,6,2 , R. M. Young 2 , M. Lyvers 4 , J. Connor 5 , R. Tyssen 6 , E. London 3 , G. Feeney 7 , 

1 

Natnl Cntr Dual Diagnosis, Innlandet Hosp Trust, Ottestad, Norway, 2 Qld Univ Technol, 

Brisbane, QLD, Australia, 3 Univ Calif Los Angeles, Los Angeles, CA, 4 Bond Univ, Gold 

Coast, QLD, Australia, 5 Univ Qld, Brisbane, QLD, Australia, 6 Behav Sciences in Medicine, 

Univ Oslo, Oslo, Norway, 7 Princess Alex Hosp, Brisbane, QLD, Australia 

52 Similarities across addictive processes: Cross-commodity discounting of alcohol, food, and 

money 

L. Moody 1 , W. K. Bickel 2 , 1 Virginia Tech, Roanoke, VA, 2 Addiction Recovery and Research 

Center, Virginia Tech Carilion Research Institute, Roanoke, VA 

53 The worse get better: Instruction following improves among the alcohol dependent rate 

dependently 

S. E. Snider, S. M. LaConte, W. K. Bickel, Addiction Recovery Research Center, Virginia 

Tech Carilion Research Institute, Roanoke, VA 

54 Prevalence and predictors of alcohol withdrawal delirium in a Thai university hospital 

R. Kalayasiri, P. Sareedenchai, Psychiatry, Faculty of Medicine, Chulalongkorn University, 

Bangkok, Thailand 

81


55 Husband/partner intoxication and intimate partner violence against women in the Philippines 

B. T. Kerridge, Epidemiology, Columbia University, Gaithersburg, MD 

56 Alcohol use and intimate partner violence among women and their partners in sub-Saharan 

Africa 

M. Greene 1 , D. M. Furr-Holden 2 , W. A. Tol 1 , 1 Mental Health, Johns Hopkins Bloomberg 

School of Public Health, Washington, DC, 2 Mental Health, Johns Hopkins Bloomberg School 

of Public Health, Baltimore, MD 

57 WITHDRAWN 

58 Using a lifetime relationships calendar with veterans to model the effects of military deployment 

on sexual partnering 

M. I. Rosen 1,2 , A. C. Black 1,2 , T. McMahon 1,2 , L. Brecht 3 , M. N. Potenza 1,2 , 1 Psychiatry, Yale 

University, West Haven, CT, 2 VA Connecticut Healthcare System, West Haven, CT, 3 School 

of Nursing, UCLA, Los Angeles, CA 

59 Associations between intervention intensity and underage drinking outcomes: A methodological 

approach from the Kansas SPF-SIG 

K. D. Anderson-Carpenter 1 , J. Watson-Thompson 2 , M. Jones 3 , L. Chaney 4 , 1 Integrated 

Substance Abuse Programs, University of California, Los Angeles, Los Angeles, CA, 

2 

The University of Kansas, Lawrence, KS, 3 Centers for Disease Control and Prevention, 

Atlanta, GA, 4 Learning Tree Institute, Greenbush, Girard, KS 

60 New epidemiological research on ‘school bonding’ and drug involvement 

M. Chandra, Epidemiology and Biostatistics, Michigan State University, East Lansing, MI 

61 WITHDRAWN EPIDEMIOLOGY 

62 Concordance between urine drug screen and self-reported cocaine use 

G. Sharma, N. Oden, P. VanVeldhuisen, The Emmes Corporation, Rockville, MD 

63 Intravenous and smoked methamphetamine produce different subjective and physiological 

effects in women 

N. E. Goeders, LSU Health Sciences Center, Shreveport, LA 

64 Comparative hazards of acute myocardial infarction among hospitalized patients with 

methamphetamine- or cocaine-use disorders: A retrospective cohort study 

J. Gatley 1 , M. Osiowy 1 , J. Sykes 2 , S. J. Kish 3 , R. Callaghan 1 , 1 Northern Medical Program, 

UNBC, Prince George, BC, Canada, 2 Princes Margaret Cancer Centre, Toronto, ON, Canada, 

3 

Human Brain Lab, CAMH, Toronto, ON, Canada 

65 Crack/Cocaine consumption and urban violence in Brazil: Data from the Brazilian National 

Alcohol and Drugs Survey 

C. S. Madruga 1 , A. Q. Miguel 1 , S. McPherson 3 , M. G. McDonell 2 , R. Laranjeira 1 , 1 Psychiatry, 

Federal University of São Paulo, Sao Paulo, Brazil, 2 College of Medical Sciences, Elson 

S. Floyd College of Medicine, Washington, WA, 3 Program of Excellence in Addictions 

Research, Washington State University, Washington, WA 

82


66 Factors predicting methamphetamine use among homeless people in Bangkok, Thailand 

C. Areesantichai 1 , U. Perngparn 1 , L. Cottler 2 , 1 Drug Dependence Research Center 

WHO Collaborating Center for Research and Training in Drug Dependence (WHOCC), 

Chulalongkorn University, Bangkok, Thailand, 2 Epidemiology, University of Florida, 


67 Release from drinking-age restrictions is associated with increases in alcohol-related motor 

vehicle collisions among young drivers in Canada 

R. Callaghan 2 , J. Gatley 2 , M. Sanches 3 , C. Benny 4 , 2 Northern Medical Program, University of 

Northern British Columbia, Prince George, BC, Canada, 3 Biostatistical Consulting, CAMH, 

Toronto, ON, Canada, 4 Community Health Sciences, UNBC, Prince George, BC, Canada 

68 Ultrasound correlates of liver disease in patients seeking treatment for alcohol use disorder 

D. Fuster 3 , A. Sanvisens 3 , P. Zuluaga 3 , E. Barluenga 4 , I. Rivas 2 , J. Tor 1 , R. Muga 1 , 1 Internal 

Medicine, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, 2 Municipal Center 

for Substance Abuse Treatment, Badalona, Spain, 3 Medicine, Hospital Germans Trias i Pujol, 

Badalona, Spain, 4 Radiology, Hospital Germans Trias i Pujol, Badalona, Spain 

69 Gender differences in patterns of prescription opioid use and binge drinking among middleaged 

Floridians 

M. Serdarevic, L. Cottler, Epidemiology, University of Florida, Gainesville, FL 

70 Changes in nonmedical use of OxyContin after reformulation with abuse deterrent properties 

H. Chilcoat, P. Coplan, N. Sessler, R.Singh, Risk Management and Epidemiology, Purdue 

Pharma, Stamford, CT 

71 Evaluating prescription drug abuse survey questions 

B. Sproule 2,1 , M. Zhang 2,1 , 1 University of Toronto, Toronto, ON, Canada, 2 Centre for 

Addiction and Mental Health, Toronto, ON, Canada 

72 Association between prescription opioid use and frequent emergency department use 

S. A. Milani, H. R. Crooke, L. Cottler, C. W. Striley, Epidemiology, University of Florida, 


73 Peer networks, marital satisfaction and nonmedical use of prescription drugs among reserve 

soldiers and partners 

S. Cercone Heavey 2 , D. Homish 2 , J. Devonish 2 , E. M. Anderson Goodell 1 , G. G. Homish 2 , 

1 

Mental Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 

2 

Community Health & Health Behavior, State University of New York at Buffalo, 

Buffalo, NY 

74 Characteristics of pain patients related to risk of aberrant opioid medication behaviors 

S. F. Butler, R. A. Black, T. A. Cassidy, K. L. Zacharoff, S. H. Budman, Inflexxion, Inc., 

Newton, MA 

75 Multiple sources of payment and risky opioid therapy among military/VA 

W. Becker 1 , E. Doyle 4 , B. Fenton 3 , J. Francis 5 , C. Brandt 3 , B. A. Moore 2 , R. Kerns 3 , 

P. Kreiner 4 , 1 Internal Medicine, VA Connecticut Healthcare System, West Haven, CT, 

2 

Psychiatry, Yale University School of Medicine, New Haven, CT, 3 VA Connecticut 

Healthcare System, West Haven, CT, 4 Brandeis University, Waltham, MA, 5 VA Central 

Office, Washington, DC 

76 Insurance is not enough: Significant increases in insurance coverage do not increase substance 

abuse treatment entry among rural Appalachian drug users 

J. R. Havens, H. K. Knudsen, M. R. Lofwall, S. L. Walsh, Center on Drug and Alcohol 

Research, University of Kentucky, Lexington, KY 

83


77 The role of adverse childhood experiences in initiation of substance use and sexual behaviors 

among opioid-using young adults 

H. Guarino 1 , P. Mateu-Gelabert 1 , S. Sirikantraporn 2 , K. Ruggles 3 , C. Syckes 1 , E. Goodbody 1 , 

S. R. Friedman 1 , 1 NDRI, New York, NY, 2 Alliant International U, San Diego, CA, 3 NYU, 

New York, NY 

78 Associations between integration and drug use among deported migrants in Tijuana, Mexico 

D. Horyniak 1,2 , M. Pinedo 3 , J. Burgos 1 , V. Ojeda 1 , 1 Division of Global Public Health, 

University of California, San Diego, La Jolla, CA, 2 Centre for Population Health, Burnet 

Institute, Melbourne, VIC, Australia, 3 Alcohol Research Group, University of California, 

Berkeley, Berkeley, CA 

79 Utilization of opioid agonist therapy among persons who inject drugs in the Seattle area 

J. I. Tsui 1 , S. N. Glick 1 , H. Thiede 2 , 1 School of Medicine, University of Washington, 

Seattle, WA, 2 Public Health–Seattle & King County, Seattle, WA 

80 Systematic review and meta-analysis of injecting related injury and disease in people who inject 

drugs 

S. Larney 2 , A. Peacock 1 , B. M. Mathers 3 , L. Degenhardt 2 , 1 School of Medicine, University 

of Tasmania, Hobart, TAS, Australia, 2 NDARC, UNSW Australia, Sydney, NSW, Australia, 

3 

Kirby Institute, UNSW Australia, Sydney, NSW, Australia 

81 Risk factors for prescription opioid misuse by duration of misuse 

V. Osborne, S. O. Lasopa, C. W. Striley, L. Cottler, Epidemiology, University of Florida, 


82 Self-compassion and substance use 

S. M. Paniagua 1 , C. L. Phelps 2 , K. D. Rosen 1 , J. S. Potter 1 , 1 Psychiatry, UT Health Science 

Center, San Antonio, TX, 2 InnerAlly, San Antonio, TX 

83 Causes of death and expected years of life lost among opioid-dependent individuals using 

agonist therapy in the U.S. and Taiwan 

K. Chang 1 , A. Saxon 4 , G. E. Woody 3 , J. Wang 5 , Y. Hser 2 , 1 General Psychiatry, Jianan 

Psychiatric Center, Ministry of Health & Welfare, Tainan, Taiwan, 2 Department of Psychiatry 

& Behavioral Sciences, UCLA, Los Angeles, CA, 3 Psychiatry, University of Pennsylvania, 

Philadelphia, PA, 4 Veterans Affairs Puget Sound Health Care System, USA, Seatle, WA, 

5 

Public Health, National Cheng Kung University, Tainan, Taiwan 

84 Increasing abuse of gabapentin and pregabalin as reported to U.S. poison centers 2006 through 

2014 

R. C. Dart 2 , B. Bucher Bartelson 4 , S. G. Severtson 3 , G. Bau 3 , J. L. Green 1 , 1 RADARS System, 

Denver Health, Denver, CO, 2 RMPDC, Denver, CO, 3 Rocky Mountain Poison and Drug 

Center, Denver, CO, 4 Research, Rocky Mountain Poison and Drug Center, Denver, CO 

85 Introducing a new research method for evaluating alcohol and other drug use among fatally 

injured victims in Latin America 

G. Andreuccetti 1 , V. Leyton 1 , I. D. Miziara 1,4 , N. P. Lemos 2 , D. R. Munoz 1 , C. J. Cherpitel 3 , 

H. B. Carvalho 1 , 1 University of Sao Paulo Medical School, Sao Paulo, Brazil, 2 Office of 

Chief Medical Examiner, San Francisco, CA, 3 Alcohol Research Group, Emeryville, CA, 

4 

Technical-Scientific Police Superintendency of the State of Sao Paulo, Sao Paulo, Brazil 

86 The impact of enrollment in methadone maintenance therapy on initiation of heavy drinking 

among people who use heroin 

J. Klimas, E. Wood, P. Nguyen, H. Dong, M. Milloy, T. Kerr, K. Hayashi, B.C. Centre for 

Excellence in HIV/AIDS, Urban Health Research Initiative, Vancouver, BC, Canada 

84


PERINATAL DRUG ABUSE 

87 Pregnancy incidence and contraceptive use among young women who inject drugs in Sydney, 

Australia 

L. Maher 1,2 , B. White 3 , C. Day 3 , K. Black 4 , 1 Centre for Immunology, Kirby Institute, 

Sydney, NSW, Australia, 2 UNSW Australia, Faculty of Medicine, Sydney, NSW, Australia, 

3 

Sydney University, Discipline of Addiction Medicine, Sydney, NSW, Australia, 4 Central 

Clinical School, Sydney University, Sydney, NSW, Australia 

88 Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder 

in the United States 

L. MacAfee 3 , A. Sawyer 2 , M. Terplan 1,3 , 1 Behavioral Health System Baltimore, 

Baltimore, MD, 2 Baltimore City Health Department, Baltimore, MD, 3 Department of 

Obstetrics and Gynecology, University of Michigan, Ann Arbor, MI 

89 Reduction in alcohol, tobacco, and illicit drug use during childbearing years in the USA: 

A comparison of pregnant and non-pregnant women 

S. M. Watchko 2 , Q. Brown 1 , S. S. Martins 1 , 1 Epidemiology, Columbia University, 

New York City, NY, 2 Department of Epidemiology, Mailman School of Public Health, 


90 Buprenorphine during pregnancy: Clearance and fetal exposure 

J. L. Coker 1 , C. McLeod 1 , S. L. Narayanan 3 , T. David 3 , J. Ritchie 4 , M. J. Mancino 1 , Z. Stowe 1 , 

1 

Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, 3 Castle Medical, 

Smyrna, GA, 4 Emory University, Atlanta, GA 

91 Where there’s smoke: Psychosocial and mental health correlates of prenatal marijuana use 

J. S. Sadicario 2 , S. S. Kelpin 2 , D. Svikis 1 , 1 Virginia Commonwealth Univ., Richmond, VA, 

2 

Psychology, Virginia Commonwealth University, Richmond, VA 

92 Are stressful life events associated with smoking cigarettes and marijuana during pregnancy? 

A. M. Allen 1 , J. Hughes 2 , A. Alexander 3 , A. Lemieux 4 , S. Allen 1 , K. Ward 3 , M. al’Absi 4 , 

1 

Family Medicine & Community Health, University of Minnesota, Minneapolis, MN, 

2 

Biostatistics, University of Minnesota, Minneapolis, MN, 3 Public Health, The University of 

Memphis, Memphis, TN, 4 Biobehavior, University of Minnesota, Duluth, Duluth, MN 

93 Cigarette purchase task: Identifying quit success in pregnant cigarette smokers 

I. A. Zvorsky 3,1 , R. Redner 3,2 , A. N. Kurti 3,2 , J. Priest 1 , S. T. Higgins 3,1 , 1 University of Vermont, 

Winooski, VT, 2 Psychiatry, University of Vermont, Burlington, VT, 3 Vermont Center on 

Behavior and Health, Burlington, VT 

94 Household smoking rules among pregnant and newly postpartum smokers 

D. R. Keith 1 , A. N. Kurti 1 , J. M. Skelly 2 , S. Higgins 1 , 1 Psychiatry, University of Vermont, 

South Burlington, VT, 2 Medical Biostatistics, University of Vermont, Burlington, VT 

95 Comparing smoking topography of usual brand cigarettes in pregnant and non-pregnant women 

C. L. Bergeria 2,3 , S. H. Heil 1,2,3 , S. C. Sigmon 1,2,3 , H. Durand 3 , S. Higgins 1,2,3 , 1 Psychiatry, 

University of Vermont, Burlington, VT, 2 Psychology, University of Vermont, Burlington, VT, 

3 

Vermont Center on Behavior and Health, Burlington, VT 

96 Initial assessment of smoking status of pregnant women enrolled in a clinical trial for smoking 

cessation 

T. Nanovskaya 1 , V. M. Fokina 2 , H. West 2 , C. Oncken 3 , M. S. Ahmed 1 , G. Hankins 1 , 1 OB/ 

GYN Maternal Fetal Medicine, University of Texas Medical Branch, Galveston, TX, 2 UTMB, 

Galveston, TX, 3 University of Connecticut Health Center, Farmington, CT 

85


97 Trajectory of mental health among low-income smokers across pregnancy and postpartum 

V. H. Coleman-Cowger 1 , B. Koszowski 1 , M. Terplan 2 , 1 Health & Analytics, Battelle, 

Baltimore, MD, 2 Behavioral Health System, Baltimore, MD 

NICOTINE: HUMAN STUDIES 

98 Validation of a purchase task for assessing the relative reinforcing efficacy of e-cigarettes 

I. Pericot-Valverde 1 , S. Fernández-Artamendi 1 , A. González-Roz 2 , C. López-Núñez 1 , 

S. E. Weidberg 1 , R. Secades-Villa 1 , 1 Department of Psychology, University of Oviedo, 

Oviedo, Spain, 2 University of Oviedo, Oviedo, Spain 

99 Delay Discounting among smokers, e-cigarette users and non-dependent controls 

S. E. Weidberg, A. González-Roz, V. Martínez-Loredo, C. López-Núñez, I. Pericot-Valverde, 

R. Secades-Villa, Department of Psychology, University of Oviedo, Oviedo, Spain 

100 Development of a conceptual framework regarding consumer perception, health, and use 

patterns of electronic cigarettes 

T. M. Dailey, E. C. McNaughton, K. Manser, M. Behling, S. F. Butler, Inflexxion, Inc, 

Newton, MA 

101 Fear-eliciting antismoking ads unintentionally motivate smokers to consider an e-cigarette: The 

boomerang effect 

S. J. Kim, L. A. Marsch, Dartmouth College, Lebanon, NH 

102 Associations between educational attainment, smoking history, quit attempts and interest 

in quitting 

R. Denlinger 2 , J. W. Tidey 2 , D. Hatsukami 3 , E. Donny 1 , 1 University of Pittsburgh, 

Pittsburgh, PA, 2 Brown University, Providence, RI, 3 University of Minnesota, 


103 Ongoing survey of alternative nicotine and tobacco use among cardiac patients 

Z. H. Morford 1 , D. Gaalema 1 , R. Elliott 1 , P. Ades 1 , S. Higgins 2 , 1 University of Vermont, South 

Burlington, VT, 2 University of Vermont, Burlington, VT 

104 Contraceptive use among female smokers 

H. S. Melbostad 2 , G. J. Badger 4 , A. K. Matusiewicz 1 , S. H. Heil 1 , 1 Psychiatry, University of 

Vermont, Burlington, VT, 2 Psychology, University of Vermont, Burlington, VT, 4 Medical 

BioStatistics, University of Vermont, Burlington, VT 

105 A computerized adaptive testing version of the ASI 

R. A. Black 1,2 , S. McCaffrey 1 , S. F. Butler 1 , 1 Inflexxion, Inc, Newton, MA, 2 Psychology, Nova 

University, Ft. Lauderdale, FL 

106 WITHDRAWN 

107 Initial subjective favorability moderates the relationship between false harm beliefs and daily 

consumption of reduced nicotine content cigarettes 

M. Mercincavage, M. L. Saddleson, A. Strasser, Center for Interdisciplinary Research on 

Nicotine Addiction and Tobacco Center of Regulatory Science, University of Pennsylvania, 


108 Anxiety sensitivity as a predictor of acute subjective effects of smoking in African Americans 

C. Guillot, R. Pang, M. Kirkpatrick, A. Leventhal, University of Southern California, Los 

Angeles, CA 

86




109 Impact of lifetime depression and anxiety on effectiveness of mass distribution of nicotine 

patches: Secondary analysis of a randomized controlled trial 

V. Kushnir 1 , B. Sproule 1 , L. Zawertailo 1 , P. Selby 1 , R. Tyndale 1 , S. Leatherdale 2 , 

J. Cunningham 1 , 1 Centre for Addiction and Mental Health, Toronto, ON, Canada, 2 University 

of Waterloo, Waterloo, ON, Canada 

110 Different trajectories of smoking behaviors across racial groups 

L. Johnson, S. Hartz, L. Bierut, Psychiatry, Washington University in St. Louis, Saint 

Louis, MO 

111 Effects of electronic vs. combustible cigarette administration on smoking withdrawal suppression 

C. G. Aguirre, A. Leventhal, M. Kirkpatrick, N. Goldenson, J. Huh, Preventive Medicine, 

University of Southern California, Los Angeles, CA 

112 The tobacco status project: Three month outcomes for a randomized controlled trial of a 

Facebook smoking cessation intervention for young adults 

D. Ramo 1 , J. Thrul 1 , K. Delucchi 1 , S. m. Hall 1 , P. Ling 1 , A. Belohlavek 1 , S. Zhao 1 , B. Han 1 , 

J. Prochaska 2 , 1 UCSF, San Francisco, CA, 2 Stanford University, Stanford, CA 

113 Tobacco cessation among poor and underserved: Expanding alternatives through communitybased 

participatory research 

P. Sheikhattari 1,2 , C. Schutzman 1,2 , T. Addison 1,2 , J. Apata 1,2 , J. Bucceri 2 , M. Gunning 2 , 

F. A. Wagner 1,2 , 1 PSRC, Morgan State University, Baltimore, MD, 2 CEASE, Baltimore, MD 

114 Impact of group motivational interviewing on enhancing treatment engagement for homeless 

veterans with nicotine dependence and other substance use disorders 

E. J. Santa Ana, S. LaRowe, K. J. Hartwell, K. Lamb, Charleston VAMC and MUSC, 


Late-Breaking Research Wednesday, 

Symposium XIV Wednesday, 

REDUCING THE HARMS OF OPIOID ANALGESIC USE IN 

HEALTH SYSTEMS 

6/8 

2:15 - 3:15 PM 

6/8 

3:30 - 5:30 PM 

Chairs: Amy S. Bohnert and Tae Woo Park 

3:30 Treatment patterns associated with overdose among patients with comorbid pain and substance 

use disorders 

Tae Woo Park, Alpert Medical School of Brown University, Providence, RI 

3:55 Opioid risk mitigation in the military health system: Results from a mixed-methods study 

Jennifer Sharpe Potter, University of Texas Health Science Center San Antonio, San 

Antonio, TX 

4:20 Investigating clinicians’ opioid prescribing and dispensing practices: A qualitative study 

Mark Edlund, RTI International, Research Triangle Park, NC 

4:45 Use of non-pharmacological strategies for pain relief in addiction treatment patients with 

chronic pain 

Lewei Allison Lin, University of Michigan Medical School, Ann Arbor, MI 

5:10 DISCUSSANT: Future directions in reducing opioid misuse and overdose 

David A Fiellin, Yale University School of Medicine, New Haven, CT 

87





THE BREAKFAST CLUB: ADOLESCENTS 

10/14 

3:30 - 5:30 PM 

Chairs: Katherine M. Serafine and Kaliris Y. Salas-Ramirez 

3:30 Taurine’s effects on cocaine reward in adolescent male and female rats 

U. Akpara, R. Liang, A. Villa-Gonzalez, D. Harrris, A. Elzanie, K. Chauhan, C. Vasquez, 

T. Irving, A. Cole, K. Y. Salas-Ramirez, Department of Physiology, Pharmacology and 

Neuroscience, CUNY School of Medicine, New York, NY, Brooklyn, NY 

3:45 Addiction-like and cognitive effects of adolescent cannabinoid self-administration in rats 

E. Kirschmann, M. Pollock, V. Nagarajan, M. M. Torregrossa, Psychiatry, University of 

Pittsburgh, Pittsburgh, PA 

4:00 Sex differences in high fat diet-induced enhancement of sensitivity to the behavioral effects of 

the dopamine D2/D3 receptor agonist quinpirole in adolescent rats 

K. M. Serafine, C. Hernandez-Casner, J. Ramos, Psychology, University of Texas at El Paso, 

El Paso, TX 

4:15 Altered intrinsic brain connectivity in prenatally cocaine-exposed adolescents 

Y. Zakiniaeiz, S. W. Yip, I. Balodis, C. Lacadie, L. C. Mayes, R. Sinha, M. N. Potenza, 

Psychiatry, Yale University, New Haven, CT 

4:30 Age and working memory predict delay discounting in adolescents in treatment for cannabis use 

disorders 

M. M. Sweeney, M. W. Johnson, Psychiatry and Behavioral Sciences, Johns Hopkins 

University School of Medicine, Baltimore, MD 

4:45 Neural activity in childhood predicts adolescent substance use initiation 

L. M. Cope, J. Heffernan, C. S. Sripada, J. E. Hardee, R. A. Zucker, M. Heitzeg, University of 

Michigan, Ann Arbor, MI 

5:00 Predicting contingency management treatment efficacy among adolescents by using measures of 

impulsivity 

A. Harvanko, J. C. Strickland, B. Reynolds, University of Kentucky, Lexington, KY 

5:15 A novel paradigm associated with callous unemotional traits among adolescents with substance 

and conduct problems: Behavioral and fMRI findings 

J. Sakai 1 , M. Dalwani 1 , S. K. Mikulich-Gilbertson 1 , S. K. McWilliams 1 , K. Raymond 1 , 

J. Tanabe 1 , M. T. Banich 2 , T. J. Crowley 1 , 1 University of Colorado, Aurora, CO, 2 University of 

Colorado Boulder, Boulder, CO 


SUPER SIZE ME: ALTERNATE ADDICTIONS 

4 

3:30 - 5:30 PM 

Chairs: Elizabeth C. Katz and Cecile M. Denis 

3:30 Naloxone-precipitated withdrawal following sucrose self-administration in C57BL/6 mice 

C. Kroll, B. D. Fischer, Cooper Medical School of Rowan University, Camden, NJ 

3:45 Chronic fructose consumption enhances cue-triggered cocaine- and food-seeking 

A. Kosheleff 1 , L. Tsan 1 , Y. Zhuang 1 , F. Gomez-Pinilla 1 , S. Ostlund 2 , N. Murphy 1 , 

N. Maidment 1 , 1 University of California Los Angeles, Encino, CA, 2 University of California 

Irvine, Irvine, CA 

88



4:00 Eating disorder, food addiction and associated factors in obese patients 

M. Fatseas 3 , M. Henry 4 , M. C. Rosa 1 , J. Collombat 3 , A. Gregoire 3 , C. Kervran 3 , B. Cherifi 4 , 

M. Auriacombe 3 , 1 Center for Drug and Alcohol Research, Federal University of Rio Grande 

do Sul, Porto Alegre, Brazil, 3 Addiction Psychiatry (CNRS USR 3413), Universite Bordeaux, 

Bordeaux, France, 4 Obesity Clinic, CHU de Bordeaux, Bordeaux, France 

4:15 Are DSM-5 criteria for SUD transferable to food addiction? IRT analysis for alcohol, tobacco, 

cannabis, opiate and food addiction in a clinical sample 

C. M. Denis 1,3 , M. C. Rosa 5,3 , F. Serre 3 , C. Kervran 3 , M. Henry 4 , B. Cherifi 4 , M. Auriacombe 1,3 , 

M. Fatseas 3 , 1 Univ. Pennsylvania, Philadelphia, PA, 3 Addiction Psychiatry, Univ. Bordeaux / 

CNRS USR 3413, Bordeaux, France, 4 Obesity Clinic, CHU de Bordeaux, Bordeaux, France, 

5 

Univ. Rio Grande, Porto Allegre, Brazil 

4:30 Video game addiction: Duration of play and impulsivity 

F. D. Buono 2 , B. A. Moore 3 , D. M. Printz 3 , D. P. Lloyd 3 , C. J. Cutter 1 , M. E. Sprong 4 , 

1 

Internal Medicine, Yale School of Medicine, New Haven, CT, 2 Psychiatry, Yale University, 

New Haven, CT, 3 Psychiatry, Yale University School of Medicine, New Haven, CT, 

4 

Rehabilitation Counseling, Northern Illinois University, DeKalb, IL 

4:45 Association between working memory, impulsivity and problematic technology use 

C. Lewis, E. C. Katz, Psychology, Towson University, Towson, MD 

5:00 Game type as a moderator of the relationship between pathological video game use, impulsivity, 

aggression, and general psychopathology 

M. S. Sferra 1 , S. Fields 1 , D. Gentile 2 , 1 Psychology, Texas A&M University, College 

Station, TX, 2 Psychology, Iowa State University, Ames, IA 

5:15 Reduced precuneus activation in adolescents at risk for food addiction 

J. Hardee, A. Gearhardt, L. M. Cope, R. Zucker, M. Heitzeg, Psychiatry, University of 



WHAT’S LOVE GOT TO DO WITH IT?: TRAUMA/PTSD 

12 

3:30 - 5:30 PM 

Chairs: Shane A. Perrine and Jacquelyn L. Meyers 

3:30 Cocaine self-administration and single prolonged stress produce hyperarousal-like, but not 

anxiety-like, behavior in rats 

M. J. Lisieski, S. A. Perrine, Psychiatry and Behavioral Neurosciences, Wayne State 

University School of Medicine, Detroit, MI 

3:45 A modified single prolonged stress episode delays acquisition of cocaine self-administration 

R. S. Hofford, M. A. Prendergast, M. T. Bardo, Psychology, University of Kentucky, 

Lexington, KY 

4:00 Pharmacological mechanisms of MDMA’s facilitative effect on fear extinction 

M. Young 1 , L. F. Berro 2 , L. Howell 1 , 1 Emory University, Atlanta, GA, 2 Yerkes National 

Primate Research Center, Emory University, Atlanta, GA 

4:15 Early life trauma, neurocognitive functioning, and substance use 

J. L. Meyers 1,2 , V. V. McCutcheon 3 , J. Salvatore 4 , D. Chorlian 1 , A. Pandey 1 , *. Collaborative 

Study on the Genetics of Alcoholism Collaborators 1 , K. K. Bucholz 3 , B. Porjesz 1 , 1 Psychiatry, 

The State University of New York, Brooklyn, NY, 2 Columbia University, New York, NY, 

3 

Washington University School of Medicine, St. Louis, MO, 4 Virginia Commonwealth 


89

June 15, 2016 


4:30 Oxytocin decreases methamphetamine-seeking and gene expression changes in rats after 

traumatic stress 

J. F. McGinty, Neuroscience, Medical University of South Carolina, Charleston, SC 

4:45 Concurrent treatment with prolonged exposure for co-occurring PTSD and substance use 

disorders: A randomized clinical trial 

D. Hien 1,2 , L. Ruglass 3 , S. Back 4 , 1 Psychology, Adelphi University, NY, NY, 2 Psychiatry, 

Columbia University College of Physicians and Surgeons, New York, NY, 3 Psychology, 

City College of New York, New York, NY, 4 Psychiatry and Behavioral Sciences, Medical 

University of South Carolina, Charleston, SC 

5:00 Nonmedical and illicit drug use: Associations with PTSD severity & symptom clusters among a 

sample of U.S. Army Reserve/National Guard Soldiers 

D. Homish 1 , S. Cercone Heavey 1 , J. Devonish 1 , J. Cornelius 2 , G. G. Homish 1 , 1 Community 

Health & Health Behavior, State University of New York at Buffalo, Buffalo, NY, 

2 

Psychiatry, University of Pittsburgh Medical Center, Pittsburgh, PA 

Business Meeting Wednesday, 

(MEMBERS ONLY) 

5:30 - 6:30 PM 

June 15, 2016 CAPRA 

DINNER AND DANCING Wednesday, 

BADGES MUST BE WORN FOR ADMISSION 

Fiesta Ballroom 

7:30 - 10:30 PM 



90

June 16, 2016 

Thursday, June 16, 2016 

Poster Session IV Thursday, 

(Breakfast) 



Set-up time begins Wednesday, 3PM 

Must be removed by Thursday 12 Noon 

PROGRAM DESCRIPTION 

1 Forging a new path: Urban Indian approaches to service improvement in Ramsey County, 

Minnesota 

A. H. Skinstad, J. Gringer Richards, L. E. Thompson, S. A. Bear, Dept of Community and 

Behavioral Health, University of Iowa, College of Public Health, Iowa City, IA 

2 Mother and child: Improving the health of opiate-dependent mothers and their babies using a 

community-based peer counselor 

T. L. Horton, L. Bechler, B. L. Wilson, M. Lanyon, c. Jurkovitz, Y. Washio, Christiana Care 

Health System, Newark, DE 

3 “Group Prenatal Care” – Providing obstetric care in a community-based substance abuse 

treatment center 

E. Zadzielski, S. Rogers, S. Gargano, Y. Washio, Christiana Care Health Services, 

Newark, DE 

4 Integrated telemedicine-based treatment for hepatitis C at an opioid agonist treatment program 

L. S. Brown 6,8 , A. Talal 2,3,4 , P. Andrews 4 , A. Mcleod 1 , M. Zeremski 5 , Y. Chen 7 , C. Sylvester 1 , 

1 

Research & Evaluation, START: Treatment & Recovery Centers, Brooklyn, NY, 2 Medicine, 

University at Buffalo, Buffalo, NY, 3 Gastroenterology, Hepatology, and Nutrition, Cornell 

University, New York, NY, 4 Medicine, START: Treatment & Recovery Centers, New 

York, NY, 5 Gastroenterology, Hepatology, and Nutrition, Cornell University, New York, NY, 

6 

CEO, START: Treatment & Recovery Centers, Brooklyn, NY, 7 Biostatistics, University at 

Buffalo, Buffalo, NY, 8 Medicine, Weill Cornell Medical College, New York, NY 

5 OverdoseFreePA.org: A resource for overdose prevention in Pennsylvania 

M. D. Reynolds, J. L. Pringle, S. Rickard-Aasen, J. Oblak, School of Pharmacy, University of 

Pittsburgh, Pittsburgh, PA 

6 Images for science communications pertinent to drug dependence research and to the general 

public 

D. Barondess, J. C. Anthony, Epidemiology and Biostatistics, Michigan State University, East 

Lansing, MI 

7 Contribution of e-learning to addiction teaching: A successful experience at the University of 


M. Auriacombe 1 , J. Alexandre 1 , J. Dubernet 1 , J. Tanguy 2 , M. Fatseas 1 , 1 Addiction Psychiatry 

(CNRS USR 3413), Universite Bordeaux, Bordeaux, France, 2 MAPI, Univ. Bordeaux, 


8 The research in addiction medicine scholars program – Developing researchers in addiction 

fellowships 

P. O’Connor 3 , J. I. Tsui 2 , D. Gobel 1 , B. Brett 5 , C. Bridden 1 , J. H. Samet 4,1 , 1 Boston Medical 

Center, Boston, MA, 2 Internal Medicine, University of Washington School of Medicine, 

Seattle, WA, 3 Yale University, New Haven, CT, 4 Boston University, Boston, MA, 5 Brett 

Consulting Group, Somerville, MA 

91


9 Specialized community disease management to reduce substance use and hospital readmissions 

J. E. Chambers 1 , A. C. Brooks 1 , M. F. Morrison 2 , J. R. McKay 3 , D. R. Gastfriend 1 , 1 Treatment 

Research Institute, Philadelphia, PA, 2 Lewis Katz School of Medicine at Temple University, 

Philadelphia, PA, 3 Department of Psychiatry, University of Pennsylvania, Philadelphia, PA 

10 Research to practice: Fidelity monitoring and lessons learned with patient navigation and HIV 

K. Gilmore 2 , D. Svikis 1 , A. Rhodes 2 , T. Moore 1 , L. Yerkes 2 , 1 Virginia Commonwealth Univ., 

Richmond, VA, 2 Virginia Department of Health, Richmond, VA 

11 Theoretical implications of gender, power, and sexual scripts for HIV prevention programs 

aimed at young, substance-using African American women 

M. Hill 1 , A. Stotts 2 , 1 Emergency Medicine, University of Texas Health Science Center, 

McGovern Medical School, Houston, TX, 2 University of Texas Medical School at Houston, 

Houston, TX 

12 RICH Recovery: Integrating primary and behavioral healthcare for individuals with substance 

use disorders 

J. May 2,1 , D. Farrell-Moore 2,1 , D. N. Masri 2,1 , B. Cox 2,1 , 1 Grants, Research, Evaluation and 

Planning, RBHA, Richmond, VA, 2 Richmond Behavioral Health Authority, Richmond, VA 

13 The Baltimore reproductive health initiative: Bringing family planning to women in treatment 

M. Terplan 1 , J. Kirschner 2 , S. Muqueeth 2 , R. Dineen 2 , 1 Behavioral Health System Baltimore, 

Baltimore, MD, 2 Baltimore City Health Department, Baltimore, MD 

14 Using electronic health records data for clinical research 

L. T. Wu 2 , S. Spratt 2 , B. Heidenfelder 2 , B. Tai 4 , U. Ghitza 4 , 2 Duke University, Durham, NC, 

4 

NIDA, Bethesda, MD 

15 Foundational development of a post-market surveillance program for e-vapor products using 

Internet forum data 

E. C. McNaughton, T. M. Dailey, M. Behling, S. F. Butler, Inflexxion, Inc., Newton, MA 

16 In-house outreach: Strategies to promote and advertise a smoking cessation program in a 

Mexican university hospital 

O. Campollo 1,2 , O. Torres 1 , 1 Center of Alcoholism and Addictions, University of Guadalajara, 

Guadalajara, Mexico, 2 Molecular Biology, Hospital Civil de Guadalajara FAA, Guadalajara, 

Mexico 

LITERATURE REVIEW 

17 Prenatal cannabis exposure and cognitive functioning: A critical review 

C. A. Torres 2 , C. L. Hart 1,3 , 1 Psychology, Columbia University, New York, NY, 2 School 

of Social Work, Columbia University, New York, NY, 3 Psychiatry, Columbia University, 

New York, NY 

18 A review of recent developments (2012-15) on the use of financial incentives with pregnant 

smokers 

D. R. Davis 1,2 , L. J. Solomon 2 , S. Higgins 2,1 , 1 Psychology, University of Vermont, 

Burlington, VT, 2 Psychiatry, University of Vermont, Burlington, VT 

19 WITHDRAWN 

20 Community-based drug treatment in Thailand 

U. Perngparn, C. Areesantichai, Drug Dependence Research Center WHO Collaborating 

Center for Research and Training in Drug Dependence (WHOCC), Chulalongkorn University, 

Bangkok, Thailand 

92


21 Systematic review: Do take-home naloxone programs effectively reduce opioid overdose deaths? 

A Bradford Hill analysis 

R. McDonald, J. Strang, Addictions Department, King’s College London, London, 

United Kingdom 

22 Prescription stimulant non-medical use: Literature review 

S. Vosburg, M. Sokolowska, Grunenthal, Morristown, NJ 

23 A systematic review of barriers and facilitators to implementing a prescription drug monitoring 

program 

A. A. Garcia 1 , K. D. Rosen 2 , E. Finley 3 , J. S. Potter 1 , 1 Psychiatry, University of Texas Health 

Science Center San Antonio, San Antonio, TX, 2 University of Texas Health Science Center, 

San Antonio, TX, 3 South Texas Veterans Healthcare System, San Antonio, TX 

24 Opioid therapy misuse factors: A systematic review 

K. Song 1,3 , D. McGeary 2 , M. Pugh 4,5 , W. Kazanis 2 , S. M. Paniagua 2 , E. Finley 4,6 , A. A. Garcia 2 , 

V. Bebarta 7 , D. Carnahan 8,9 , J. S. Potter 2 , 1 Pharmacotherapy Education & Research Center, 

University of Texas Health Sciences Center at San Antonio, San Antonio, TX, 2 Psychiatry, 

UT Health Science Center, San Antonio, TX, 3 Pharmacy, South Texas Veterans Healthcare 

System, San Antonio, TX, 4 South Texas Veterans Healthcare System, San Antonio, TX, 

5 

Epidemiology & Biostatistics, University of Texas Health Sciences Center at San Antonio, 

San Antonio, TX, 6 Division of Clinical Epidemiology, University of Texas Health Sciences 

Center at San Antonio, San Antonio, TX, 7 San Antonio Military Medical Center, San 

Antonio, TX, 8 Defense Health Agency, San Antonio, TX, 9 United States Air Force Medical 

Support Agency, San Antonio, TX 

PREVENTION 

25 Child-parent attachment mediates but not moderates parent and child substance involvement 

Z. Zhai 2 , T. Ridenour 1 , R. E. Tarter 3 , 1 Research Triangle Institute, Allison Park, PA, 

2 

Psychiatry, Yale University School of Medicine, New Haven, CT, 3 University of Pittsburgh 

School of Pharmacy, Pittsburgh, PA 

26 Are distinct parenting practices all equally protective against adolescent substance use? 

L. A. Ghandour, N. J. El Salibi, N. Yassin, R. Afifi, American University of Beirut, Beirut, 

Lebanon 

27 Conflicts between youths and their parents in relation to future NIDA prevention research 

J. R. Parra-Cardona 1 , H. H. Yeh 2 , J. C. Anthony 2 , 1 Michigan State University, East 

Lansing, MI, 2 Epidemiology, Michigan State University, East Lansing, MI 

28 Is parenting really that stressful? Daily behavioral stress in drug-using parents compared to 

non-parents 

A. Moreland 1 , D. Brown 3 , N. Baker 2 , A. McRae-Clark 1 , 1 Psychiatry and Behavioral Sciences, 

Medical University of South Carolina, Charleston, SC, 2 Medical University of South Carolina, 

Charleston, SC, 3 Howard University, Washington, DC 

29 Codeine misuse/dependence: Best practice and future innovations in addressing risk, harm and 

successful treatment 

C. D. Parry 1 , M. van Hout 2 , I. Norman 3 , 1 Alcohol, Tobacco & Other Drug Research Unit, 

South African Medical Research Council, Cape Town, South Africa, 2 School of Health 

Sciences, Waterford Institute of Technology, Waterford, Ireland, 3 Florence Nightingale 

Faculty of Nursing & Midwifery, King’s College London, London, United Kingdom 

93


30 An exploratory factor analysis of a brief self-report scale to detect neurocognitive impairment 

among MMT patients 

M. Copenhaver 1,2 , R. Shrestha 2,3 , F. L. Altice 4 , 1 Allied Health Sciences, University of 

Connecticut, Storrs, CT, 2 Center for Health, Intervention, and Prevention, University of 

Connecticut, Storrs, CT, 3 Community Medicine & Health Care, University of Connecticut 

Health Center, Farmington, CT, 4 Department of Medicine, Yale University, New Haven, CT 

31 The Affordable Care Act and HIV/HCV testing in substance use disorder treatment programs 

C. N. Behrends 5 , J. A. Frimpong 1 , T. D’Aunno 2 , H. Pollack 4 , B. Schackman 5 , P. Friedmann 3 , 

1 

Columbia University, New York, NY, 2 New York University, New York, NY, 3 Baystate 

Health, Springfield, MA, 4 University of Chicago, Chicago, IL, 5 Weill Cornell Medical 

College, New York, NY 

32 Harm reduction service utilization and HIV incidence among people who inject drugs in Ukraine 

D. C. Ompad 1 , J. Wang 1 , K. Dumchev 3 , J. Barska 4 , M. Samko 4 , O. Zeziulin 3 , T. Salyuk 4 , 

O. Varetska 4 , J. DeHovitz 5 , 1 New York University, New York, NY, 3 Ukrainian Institute on 

Public Health Policy, Kiev, Ukraine, 4 Alliance for Public Health Ukraine, Kiev, Ukraine, 

5 

SUNY Downstate Medical Center, Brooklyn, NY 

33 HIV pre-exposure prophylaxis for people who inject drugs: Willingness to prescribe among 

general internists 

E. J. Edelman 1 , B. A. Moore 1 , G. Berkenblit 2 , S. Calabrese 1 , C. Cunningham 4 , D. A. Fiellin 1 , 

V. Patel 4 , K. A. Phillips 3 , J. Tetrault 1 , M. Shah 5 , O. Blackstock 4 , 1 Yale, New Haven, CT, 

2 

Johns Hopkins, Baltimore, MD, 3 NIDA-IRP, NIH, Baltimore, MD, 4 Montefiore, Bronx, NY, 

5 

UIC, Chicago, IL 

34 High-risk behaviors among Iranian female drug users inspiring health belief model 

E. Merghati-khoei 1 , M. Jamshidimanesh 1 , I. Ilika 1 , M. Hosseini 2 , 1 Iranian National Center for 

Addiction Studies, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of), 

2 

Epidemiology, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of) 

35 Screening for oral cancer in tobacco and/or alcohol addicts: A comparison of different 

organizations 

S. Rollier, Public Health, Centre Hospitalier Régional Universitaire de TOURS, Tours, France 

36 The interaction of masculine gender norm conformity and depression predict alcohol use in 

African American young adult men 

F. Fonseca, C. M. Risco, M. L. Boyd, T. S. Chaudhry, G. M. Munayco, C. I. Burt, 

C. W. Lejuez, R. Yi, Psychology, University of Maryland, College Park, MD 

37 Marijuana use in young adult women & men attending primary care: Results from a pilot study 

integrating behavioral health care into primary care 

G. Lapham, M. Addis, A. K. Lee, C. Achtmeyer, J. Richards, E. Ludman, T. Gildred, 

R. Caldeiro, L. Marx, P. Lozano, K. A. Bradley, Group Health Research Institute, Seattle, WA 

38 Application of system dynamics to inform a model of adolescent SBIRT implementation in 

primary care settings 

S. G. Mitchell 1 , D. Lounsbury 2 , Z. Li 5 , R. P. Schwartz 1 , J. Gryczynski 1 , A. Kirk 3 , M. Oros 4 , 

C. Hosler 4 , K. Dusek 1 , B. Brown 1 , 1 Friends Research Institute, Baltimore, MD, 2 Albert 

Einstein College of Medicine, Yeshiva University, Bronx, NY, 3 Total Health Care, 

Baltimore, MD, 4 The Mosaic Group, Baltimore, MD, 5 College of Global Public Health, 

New York University, New York, NY 

39 Key ingredients for conducting daily or weekly IVR/SMS surveys 

L. Massey 1 , M. A. Walton 1 , R. M. Cunningham 2 , J. Cranford 1 , A. Buu 3 , 1 Psychiatry, 

University of Michigan, Ann Arbor, MI, 2 Emergency Medicine, University of Michigan, 

Ann Arbor, MI, 3 School of Nursing, University of Michigan, Ann Arbor, MI 

94


40 E-cigarette expectancies: Initial qualitative assessment for measure development 

P. T. Harrell 1 , G. Quinn 2 , B. Vesely 1 , T. Brandon 2 , 1 Pediatrics, Eastern Virginia Medical 

School, Norfolk, VA, 2 Health Outcomes & Behavior, Moffitt Cancer Center, Tampa, FL 

41 WITHDRAWN 

POLYDRUG 

42 Psychedelic-associated addiction remission: An online survey 

A. Garcia-Romeu, R. R. Griffiths, M. W. Johnson, Psychiatry, Johns Hopkins, Baltimore, MD 

43 A pilot study of the feasibility and potential effectiveness of using smartphones to provide 

recovery support 

C. K. Scott 1 , M. L. Dennis 1 , D. Gustafson 2 , K. Johnson 2 , 1 Lighthouse Institute, Chestnut 

Health Systems, Chicago, IL, 2 CHESS, University of Wisconsin, Madison, WI 

44 Healthcall on smartphone: A brief intervention to reduce concurrent drug and alcohol use 

E. Aharonovich 1,2 , E. Greenstein 2 , A. Le 2 , D. S. Hasin 1,2 , 1 Psychiatry, Columbia University 

Medical Center, New York, NY, 2 NYSPI, New York, NY 

45 Clinician involvement with internet-delivered treatment and association to outcomes 

A. Campbell 1 , E. V. Nunes 1 , M. Pavlicova 2 , 1 Department of Psychiatry, Columbia University 

Medical Center, New York, NY, 2 Columbia University, New York, NY 

46 Comparing predictors of treatment completion and length of stay for outpatient treatment 

G. Stahler, J. Mennis, Temple University, Philadelphia, PA 

47 Housing status, psychiatric distress, and substance use among sober living house residents 

D. L. Polcin, R. Korcha, A. Mericle, S. Gupta, J. Witbrodt, Alcohol Research Group, Public 

Health Institute, Emeryville, CA 

48 Intrinsic and extrinsic motivation predict treatment outcome in a sample of HIV+ drug users 

D. Cannizzaro 1 , M. Stohl 1 , D. Hasin 1,2 , E. Aharonovich 1,2 , 1 New York State Psychiatric 

Institute, New York, NY, 2 Psychiatry, Columbia University, New York, NY 

49 Methadone maintenance therapy and comorbid substance use: A brief qualitative report 

N. Puri, R. McNeil, W. Small, Urban Health Research Institute, BC Centre for Excellence in 

HIV/AIDS, Vancouver, BC, Canada 

50 Performance of the TAPS-I brief screening tool in primary care 

J. Gryczynski 2 , J. McNeely 4 , L. T. Wu 1 , G. Subramaniam 3 , G. Sharma 5 , C. Nordeck 2 , 

A. Sharma 2 , L. A. Cathers 6 , C. Cushing 3 , D. Svikis 6 , E. Jelstrom 5 , K. O’Grady 7 , 

R. P. Schwartz 2 , 1 Duke University, Durham, NC, 2 Friends Research Institute, Baltimore, MD, 

3 

NIDA, Rockville, MD, 4 NYU, New York, NY, 5 The EMMES Corporation, Rockville, MD, 

6 

VCU, Richmond, VA, 7 Univ. of Maryland, College Park, MD 

51 Prevalence and correlates of recovery from drug dependence 

J. A. Cranford 2 , C. J. Boyd 1 , S. McCabe 3 , 1 Health Behavior and Behavioral Science, 

University of Michigan, Ann Arbor, MI, 2 Psychiatry, University of Michigan, Ann Arbor, MI, 

3 

Institute for Research on Women & Gender, University of Michigan, Ann Arbor, MI 

COMORBIDITY 

52 Feasibility and satisfaction of the women’s recovery group for patients with co-occurring 

substance use and eating disorders 

S. F. Greenfield 1,2,3 , D. E. Sugarman 1,2,3 , B. Iles 2 , E. Dechant 3 , T. Weigel 3 , P. Tarbox 3 , 1 Harvard 

Medical School, Boston, MA, 2 Division of Alcohol and Drug Abuse, McLean Hospital, 

Belmont, MA, 3 Division of Women’s Mental Health, McLean Hospital, Belmont, MA 

95


53 Smartphone-enhanced behavioral activation treatment for substance use and depression 

Y. Chen 2 , J. A. De Leo 2 , L. Matalenas 1 , A. C. McLaughlin 1 , A. Petruzzella 2 , E. Jones 2 , 

S. B. Daughters 2 , 1 Department of Psychology, North Carolina State University, Raleigh, NC, 

2 

Department of Psychology and Neuroscience, University of North Carolina at Chapel Hill, 

Chapel Hill, NC 

54 Nicotine metabolite ratio and associations with smoking topography in a population with 

affective disorders 

D. Gaalema 2 , J. W. Tidey 1 , R. Tyndale 3 , S. Higgins 2 , 1 Center for Alcohol & Addictions 

Studies, Brown University, Providence, RI, 2 University of Vermont, Burlington, VT, 

3 

University of Toronto, Toronto, ON, Canada 

55 OCD symptom severity and tobacco withdrawal symptomatology among African American 

smokers 

M. S. Bello, J. F. McBeth, R. Pang, A. Leventhal, Preventive Medicine, University of 

Southern California, Los Angeles, CA 

56 Emotion dysregulation in adult smokers with and without ADHD: Baseline differences and 

abstinence-induced effects 

J. T. Mitchell 2 , C. W. Lejuez 6 , F. McClernon 2 , J. Beckham 2,5 , R. A. Brown 7 , S. H. Kollins 1 , 

1 

Psychiatry, Duke University Medical Center, Durham, NC, 2 Psychiatry & Behavioral 

Sciences, Duke University Medical Center, Durham, NC, 5 Veterans Affairs Medical Center, 

Durham, NC, 6 University of Maryland, College Park, MD, 7 University of Texas at Austin, 

Austin, TX 

57 Facets of mindfulness mediate the relationship between depressive symptoms and smoking 

expectancies 

C. Vinci 1 , C. A. Spears 3 , M. R. Peltier 1 , A. Copeland 1 , 1 UT MD Anderson Cancer Center, 

Houston, TX, 3 The Catholic University of America, Washington, DC 

58 High prevalence of major depression among treatment-seeking ketamine-dependent patients 

L. Chen 1 , K. Xu 2 , C. Chen 4 , M. Huang 3 , 1 General Psychiatry, Taipei City Psychiatric 

Center, Taipei City Hospital, Songde Branch, Taipei, Taiwan, 2 Yale School of Medicine, 

New Haven, CT, 3 Taipei City Psychiatric Center, Taipei, Taiwan, 4 Department of Psychiatry, 

Chang Gung Memorial Hospital, Keelung, Taiwan 

59 Major depressive disorder and family history of alcoholism in two treatment samples: Does 

gender matter? 

K. M. Polak 1 , A. Edwards 2 , K. S. Kendler 2 , D. Svikis 1 , E. Ngjelina 1 , S. Spicer 1 , 1 Psychology, 

Virginia Commonwealth University, Henrico, VA, 2 Psychiatry, Virginia Commonwealth 


60 Substance use disorder and home neighborhood disorder do not predict posttraumatic stress 

symptoms 

S. K. Hertzel, L. Moran, W. J. Kowalczyk, D. H. Epstein, K. L. Preston, K. A. Phillips, 

Treatment Section, NIDA IRP, Baltimore, MD 

61 Predictors of barriers to mental healthcare service utilization in returning veterans 

M. B. Benz 1 , B. Borsari 1,2 , J. Metrik 1,3 , 1 Center for Alcohol and Addiction Studies, Brown 

University, Providence, RI, 2 San Francisco VAMC, San Francisco, CA, 3 Providence VAMC, 

Providence, RI 

62 Greater psychiatric morbidity among youth with synthetic cannabinoid use in residential 

treatment 

V. L. Selby 2,1 , C. Storr 2 , M. Fishman 3,1 , 1 Maryland Treatment Centers, Baltimore, MD, 

2 

University of Maryland School of Nursing, Baltimore, MD, 3 Johns Hopkins School of 

Medicine, Baltimore, MD 

96


63 Improvement in psychiatric symptoms during Interim buprenorphine treatment 

J. M. Streck 1 , T. A. Ochalek 1 , B. Hruska 3 , J. D. Pusey 3 , S. C. Sigmon 3 , 1 Psychological Science, 

University of Vermont, Burlington, VT, 3 Psychiatry, University of Vermont, Burlington, VT 

64 The impact of addiction medications on outcomes for persons with co-occurring PTSD and 

opioid use disorders 

E. Saunders 1 , M. P. McGovern 4 , C. Lambert-Harris 2 , A. Meier 4 , B. McLeman 3 , 1 The 

Dartmouth Institute, Lebanon, NH, 2 Psychiatry, Dartmouth Geisel School of Medicine, 

Lebanon, NH, 3 Dartmouth Psychiatric Research Center, Lebanon, NH, 4 Psychiatry, Dartmouth 

Geisel School of Medicine, Lebanon, NH 

65 Development and pilot test of integrated cognitive behavioral therapy for anxiety and opioid use 

disorder 

K. McHugh, S. F. Greenfield, R. Weiss, McLean Hospital/Harvard Medical School, 

Belmont, MA 

66 Life in the barrio: Stress, depression and drug use 

Y. Villarreal 1 , M. R. Klawans 1 , L. Torres 2 , P. Bordnick 2 , A. Stotts 1 , 1 McGovern Medical 

School, University of Texas Health Science Center at Houston, Houston, TX, 2 Graduate 

College of Social Work, University of Houston, Houston, TX 

67 Anxiety disorders as a risk factor for needle sharing among cocaine users: Results from the 

COSMO study 

A. Levesque 2,3 , E. Roy 1 , D. Jutras-Aswad 2,5 , G. Zang 2 , A. Artenie 2,3 , J. Bruneau 2,4 , 1 Community 

Health Sciences, Université de Sherbrooke, Longueuil, QC, Canada, 2 Research Center, Centre 

Hospitalier de l’Université de Montréal, Montreal, QC, Canada, 3 Family Medicine, McGill 

University, Montreal, QC, Canada, 4 Family and Emergency Medicine, Université de Montréal, 

Montreal, QC, Canada, 5 Psychiatry, Université de Montréal, Montréal, QC, Canada 

68 Acute tryptophan depletion in cocaine dependent subjects with comorbid-depression 

M. Torrens 2,1,3 , J. I. Mestre-Pintó 1 , C. Pérez-Mañà 1,3 , E. Papaseit 1,3 , F. Fonseca 2,1,3 , M. Farré 4,1,3 , 

1 

Institut Hospital del Mar d’Investigacions Mèdiques, PSMAR, Barcelona, Spain, 2 Institut de 

Neuropsiquiatria i Addiccions, Parc de Salut Mar, Barcelona, Spain, 3 Universitat Autònoma 

de Barcelona, Barcelona, Spain, 4 Hospital Universitari Germans Trias i Pujol-IGTP, Badalona, 

Spain 

69 Effect of vasopressin and oxytocin on ACTH secretion in cocaine-dependent patients 

M. S. Heller, F. R. Levin, E. V. Nunes, W. N. Raby, Psychiatry, Columbia University, 

New York, NY 

70 Effects of plasma pregnanolone levels on stress response, mood and drug craving in cocainedependent 

men and women 

V. Milivojevic 1 , H. C. Fox 1 , J. Covault 2 , R. Sinha 1 , 1 Psychiatry, Yale University School of 

Medicine, New Haven, CT, 2 Psychiatry, University of Connecticut School of Medicine, 

Farmington, CT 

IMPULSIVITY 

71 Self-reported impulsivity is related to age at first methamphetamine use 

A. Cservenka 2 , L. Ray 1,2,3 , 1 Psychology, University of California, Los Angeles, 

Los Angeles, CA, 2 Psychiatry and Biobehavioral Sciences, University of California, Los 

Angeles, Los Angeles, CA, 3 Brain Research Institute, University of California, Los Angeles, 


72 Differences in clinical presentation between high and low impulsive methamphetamine users 

E. E. Hartwell 2,3 , L. Ray 2,1 , 1 Psychiatry, UCLA, Los Angeles, CA, 2 Psychology, UCLA, 

Los Angeles, CA, 3 Integrated Substance Abuse Programs, UCLA, Los Angeles, CA 

97


73 Behavioral impulsivity as a predictor of success in a smoking cessation in adolescents 

S. M. Dowd 1 , S. Fields 1 , B. Reynolds 2 , 1 Psychology, Texas A&M University, College 

Station, TX, 2 University of Kentucky, Lexington, KY 

74 Impulsivity, sensation seeking and substance use among adolescents: A longitudinal research 

study 

L. Carla, V. Martinez-Loredo, S. Fernández Artamendi, J. Fernández-Hermida, 

I. Pericot-Valverde, W. Sara, R. Secades-Villa, University of Oviedo, Spain, Oviedo, Spain 

75 Assessing naturalistic risk-taking in nondaily smokers using a novel momentary balloon 

analogue risk task 

R. R. MacLean 3,1,2 , J. M. Smyth 3 , C. F. Geier 3 , S. J. Wilson 3 , 1 VA Connecticut Healthcare 

System, West Haven, CT, 2 Yale University, New Haven, CT, 3 Pennsylvania State University, 

University Park, PA 

76 Psychopathological symptoms, impulsivity and decision making in HIV patients with and 

without tobacco smoking 

A. Lim, E. Lau, L. Chang, Department of Medicine, University of Hawaii, John A. Burns 

School of Medicine, Honolulu, HI 

STIMULANTS: HUMAN STUDIES 

77 History of cocaine sensitization in humans is associated with lipidomic changes similar to those 

in cocaine-sensitized rats 

K. L. Preston 2 , K. A. Phillips 4 , J. J. Wagner 3 , B. Cummings 3 , D. H. Epstein 1 , 1 Treatment 

Section, NIDA IRP, Baltimore, MD, 2 Clinical Pharmacology and Therapeutics Research 

Branch, NIDA Intramural Research Program, Baltimore, MD, 3 Univ. of Georgia, Athens, GA, 

4 

Intramural Research Program, National Institute on Drug Abuse, National Institutes of 

Health, Baltimore, MD 

78 Regional and network-based alterations in D 2 

/D 3 

receptor availability in cocaine use disorder 

P. D. Worhunsky 1,2 , D. Matuskey 1,2 , J. Gallezot 1 , N. Nabulsi 1 , G. A. Angarita 2 , 

V. D. Calhoun 3,4,2 , R. T. Malison 2 , M. N. Potenza 1,5 , R. E. Carson 1 , 1 Radiology & Biomedical 

Imaging, Yale School of Medicine, New Haven, CT, 2 Psychiatry, Yale School of Medicine, 

New Haven, CT, 3 Electrical & Computer Engineering, University of New Mexico, 

Albuquerque, NM, 4 The Mind Research Network, Albuquerque, NM, 5 Neuroscience, Yale 

School of Medicine, New Haven, CT 

79 A careful assessment of cognitive functioning in individuals with cocaine use disorder 

K. M. Frazer 1 , J. J. Manly 2 , G. Downey 1,3,4 , C. L. Hart 1,3,4 , 1 Psychology, Columbia University, 

New York, NY, 2 Neurology, Columbia University College of Physicians and Surgeons, 

New York, NY, 3 Division on Substance Abuse and Department of Psychiatry, New York 

State Psychiatric Institute, New York, NY, 4 Columbia University College of Physicians and 

Surgeons, New York, NY 

80 Executive functioning and outpatient treatment adherence after intensive inpatient care in 

cocaine dependence: A six-month follow-up study 

P. D. Goncalves 3 , M. Ometto 2 , A. Malbergier 2 , P. Martins 2 , L. Beraldo 2 , B. Santos 4 , 

S. Nicastri 2 , A. Andrade 2 , P. J. Cunha 1 , 1 Department of Psychiatry, Laboratory of Psychiatric 

Neuroimaging (LIM 21), São Paulo, Brazil, 2 Psychiatry, University of São Paulo, São Paulo, 

Brazil, 3 Psychiatry, University of California San Diego, San Diego, CA, 4 University of Sao 

Paulo, Sao Paulo, Brazil 

98


81 Acute inhibitory control training in cocaine users 

J. L. Alcorn 2 , E. Pike 1,2 , J. A. Lile 1,2,3 , W. W. Stoops 1,2,3 , C. R. Rush 1,2,3 , 1 Psychology, 


Lexington, KY, 3 Psychiatry, University of Kentucky, Lexington, KY 

82 Effects of mixed amphetamine salts dose and belief about drug assignment on cognitive 

performance in college students 

K. Cropsey, M. Froelich, P. Hendricks, R. Fargason, University of Alabama at Birmingham, 

Birmingham, AL 

83 Cocaine decreases preference for condom use as function of delayed condom availability and 

STI risk 

M. W. Johnson 1 , E. S. Herrmann 2 , P. S. Johnson 3 , M. M. Sweeney 1 , 1 Psychiatry and 

Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, 

2 

New York State Psychiatric Institute, New York, NY, 3 Psychology, California State 

University, Chico, Chico, CA 

84 The influence of buspirone maintenance on the pharmacodynamic effects of methamphetamine 

A. R. Reynolds 1 , W. W. Stoops 1,2,3 , J. A. Lile 1,2,3 , C. R. Rush 1,2,3 , 1 Behavioral Science, 

University of Kentucky, Lexington, KY, 2 Psychology, University of Kentucky, 


85 Impact of lisdexamfetamine on retention of methamphetamine-dependent patients in a 

residential facility 

M. J. Mancino 2 , J. D. Thostenson 3 , J. B. Guise 2 , J. McGaugh 2 , A. Oliveto 2 , 2 Psychiatry, 

University of Arkansas for Medical Sciences, Little Rock, AR, 3 Biostatistics, University of 


86 Cue-induced cocaine craving increases with aripiprazole treatment in methadone-maintenance 

patients 

L. Moran 1 , K. A. Phillips 1 , W. J. Kowalczyk 1 , U. Ghitza 2 , D. H. Epstein 1 , K. L. Preston 1 , 

1 

NIDA-IRP, Baltimore, MD, 2 NIDA, Baltimore, MD 

87 A novel approach to naltrexone injections may reduce complications and increase adherence 

J. Walker 1 , D. Santos 3 , C. Rowe 1 , G. Santos 1,2 , S. Jung 1 , P. Coffin 1,4 , 1 Substance Use Research 

Unit, San Francisco Department of Public Health, San Francisco, CA, 2 Community Health 

Systems, University of California San Francisco, San Francisco, CA, 3 Housing and Urban 

Health, San Francisco Department of Public Health, San Francisco, CA, 4 Division of HIV/ 

AIDS, University of California, San Francisco, San Francisco, CA 

88 Changes in quality of life in cocaine-dependent participants provided treatment with 

buprenorphine and naloxone and extended-release naltrexone 

D. Blumberg 1 , F. Carrizales 2 , W. Kazanis 2 , M. P. Hillhouse 3 , A. G. Matthews 4 , J. S. Potter 2 , 

1 

NIDA Clinical Coordinating Center, The Emmes Corporation, Rockville, MD, 2 Psychiatry, 

UT Health Science Center, San Antonio, TX, 3 Integrated Substance Abuse Programs, 

University of California, Los Angeles, CA, 4 The Emmes Corporation, Rockville, MD 

89 Participant treatment assignment perceptions in the NIDA CTN cocaine use reduction with 

buprenorphine study 

A. G. Matthews 2 , M. P. Hillhouse 1 , C. Thomas 1 , W. Ling 1 , D. Blumberg 2 , 1 UCLA, Los 

Angeles, CA, 2 Emmes, Rockville, MD 

90 Use of contingency management for crack cocaine dependence in South America: Preliminary 

results from a randomized clinical trial 

A. Q. Miguel 1 , C. S. Madruga 2 , S. McPherson 3 , M. G. McDonell 3 , J. M. Roll 3 , R. Laranjeira 2 , 

1 

Psychiatry, Federal University of São Paulo, Sao Paulo, Brazil, 2 Psychiatry, Universidade 

Federal de São Paulo, Sao Paulo, Brazil, 3 Washington State University, Spokane, WA 

99


PRESCRIPTION DRUGS 

91 Early exposure to prescription drugs and substance use disorder symptoms in adulthood 

P. T. Veliz 1 , J. Schulenberg 2 , S. McCabe 1 , 1 Institute for Research on Women & Gender, 

University of Michigan, Ann Arbor, MI, 2 Institute for Social Research, University of 


92 Reasons for prescription opioid misuse while playing in the NFL associated with current use 

and misuse among retired players 

E. M. Dunne 1 , C. W. Striley 2 , N. E. Whitehead 1 , L. Cottler 2 , 1 Clinical and Health Psychology, 

University of Florida, Gainesville, FL, 2 Epidemiology, University of Florida, Gainesville, FL 

93 Physical health of women recovering from prescription opioid abuse 

K. R. Marks, M. Delaney, C. Leukefeld, Behavioral Science, University of Kentucky, 

Lexington, KY 

94 Association between lifetime heroin use and perceived risk of heroin among nonmedical 

prescription opioid users 

V. R. Votaw 1 , K. McHugh 1,3 , 1 McLean Hospital, Belmont, MA, 3 Harvard Medical School, 

Boston, MA 

95 Patient perspectives of transitioning from prescription opioids to heroin and the role of route of 

administration 

L. Monico, S. G. Mitchell, Friends Research Institute, Baltimore, MD 

96 Defining problematic pharmaceutical opioid use among people prescribed opioids for chronic 

non-cancer pain: Different measures, same patients? 

G. Campbell 5 , R. Bruno 2 , M. Cohen 3 , W. Hall 4 , S. Nielsen 5 , N. Lintzeris 1 , B. Larance 5 , 

R. P. Mattick 5 , M. Farrell 5 , L. Degenhardt 5 , 1 Langton Centre, Sydney, NSW, Australia, 

2 

School of Medicine, University of Tasmania, Hobart, TAS, Australia, 3 Clinical School, St. 

Vincents, Sydney, NSW, Australia, 4 Centre for Youth Substance Abuse Research, University 

of Queensland, Brisbane, QLD, Australia, 5 National Drug and Alcohol Research Centre, 

UNSW, Sydney, NSW, Australia 

97 A fully automated algorithm for identifying patients with problem prescription opioid use using 

electronic health record data 

D. Carrell 1 , J. Mardekian 2 , D. Cronkite 1 , A. Ramaprasan 1 , K. Hansen 1 , D. E. Gross 2 , 

R. E. Palmer 2 , E. Masters 2 , M. Von Korff 1 , 1 Group Health Research Institute, Seattle, WA, 

2 

Pfizer Inc., New York, NY 

98 Prescribing opioids safely in the emergency department study: Predictors of emergency 

department discharge with high morphine milligram equivalent prescription 

K. Hawk 1 , S. Weiner 2 , J. Dziura 1 , D. A. Fiellin 3 , D. DaEun 4 , L. Nelson 5 , J. Hoppe 6 , J. Perrone 7 , 

G. D’Onofrio 1 , 1 Emergency Medicine, Yale University, New Haven, CT, 2 Emergency 

Medicine, Brigham & Women’s Hospital, Boston, MA, 3 Internal Medicine, Yale University, 

New Haven, CT, 4 Harvard Medical School, Boston, MA, 5 Emergency Medicine, NYU, 

New York, NY, 6 Emergency Medicine, University of Colorado, Denver, CO, 7 Emergency 

Medicine, University of Pennsylvania, Philadelphia, PA 

100



99 Patterns of prescription drug use in Spain: The European opioid treatment patient survey 

F. Fonseca 2,4,5 , M. Torrens 2,4,5 , M. Farré 6,4,5 , J. L. Green 1 , I. Maremmani 7,8 , M. Guareschi 8 , 

M. Auriacombe 3 , N. Scherbaum 9 , T. Clausen 10 , D. Hill 11 , R. C. Dart 1 , 1 RADARS System, Denver 

Health, Denver, CO, 2 Institut de Neuropsiquiatria i Addiccions, Parc de Salut Mar, Barcelona, 

Spain, 3 Addiction Psychiatry (CNRS USR 3413), Universite Bordeaux, Bordeaux, France, 4 Institut 

Hospital del Mar d’Investigacions Mèdiques, PSMAR, Barcelona, Spain, 5 Universitat Autònoma 

de Barcelona, Barcelona, Spain, 6 Hospital Universitari Germans Trias i Pujol-IGTP, Badalona, 

Spain, 7 Department of Neurosciences, Santa Chiara University Hospital, Pisa, Italy, 8 Associazione 

per l’Utilizzo delle Conoscenze Neuroscientifiche a fini Sociali, Pietrasanta, Italy, 9 Department 

of Psychiatry, LVR Clinic, Essen, Germany, 10 Norwegian Centre for Addiction Research, Oslo, 

Norway, 11 NHS Lanarkshire, Motherwell, United Kingdom 

100 Alcohol, cannabis, and cigarette use and non-medical prescription drug use stages 

B. J. Arterberry 2 , S. R. Horbal 1 , H. Lin 1 , A. Buu 2 , 1 Indiana University, Bloomington, IN, 

2 

University of Michigan, Ann Arbor, MI 

101 Collaborative care for injured patients with prescription drug misuse: A feasibility study 

L. K. Whiteside 1 , D. Darnell 2 , K. Jackson 1 , D. Donovan 2,3 , D. Zatzick 2 , 1 Division of 

Emergency Medicine, University of Washington, Seattle, WA, 2 Psychiatry and Behavioral 

Sciences, University of Washington, Seattle, WA, 3 Alcohol and Drug Abuse Institute, 

University of Washington, Seattle, WA 

102 Acceptability and feasibility of an intervention for overdose and HIV risk during addictions 

treatment for patients with prescription opioid misuse 

A. S. Bohnert, M. Walton, F. Blow, L. Thomas, M. llgen, Psychiatry, University of Michigan, 

Ann Arbor, MI 

103 Change in overdose/poisoning diagnoses in patients prescribed oxycontin after its reformulation 

with abuse-deterrent properties 

P. Coplan 1 , A. Kadakia 3 , R. Singh 3 , A. DeVeaugh-Geiss 1 , 1 Risk Management and 

Epidemiology, Purdue Pharma, Stamford, CT, 3 Purdue, Stamford, CT 

104 Timing of sexual abuse, sexual risk behaviors and substance use among U.S. women 

M. Cook, Integrated Substance Abuse Programs, University of California, Los Angeles, CA 

Symposium XV Thursday, 

RISKY BUSINESS: NEUROBIOLOGICAL MECHANISMS OF 

RISKY DECISION MAKING IN DRUG ABUSE 

AND ADDICTION 

Chairs: Shelley Su and Carlos Blanco 

10/14 

10:00 - 12:00 PM 

10:00 Dopaminergic modulation of frontal-amygdalar-striatal circuits subserving risk/reward 

decision making 

Stan Floresco, University of British Columbia, Vancouver, BC, Canada 

10:25 Risky decision making, cocaine self-administration, and dopamine signaling 

Barry Setlow, University of Florida, Gainesville, FL 

10:50 Linking neural networks to markers of dopamine signaling and risky decision-making in 

methamphetamine dependence 

Milky Kohno, University of California, Los Angeles, CA 

11:15 The danger of inadequate risk and reward processing in drug addiction 

Martin P Paulus, Laureate Institute for Brain Research, Tulsa, OK 

11:40 DISCUSSANT: Risky decision making: towards integrating basic and clinical perspectives 

Carlos Blanco, NIH/NIDA/DESPR, Bethesda, MD 

101



Oral Communications 20 Thursday, 

TRADING PLACES: RACE/SOCIO-ECONOMIC STATUS 

4 

10:00 - 12:00 PM 

Chairs: Debra Furr-Holden and Raymond L. Moody 

10:00 Alcohol use among Native Americans compared to whites: Examining the veracity of the ‘Native 

American elevated alcohol consumption’ belief 

J. K. Cunningham 2,1 , T. A. Solomon 1 , M. L. Muramoto 2 , 1 Native American Research and 

Training Center, University of Arizona, Tucson, AZ, 2 Family and Community Medicine, 

University of Arizona, Tucson, AZ 

10:15 Racial, ethnic and gender disparities in substance use at discharge 

E. Guerrero 1 , K. Fenwick 1 , Y. Kong 1 , H. Amaro 2 , 1 School of Social Work, University of 

Southern California, Los Angeles, CA, 2 Social Work and Preventive Medicine, University of 

Southern California, Los Angeles, CA 

10:30 Emotion regulation moderates the relationship between perceived discrimination and risk 

behaviors in African American college students 

A. M. Heads 1 , L. G. Castillo 2 , A. Glover 2 , J. Schmitz 1 , 1 University of Texas HSC Houston, 

Houston, TX, 2 Texas A&M University, College Station, TX 

10:45 The impact of discrimination on drug dependence among gay and bisexual men: A look at the 

role of emotion dysregulation 

R. L. Moody 1,2 , J. T. Parsons 1,2 , C. Grov 2 , 1 Psychology, Graduate Center, City University of 

New York, New York, NY, 2 Center for HIV Educational Studies and Training (CHEST), 

New York, NY 

11:00 Association between any major discrimination and current cigarette smoking among adult 

African American men 

L. J. Parker 1 , B. Kinlock 1 , D. Chisolm 3 , D. Furr-Holden 2 , R. Thorpe 1 , 1 Health, Behavior, and 

Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 2 Mental Health, 

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, 3 Sociology, Morgan State 

University, Baltimore, MD 

11:15 Environmental smoke exposure among daily smokers with low v.s. high educational attainment 

J. W. Tidey 2 , R. Denlinger 1 , D. Hatsukami 4 , E. Donny 3 , 1 Behavioral and Social Sciences, 

Brown University, Providence, RI, 2 Center for Alcohol & Addictions Studies, Brown 

University, Providence, RI, 3 Psychology, University of Pittsburgh, Pittsburgh, PA, 4 Masonic 

Cancer Center, University of Minnesota Medical School, Minneapolis, MN 

11:30 Diminished alternative reinforcement mediates socioeconomic disparities in adolescent 

substance use: A longitudinal study 

N. Andrabi 1 , A. Leventhal 1 , R. Khoddam 2 , 1 Institute for Preventive Medicine, University of 

Southern California, Los Angeles, CA, 2 Psychology, University of Southern California, Los 

Angeles, CA 

11:45 Perceived social support and socioeconomic status predict maternal delay discounting behavior 

and neural function in healthy postpartum women 

L. K. Brents, J. Young, B. Knight, J. L. Coker, S. L. Ray-Griffith, Z. Stowe, G. A. James, 

C. Kilts, University of Arkansas for Medical Sciences, Little Rock, AR 

102




TRAINSPOTTING: OVERDOSE 

6/8 

10:00 - 12:00 PM 

Chairs: Alexander Y. Walley and Amy Peacock 

10:00 Use of a prescription opioid registry to examine opioid misuse and overdose 

C. Campbell 1 , A. Bahorik 3 , C. Weisner 1,3 , P. VanVeldhuisen 2 , A. Rubinstein 4 , T. Ray 1 , 

1 

Division of Research, Kaiser Permanente Northern California, Oakland, CA, 2 The EMMES 

Corporation, Rockville, MD, 3 Psychiatry, UCSF, San Francisco, CA, 4 Anesthesiology, Kaiser 

Permanente, Santa Rosa Medical Center, Santa Rosa, CA 

10:15 Polypharmacy and non-fatal overdose in patients with HIV infection and substance dependence 

T. W. Kim, A. Y. Walley, A. S. Ventura, G. Lerner, G. Patts, T. Heeren, R. Saitz, Boston 

University Schools of Medicine and Public Health, Boston, MA 

10:30 Same-day use of opioids and depressants: A retrospective diary study 

A. Peacock 5,3 , R. Bruno 5 , B. Larance 4 , N. Lintzeris 1 , R. Ali 2 , D. Oen 3 , O. Sotade 3 , N. White 2 , 

L. Degenhardt 3 , 1 Langton Centre, Sydney, NSW, Australia, 2 University of Adelaide, 

Adelaide, SA, Australia, 3 National Drug and Alcohol Research Centre, University of NSW, 

Sydney, NSW, Australia, 4 University of New South Wales, Sydney, NSW, Australia, 5 School 

of Medicine, University of Tasmania, Hobart, TAS, Australia 

10:45 Factors associated with nonfatal overdose among young opioid users: Heroin and 

benzodiazepine use, prescription opioid and heroin injection and HCV status 

P. Mateu-Gelabert 1 , H. Guarino 1 , D. Frank 1 , K. Ruggles 3 , C. Syckes 1 , E. Goodbody 1 , 

S. R. Friedman 1 , 1 NDRI, New York, NY, 3 NYU, New York, NY 

11:00 Overdose risk behaviors during the period preceding non-fatal overdose events among veterans 

A. S. Bennett 1 , E. R. Pouget 2 , L. Elliott 2 , A. Golub 2 , A. Rosenblum 2 , P. Britton 3 , 1 National 

Development and Research Institutes, New York City, NY, 2 NDRI, New York, NY, 3 Medical 

Center, University of Rochester, Rochester, NY 

11:15 Integrating opioid overdose prevention in the emergency department 

R. McCormack, MD 2 , C. Koziatek, MD 2 , A. Rubin 1 , L. O’Donnell 2 , L. Nelson 1 , 1 NYU School 

of Medicine, New York, NY, 2 Ronald O. Perelman Department of Emergency Medicine, NYU 

School of Medicine, New York, NY 

11:30 Effect of local health department leadership on community overdose prevention coalitions 

A. A. Alexandridis, N. Dasgupta, C. Ringwalt, C. Sanford, A. McCort, Injury Prevention 

Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 

11:45 Help-seeking among community responders trained in overdose prevention and naloxone 

administration 

A. Y. Walley 1 , J. Sisti 4 , L. Forman 2 , S. Ruiz 3 , Z. Xuan 2 , 1 BU School of Med, Boston, MA, 2 BU 

School of Public Health, Boston, MA, 3 Mass Dept of Public Health, Boston, MA, 4 Harvard 

School of Public Health, Boston, MA 

103





COCAINE COWBOYS: CLINICAL STUDIES 

12 

10:00 - 11:00 AM 

Chairs: William W. Stoops and Margaret Haney 

10:00 Changes in brain white matter integrity after PPAR-gamma agonist treatment for cocaine use 

disorder 

S. D. Lane 1 , K. M. Hasan 5 , B. Mwangi 1 , P. A. Narayana 5 , J. Vincent 1 , F. Moeller 4 , 

J. Steinberg 4 , K. Dineley 3 , K. A. Cunningham 2 , J. Schmitz 1 , 1 Psychiatry & Behavioral 

Sciences, University of Texas Health Science Center - Houston, Houston, TX, 2 Center for 

Addiction Research, University of Texas Medical Branch, Galveston, TX, 3 Neurology, 

University of Texas Medical Branch, Galveston, TX, 4 Institute for Drug and Alcohol Studies, 

Virginia Commonwealth University, Richmond, VA, 5 Diagnostic and Interventional Imaging, 

University of Texas Health Science Center - Houston, Houston, TX 

10:15 Modafinil reduces cocaine self-administration in humans: Effects vary as a function of cocaine 

‘priming’ and cost 

M. Haney 1 , E. Rubin 2 , R. Foltin 1 , 1 Psychiatry, Columbia University Medical Center, 

New York, NY, 2 Psychiatry, Harlem Hospital, New York, NY 

10:30 Safety and tolerability of cocaine during phendimetrazine maintenance 

W. W. Stoops 1,2,3 , J. A. Lile 1,2,3 , L. R. Hays 3 , A. O. Rayapati 3 , C. R. Rush 1,2,3 , 1 Behavioral 

Science, University of Kentucky, Lexington, KY, 2 Psychology, University of Kentucky, 


10:45 Effect of a glucocorticoid receptor antagonist - mifepristone - on relapse risk in cocainedependent 

men 

W. N. Raby 1,2 , F. R. Levin 1 , E. V. Nunes 1 , 1 Psychiatry, Columbia University, New York 

City, NY, 2 Psychiatry, Albert Einstein College of Medicine, Bronx, NY 


BUFFALO SOLDIERS: OPIOID PRECLINICAL STUDIES 

12 

11:15 - 12:15 PM 

Chair: Hsiao-Ying Wey 

11:15 Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and 

(+)-naloxone as toll-like receptor 4 antagonists 

X. Wang, Chemical Biology Laboratory, Changchun Institute of Applied Chemistry, Chinese 

Academy of Sciences, Changchun, China 

11:30 Simultaneous PET/MRI of static and dynamic functional connectivity to opioids 

H. Wey, B. R. Rosen, J. B. Mandeville, Martinos Center for Biomedical Imaging, Department 

of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 

11:45 Individual differences in heroin reward perception in C57BL/6 mice 

C. Wincott, B. Reed, V. Yuferov, M. Kreek, Laboratory of the Biology of Addictive Diseases, 

The Rockefeller University, New York, NY 

12:00 Remifentanil vs. food choice under a dependent schedule 

J. J. Chow, J. S. Beckmann, Psychology, University of Kentucky, Lexington, KY 

104


June 16, 2016 


BRUNCH WITH CHAMPIONS Thursday, 

(PRE-REGISTRATION ONLY) 


REEFER MADNESS: CANNABIS AND CANNABINOIDS 

CAPRA 

12:00 - 1:15 PM 

10/14 

1:15 - 3:15 PM 

Chairs: Jan Copeland and Staci Gruber 

1:15 Serotonergic responsiveness after repeated exposure to the synthetic cannabinoid JWH-018 

J. S. Elmore, M. H. Baumann, IRP, NIDA, NIH, Baltimore, MD 

1:30 Cannabidiol attenuates a spatial working memory impairment caused by THC in monkey 

M. A. Taffe 1 , C. Glavis-Bloom 2 , J. D. Nguyen 1 , 1 CNAD, The Scripps Research Institute, La 

Jolla, CA, 2 SRI, International, Menlo Park, CA 

1:45 Splendor in the Grass? A pilot study assessing the impact of medical marijuana on cognition 

S. Gruber 1,2 , M. Dahlgren 1,3 , K. Sagar 1 , A. Gonenc 1,2 , M. Racine 1 , R. Smith 1 , S. E. Lukas 2,4 , 

1 

Cognitive & Clinical Neuroimaging Core, McLean Hospital - Imaging Center, Belmont, MA, 

2 

Department of Psychiatry, Harvard Medical School, Belmont, MA, 3 Department of 

Psychology, Tufts University, Medford, MA, 4 Behavioral Pharmacology Research Lab, 

McLean Hospital, Belmont, MA 

2:00 Sleep-related problems in adults receiving medical cannabis 

M. Ilgen 2,1 , K. Bohnert 2,1 , 1 Psychiatry, University of Michigan, Ann Arbor, MI, 2 VA Center for 

Clinical Management Research (CCMR), Ann Arbor, MI 

2:15 Reductions in traffic fatalities rates across states with operational dispensaries of marijuana 

J. Santaella 1 , C. Mauro 2 , M. M. Wall 2 , J. H. Kim 1 , S. S. Martins 1 , 1 Epidemiology, Columbia 

University, New York City, NY, 2 Biostatistics, Columbia University, New York, NY 

2:30 Illicit drug use among young adult marijuana users in Los Angeles: Implications for medical 

use 

E. V. Fedorova, S. E. Lankenau, Community Health and Prevention, Drexel University, 


2:45 The relationship of age to cannabis use and motives for use among medical cannabis dispensary 

patients 

J. E. Sottile 1 , N. A. Haug 1 , C. B. Padula 2 , A. Heinz 2,3 , M. O. Bonn-Miller 2,3 , 1 Palo Alto 

University, Palo Alto, CA, 2 Psychiatry, VA Palo Alto Health Care System, Palo Alto, CA, 

3 

Center of Excellence in Substance Abuse Treatment and Education, VA Palo Alto Health 

Care System, Menlo Park, CA 

3:00 Comparison of brief versus extended feedback in an online intervention for cannabis users: 

A randomised controlled trial 

J. Copeland 2 , S. Rooke 1 , L. Gibson 2 , 1 Nil, Sydney, NSW, Australia, 2 National Cannabis 

Prevention and Information Centre, University of NSW, Sydney, NSW, Australia 

105




200 CIGARETTES: NICOTINE 

4 

1:15 - 3:15 PM 

Chairs: Yasmin Mashhoon and Elias M. Klemperer 

1:15 Increased nicotine exposure decreases sensitivity to the nicotine-like effects of AChE inhibitors 

in monkeys discriminating nicotine 

M. J. Moerke, L. McMahon, Pharmacology, University of Texas Health Science Center, 


1:30 Effects of chronic nicotine treatment and discontinuation on nicotine self-administration 

S. Kohut, C. Barkin, J. Bergman, McLean Hospital/Harvard Medical School, Belmont, MA 

1:45 Repetitive transcranial magnetic stimulation of the dorsal lateral prefrontal cortex inhibits 

medial orbitofrontal activity in smokers 

X. Li 1 , G. Sahlem 1 , C. A. Hanlon 1 , K. J. Hartwell 1 , B. Badran 1 , S. Henderson 1 , M. George 1,2 , 

1 

Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, 

Charleston, SC, 2 Psychiatry, Ralph H. Johnson VA Medical Center, Charleston, SC 

2:00 A behavioral and neurophysiological examination of the impact of smoking abstinence on drug 

and non-drug reinforcement 

N. Schlienz 1,2 , L. Hawk 2 , 1 Psychiatry and Behavioral Sciences, The Johns Hopkins University 

School of Medicine, Baltimore, MD, 2 Psychology, State University of New York at Buffalo, 

Amherst, NY 

2:15 Nicotine withdrawal induces neural and behavioral deficits in reward processing 

J. Oliver 1 , D. E. Evans 2 , M. Addicott 1 , T. Brandon 2 , D. J. Drobes 2 , 1 Psychiatry and Behavioral 

Sciences, Duke University, Durham, NC, 2 Health Outcomes and Behavior, Moffitt Cancer 

Center, Tampa, FL 

2:30 The effects of nicotine administration and drug cue on impulsivity 

S. Martinez 1,2,3 , J. D. Jones 1 , A. Bisaga 1 , S. D. Comer 1 , 1 Division on Substance Abuse, 

New York State Psychiatric Institute and Department of Psychiatry, College of Physicians and 

Surgeons, Columbia University, New York, NY, 2 Derner Institute of Advanced Psychological 

Studies, Adelphi University, Garden City, NY, 3 Translational Research Training Program in 

Addiction, City College of New York, New York, NY 

2:45 Reduction in cigarettes per day prospectively predicts quit attempts and cessation in smokers 

who are not ready to quit 

E. M. Klemperer, J. Hughes, Psychiatry and Psychological Sciences, University of Vermont, 

Burlington, VT 

3:00 Early age of cigarette smoking onset is associated with greater P300 smoking cue reactivity 

Y. Mashhoon 1 , J. Betts 2 , S. L. Farmer 2 , S. E. Lukas 1 , 1 McLean Imaging Center, Harvard 

Medical School | McLean Hospital, Belmont, MA, 2 McLean Imaging Center, McLean 

Hospital, Belmont, MA 

106



SWEEPSTAKES DRAWING Thursday, 

YOU MUST BE SEATED IN ONE OF THE SESSIONS 

STARTING AT 1:15 PM IN ORDER TO HAVE YOUR 

BADGE COLLECTED 

6/8 

3:15 - 3:45 PM 

HAVE A SAFE TRIP HOME! 

SEE YOU IN MONTREAL, CANADA, JUNE 17-22, 2017 

107

AUTHOR INDEX 

Aarde, S. M. 14 

Abatemarco, D. J. 69 

Abdolahi, A. 11 

Abel, J. 3 

Abraham, A. 78 

Acheampong, A. 19, 62 

Achtmeyer, C. 94 

Acri, Jane B. 51 

Addicott, M. 12, 106 

Addis, M. 94 

Addison, T. 87 

Adebowale, T. 10 

Ades, P. 86 

Afifi, R. 93 

Aguirre, C. G. 87 

Ahamad, K. 4, 59 

Aharonovich, Efrat 9, 57, 95 

Ahmed, M. S. 69, 85 

Aiken, A. 60 

Aklin, Will 65 

Akpara, U. 88 

Akutagava-Martins, G. C. 79 

al’Absi, M. 85 

Albizu, C. 62 

Alcorn, J. L. 99 

Alcover, K. C. 20, 56 

Aldrich, Jane 73 

Alexander, A. 85 

Alexandre, J. 63, 91 

Alexandridis, A. A. 103 

Alford, D. 77 

Ali, R. 103 

Alia-Klein, N. 56 

Alicata, D. 69 

Alicea-Rodríguez, A. 62 

Allen, A. M. 85 

Allen, L. 22 

Allen, S. 85 

Allen, S. T. 58 

Allende-labastida, J. 67 

Almeida, R. 65 

Alshaarawy, O. 20, 68 

Altarifi, A. 12 

Altice, F. L. 94 

Altshuler, R. 3 

Alving, C. 12 

Amador, C. 80 

Amaral, R. 21 

Amaro, H. 102 

Ananthan, S. 66 

Anastasio, Noelle C 52, 65, 80 

Andersen, M. L. 64 

Andersen, R. 17, 56 

Anderson Goodell, E. M. 57, 83 

Anderson, B. J. 11 

Anderson, K. 75 

Anderson-Carpenter, K. D. 82 

Andrabi, N. 102 

Andrade, A. 21, 98 

Andreuccetti, G. 84 

Andrews, A. M. 80 

Andrews, P. 91 

Angarita, G. A. 98 

Anglin, D. M. 18 

Anthony, James C. 6, 7, 19, 20, 56, 

60, 61, 63, 68, 91, 93 

Antoline, J. 12 

Apata, J. 87 

Areesantichai, C. 83, 92 

Arfken, C. L. 12 

Arger, C. A. 53 

Armendariz, A. 12 

Arout, Caroline A. 69 

Arria, A. M. 20, 55 

Arroyo Currás, N. 14 

Artenie, A. 97 

Arterberry, B. J. 101 

Artigiani, Erin 26 

Aston, E. R. 53 

Aubé, Jeff 73 

Auriacombe, Marc 63, 74, 89, 

91, 101 

Austad, C. 14 

Ayo, S. 10 

Babbin, S. F. 60 

Babson, K. 21 

Bacciardi, S. 11 

Back, S. 90 

Badger, G. J. 86 

Badran, B. 106 

Bagley, J. R. 80 

108 

Bagley, S. M. 77 

Bahorik, A. L. 4, 103 

Bailey, S. R. 21 

Baker, N. 10, 54, 55, 59, 93 

Baladi, Michelle 53 

Balodis, I. 61, 88 

Balster, Robert 71 

Banducci, A. N. 60 

Bangel, S. 57 

Banich, M. T. 15, 88 

Banks, Matt 51 

Banta-Green, C. J. 22 

Banu, L. 76 

Bara, J. 58 

Barbieri, V. A. 78 

Barbosa, C. 21 

Barbosa-Leiker, Celestina 63, 71 

Bardo, M. T. 3, 10, 66, 75, 89 

Bares, Cristina B 5 

Barkin, C. 106 

Barluenga, E. 83 

Barondess, D. 91 

Barr, P. B. 55 

Barrett, F. S. 14 

Barska, J. 94 

Bart, Gavin 51 

Bastos, F. I. 63 

Bates, M. 76 

Batki, S. L. 57 

Batten, S. R. 80 

Bau, G. 84 

Baumann, M. H. 24, 105 

Baumeister, S. 17 

Bauza, L. N. 22 

Bazzi, A. R. 58 

Beadnell, B. 58 

Bear, S. A. 91 

Beardsley, Patrick 6 

Bebarta, V. 93 

Bechara, A. 15 

Bechler, L. 91 

Beck, J. G. 90 

Becker, W. 77, 78, 83 

Beckham, J. 96 

Beckmann, J. S. 80, 104 

Bedi, G. 55, 70

AUTHOR INDEX 

Beebe, K. 77 

Behling, M. 86, 92 

Behrends, C. N. 94 

Beiter, R. M. 3 

Belkoff, A. 75 

Bell, R. P. 15, 16, 25 

Bell, S. 16 

Bello, M. S. 96 

Belohlavek, A. 87 

Benesch, C. 11 

Benner, M. 18 

Bennett, A. S. 103 

Benny, C. 83 

Benz, M. B. 96 

Beraldo, L. 98 

Berens, P. 68 

Bergeria, C. L. 85 

Bergman, Jack 51, 53, 106 

Berkenblit, G. 94 

Berkowitz, J. 69 

Berro, L. F. 64, 89 

Bertz, J. W. 76 

Besharat, A. C. 17 

Betts, J. 70, 106 

Beuttel, L. A. 52 

Bianco, A. 53 

Bickel, Warren Kurt 1, 2, 53, 61, 

75, 76, 81 

Bierut, L. 87 

Bigelow, G. 10, 54, 78 

Bisaga, A. 78, 106 

Bjork, J. 15, 55 

Black, A. C. 82 

Black, J. 53 

Black, K. 85 

Black, R. A. 83, 86 

Blackstock, O. 94 

Blaker, A. 13 

Blanco, Carlos 73, 101 

Blanken, P. 79 

Blevins, E. 75 

Block, R. 11 

Blokhina, E. 9, 11, 56, 59 

Blough, B. 12, 64 

Blow, F. 101 

Blumberg, D. 99 

Boak, A. 61 

Bobashev, G. 21, 60 

Boggs, D. 21 

Bohnert, Amy S. 21, 87, 101 

Bohnert, K. 54, 105 

Bold, K. 60 

Bonadonna, J. 3 

Bonar, E. E. 54 

Bonci, Antonello 2 

Bone, C. W. 56 

Bonn-Miller, Marcel O. 21, 60, 

67, 105 

Bonson, K. 63 

Bordnick, P. 17, 97 

Borodovsky, J. 19, 76 

Borsari, B. 96 

Boyd, C. J. 95 

Boyd, M. L. 94 

Bozinoff, N. 58 

Bozzo, J. 69 

Bradley, C. A. 13, 25, 52 

Bradley, K. A. 94 

Brady, Kathleen T. 65 

Brandon, T. 95, 106 

Brands, B. 19 

Brandt, C. 83 

Brandt, L. 75 

Brecht, L. 82 

Breiter, H. C. 20 

Brents, L. K. 102 

Bresani, Elena 70, 79 

Brett, B. 91 

Bridden, C. 11, 59, 91 

Brimijoin, S. 3 

Brincks, A. M. 61 

Britton, P. 103 

Brooks, A. C. 4, 92 

Brooks, D. J. 54 

Brooks, S. J. 14 

Brown, B. 94 

Brown, D. 93 

Brown, L. S. 91 

Brown, Qiana 5, 18, 19, 55, 

68, 85 

Brown, R. A. 96 

Brown, R. W. 13, 52, 81 

109 

Brown, Sandra A 5 

Browne, Felicia 27 

Bruijnzeel, Adriaan 2 

Bruneau, J. 97 

Bruno, Raimondo 6, 60, 100, 103 

Bucceri, J. 87 

Bucher Bartelson, B. 84 

Bucholz, K. K. 89 

Buchthal, S. 69 

Buckman, J. 76 

Budman, S. H. 83 

Budney, Alan J. 19, 60, 67 

Bugbee, B. A. 20, 55 

Buono, F. D. 76, 89 

Burdick, T. 19, 21 

Burgos, J. 84 

Burlew, K. 57 

Burmeister, M. 52 

Burnett, J. 17 

Burns, L. 63 

Burris, S. 22 

Burt, C. I. 94 

Butelman, Eduardo 10, 12 

Butler, R. 68 

Butler, S. F. 83, 86, 92 

Buttram, M. E. 21, 24, 56 

Buu, A. 94, 101 

Byrne, E. 4 

Cahanap, T. 64 

Cahill, Larry 73 

Cai, X. 69 

Calabrese, S. 94 

Caldeira, K. M. 20, 55 

Caldeiro, R. 94 

Calderon, S. N. 63 

Calhoun, V. D. 98 

Callaghan, R. 82, 83 

Camenga, D. R. 60 

Campbell, A. 55, 56, 95 

Campbell, C. 4, 103 

Campbell, G. 100 

Campollo, O. 92 

Cannella, L. 17 

Cannizzaro, D. 95 

Canterberry, M. 10

AUTHOR INDEX 

Cao, V. 78 

Cao, Z. 3 

Carbonaro, T. M. 64 

Carla, L. 98 

Carliner, H. 18, 19, 55, 57 

Carlson, A. K. 3 

Carlson, E. 68 

Carnahan, D. 93 

Carpenedo, C. M. 4 

Carpenter, C. A. 3 

Carrell, D. 100 

Carrico, Adam 11, 74 

Carrizales, F. 99 

Carroll, Ivy 73 

Carroll, Kathleen 9, 14, 16, 61 

Carroll, Marilyn E. 3, 73 

Carson, R. E. 98 

Carter, L. P. 17, 53 

Carvalho, H. B. 84 

Cassidy, R. 16 

Cassidy, T. A. 83 

Castillo, L. G. 102 

Cathers, L. A. 95 

Caudarella, A. 11 

Cavallo, D. A. 60 

Cercone Heavey, S. 57, 83, 90 

Cerda, M. 18 

Chairs, Co- 6 

Chaisson, C. 11, 59 

Chalk, M. 78 

Chambers, J. E. 92 

Chandra, M. 82 

Chandrasekar, P. 76 

Chaney, L. 82 

Chang, J. S. 77 

Chang, K. 84 

Chang, L. 11, 55, 69, 98 

Chang, W. 11 

Chaudhry, T. S. 94 

Chauhan, K. 10, 88 

Chen, C. 9, 96 

Chen, J. 81 

Chen, L. 63, 96 

Chen, M. 77 

Chen, Rong 23 

Chen, Y. 13, 25, 59, 91, 96 

Cheng, C. 95 

Cheng, D. M. 11, 56, 59, 77 

Cheng, H. G. 58, 60 

Cherifi, B. 89 

Cherpitel, C. J. 84 

Chiapperino, D. 63 

Chilcoat, H. 17, 83 

Childress, Anna Rose 8, 15, 16 

Chisolm, D. 102 

Chiu, J. 77 

Choi, J. 54 

Chorlian, D. 89 

Chow, J. J. 104 

Chow, L. 13 

Chung, S. 60 

Ciciurkaite, G. 62 

Cisewski, J. A. 21 

Claborn, K. 58 

Clair, V. 4 

Clare, P. 60 

Clark, S. 69 

Clark, Westley 51 

Clausen, T. 101 

Cloherty, G. 59 

Coelho Pinguello, A. 59 

Coffin, Phillip 26, 57, 99 

Cohen, D. J. 21 

Cohen, M. 100 

Cohn, J. A. 12 

Coker, J. L. 85, 102 

Cole, A. 88 

Cole, J. 69 

Cole, M. 14 

Coleman-Cowger, V. H. 86 

Collaborative Study on the 

Genetics of Alcoholism 

Collaborators, *. 89 

Collins, G. T. 53, 64, 66 

Collins, R. L. 54 

Collombat, J. 89 

Comer, Sandra 1, 17, 53, 59, 70, 

78, 106 

Comfort, M. L. 58 

Cone, E. 63 

Connelly, K. L. 64 

110 

Conniff, J. 68 

Connor, J. 81 

Conrod, Patrica 65 

Cook, J. E. 13 

Cook, J. M. 68 

Cook, M. 54 

Coop, Andrew 8 

Cooper, Ziva D. 53, 70 

Cope, L. M. 88, 89 

Copeland, A. 96 

Copeland, Jan 6, 105 

Copenhaver, M. 57, 94 

Copersino, M. L. 70 

Coplan, P. 17, 22, 83, 101 

Cordero, D. 12 

Cornelius, J. 90 

Corsi, Karen F 27 

Cosgrove, Kelly 65 

Cottler, Linda 19, 20, 22, 26, 55, 

56, 62, 83, 84, 100 

Courtney, K. E. 15 

Covault, J. 97 

Cox, B. 92 

Crane, H. M. 58 

Cranford, J. A. 54, 94, 95 

Croff, R. 78 

Crofton, E. 64, 81 

Cronkite, D. 100 

Crooke, H. R. 19, 83 

Crooks, P. A. 3, 66 

Cropsey, K. L. 62, 99 

Crosier, B. S. 19, 76 

Crouch, P. 11 

Crowell, S. E. 95 

Crowley, Thomas J 65, 88 

Crystal, S. 78 

Csernansky, J. G. 20 

Cservenka, A. 97 

Culver, J. P. 66 

Culverhouse, A. 3 

Cummings, B. 98 

Cummins, E. D. 13, 81 

Cunha, P. J. 21, 98 

Cunningham, C. 94 

Cunningham, E. 69 

Cunningham, J. K. 87, 102

AUTHOR INDEX 

Cunningham, K. A. 15, 65, 67, 

80, 104 

Cunningham, R. M. 54, 76, 94 

Curry, D. 75 

Curtis, Brenda L 70 

Cushing, C. 95 

Cutter, C. J. 89 

Czoty, Paul W. 23 

D’Aunno, T. 76, 94 

D’Onofrio, G. 100 

DaEun, D. 100 

Dager, A. D. 14 

Dahlgren, M. 105 

Dailey, T. M. 86, 92 

Dale, Anders 5 

Dalwani, M. 15, 88 

Daniulaityte, Raminta 27 

Darnell, D. 101 

Darnley, S. 15 

Darst-Campbell, M. 11 

Dart, R. C. 84, 101 

Dasgupta, N. 103 

Daughters, S. B. 16, 25, 75, 96 

Davenport, P. 15 

David, T. 85 

Davidson, T. 79 

Davis, D. R. 92 

Day, C. 85 

de Jong, Y. 59 

de la Torre, R. F. 17 

De Leo, J. A. 96 

de Souza Fernandes, E. 17 

Dean, S. A. 52 

DeBeck, K. 22, 58 

Dechant, E. 95 

DeCicco-Skinner, K. 81 

DeFulio, A. 78 

Degenhardt, L. 77, 84, 100, 103 

Degeorge, D. 75 

DeHovitz, J. 94 

del Franco, A. 13 

del Rio, C. 61 

Delaney, M. 100 

Delucchi, K. 61, 87 

DeMartini, A. 57 

Denehy, E. D. 3 

Denis, Cecile M. 88, 89 

Denlinger, R. 20, 86, 102 

Denner, L. 80 

Dennis, Michael L 20, 21, 26, 95 

Denton, A. R. 81 

Derri, J. 57 

Desai, A. 59 

Desarno, M. 53 

DeVeaugh-Geiss, A. 17, 22, 101 

DeVito, E. E. 16 

DeVoe, J. E. 21 

Devonish, J. 83, 90 

DeVries, W. 10, 81 

Dewey, William L. 51 

Dias, N. 16, 70 

Dickson, M. F. 61, 62 

Dillon-Carter, O. 24 

Dimet, A. 80 

Dineen, R. 92 

Dineley, K. 67, 80, 104 

Ditre, J. 69 

Dolan, S. 64 

Dombrowski, J. C. 58 

Domingo, C. 52 

Dong, G. 16 

Dong, H. 11, 58, 59, 84 

Dongo, V. 21 

Donny, E. 16, 20, 25, 86, 102 

Donovan, D. 58, 101 

Dose, J. M. 81 

Douet, V. 55 

Dowd, S. M. 98 

Dowd, W. 21 

Dowdle, L. T. 10, 81 

Dowling, Gaya 5 

Downey, G. 98 

Doyle, E. 83 

Drainoni, M. 58, 61 

Drobes, D. J. 106 

Du, H. C. 65 

Dubernet, J. 91 

Ducat, E. 11 

Dugosh, K. L. 61, 66 

Dumchev, K. 94 

Dunn, A. 12 

111 

Dunn, Kelly E. 9, 10, 26 

Dunn, T. 67 

Dunne, E. M. 100 

Duplessy-Garcon, C. 58 

Durand, H. 53, 85 

Dusek, K. 94 

Dwoskin, Linda P 3, 36, 73 

Dziura, J. 100 

Eans, S. 12 

Eddy, C. 61 

Edelman, E. J. 78, 94 

Edlund, Mark 87 

Edwards, A. 96 

Edwards, R. R. 54 

Eggleston, B. 21 

Eichberg, C. 16 

El Salibi, N. J. 93 

El-Bassel, N. 67 

Elhauge, T. 17 

Elkoussi, A. A. 24 

Ellen, J. M. 60 

Elliott, A. 22 

Elliott, L. 103 

Elliott, R. 86 

Elmore, J. S. 105 

Elzanie, A. 10, 88 

Emurian, C. E. 14 

Epstein, D. H. 57, 76, 96, 98, 99 

Epstein-Ngo, Q. 76 

Erensen, J. G. 22 

Ernst, T. 55, 69 

Eron, J. J. 58 

Espinoza, I. 18 

Euren, J. 57 

Evans, D. E. 106 

Evans, E. 55, 59, 62 

Evans, S. 54 

Even-Sapir, E. 14 

Fairman, B. J. 20 

Fallahi, C. 14 

Fant, R. V. 63 

Fargason, R. 99 

Farmer, S. L. 106 

Farokhnia, Mehdi 52, 53

AUTHOR INDEX 

Farré, M. 17, 97, 101 

Farrell, M. 66, 78, 100 

Farrell-Moore, D. 92 

Fatseas, M. 63, 74, 89, 91 

Favor, K. 4 

Feaster, Daniel J. 61, 71 

Fedorova, E. V. 105 

Fedota, J. 70 

Feeney, G. 81 

Felton, J. W. 18, 60 

Fenton, B. 83 

Fenwick, K. 102 

Fernández-Artamendi, S. 86, 98 

Fernández-Hermida, J. 98 

Ferrato, D. 68 

Ferré, S. 55 

Ferrell, A. WITHDRAWN 

Festinger, David S. 61, 66 

Fields, S. 89, 98 

Fiellin, David A 77, 78, 87, 

94, 100 

Fiestas, F. 21 

Figueiro, M. G. 76 

Filbey, Francesca 8 

Fingerhood, M. 68, 78 

Finley, E. 93 

Finnegan, Loretta 68 

Fischer, B. D. 88 

Fischer, G. 75 

Fishman, M. 96 

Fitzmaurice, G. 9 

Flagel, S. 80 

Flannery, M. 10, 81 

Flax, S. M. 81 

Fleischer, L. M. 12 

Flores, D. V. 17 

Floresco, Stan 101 

Fokina, V. M. 69, 85 

Foltin, R. 70, 104 

Fonseca, F. 17, 18, 94, 97, 101 

Ford, J. A. 18 

Ford, J. H. 78 

Forman, L. 56, 103 

Forray, A. 69 

Forster, M. J. 13, 64 

Fortmann, S. P. 21 

Fox, E. A. 76 

Fox, H. C. 97 

Fox, R. G. 65 

France, C. P. 51, 64 

Francis, J. 83 

Franck, C. 61, 76 

Frank, D. 103 

Frank, E. 4 

Franklin, T. 15, 16 

Franklin, Teresa 5 

Frazer, K. M. 98 

Freedman, Andrew 27 

Freeman, K. 13, 25, 67 

Freisthler, Bridget 27 

Friedman, S. R. 84, 103 

Friedmann, P. 76, 94 

Frimpong, J. A. 61, 76, 94 

Frisch, O. 14 

Froelich, M. 99 

Froeliger, B. 16 

Funada, M. 13 

Furr-Holden, Debra 76, 82, 102 

Fuster, D. 83 

Gaalema, Diann 26, 53, 86, 96 

Gaines, T. 58 

Gaither, J. R. 78 

Galea, S. 20 

Galindo, K. 66 

Gallezot, J. 98 

Gan, G. 56 

Gandhi, D. 77 

Gannon, B. M. 53, 66 

Gao, J. 67 

Garcia, A. A. 93 

Garcia-Romeu, A. 95 

Gargano, S. 91 

Garment, A. 10 

Gastfriend, David R 66, 71, 92 

Gatch, M. B. 13, 64 

Gatley, J. 82, 83 

Gawrysiak, M. 15 

Gbedemah, M. 20 

Gearhardt, A. 89 

Gehlert, D. R. 81 

Geier, C. F. 98 

112 

Gelberg, L. 17, 56 

Geng, E. H. 58 

Gentile, D. 89 

George, M. 81, 106 

Gerak, L. R. 64 

Ghadban, R. 92 

Ghahremani, D. 15 

Ghandour, L. A. 93 

Ghee, S. M. 10 

Ghitza, U. 92, 99 

Gibson, L. 105 

Gibson, S. 11 

Gifford, A. 59 

Gilbertson, S. 65 

Gildred, T. 94 

Gilmore, K. 92 

Gipson-Reichardt, C. 13 

Glanton Holzhauer, Cathryn 74 

Glavis-Bloom, C. 105 

Glennon, R. A. 24 

Glick, S. N. 22, 84 

Glover, A. 102 

Gnatienko, N. 11, 56, 59 

Gnegy, Margaret 3, 23 

Gobel, D. 91 

Goeders, N. E. 82 

Goenaga, J. 13 

Golbeck, Jennifer 26 

Goldenson, N. 61, 87 

Goldfeld, K. 10 

Goldman, M. 16 

Goldstein, N. D. 68 

Goldstein, R. 56 

Goldstick, J. E. 76 

Golub, A. 103 

Gomez Luna, S. E. 60 

Gomez-Pinilla, F. 88 

Goncalves, P. D. 21, 98 

Gonenc, A. 105 

González-Roz, A. 56, 62, 68, 86 

Gonzalez-Zuniga, P. 58 

Goodbody, E. 84, 103 

Gooden, L. 61 

Goodwin, R. 19, 20 

Gopinath, K. 24 

Gordon, A. R. 57

AUTHOR INDEX 

Gordon, K. S. 78 

Gorodetzky, Charles 9, 10 

Gosden, J. 66 

Goswami, D. 79 

Goulet, J. 78 

Gourevitch, M. 10, 81 

Gowing, L. 77 

Grant, A. C. 67 

Grant, B. F. 19 

Grant, Y. 14 

Grasing, K. 52 

Gray, K. M. 16, 59 

Grazioli, F. 59 

Greco, P. 59 

Greemland, M. 14 

Green, J. L. 17, 84, 101 

Green, Thomas 23, 64, 81 

Greene, M. 74, 82 

Greenfield, S. F. 95, 97 

Greenstein, E. 95 

Greenwald, Mark 12, 18, 52, 

65, 78 

Gregoire, A. 89 

Grella, C. E. 55 

Griffin, M. L. 9, 25 

Griffiths, Paul 6 

Griffiths, R. R. 14, 64, 95 

Gringer Richards, J. 91 

Grishina, O. 78 

Gross, D. E. 100 

Grossman, E. 10 

Grov, C. 102 

Gruber, Staci 105 

Gruber, V. 77 

Gryczynski, G. 77 

Gryczynski, J. 63, 77, 94, 95 

Gu, H. 70 

Guareschi, M. 101 

Guariglia, C. 12 

Guarino, H. 76, 84, 103 

Gudjonsson, G. 62 

Guerrero, E. 102 

Guillot, C. 86 

Guimaraes, L. S. 65 

Guise, J. B. 77, 99 

Gullo, K. 10 

Gunning, M. 87 

Gunter, B. W. 13 

Gupta, S. 95 

Gustafson, D. 95 

Gutierrez, K. M. 60 

Ha, D. 59 

Haddad, L. 92 

Haddox, J. D. 22 

Hager, N. 16 

Hahn, J. 57 

Haile, C. N. 68 

Hall, S. m. 87 

Hall, W. 100 

Hallyburton, M. 75 

Hamilton, H. 19, 61 

Han, B. 87 

Hand, A. 10 

Hand, D. J. 69 

Haney, M. 53, 70, 104 

Haney, Margaret 104 

Haney, Meg 70 

Hankins, G. 69, 85 

Hanlon, C. A. 10, 81, 106 

Hanlon, Colleen A 2 

Hanlon, Colleen A. 2 

Hanrahan, M. 22 

Hansen, K. 100 

Hardee, J. 89 

Hardee, J. E. 88 

Harding, M. H. 52 

Hardy, D. 56 

Hargrave, S. 79 

Harikrishnan, V. 17, 83 

Harrell, P. T. 95 

Harrris, D. 88 

Hart, C. L. 92, 98 

Hartwell, E. E. 97 

Hartwell, K. J. 55, 87, 106 

Hartz, S. 87 

Hartzler, B. 58 

Harvanko, A. 88 

Hasan, K. M. 104 

Hasin, D. S. 18, 19, 20, 55, 57, 

68, 95 

Hasson, A. 77 

113 

Hatsukami, D. 16, 20, 86, 102 

Haug, N. A. 21, 105 

Havens, J. R. 61, 62, 83 

Hawk, K. 100 

Hawk, L. 106 

Hayama, S. 69 

Hayashi, K. 11, 22, 59, 84 

Haynes, L. 61 

Hays, L. R. 104 

Heads, A. M. 102 

Heal, David John 66, 72 

Heeren, T. 103 

Heffernan, J. 88 

Heidenfelder, B. 92 

Heil, Sarah Hughes 10, 52, 53, 56, 

77, 85, 86 

Heilig, M. 81 

Heintzman, J. 21 

Heinz, A. 105 

Heinze, J. 76 

Heitzeg, M. 88, 89 

Heller, M. S. 97 

Henderson, S. 106 

Hendricks, P. 62, 99 

Henningfield, Jack 17, 63, 72 

Henry, M. 89 

Hernandez-Casner, C. 88 

Herrmann, E. S. 70, 99 

Hertzel, S. K. 57, 96 

Hicks, C. 80 

Hien, D. 55, 62, 90 

Higgins, S. T. 10, 20, 53, 77, 85, 

86, 92, 96 

Hill, D. 101 

Hill, M. 92 

Hillhouse, M. P. 99 

Hine, C. 69 

Hlaing, W. 19 

Hoang, V. 78 

Hobkirk, A. L. 12, 15 

Hodgkinson, C. 53 

Hoffman, K. 19, 21 

Hoffman, M. K. 68 

Hofford, R. S. 89 

Holtyn, A. 68, 78 

Homish, D. 57, 83, 90

AUTHOR INDEX 

Homish, G. G. 57, 83, 90 

Honce, J. 15 

Hoopes, M. J. 21 

Hoover, D. 13 

Hoppe, J. 100 

Hopyan, T. 63 

Horbal, S. R. 101 

Horton, T. L. 91 

Horwood, L. J. 82 

Horyniak, D. 84 

Hosler, C. 94 

Hosseini, M. 94 

Howell, Leonard 24, 51, 64, 75, 

80, 89 

Howell, R. 4 

Hruska, B. 10, 77, 97 

Hser, Y. 62, 84 

Hsieh, H. 76 

Hu, L. 4, 77 

Hu, M. 20, 56 

Huang, D. Y. 62 

Huang, E. 13 

Huang, M. 96 

Huang, T. 13 

Huang, Y. 64 

Hudson, J. I. 14 

Hudzik, T. J. 53 

Huedo-Medina, T. B. 57 

Huentelman, M. 80 

Huffaker, S. 57 

Hughes, J. 85, 106 

Huh, J. 87 

Hui, D. 77 

Hunkele, K. 14 

Hutchinson, D. 60 

Hymel, K. 12 

Ialomiteanu, A. 19 

Ialongo, N. 60 

Ibrahim, J. 22 

Idrisov, B. 11 

Iguchi, Martin Y. 51 

Iles, B. 95 

Ilgen, M. 54, 105 

Ilika, I. 94 

Ilyuk, R. 78 

Iniguez, S. D. 24 

Ironson, G. 82 

Irvine, J. 21 

Irving, T. 88 

Iverson, E. 54 

Iwamoto, D. 18 

Jaafar, M. 18 

Jackson, K. 101 

Jackson, N. 75 

Jacobson, A. E. 12 

Jaffe, J. H. 63, 77 

Jagannathan, K. 15, 16 

Jain, J. P. 11 

Jalah, R. 12 

James, G. A. 102 

Jamshidimanesh, M. 94 

Janes, A. 16, 70 

Janganati, V. 66 

Jarlais, Don Des 74 

Jarvis, B. 68, 78 

Jefee-Bahloul, H. 18 

Jelstrom, E. 95 

Jernigan, Terry 5 

Jiang, C. 69 

Jiang, I. 25 

John, W. S. WITHDRAWN 

Johnson, A. 3 

Johnson, J. Aaron A. 4 

Johnson, K. A. 25, 75, 78, 95 

Johnson, L. 87 

Johnson, Matthew W. 14, 24, 64, 

88, 95, 99 

Johnson, P. S. 99 

Johnson, S. K. 22 

Johnston, L. A. 18 

Jones, Hendree E. 52, 66, 96 

Jones, J. D. 17, 59, 78, 106 

Jones, M. 82 

Jones, S. A. 13 

Jordans, M. J. 74 

Joseph, J. 14 

Jung, S. 99 

Jurkovitz, c. 91 

Justice, A. 78 

Justinova, Zuzana 51 

114 

Jutkiewicz, E. M. 3 

Jutras-Aswad, D. 97 

Kadakia, A. 22, 101 

Kahana, Shoshana 74 

Kalayasiri, R. 81 

Kaltenbach, Karol 52, 69 

Kaminer, Y. 59 

Kampman, K. M. 15, 16 

Kanayama, G. 14 

Kane, J. C. 74 

Kaphalia, B. 67 

Kaplan, L. M. WITHDRAWN 

Karakula, S. L. 9, 25 

Karolak, S. 58 

Katz, Elizabeth C. 88, 89 

Kaufman, M. J. 12, 14 

Kazanis, W. 93, 99 

Kazankov, K. 78 

Kearney-Ramos, T. 81 

Kearns, D. 79 

Keith, D. R. 85 

Kelly, S. M. 63, 77 

Kelly, T. H. 14 

Kelpin, S. S. 4, 85 

Kelsh, D. 17 

Kendler, K. S. 96 

Kennedy, R. 3 

Kenny, Paul 8 

Kermack, A. 10, 81 

Kerns, R. 78, 83 

Kerr, T. 11, 58, 59, 84 

Kerridge, B. T. 82 

Kerrigan, D. 63 

Kervran, C. 89 

Kessler, F. H. 65, 79 

Keyes, K. 18 

Keyser-Marcus, L. 55 

Khoddam, R. 61, 75, 102 

Kibitov, A. 9 

Kieschnick, D. 21 

Kiguchi, N. 64 

Kilts, C. 102 

Kim, H. 77 

Kim, J. H. 21, 105 

Kim, J. K. 3

AUTHOR INDEX 

Kim, Jae K. 1, 3 

Kim, S. 75, 77 

Kim, S. J. 86 

Kim, T. W. 103 

Kimmel, Heather 23 

King, H. E. 81 

Kinlock, B. 102 

Kioumarsi, A. 21 

Kippin, T. E. 14, 80 

Kirby, Kimberly C. 4, 70, 71, 79 

Kirby, S. 52, 81 

Kiriazova, T. 62 

Kirk, A. 94 

Kirkpatrick, M. 25, 69, 75, 86, 87 

Kirschmann, E. 88 

Kirschner, J. 92 

Kish, S. J. 82 

Kishioka, S. 64 

Kivell, B. M. 3 

Klawans, M. R. 59, 68, 97 

Klein, Michael 63, 72 

Klemperer, Elias M. 20, 106 

Klimas, J. 84 

Kline-Simon, A. H. 4 

Knight, B. 102 

Knight, E. 22 

Knopik, V. 53 

Knudsen, H. K. 61, 83 

Ko, M. 64 

Kober, H. 16 

Koffarnus, M. N. 53, 61, 76 

Kohn, R. 11 

Kohno, Milky 101 

Kohrt, B. A. 74 

Kohut, S. 106 

Kollins, S. H. 75, 96 

Kong, F. 81 

Kong, G. 60 

Kong, Y. 102 

Koocher, G. P. 54 

Korcha, R. 95 

Korthuis, T. 19, 59 

Kosheleff, A. 88 

Koshy, S. 64 

Kosten, T. 9, 15, 52, 67, 68 

Koszowski, B. 86 

Koustova, Elena 8 

Kowalczyk, W. J. 76, 96, 99 

Koziatek, MD, C. 103 

Kozink, R. 75 

Kral, A. 58 

Krawczyk, N. 63 

Krebs, C. A. 52 

Krebs, E. 22, 62 

Kreek, M. 11, 12, 79, 104 

Kreiner, P. 83 

Kreisler, A. 80 

Krishnan-Sarin, S. 60, 61 

Kroll, C. 88 

Krupitsky, E. 9, 11, 59, 78 

Kubicki, M. 14 

Kuhar, Michael 71 

Kunkel, L. 19, 59 

Kunoe, N. 9 

Kurti, A. N. 20, 85 

Kurtz, S. P. 21, 24, 56 

Kushnir, V. 87 

Kuypers, K. 17 

Kwiatkowski, E. 19, 55, 56 

Kypri, K. 60 

L. Huskinson, Sally 13, 25 

Labelle, C. 77 

Lacadie, C. 88 

LaConte, S. M. 81 

Lacy, R. 75 

LaLiberte, B. V. 78 

Lamb, K. 87 

Lambdin, B. 58 

Lambert-Harris, C. 79, 97 

Lanaway, D. 18 

Lane, S. D. 15, 80, 104 

Langleben, D. 15, 78 

Lanier, R. K. 63 

Lankenau, S. E. 21, 54, 105 

Lanyon, M. 91 

Lapham, G. 94 

Lappan, S. 62 

Larance, B. 77, 100, 103 

Laranjeira, R. 82, 99 

Larney, S. 84 

LaRowe, S. 87 

115 

Lasopa, S. O. 20, 84 

Latif, Z. 9 

Latypov, A. 57 

Lau, E. 98 

Lauby, J. 4 

Le, A. 57, 95 

Le, C. 16 

Leake, B. 17 

Leatherdale, S. 87 

Ledgerwood, D. M. 18, 78 

Lee, A. K. 94 

Lee, Dustin C. 19, 67 

Lee, J. D. 10, 59, 81 

Lee, M. J. 22 

Lee, N. 3, 66 

Leed, R. 19 

Lefever, T. 64 

Leggio, Lorenzo 2, 53 

Leickly, E. 68 

Lejuez, C. W. 18, 60, 94, 96 

Lemieux, A. 85 

Lemos, N. P. 84 

Leong, K. 10 

Lerman, H. 14 

Lerner, Alicja 72 

Lerner, G. 103 

Leukefeld, C. 61, 62, 66, 100 

Leventhal, Adam 18, 25, 61, 67, 

69, 70, 75, 86, 87, 96, 102 

Levesque, A. 97 

Levi Minzi, M. A. 56 

Levi, Y. 58 

Levin, F. R. 54, 62, 97, 104 

Levit, A. 78 

Levran, O. 79 

Levy-Cooperman, N. 54 

Lewis, C. 89 

Leyton, V. 84 

Li, Jun-Xu 1, 23 

Li, X. 106 

Li, Z. 94 

Liang, R. 10, 88 

Liang, Y. 79 

Liao, D. 75 

Liautaud, M. M. 18 

Lichti, C. F. 81

AUTHOR INDEX 

Liebschutz, J. M. 11 

Lile, J. A. 14, 99, 104 

Lim, A. 98 

Lim, J. 56 

Lima, D. R. 21 

Lin, H. 101 

Lin, J. 76 

Lin, L. A. 21 

Lin, Lewei Allison 87 

Lindblad, R. 4, 59, 77 

Lindhardt, K. 17 

Ling, P. 87 

Ling, W. 77, 99 

Lintzeris, N. 77, 100, 103 

Lioznov, D. 56, 59 

Lisieski, M. J. 65, 89 

Lister, J. J. 18, 65, 78 

Little, A. Roger 73 

llgen, M. 21, 101 

Lloyd, D. P. 76, 89 

Lofwall, M. R. 77, 83 

London, E. 81 

Long, Ed 51 

Lopez, A. 58 

Lopez, Marsha 7, 27 

Lopez-Castro, T. 55, 62 

Lopez-Gamundi, P. 80 

López-Núñez, C. 86 

Lopez-Quintero, C. 19, 20, 60 

Lorvick, J. 58 

Loscalzo, E. 78 

Lounsbury, D. 94 

Lozano, P. 94 

Lu, L. 77 

Lu, Y. 17 

Luba, R. 59 

Ludman, E. 94 

Luedtke, R. R. 3 

Luitel, N. 74 

Lukas, Scott E. 70, 105, 106 

Lum, P. J. 59 

Lundahl, L. H. 12, 52, 65 

Lunze, K. 11 

Luo, Sean 71 

Luo, X. 16 

Lupulescu-Mann, N. 78 

Lutton, E. 80 

Luxon, B. 81 

Lyall, A. E. 14 

Lynch, Minda 1, 2 

Lynch, Wendy J. 3 

Lyvers, M. 81 

Ma, L. 15, 55 

MacAfee, L. 85 

Mach, R. H. 3 

MacKillop, J. 53 

MacLean, R. R. 98 

MacPherson, L. 18, 60 

Madras, Bertha 8, 71 

Madruga, C. S. 11, 82, 99 

Magee, C. P. 75 

Magura, S. 22 

Mahaffey, Carlos C. 66 

Maher, L. 85 

Mahony, A. 54 

Maidment, N. 80, 88 

Maki, P. 56 

Makris, N. 14 

Malbergier, A. 21, 98 

Malcolm, R. J. 54 

Maldonado, A. 60 

Malison, R. T. 98 

Mallet-Lambert, I. 62 

Maltbie, E. A. 24 

Mamey, M. 63 

Mancino, M. J. 77, 85, 99 

Mandeville, J. B. 104 

Mandler, R. 59, 61 

Manhapra, A. 77 

Manly, J. J. 98 

Mann, R. 19, 61, 63 

Manser, K. 86 

Manubay, J. M. 17 

Marchi, N. 65 

Mardekian, J. 100 

Maremmani, A. G. 11 

Maremmani, I. 101 

Mariani, J. J. 54 

Marino, M. 21 

Marks, K. R. 61, 100 

Marotta, P. 67 

116 

Marsch, L. A. 86 

Marsden, J. 66 

Martin, C. 14 

Martin, E. 56 

Martin, R. 69 

Martinez, S. 106 

Martínez-Loredo, V. 86, 98 

Martins, P. 98 

Martins, S. S. 18, 19, 21, 55, 60, 

68, 85, 105 

Marusich, J. A. 64 

Marx, L. 94 

Mashhoon, Yasmin 16, 106 

Mason, Walter 27 

Masri, D. N. 92 

Massey, L. 94 

Masters, E. 100 

Matalenas, L. 96 

Mateu-Gelabert, P. 76, 84, 103 

Mateus, J. F. 17 

Mathers, B. M. 84 

Matheson, T. 57 

Matous, A. L. 70 

Matson, P. A. 60 

Matsumoto, T. 64 

Matsuzaki, S. 64 

Matthews, A. G. 99 

Matthews, W. C. 58 

Mattick, R. P. 60, 82, 100 

Matusiewicz, A. K. 56, 86 

Matuskey, D. 98 

Matveev, N. 9 

Matyas, G. R. 12 

Mauro, C. 21, 105 

Mauro, P. M. 18, 19, 21, 55 

Maxwell, Jane C. 6 

May, A. C. 15, 25 

May, J. 92 

Mayer, K. H. 58 

Mayes, L. C. 88 

Mayfield, S. M. 3 

Mbonu, T. 18 

McBeth, J. F. 69, 96 

McBride, N. 60 

McCabe, Sean 23, 95, 100 

McCaffrey, S. 86

AUTHOR INDEX 

McCarty, Dennis 19, 21, 51, 59, 78 

McClernon, F. J. 16, 20, 75, 96 

McClure, Erin A 6, 59 

McConnell, P. 16 

McCormack, MD, R. 103 

McCort, A. 103 

McCuistian, C. L. 57 

McCutcheon, V. V. 89 

McDermott, K. 9 

McDonald, R. D. 81, 93 

McDonell, M. G. 11, 68, 82, 99 

McGaugh, J. 77, 99 

McGeary, D. 93 

McGeary, J. 53 

McGinty, J. F. 90 

McGovern, M. P. 79, 97 

McGrath, Erica 67 

McHugh, K. 9, 25, 97, 100 

McKay, J. R. 92 

McKelvey, K. 61 

McLaughlin, A. C. 96 

McLaughlin, J. P. 12 

McLeman, B. 79, 97 

Mcleod, A. 91 

McLeod, C. 85 

McMahon, L. 106 

McMahon, T. 82 

McNaughton, E. C. 86, 92 

McNeely, J. 4, 10, 95 

McNeil, R. 95 

McPherson, Sterling M. 11, 63, 

68, 71, 82, 99 

McRae-Clark, A. 10, 54, 55, 93 

McWilliams, S. K. 88 

Meacham, M. C. 58 

Meade, C. S. 12, 15 

Meade, Christina S. 74 

Means, S. 22 

Meda, S. 14 

Medina, J. 12 

Meier, A. 79, 97 

Melbostad, H. S. 56, 86 

Mellis, A. 61 

Mendez, I. A. 80 

Mendoza, R. 3 

Mennis, J. 95 

Menzaghi, F. 66 

Mercincavage, M. 20, 86 

Merghati-khoei, E. 94 

Mericle, A. 95 

Merkel, S. 17, 80 

Merry, B. 69 

Messiah, S. 19 

Mestre-Pintó, J. I. 97 

Mété, D. 63 

Metrik, J. 53, 96 

Metsch, L. R. 61 

Metz, V. 17, 59 

Metzger, D. 4 

Meyerhoff, Dieter 23 

Meyers, Jacquelyn L. 89 

Meyers, Kathleen 70, 79 

Mezghanni, M. 76 

Miech, R. 18 

Miguel, A. Q. 11, 82, 99 

Mikhailov, A. 78 

Mikulich-Gilbertson, Susan 

Kay 71, 88 

Milam, A. J. 76 

Milani, S. A. 83 

Milivojevic, V. 97 

Miller, G. M. 12 

Miller, R. 80 

Milloy, M. 11, 22, 69, 84 

Minerva, A. R. 24 

Mintzopoulos, D. 12 

Mishlen, K. 78 

Mitchell, J. T. 96 

Mitchell, S. G. 63, 77, 94, 100 

Mithoefer, O. 81 

Miziara, I. D. 84 

Moeller, F. 15, 55, 104 

Moeller, S. 56 

Moerke, M. J. 106 

Mogali, S. 17 

Monge, Z. 15 

Monico, L. 100 

Montgomery, L. 57 

Moody, L. 81 

Moody, Raymond L. 102 

Mooney, L. 77 

Moore, A. 75 

117 

Moore, B. A. 10, 76, 77, 83, 89, 94 

Moore, R. D. 58 

Moore, T. 92 

Moran, L. 57, 96, 99 

Morean, M. E. 60 

Moreland, A. 93 

Morford, Z. H. 86 

Morie, K. P. 14 

Morris, R. J. 21 

Morrison, M. F. 92 

Moskowitz, A. L. 55 

Moss, Howard 23 

Muench, J. 19 

Muga, R. 83 

Mugavero, M. 58 

Muller, D. 79 

Muller, M. 81 

Mullins, C. 81 

Munayco, G. M. 94 

Munoz, D. R. 84 

Muqueeth, S. 92 

Muramoto, M. L. 102 

Muritala, M. 10 

Murphy, N. 80, 88 

Murray, Margaret 5 

Musau, A. 4 

Mutch, L. 62 

Mutiso, V. 4 

Mwangi, B. 104 

Myers, B. 64 

Nabulsi, N. 98 

Nader, M. 53 

Nagarajan, R. M. 69 

Nagarajan, V. 88 

Najman, J. 60, 82 

Nanovskaya, T. 69, 85 

Napravnik, S. 58 

Narayana, P. A. 15, 104 

Narayanan, S. L. 85 

Nardone, N. 20 

Nazarian, Arbi 2, 12 

Ndetei, D. 4 

Neelakantan, H. 80 

Nefau, T. 58 

Negus, S. S. 3, 12

AUTHOR INDEX 

Neisewander, J. L. 3 

Nelson, L. 100, 103 

Ngjelina, E. 96 

Nguyen, J. D. 14, 105 

Nguyen, P. 84 

Nicastri, S. 21, 98 

Nich, C. 14 

Nickell, J. R. 3, 66 

Niculete, M. E. 21 

Nielsen, D. A. 9, 52 

Nielsen, E. M. 52 

Nielsen, S. 77, 100 

Nieto, S. J. 67 

Nijhawan, A. 61 

Nolan, S. 4 

Nordeck, C. 95 

Norman, I. 93 

Norman, W. 69 

Northrup, T. 59, 68 

Nosyk, Bohdan 22, 62, 71 

Novak, S. P. 54 

Nunes, E. V. 95, 97, 104 

Nunes, Edward V. 5, 6 

O’Brien, Bess 1 

O’Brien, C. P. 15, 16 

O’Brien, Moira 26 

O’Connor, P. 91 

O’Donnell, L. 103 

O’Grady, K. E. 20, 55, 63, 77, 95 

O’Malley, P. 18 

Obi, R. 81 

Oblak, J. 91 

Ochalek, T. A. 10, 77, 97 

Oden, N. 4, 59, 82 

Oen, D. 103 

Oishi, K. 69 

Ojeda, V. 84 

Olding, M. 22 

Olesti, E. 17 

Oliver, E. B. 24 

Oliver, J. 75, 106 

Oliveto, A. 77, 99 

Olonoff, M. 54 

Olsen, Y. 77 

Ometto, M. 21, 98 

Ompad, D. C. 94 

Oncken, C. 69, 85 

Ondersma, Steven J. 4, 6 

Opheim, A. 9 

Oros, M. 94 

Osborne, V. 84 

Oser, C. B. 61, 62 

Osiowy, M. 82 

Ostlund, S. 80, 88 

Otiashvili, D. 57 

Ott, J. 79 

Øvergård, M. J. 17 

Pacek, L. 20 

Pachado, M. P. 65 

Padula, C. B. 105 

Pagano, M. 21, 24 

Pagni, B. 13 

Palmatier, M. I. 13, 25, 52 

Palmer, R. E. 100 

Pan, X. 13 

Pandey, A. 89 

Panee, J. 11 

Pang, R. 18, 70, 75, 86, 96 

Paniagua, S. M. 84, 93 

Papaseit, E. 17, 97 

Papini, S. 55, 62 

Park, Tae Woo 87 

Parker, L. J. 102 

Parker, M. A. 61 

Parks, C. 63 

Parks, R. 3 

Parra-Cardona, J. R. 93 

Parry, C. D. 93 

Parsons, J. T. 102 

Parsons, L. 14 

Partilla, J. S. 24 

Parvaz, Muhammad A. 9, 56 

Patel, D. N. 55 

Patel, V. 94 

Pater, H. 16 

Paterson, B. 81 

Patterson Bhatraju, E. 10 

Patton, G. 82 

Patts, G. J. 11, 58, 103 

Paulus, Martin P 15, 25, 101 

118 

Pavlicova, M. 54, 95 

Payment, M. 19 

Paz, A. L. 68 

Peachman, K. K. 12 

Peacock, Amy 84, 103 

Pearlson, G. 14 

Pechansky, F. P. 65, 79 

Peckham, A. 21 

Peechatka, A. L. 16 

Peiper, N. 54 

Peltier, M. R. 96 

Penetar, D. 70 

Peralta, R. L. 55 

Perez Diaz, M. 64, 80 

Perez, P. 78 

Pérez-Mañà, C. 17, 97 

Pericot-Valverde, I. 86, 98 

Perngparn, U. 83, 92 

Perrine, Shane A. 65, 89 

Perrone, J. 100 

Perry, E. 53 

Pester, M. 25 

Peteet, B. 57, 62 

Peterson, A. B. 3 

Peterson, D. J. 13, 81 

Petro, J. 13 

Petruzzella, A. 25, 96 

Petry, N. 25 

Peyser, Deena 75, 76 

Pfefferbaum, Adolf 8 

Phelps, C. L. 84 

Phillips, K. A. 57, 76, 94, 96, 

98, 99 

Phillips, K. T. 11 

Philogene, H. 24 

Pickover, A. M. WITHDRAWN 

Pike, E. 99 

Pinedo, M. 84 

PING Consortium, T. 55 

Pitts, E. G. 24 

Platt, D. 13, 67 

Platt, E. 22 

Platt, J. 19 

Plaxco, K. 14 

Ploense, K. 14 

Polak, K. M. 96

AUTHOR INDEX 

Polcin, D. L. 95 

Pollack, H. 76, 94 

Polli, J. R. 13 

Pollock, M. 88 

Ponce-Terashima, J. 19, 21 

Pope, Jr., H. G. 14 

Porjesz, B. 89 

Potenza, M. N. 14, 16, 61, 82, 

88, 98 

Potter, Jennifer Sharpe 84, 87, 

93, 99 

Pouget, E. R. 103 

Powell, Claudia 27 

Powell, G. 3, 13 

Powers, C. 58 

Prado, G. 19 

Pravetoni, Marco 8 

Prendergast, M. A. 89 

Preston, K. L. 57, 76, 96, 98, 99 

Preston-Campbell, R. N. 56 

Price, A. E. 15, 80 

Price, C. WITHDRAWN 

Priest, J. 20, 85 

Pringle, J. L. 91 

Printz, D. M. 76, 89 

Prisinzano, Thomas 3, 73 

Prochaska, J. 87 

Pugh, M. 93 

Pugh, T. 61 

Puri, N. 95 

Puro, J. 21 

Purpura, M. 10 

Pusey, J. D. 77, 97 

Quinn, E. 59, 77 

Quinn, G. 95 

Quisenberry, A. 53, 76 

Rabinovitz, S. 22 

Raby, W. N. 97, 104 

Racine, M. 105 

Rahim-Juwel, R. 18, 19, 55 

Raj, A. 56, 59 

Ramaekers, J. 17 

Ramaprasan, A. 100 

Ramchand, Rajeev 7 

Ramesh, D. 70 

Ramirez, S. 17, 80 

Ramirez-Coombs, E. 15 

Ramo, D. 61, 87 

Ramo, Danielle 6 

Ramos, J. 88 

Randall-Thompson, J. 63 

Randesi, M. 79 

Rao, H. 16 

Rao, M. 12 

Rappeneau, V. 13 

Raskin, S. 14 

Ratcliffe, Sian 72 

Rawls, S. 3, 17, 24, 80 

Ray, B. M. 11 

Ray, L. 15, 69, 97 

Ray, T. 103 

Rayapati, A. O. 104 

Ray-Griffith, S. L. 102 

Raymond, K. 88 

Razmpour, R. 17 

Rea, M. 76 

Redner, R. 20, 85 

Reed, B. 12, 104 

Reed, M. 21 

Reed, S. C. 70 

Reese, E. D. 16, 25 

Regier, P. S. 15, 16 

Regner, M. F. 15 

Reichel, C. M. 10 

Reichin, S. 76 

Reitz, A. 24 

Reske, M. 25 

Reynolds, A. R. 99 

Reynolds, B. 88, 98 

Reynolds, M. D. 91 

Rhodes, A. 92 

Ribeiro, A. 11 

Rice, Kenner 1, 12, 24, 53, 66 

Rich, M. T. 64 

Richards, J. 94 

Richardson, J 26 

Richardson, L. 22, 58 

Rickard-Aasen, S. 91 

Rico, M. 17 

Ridenour, T. 93 

119 

Rieb, Launette M. 69 

Ries, R. 68 

Rigg, K. 18 

Riggs, L. M. 24 

Riley, A. L. 79, 81 

Rimland, D. 78 

Ringwalt, C. 103 

Risco, C. M. 18, 94 

Ritchie, J. 85 

Ritter, A. 78 

Rivas, I. 83 

Roberts, J. D. 69 

Robinson, A. M. 75 

Rocha, Beatriz 8 

Rock, A. 12 

Rodriguez, B. 58 

Roesch, S. 58 

Rogers, S. 91 

Roll, J. M. 68, 99 

Rollier, S. 94 

Roman, T. 79 

Rooke, S. 105 

Rorick-Kehn, L. 81 

Rosa, C. 4 

Rosa, M. C. 89 

Rose, G. 10, 77 

Rosello, R. 15 

Rosen, B. R. 104 

Rosen, K. D. 84, 93 

Rosen, M. I. 82 

Rosenblum, A. 103 

Rosenheck, R. A. 69 

Rosenthal, R. 77 

Ross, T. 16, 70 

Rosselli, M. 68 

Rotrosen, J. 81 

Rowe, A. 18 

Rowe, C. 57, 99 

Rowlett, J. K. 13, 25, 67, 79 

Roy, E. 97 

Rubin, A. 103 

Rubin, E. 104 

Rubin, L. 56 

Rubinstein, A. 103 

Rubinstein, M. 61 

Ruby, J. 9

AUTHOR INDEX 

Ruggieri, E. 53 

Ruggles, K. 84, 103 

Ruglass, L. 55, 90 

Ruiz, M. 58 

Ruiz, S. 103 

Rupprecht, L. E. 25 

Rush, C. R. 25, 99, 104 

Rybakova, K. 78 

Sacco, P. 75 

Saddleson, M. L. 86 

Sadicario, J. S. 85 

Sagar, K. 105 

Sahlem, Gregory 2, 54, 106 

Saika, F. 64 

Saint-Fleur, A. 18 

Saitz, R. 58, 103 

Sakai, J. 15, 88 

Sakloth, F. 24 

Salas-Ramirez, K. Y. 10, 88 

Salas-Ramirez, Kaliris Y. 88 

Salmeron, B. 70 

Salvatore, J. 89 

Salyuk, T. 94 

Samet, J. H. 11, 56, 59, 77, 91 

Samko, M. 94 

Sanches, M. 83 

Sanchez, K. 75 

Sanders, E. M. 25 

Sanford, C. 103 

Santa Ana, E. J. 87 

Santaella, J. 21, 60, 105 

Santiago Rivera, O. J. 56 

Santos, B. 98 

Santos, D. 57, 99 

Santos, G. 11, 57, 99 

Sanvisens, A. 83 

Sara, W. 98 

Saraiya, T. 56 

Sareedenchai, P. 81 

Sarvet, A. L. 18, 19, 55, 57 

Satre, D. 4, 57 

Saunders, E. 79, 97 

Sawyer, A. 85 

Saxon, A. 77, 84 

Schackman, B. 94 

Scheer, S. 11 

Scherbaum, N. 101 

Scherer, J. N. 65 

Schindler, C. W. 24 

Schlienz, N. 106 

Schmidt, Heath 2 

Schmidt, L. 78 

Schmitz, J. 15, 102, 104 

Schuch, J. B. 79 

Schulenberg, J. 18, 100 

Schutzman, C. 87 

Schwandt, M. 53 

Schwartz, R. P. 4, 61, 63, 77, 94, 95 

Scofield, M. 13 

Scott, B. 11 

Scott, C. K. 20, 21, 95 

Seale, P. 4 

Secades-Villa, R. 86, 98 

Segura, L. E. 60 

Seitz, J. 14 

Seitz-Brown, C. 75 

Selby, P. 87 

Selby, V. L. 96 

Sellers, E. 17 

Serafine, Katherine M. 88 

Serdarevic, M. 83 

Sereda, Y. 62 

Serre, F. 74, 89 

Sessler, N. 83 

Setlow, Barry 101 

Setnik, Beatrice 72 

Severtson, S. G. 84 

Sferra, M. S. 89 

Shah, M. 94 

Shanahan, M. 78 

Sharma, A. 95 

Sharma, G. 4, 82, 95 

Sharma-Haase, K. 9 

Shaw, J. 66 

Sheikhattari, P. 87 

Sherman, B. J. 10 

Sherman, S. 58 

Shimamoto, A. 13 

Shimane, T. 64 

Shinday, N. M. 79 

Shiu, K. 61, 76 

120 

Shmulewitz, D. 18, 19, 55, 68 

Short, V. 69 

Shorter, D. 52 

Showalter, H. 3 

Shram, M. 54 

Shrestha, R. 57, 94 

Shukla, N. 78 

Sierka, C. 66 

Sigmon, S. C. 10, 53, 77, 85, 97 

Silins, E. WITHDRAWN 

Silverberg, M. 57 

Silverman, K. 68, 78 

Simon, P. 60 

Singh, R. 22, 101 

Singh, S. 10 

Sinha, R. 88, 97 

Sirikantraporn, S. 84 

Sisti, J. 103 

Skak, N. 17 

Skalisky, J. 68 

Skanderson, M. 78 

Skelly, J. M. 85 

Skinstad, A. H. 91 

Skranes, J. 69 

Slater, K. 70 

Slater, N. 66 

Small, W. 95 

Smethells, John R. 3, 73 

Smith, M. A. 75 

Smith, M. D. 17 

Smith, M. T. 54 

Smith, R. 105 

Smith, T. T. 16, 25 

Smits, J. 55 

Smyth, J. M. 98 

Snider, S. E. 81 

Sofuoglu, Mehmet 9, 69 

Sokolowska, M. 93 

Solli, K. 9 

Solomon, L. J. 92 

Solomon, T. A. 102 

Somerson, J. 14 

Song, K. 93 

Sorensen, J. 59, 61, 77 

Sorenson, R. 3 

Sorsdahl, K. 64

AUTHOR INDEX 

Sotade, O. 103 

Soto, C. 65 

Sottile, J. E. 21, 105 

Sparenborg, S. 77 

Spears, C. A. 96 

Spencer, R. H. 66 

Spicer, S. 96 

Spilman, S. 75 

Spitzer, E. 11 

spodick, j. 69 

Spratt, H. 81 

Spratt, S. 92 

Sprong, M. E. 89 

Sproule, B. 83, 87 

Squeglia, L. M. 59 

Srebnik, D. 68 

Sripada, C. S. 88 

Stahler, G. 95 

Stanger, C. 60 

Staton-Tindall, M. 57, 61, 62 

Stein, D. J. 14, 64 

Stein, Elliot 8, 16, 70 

Stein, Jack 71 

Stein, M. 11 

Steinberg, H. 21 

Steinberg, J. 15, 55, 104 

Steketee, J. D. 80 

Sterling, R. 78 

Stevens, Sally 26 

Stevens-Watkins, D. 66 

Stewart, J. L. 15, 25 

Stillwell, G. 66 

Stitzer, M. 53 

Stohl, M. 95 

Stolf, A. R. 79 

Stoltman, Jonathan J. 5 

Stone, M. 75 

Stoops, William W. 25, 99, 104 

Storholm, E. D. 57 

Storr, C. 60, 96 

Stotts, A. 59, 68, 92, 97 

Stouffer, D. G. 14 

Stowe, Z. 85, 102 

Stoytcheva, B. 55 

Strain, E. C. 10, 54 

Strang, J. 93 

Strasser, A. 20, 86 

Strathdee, S. 58 

Streck, J. M. 97 

Strickland, Justin C 5, 25, 75, 88 

Striley, C. W. 19, 20, 22, 55, 56, 62, 

83, 84, 100 

Stringfellow, E. 63 

Stutz, S. J. 80 

Su, Shelley 101 

Subramaniam, G. 4, 95 

Sugarman, D. E. 95 

Suh, J. 15, 16 

Sullivan, M. A. 58, 59, 78 

Summers, K. C. 80 

Sun, W. 66 

Suzuki, M. 24 

Sved, A. F. 25 

Svikis, D. 4, 85, 92, 95, 96 

Swalve, N. 3 

Sweeney, M. M. 88, 99 

Sweitzer, M. 16, 75 

Swendsen, J. 74 

Syckes, C. 84, 103 

Sykes, J. 82 

Sylvester, C. 59, 91 

Szobot, C. 79 

Tabit, Mary 71, 79 

Taffe, M. A. 14, 105 

Tai, B. 92 

Talal, A. 59, 91 

Tallarida, C. S. 17 

Tamashunas, N. 12 

Tanabe, Jody 15, 65, 88 

Tanguy, J. 91 

Tanum, L. H. 9 

Tapert, Susan 5, 15, 25 

Tarbox, P. 95 

Tartarini, W. 70 

Tarter, R. E. 93 

Techer, L. 63 

Teixeira, P. 61 

Tennen, H. 14 

Terplan, Mishka 52, 85, 86, 92 

Tetrault, J. 94 

Theunisen, E. 17 

121 

Thibault, V. 58 

Thiede, H. 22, 84 

Thomas, A. 59 

Thomas, B. F. 6, 64 

Thomas, C. 77, 99 

Thomas, L. 101 

Thompson, E. 95 

Thompson, L. E. 91 

Thorberg, F. A. 81 

Thorndike, E. 24 

Thorpe, R. 102 

Thorsell, A. 81 

Thostenson, J. D. 77, 99 

Thrul, J. 87 

Tidey, J. W. 16, 53, 86, 96, 102 

Tiruveedhulaand, V.V.N.P.B. 68 

Todhunter, B. 78 

Todtenkopf, Mark S. 73 

Tofighi, B. 10, 59, 81 

Tol, W. A. 74, 82 

Tomiyama, K. 13 

Tompkins, D. A. 10, 54 

Tor, J. 83 

Torregrossa, M. M. 64, 88 

Torrens, M. 17, 97, 101 

Torres, C. A. 92 

Torres, L. 17, 97 

Torres, O. 12, 92 

Toumbourou, J. 82 

Toussova, O. 56, 59 

Towe, S. L. 12 

Townsend, D. 67 

Trachtenberg, A. 63 

Traynor, John 23 

Tross, S. 61 

Tsan, L. 88 

Tsui, J. I. 22, 34, 56, 84, 91 

Tyburski, M. 76 

Tyndale, R. 87, 96 

Tyssen, R. 81 

Umbricht, A. 78 

Unterwald, E. M. 64 

Upchurch, D. 55 

Urada, D. 56, 62 

Utevsky, A. V. 15

AUTHOR INDEX 

Vaddiparti, K. 19, 20 

Vahabzadeh, M. 76 

Vahidi, M. 17, 56 

Vallender, E. J. 79 

van den Brink, W. 79 

van Hout, M. 93 

Van Nunen, L. 14 

van Ree, J. M. 79 

van Wijngaarden, E. 11 

Vandewater, S. 14 

Vandrey, Ryan 20, 21, 67 

VanVeldhuisen, P. 4, 77, 

82, 103 

Varetska, O. 94 

Vasquez, C. 88 

Vassileva, J. 55, 56 

Vazquez Sanroman, D. B. 10 

Vélez Pastrana, M. 62 

Veliz, P. T. 100 

Ventura, A. S. 58, 103 

Verbitskaya, E. 9 

Vergara-Rodriguez, P. 59 

Vesely, B. 95 

Vidot, Denise C. 5, 19, 62 

Vieira, P. 14 

Viera, P. 10 

Villa-Gonzalez, A. 88 

Villarreal, Y. 59, 68, 97 

Vince, B. 17 

Vincent, J. 104 

Vincent, K. B. 20, 55 

Vinci, C. 96 

Vittinghoff, E. 57 

Vlahov, D. 57 

Vocci, F. 77 

Vogelman, J. 59 

Volkow, Nora 8 

Von Korff, M. 100 

Vosburg, S. 93 

Votaw, V. R. 100 

Vsevolozhskaya, O. A. 56, 63 

Wadolowski, M. 60 

Wagman, J. A. 56 

Wagner, F. A. 56, 63, 87 

Wagner, J. J. 98 

Wakim, P. 4 

Walker, J. R. 55, 99 

Wall, M. M. 18, 19, 20, 21, 

55, 105 

Wallace, J. 18 

Walley, Alexander Y. 58, 59, 

77, 103 

Walsh, S. L. 10, 83 

Walters, H. M. 24 

Walton, M. A. 54, 76, 94, 101 

Wang, G. 17 

Wang, H. 11 

Wang, J. 84, 94 

Wang, L. 22 

Wang, M. 12 

Wang, X. 104 

Ward, G. 76 

Ward, K. 85 

Wardle, M. 80 

Washio, Y. 68, 91 

Watchko, S. M. 85 

Waters, Andrew 9 

Watson-Thompson, J. 82 

Webster, L. R. 17, 54 

Webster, M. 61, 62 

Wechsberg, Wendee 57, 74 

Weerts, Elise M. 67, 68 

Weglicki, L. 92 

Wehmeyer, K. 78 

Weidberg, S. E. 86 

Weigel, T. 95 

Weinberger, A. H. 19 

Weiner, S. 100 

Weinstein, A. M. 14 

Weinstein, S. 78 

Weinstein, Z. M. 77 

Weiser, S. D. 11 

Weisner, C. 4, 103 

Weiss, R. 9, 25, 97 

Weiss, Susan 5 

Weiss, V. G. 75 

Wesley, M. J. 14 

West, H. 69, 85 

Westmoreland, S. 79 

Wetherill, R. 15, 16 

Wetherington, Cora Lee 65 

122 

Wetzell, B. B. 81 

Wey, H. 104 

Wey, Hsiao-Ying 104 

Wherry, J. 13, 52 

White, B. 85 

White, N. 103 

Whitehead, N. E. 100 

Whiteside, L. K. 101 

Wickens, C. 63 

Wiersema, J. 61 

Wiley, J. 54, 64 

Williams, E. A. 13, 25 

Williams, G. 11 

Wilson, A. G. 61, 66 

Wilson, B. L. 91 

Wilson, M. 80 

Wilson, S. J. 98 

Wincott, C. 104 

Windisch, K. 12 

Winoske, K. J. 67 

Winter, M. R. 77 

Wish, Eric 26 

Witbrodt, J. 95 

Wolff, K. 62 

Wong, C. F. 54 

Wong, S. 81 

Wood, E. 4, 11, 58, 59, 69, 84 

Wood, R. 14 

Woodcock, E. A. 52, 65 

Woody, G. E. 78, 84 

Worhunsky, P. D. 98 

Wu, L. T. 4, 92, 95 

Wu, P. 67 

Wulfert, E. 74 

Xenitidis, K. 62 

Xia, J. 55 

Xia, R. 17 

Xu, H. 52 

Xu, J. 16 

Xu, K. 96 

Xuan, S. 18 

Xuan, Z. 103 

Yamakawa, R. 69 

Yamamoto, Bryan K 13, 23

AUTHOR INDEX 

Yamamoto, D. 15 

Yang, Yihong 8 

Yao, W. D. 79 

Yassin, N. 93 

Yates, J. R. 75 

Yeh, H. H. 93 

Yerkes, L. 92 

Yi, J. Y. 16, 25 

Yi, R. 94 

Yip, S. W. 14, 61, 88 

Yonkers, K. A. 69 

Yoon, Jin H. 6 

Young, D. 3 

Young, J. 102 

Young, K. A. 15 

Young, M. 89 

Young, R. M. 81 

Young, S. 59, 62 

Young-Wolff, K. C. 4 

Yuferov, V. 79, 104 

Zimmerman, M. 76 

Zorrilla, E. 80 

Zucker, R. A. 88, 89 

Zule, W. 57 

Zulich, A. 22 

Zuluaga, P. 83 

Zuo, C. 70 

Zvartau, E. 9 

Zvolensky, M. J. 20 

Zvorsky, I. A. 20, 85 

Zacharoff, K. L. 83 

Zadzielski, E. 91 

Zah, V. 9 

Zakiniaeiz, Y. 88 

Zang, G. 97 

Zaplatkin, I. 78 

Zaslav, D. 79 

Zatzick, D. 101 

Zavala, A. R. 24 

Zavala, R. 59 

Zawertailo, L. 87 

Zentgraf, K. 79 

Zeremski, M. 59, 91 

Zestos, A. 3 

Zeziulin, O. 94 

Zhai, Z. 93 

Zhan, C. 66 

Zhang, M. 83 

Zhang, Y. 64, 79, 81 

Zhao, S. 87 

Zheng, G. 3, 66 

Zhu, J. 66 

Zhu, M. 52 

Zhuang, Y. 88 

Zilverstand, A. 56 

123

SYMPOSIA 

Sunday, June 12 

President’s Symposium 

TITLE: Where There’s Smoke: U.S., Australasian, and European Cannabis Policies and Use 

AUTHOR: Deborah Hasin 1,2 

INSTITUTIONS: 1 Columbia University; 2 New York State Psychiatric Institute 

Americans increasingly see marijuana as a harmless substance and favor its legalization; changes in state 

laws regarding marijuana reflect these changing attitudes. Time trends in adolescent marijuana use are 

reviewed, and the strength of evidence examined for a relationship between medical marijuana laws and 

adolescent use. Increases over time in adult marijuana use, marijuana use disorders and other marijuanarelated 

consequences are also reviewed, for the population as a whole and within major population 

subgroups. 

AUTHOR: Alison Ritter 3 

INSTITUTION: 3 University of New South Wales 

Cannabis use in Australia has been one of the highest in the world, yet cannabis policies in Australia have 

not substantially changed and there is little appetite for a less prohibitionist approach (for example, as of 

2013, only 26% of the population supported cannabis legalisation). Given policy stasis in Australia, it is 

interesting to reflect on possible drivers for changing cannabis prevalence (which has decreased from 18% 

last year use in 1998 to 10% last year use in 2013). Factors such as attitudes to smoking, and/or awareness 

of health effects, may be more important than formal drug policies in driving changes in cannabis 

prevalence rates. 

AUTHOR: Marc Auriacombe 4,5,6 

INSTITUTIONS: 4 University of Bordeaux (France); 5 CH Ch. Perrens and CHU Bordeaux, France; 

6 

University of Pennsylvania 

Marijuana regulations across European countries vary wildly regarding both what is permitted and what is 

not. There are also significant differences across countries in enforcement of cannabis laws. This gives us 

an opportunity to examine data available in the different countries in relation to each country’s specific 

regulations. Prevalence of overall use in adolescents and adults, as well as estimates of problem use will be 

reviewed in this perspective.


SYMPOSIA 

I. Developing innovative brain stimulation treatment options for substancedependent 

individuals: Translating basic science knowledge of neural 

circuits to our clinics 

Chairs: Colleen Hanlon and Antonello Bonci 

In the last decade we have become increasingly aware of the role that frontal- striatal 

circuits have on drug-taking behavior and relapse. Using elegant molecular techniques, 

we are able to change drug-taking behavior by modulating these circuits. Until recently, 

however, there were no techniques available to modulate these circuits in our patients. 

Developing brain stimulation as a treatment option for addiction is one of the goals of 

NIDA’s new strategic plan. SPECIFIC AIMS: We will introduce transcranial magnetic 

stimulation (TMS), provide a theoretical model for approaching addiction treatment, 

and highlight current TMS research in a diverse population of patients with substance 

use disorders (SUD). APPROACH: First, we will describe a theoretical framework for 

selecting neural circuit based targets likely to be fruitful candidates for SUD treatment. 

This will be followed by presentations from several laboratories that are evaluating the 

efficacy of TMS as a tool to decrease craving and/or increase cognitive control in 

alcoholics, nicotine smokers, prescription opiate users, and cocaine users. Each of 

these presentations will highlight both the successes and the challenges they faced 

when applying these techniques to patients. Finally, we will return to the theoretical 

model and describe links to both basic science research as well as pragmatic issues 

required to bring TMS to outpatients. 

II. 

Influence of metabolic hormones on reward processing and addiction 

Chairs: Arbi Nazarian and Minda Lynch 

Peripherally based metabolic hormones play significant roles in regulation of 

homeostatic feeding and satiation systems, with their dysregulation leading to 

conditions such as obesity and diabetes. More recent examinations have revealed that 

metabolic hormones are also active modulators of natural hedonic processing for food, 

as well as modulators of reward processing to drugs of abuse by acting within the 

mesocorticolimbic system. Understanding the neurobiological mechanisms of 

metabolic hormones can shed light on the contribution of these hormones on reward 

signaling in the brain and facilitate development of novel therapeutic approaches for 

the treatment of drug and food addiction. In this symposium, findings will be 

presented demonstrating the modulatory role of metabolic hormones in alcoholism in 

humans, rodent models of nicotine and cocaine abuse, as well as food intake. The aim 

of this symposium is to 1) introduce the audience to metabolic hormones, as 

modulators of reward processing; 2) develop an understanding of the intricate 

interaction of the peripheral endocrine system with reward signaling; and 3) encourage 

consideration and investigation of the influence of metabolic hormones in studies of 

addiction.

SYMPOSIA 

Monday, June 13 

III. 

Identifying system-level biomarkers of substance abuse using functional 

connectivity of the brain 

Chairs: Yihong Yang and Elliot Stein 

Substance abuse is a complex neuropsychiatric disorder manifested as dysregulations 

of multiple cognitive and affective constructs. Recent advances in neuroimaging have 

shown promise in identifying system-level biomarkers that are closely associated with 

the behavioral phenotype and may be potentially useful for individualized treatment 

and predicting therapeutic outcome. In particular, brain functional connectivity, 

derived from the synchronized fluctuations of the resting-state functional MRI signal 

between brain regions, has undergone rapid technological developments and 

consequently as a noninvasive imaging tool to assess neuroplasticity of brain circuits 

and networks in various neuropsychiatric disorders. In this symposium, we will 

present the latest developments in identifying imaging biomarkers of substance use 

disorders using functional connectivity. The four speakers will present recent data 

from their labs using a number of analytical approaches to understand the circuitry 

underlying the abuse profile of cocaine, marijuana, alcohol and nicotine. Finally, these 

recent developments will be discussed in view of emerging theory related to druginduced 

imbalance of neuronal circuits. We will also discuss the potential value of 

these imaging biomarkers 1) as therapeutic targets; 2) in the prediction of group or 

subgroup membership and monitoring of treatment outcomes; and 3) in translational 

and “back-translational” studies using preclinical models. 

IV. 

Cognitive function as a novel treatment target for drug addiction 

Chairs: Mehmet Sofuoglu and Kathleen Carroll 

The aim of this symposium is to review the promise of cognitive function as a novel 

target for behavioral and pharmacological treatments for drug addiction. Results will 

be presented showing that oral methylphenidate enhances performance and 

underlying fronto-striatal function on tasks of inhibitory control and drive, and 

resting-state functional connectivity, in cocaine addiction. Data will be shown from 

randomized trials designed to determine whether engagement in daily technological 

enhancements (interactive voice response or smartphone app), as a cognitiveenhancement 

strategy, and brief interventions to reduce drug use were more effective 

than brief interventions alone among drug users treated in HIV comprehensive care 

settings. Following a brief overview of the potential utility of attentional retraining 

interventions for addictions that aims to reverse attentional bias to drug cues, and 

therefore cue-provoked craving and drug use, recent data in which cognitive biases for 

cigarette smoking are assessed and modified on mobile devices will be presented. 

Findings will be presented from a recently completed clinical trial that tested efficacy 

of a cognitive enhancer, galantamine (a cholinesterase inhibitor) and computerized 

cognitive behavioral therapy (CBT4CBT), alone and in combination, on treatment 

outcome and cognitive functioning among cocaine users. A discussion of the 

implications of these findings for developing novel treatment approaches for drug 

addiction and providing future research directions will conclude the symposium.

SYMPOSIA 


V. Identifying system-level biomarkers of substance abuse using functional 

connectivity of the brain 

Chairs: Margaret Gnegy and John Traynor 

Substance abuse is a complex neuropsychiatric disorder manifested as dysregulations 

of multiple cognitive and affective constructs. Recent advances in neuroimaging have 

shown promise in identifying system-level biomarkers that are closely associated with 

the behavioral phenotype and may be potentially useful for individualized treatment 

and predicting therapeutic outcome. In particular, brain functional connectivity, 

derived from the synchronized fluctuations of the resting-state functional MRI signal 

between brain regions, has undergone rapid technological developments and 

consequently as a noninvasive imaging tool to assess neuroplasticity of brain circuits 

and networks in various neuropsychiatric disorders. This symposium will present the 

latest developments in identifying imaging biomarkers of substance use disorders 

using functional connectivity. Recent data will be presented using a number of 

analytical approaches to understand the circuitry underlying the abuse profile of 

cocaine, marijuana, alcohol and nicotine. These developments will be reviewed in light 

of emerging theory related to drug-induced imbalance of neuronal circuits. In addition, 

the potential value of imaging biomarkers will be discussed as therapeutic targets; in 

the prediction of group or subgroup membership and monitoring of treatment 

outcomes; and in translational and “back-translational” studies in preclinical models. 

VI. 

Intracellular signaling molecules as targets for stimulant abuse treatment 

Chairs: Heather Kimmel and Paul W. Czoty 

Epidemiological data suggests that poly-substance use, the use of more than one drug 

over a period of time, is common; yet basic and clinical research typically examine the 

consequences of a single drug at a time. Polysubstance users have an increased risk of 

developing comorbid psychiatric and other health conditions. Current prevention and 

treatment approaches are under-developed, indicating a need to understand the 

antecedent and consequential circumstances surrounding polysubstance use. This 

symposium will showcase current epidemiological, clinical, and basic research findings 

describing current polysubstance use trends and subsequent health outcomes. We will 

describe recent polysubstance use findings from two different nationally 

representative cross-sectional studies of youth and adults. Building upon these crosssectional 

data, we will discuss novel longitudinal research tracking polysubstance use 

from adolescence through young adulthood. A clinical perspective will be provided, 

presenting neuroimaging and neurocognitive data to demonstrate differing cognitive 

outcomes in alcohol dependent individuals who also use stimulants compared to 

alcoholics that do not use stimulants. Data will demonstrate that serial alcohol and 

methamphetamine administration in rodents exacerbates the neurotoxic effects of 

either drug alone. The discussion will integrate these data to discuss how these 

findings inform each other. Bringing these diverse perspectives together will facilitate 

discussions of how epidemiological data can inform basic animal and clinical research 

and, conversely, how findings from basic and clinical research can guide 

epidemiological research.

SYMPOSIA 

Tuesday, June 14 

VII. 

5HT2A and 5HT2C ligands as potential therapeutics for substance use 

disorders 

Chairs: Jane B. Acri and Leonard Howell 

We will present and discuss data relevant to the clinical advancement of 5HT2 ligands 

as substance use treatment medications. There are no approved medications for 

cocaine, methamphetamine, or THC use disorders, and these results may suggest 

clinical efficacy for substance use disorders. The 5HT system can influence the abuserelated 

effects of cocaine and other drugs of abuse through its direct and indirect 

interactions with dopaminergic systems in key brain areas. The regional distribution 

of 5HT2A and 5HT2C involve the prefrontal cortex, the nucleus accumbens and the 

ventral tegmental area. The two receptor systems can functionally oppose each other 

in terms of their regulation of the dopaminergic signaling. Several selective ligands 

have recently been developed by pharma for different indications; lorcaserin a 5HT2C 

agonist is in clinical use for weight reduction, and pimavanserin, a 5HT2A antagonist 

may soon be approved for the treatment of psychosis in Parkinson’s Disease. Clinical 

availability of selective ligands will greatly enhance our ability to translate these 

findings in human clinical trials. These compounds have recently been evaluated in 

drug self-administration models using non-human primates trained to self-administer 

cocaine, methamphetamine, or THC, using FR, PR, or choice models. These results will 

be presented and discussed in terms of relevance to the treatment of substance use 

disorders. 

VIII. Neonatal Abstinence Syndrome: Context and consequences in 2016 

Chairs: Karol Kaltenbach and Hendree Jones 

Under the banner of fetal protection, judges and prosecutors have implemented 

punitive approaches against women who use prescribed and non-prescribed opioids 

during pregnancy. Policy makers mirror such punitive approaches in laws passed that 

focus on women who use drugs while pregnant. The symposium will review the current 

situation for women who use substances during pregnancy and their NAS-diagnosed 

babies. These actions in the judicial-political sphere suggest that the science of NAS is 

well understood. While there are numerous reports in the empirical literature 

documenting efforts to assess and treat NAS over the past 50 years, rigorous studies 

testing the best ways to assess and treat these infants are relatively recent as are 

studies that identify factors that exacerbate or mitigate the severity of NAS. The state 

of the science in assessment; efficacy of medication used to treat NAS; and protocols 

for initiation of treatment and weaning will be described. Factors that have been 

recently been identified that exacerbate the severity and length of treatment as well as 

changes in hospital policies and practices that been shown to be effective in reducing 

NAS severity will be discussed. These presentations will outline how a diagnosis of 

NAS is not a diagnosis of maternal substance use disorder; an indication of a negative 

relationship between substance use and fetal outcome

SYMPOSIA 


IX: 

Translational markers of substance use vulnerability: Receptors, riskprocessing, 

and psychopathology 

Chairs: Noelle C. Anastasio and Thomas Crowley 

Among human children and adolescents, externalizing behaviors, including impulsivity 

and risk-taking, predict adolescent and adult substance use disorders. Our 

translational studies of substance-naive human and non-human subjects suggest that 

aberrant brain function underlies aberrant early behaviors and reflects a neural 

vulnerability to substance use disorders. An imbalance in the cortical glutamatergic 

system as an underpinning of inherent impulsivity in rodents may be driven by 

dysregulation of N-methyl-D-aspartate receptor signaling and selective NMDAR 

potentiation may reduce high inherent impulsivity. Earlier work demonstrating that in 

a risky-decision game, adolescents with substance and conduct problems (SCP) had 

widespread brain hypoactivity will be extended to the same game-stimulated neural 

activity in numerous brain regions of drug-naïve 9-11 year-olds. Correlation with 

participants' parent-rated externalizing scores suggests that aberrant brain function 

antedates, and may contribute to, SCP in many adolescents. Data from the IMAGEN 

study, a longitudinal cohort of 2200 adolescents who underwent genetic, neuroimaging 

and behavioral assessments, will be presented. Correlates of factors of 

psychopathology within a hierarchical structural model associated with psychiatric 

conditions, including substance use disorder, will be shown. This panel will emphasize 

that a greater understanding of the vulnerability to the development of substance use 

disorders requires the cross-talk and contribution of cross-discipline, cross-species 

studies. 

X: Imaging the male & female addicted brain: Structural and functional 

differences and implications for precision medicine 

Chairs: Cora Lee Wetherington and Will M. Aklin 

The Precision Medicine Initiative was announced by President Obama in the 2015 State 

of the Union address, and was subsequently described by Francis Collins & Harold 

Varmus (NEJM, 2015) as “prevention and treatment strategies that take individual 

variability into account.” Because biological sex is the most fundamental difference 

among individuals, studying differences in outcomes between men and women is lowhanging 

fruit in achieving precision medicine. Speakers in this symposium will present 

sex differences in neuroimaging data that are providing a window on potential targets, 

both behavioral and pharmacologic, to enhance precision medicine, from both 

prevention and treatment perspectives. A brief review of sexual dimorphism in brain 

structure and connectivity in healthy people will precede discussion of sex-specific 

differences in cortical and subcortical gray-matter volume and correlated drug use and 

behavioral measures in long-term abstinent stimulant users. Data from the PET image 

analysis, lp-ntPET, will be shown, which can provide real-time ‘movies’ and 

quantification of dopamine release during smoking, and has revealed sex differences 

in dopamine release in the ventral striatum and dorsal putamen and its relationships 

to mood and reward in smokers. Also presented will be data from males and females 

with substance use disorders, with and without trauma histories, comparing their 

resting-state functional connectivity, their response to pharmacologic probes of neural 

systems, and their response to drug-related cues.


SYMPOSIA 

XI. 

Not your average joint: Alternative methods of cannabis consumption 

Chairs: Adam Leventhal and Marcel O. Bonn-Miller 

With increasing legalization of cannabis, there has been a proliferation of the number 

and types of cannabis preparations and drug delivery devices available on the market. 

Consequently, smoking cannabis is no longer the exclusive route of cannabinoid 

consumption prominent in the population. Oral consumption of edible cannabis 

products, transdermal application of topical cannabinoid ointments, and vaporization 

of cannabis plant, oils, and liquid extracts via e-cigarettes and other electronic devices 

are becoming increasingly popular. Unfortunately, many drug dependence researchers, 

clinicians, and policy makers are unaware of this trend and the emerging science on 

alternative routes of cannabis administration. This symposium synthesizes laboratory, 

clinical, and population-based research on the pharmacology, clinical correlates, and 

epidemiology of cannabis consumption via alternative routes. Human laboratory 

research on the acute pharmacokinetic and pharmacodynamic dose-effects of oral 

cannabis will be presented and contrasted to prototypical drug effect profiles of 

cannabis smoking. Clinical research pertaining to use of various cannabis preparations 

among cannabis-dependent individuals and patients using for therapeutic and 

recreational purposes will be discussed. Survey data characterizing cannabis vaping in 

adolescent and adult cannabis users will be presented. Also discussed will be the 

epidemiology of cannabis use by route of consumption and novel data on the 

prevalence and mental health correlates of adolescent cannabis vaping and use of 

edible cannabis products. The session will close with a discussion of translation across 

basic, clinical, and epidemiologic perspectives, and implications for regulation. 

Wednesday, June 15 

XII: 

Medicinal chemistry of novel kappa opioid receptor ligands 

Chairs: F.I. Carroll and Thomas Prisinzano 

Every since the discovery of the potent and selective kappa opioid receptor antagonists 

nor-BNI and kappa opioid receptor agonist such as U69,593 as well as other 

antagonists and agonists of this receptor system there has been continuing interest in 

basic medicinal chemistry studies that this receptor plays in numerous biological 

processes. Animal behavioral studies have shown that both antagonists and agonists 

have high potential for treating substance abuse (nicotine, alcohol, cocaine, 

methamphetamine and opiates) as well as other CNS disorders (depression, anxiety, 

attention deficit hyperactivity disorder, pain, and others). This symposium will provide 

information concerning newer kappa opioid receptor ligands for treating substance 

abuse. The presentations will include studies directed towards 1) the effect of 

substitution for the tryptophan residue in the natural product CJ-15,208; 2) a better 

understanding of the medicinal chemistry properties of salvinorin A and analogs; 3) 

the optimization of biased kappa opioid receptor ligands; and 4) the effect of changing 

the 3,4-dimethyl-4-(3-hyrroxyphenyl)piperidine part of JDTic on its medicinal 

chemistry properties. The basic medicinal chemistry research information presented in 

these four presentations will provide a better understanding of how the kappa opioid 

receptor target will lead to potential pharmacotherapies for treatment of various 

substance abuse problems and other CNS disorders.

SYMPOSIA 

Wednesday, June 15 

XIII: 

Bio-behavioral research on HIV among people who use drugs 

Chairs: Christina S. Meade and Adam W. Carrico 

Since the beginning of the HIV/AIDS epidemic, drug users have been at increased risk 

for HIV infection and transmission, both through risky injection drug practices and 

risky sexual behaviors. As the epidemic has evolved, drug users have faced increasing 

disparities related to HIV testing treatment, and retention in care— with 

correspondingly poorer clinical and psychosocial outcomes. Moreover, drug addiction 

can interfere with HIV treatment outcomes, both directly through biological processes 

and indirectly through difficulties with HIV disease management. With the goal of an 

AIDS-free generation, funding priorities now emphasize biomedical approaches. 

However, behavioral research remains critical to ensure that all individuals – no matter 

how difficult to reach – can derive the maximum benefits from new biomedical 

treatments to reduce the transmission of HIV and effectively manage HIV-associated 

comorbidities. This symposium highlights major advances from interdisciplinary 

research teams led by behavioral scientists. The presentations cover bio-behavioral 

approaches to identifying behavioral risks among high-risk groups, neurocognitive 

impacts on decision-making processes relevant to HIV risk, and multi-component 

interventions to reduce risk of HIV transmission and improve HIV-related outcomes. 

The discussant will review the results of these studies in light of new NIH priorities for 

HIV/AIDS research among persons who use and abuse drugs. 

XIV: 

Reducing the harms of opioid analgesic use in health systems 

Chairs: Amy Bohnert and Tae Woo Park 

Reducing the harms of opioid medications used in the treatment of pain has become a 

major priority of health systems, public health agencies, and policymakers. Because 

opioid prescribing has been linked to overdose and misuse on a population and 

individual level, improving treatment practices is a major focus of efforts to address 

this problem. We will report emerging evidence related to efforts to reduce the harms 

of opioids in treatment settings. Patients in addictions treatment settings will 

represent a group of particular attention for several of the studies reported. One 

avenue of health system-based prevention is to use information readily in electronic 

medical records to identify those patients receiving opioids at greatest risk for harm. 

We will present on patient and treatment characteristics associated with opioid misuse 

in a military population as well as overdose specifically among addictions treatment 

clients. We will seek to further elucidate risk reduction strategies through qualitative 

interviews with health care providers. This will include examining the feasibility of a 

military prescription drug monitoring program. Additionally, a series of interviews 

with primary care providers and pharmacists will explore their decision-making 

processes when balancing the benefits and risks of prescribing and dispensing opioids 

for chronic non-cancer pain. We will also report on use of non-pharmacological pain 

management strategies among individuals with comorbid chronic pain and substance 

use disorders to explore avenues for reducing reliance on opioids for analgesia. The 

discussion will focus on the translation of these findings to patient-, provider-, and 

system-level interventions.

SYMPOSIA 

Thursday, June 16 

XV: 

Risky business: Neurobiological mechanisms of risky decision making 

in drug abuse and addiction 

Chairs: Shelly Su and Carlos Blanco 

Individuals with substance use disorders exhibit deficits in executive function, 

including the inability to think flexibly, to update and manipulate information, and to 

inhibit choices and actions that are irrelevant to the current goals. New and exciting 

findings indicate a relationship between drug abuse vulnerability and risk preference, 

or the preference for an uncertain delivery of a large reward over certain delivery of a 

small reward. The purpose of this symposium is to showcase this emerging area of 

research and highlight the neural circuitry subserving drug-induced risky decision 

making in basic animal and human-based laboratory research. The symposium will 

begin with data characterizing the neural systems that integrate information regarding 

cost/benefit analysis in a probabilistic discounting task in healthy, drug-naïve rodents. 

Building upon this neural circuitry, evidence will be presented for a bi-directional 

relationship between risky decision making and cocaine self-administration in rodents 

and the contributions of dopamine signaling to this association. Behavioral and 

neuroimaging data from healthy and methamphetamine-dependent participants 

engaging in the Balloon Analog Risk Task, which parallels the same cognitive deficits 

and neural networks observed in rodent models, will be presented. A translational 

perspective and data on altered risk perceptions and changes in neural patterns of 

activity in drug-dependent individuals will be discussed.

WORKSHOPS 


I. Navigating key stages of a career in addiction science: Graduate school, 

post-doc and early-career 

Chairs: Teresa Franklin and Denise Vidot 

You are a budding addictions-focused Investigator with new ideas, new techniques and 

new approaches and— you are presenting a poster or a talk at CPDD— maybe this is 

your first, or your third, but it is an important moment in your career— 

Congratulations! In addition to presenting your work, the opportunities to learn and 

network at CPDD are monumental! For example, this workshop, which will focus on 

issues specific to 3 key stages in your early career, Pre-Doctoral, Post-Doctoral, and 

Early Career/Faculty, could be helpful to you. Three of your colleagues, who have 

‘Been There, Done That’ want to share their experiences with you. Each presentation 

will outline steps that can be taken to maximize your career stage-specific experience 

and make you a competitive job applicant for the next stage of your career. Examples 

of topics that will be covered include how to choose your mentors; striking a balance 

between executing your mentor’s vision and growing as an independent scientist; how 

to narrow down an innovative and significant research question; publishing amidst 

other responsibilities; obtaining grant-writing experience; applying for awards; 

establishing your niche and conveying its importance to potential employers; 

collaborating and networking; deciding whether to teach; life-work balance; finding the 

NIH funding mechanisms that are most appropriate for you; how to begin writing your 

grant; and crucial to it all - time management strategies. 

II. 

The landmark Adolescent Brain Cognitive Development Study (ABCD): A 

detailed discussion of the study goals, methodologies, and project start-up 

Chairs: Susan R.B. Weiss and Margaret M. Murray 

Adolescence, a time of dramatic physical, emotional, and intellectual growth, is a 

developmental period that sets the foundation for an individual’s life trajectory. While 

advances in brain imaging and cognitive neuroscience are providing insights into the 

developing brain, to date, few studies have been able to capture the factors that 

influence this development over time in large and diverse populations. Children and 

adolescents are exposed to myriad internal and external influences that interact with 

their changing biology and genetic and environmental vulnerabilities that affect their 

development. To gain better understanding of brain, cognitive, social, and emotional 

development trajectories from childhood through adolescence; the NIH launched the 

landmark ABCD in the fall of 2015. This unparalleled prospective, longitudinal, multisite 

study will combine developmental psychology, neuroimaging, cognitive 

neuroscience, genetics, and epidemiology with advanced techniques in bioassays, 

bioinformatics, and mobile assessment to follow 10,000 9-10-year-olds recruited at 19 

sites around the country. This workshop brings together representatives from the 

ABCD Research Consortium leadership to present the goals of the study, assessments 

and technologies being used to address these goals, and sampling methodology 

designed to recruit and retain subjects with multiple dimensions of diversity (i.e., race, 

ethnicity, education, urban and rural environments). Project start-up information will 

also be shared. Findings from ABCD are expected to increase the ability to distinguish 

environmental, sociocultural, and genetic factors relevant to substance use and brain 

development and to inform prevention, treatment, and public health strategies.

WORKSHOPS 


III. 

Emerging technology for human subjects research 

Chairs: Jonathan JK Stoltman and Edward Nunes 

The College on Problems of Drug Dependence Committee on Human Research presents 

a practical workshop that includes human researchers of both junior and senior status 

with diverse interests within the substance abuse field. The workshop is positioned to 

benefit both junior and senior investigators in the audience by exposure to new 

technology. In addition, roughly a third of the time will be a question-and-answer 

session with discussion regarding ethical and legal issues facilitated by an expert 

senior discussant. The workshop will provide all attendees with different perspectives 

and best practices at other universities, thereby enhancing translation from the 

workshop to real world implementation. The basic workshop design includes brief 

description of new technology, the opportunities they hold, and the challenges we 

might face implementing them. Summaries will be provided for popular and novel 

technologies for human subject research. The workshop is designed to cover 

technology throughout the research stages of reaching IRB approval; recruiting; and 

data collection. Specifically, two popular methods of online recruitment and data 

collection will be discussed (Amazon Mechanical Turk and Facebook), HIPAA, 

technology to deliver interventions, and technology monitoring in ecological 

environments. A variety of technology and substance-using populations will be 

covered. 

IV. 

International emergence and abuse of new psychotropic substances 

(NPS), their toxicity and the current regulatory response 

Chairs: Patrick Beardsley and Jane C. Maxwell 

New psychotropic substances (NPS) of abuse continue to emerge and cause harm 

worldwide. Commonly associated NPS drug classes have been the synthetic 

cannabinoids and cathinones, but newly emerging benzodiazepines, dissociative 

anesthetics and opioid and opioid-mimicking drugs have recently added to this 

onslaught. Not only is their number and diversity a challenge, but also their 

transience, detection and geographical heterogeneity, which provide special issues to 

health practitioners and regulatory authorities relative to more established abused 

drugs. The fact that their availability and supply are often mediated through the 

diffuseness of the Internet compounds the problems of their control. The specific aims 

of this workshop are to illuminate the international diversity of the NPS problem, the 

harm they cause, and how regulatory authorities are responding to their challenge. 

Hopefully, this information will better alert and inform those practitioners confronting 

NPS health issues, and enkindle interest in their research by scientists. The workshop 

will address forensic challenges associated with NPSs and their toxicology, present an 

international canvas of the NPS problem, focusing on the NPS story in Australasia, 

Europe and the United States. It will conclude with a summary of the presented topics 

and a focus on the international regulatory response in its attempt to control the NPS 

problem.

WORKSHOPS 


V. Epidemiology and public health research methods 

Chairs: James Anthony and Jan Copeland 

This workshop will begin with an overview of high priority program 

announcements for the NIDA Division of Epidemiology, Service, and Prevention 

Research (DESPR), DESPR funding opportunities, and DESPR-initiated data archives 

for public and restricted use epidemiological datasets. Then, we turn to some 

innovations in statistical estimation and inference for prevention, health services, 

and treatment research when randomization is not possible (e.g., estimation of the 

effects of childhood-onset cannabis use in relation to brain imaging outcomes). 

The final segment of the workshop will be a chair-organized and chair-led but 

generally open discussion about the promise and pitfalls of using data from 

Google Trends, Facebook, Twitter, and other social media in NIDA, NIAAA, NCI, 

and FDA epidemiology and public health research on nicotine products, cannabis 

products, and related topics. 


VI. 

21 st Annual Contingency Management Working Group 

Chairs: Diann Gaalema and Kelly Dunn 

The Contingency Management (CM) Working Group, held annually during the CPDD 

convention, is an opportunity for the dissemination and discussion of current research 

regarding the use of CM interventions to promote behavior change and reduce drug 

use. CM is a behavioral treatment strategy that has demonstrated consistent success in 

promoting abstinence from a wide-range of drugs and across many ars different 

treatment populations. It is also being used to promote change inbehaviors impacting 

the course of other chronic diseases (e.g., obesity, diabetes). At the 21st Annual 

Meeting of the CM Working Group, junior and senior researchers will present 

preliminary data from ongoing studies involving CM. The goal for this working group 

is to provide an informal outlet for discussion of ongoing CM research, with an 

emphasis on developing or improving research strategies by seeking audience input, 

and providing opportunities for junior and senior researchers to interact.

WORKSHOPS 


VII. 

Introducing the National Drug Early Warning System (NDEWS) 

Chairs: Eric D. Wish and Moira O’Brien 

In 2014, the National Institute on Drug Abuse (NIDA) funded the Center for Substance 

Abuse Research (CESAR) at the University of Maryland, College Park, to serve as the 

Coordinating Center for its new National Drug Early Warning System (NDEWS). NDEWS 

builds on the infrastructure of a successful earlier NIDA project, the Community 

Epidemiology Workgroup (CEWG). NDEWS supports the cross-disciplinary collection 

and exchange of information on the availability of drugs, consumption of drugs, and 

consequences of drug use. NDEWS-coordinated activities include early detection and 

communication by the NDEWS virtual network, social media scans, and a partnership 

with the American Association of Poison Control Centers. NDEWS also monitors 

emerging local drug trends in 12 Sentinel Community Sites (SCS) and through targeted 

Hot Spot Studies. This workshop will present the methods and findings generated by 

NDEWS during its first two years. The presenters will 1) introduce NDEWS and review 

its components; 2) highlight NDEWS advancements; 3) discuss emerging drug use 

patterns and trends in the SCSs; 4) highlight emerging drug use trends and patterns in 

San Francisco (a SCS); 5) review the results of recent ethnographic interviews 

conducted as part of a Hot Spot study on the use of synthetic cannabinoids; and 6) 

describe new techniques for scanning and interpreting drug-related tweets. 

VIII. 

A gender lens to addressing adolescent substance use disorders and 

trauma with systems level approach / SASATE Business Meeting 

Chairs: Michael Dennis and Sally Stevens 

Adolescents who have experienced trauma report more substance use, criminal 

activity, homelessness, and mental and physical health challenges. These youth are in 

need of trauma-informed integrated services — including girls and lesbian, gay, 

bisexual, transgender (LGBT) youth. The effectiveness of treatment can be improved if 

services incorporate a systems-integration approach specifically tailored to these highrisk 

groups. The specific aims of the workshop are to (1) provide an overview of 

adolescent substance use disorders and trauma by sex and gender identity; and (2) 

present outcome data on the effectiveness of systems-integrated, trauma informed, 

gender- and LGBT-targeted interventions for substance-involved adolescents who 

present with histories of trauma. Reports will include information on substance use 

disorders and trauma symptoms in national data from adolescents entering substance 

abuse treatment by sex and sexual identity; substance use, trauma, sexual behaviors, 

and outcomes of a trauma-informed and systems-integrated intervention effective in 

reducing substance use, trauma symptoms, and risky sexual behaviors among 

adolescent girls; trauma-responsive system of care for LGBT youth and how this 

system of care improved outcomes with regard to substance use, mental health and 

homelessness for this population; a clustered randomized pilot trial that reached 

female adolescent dropouts who use drugs in a South African study and have been 

traumatized and live in violent poor townships, their response to a pilot study and the 

government response.

WORKSHOPS 


IX. Marijuana laws: the changing legal landscape and its consequences 

Chairs: Marsha Lopez Andrew Freedman 

Marijuana is still illegal under federal law, but over half the states in the US have 

decriminalized or legalized it in some form. The effects of these changes are highly 

controversial. Public opinion about marijuana use is rapidly becoming more 

permissive, while proliferating marijuana dispensaries for medical or recreational use 

are providing ways to consume marijuana not previously seen at this scale, including 

marijuana-infused food and beverage products, electronic delivery devices, and 

emerging marijuana tourism in states with legalized recreational use. Many questions 

remain unanswered about the impact of these developments on the risk for marijuana 

use and related problems, questions that are the focus of intense public and scientific 

debate as the public considers and votes on medical and recreational marijuana laws, 

and as clinicians and policy-makers seek guidance from research findings. This 

workshop brings together important new findings from studies of these issues, 

including information on how adolescent attitudes and behaviors have been 

influenced by the law changes in Washington; how patterns of medical marijuana 

use in California correspond to health outcomes; how trends in hospital and poison 

center usage have been impacted by medical and recreational legalization policies in 

Colorado; and how social media is being used to track emerging cannabis trends. 


X. Research and emerging strategies for parents of substance-involved 

adolescents and youth: Results from NIDA’s Parents’ Translational 

Research Center 

Chairs: Kimberly C. Kirby and Elena Bresani 

Use of illicit drugs, binge drinking, and heavy alcohol are highest among adolescents 

and young adults (16-29 years old), and heroin use and overdose has increased over 

the past 5 years among young adults (21-29 years). As their children begin to 

deteriorate in the face of increasing drug use severity, parents are often desperate and 

unsure how to help. An abundance of advice is available, but much of it is conflicting 

and very little has a basis of empirical support. The goal of this workshop is to present 

the translational research that has been completed during the past 5 years by the first 

NIDA-funded center focused on the needs of parents of drug-involved adolescents and 

young adults. Speakers will present findings from research addressing parental 

responses to substance use at a broad continuum of severity, beginning with factors 

influencing parents’ initial detection and response to substance use (N=1,102), through 

guidelines for selecting and evaluating treatment options (N=208) and changes in 

adolescent service provision (N=435), to methods for facilitating treatment entry of 

treatment resistant adolescents and young adults (N=59). Future research and the 

importance of providing parents with information and practical tools for addressing 

substance use of their adolescents and young adults will be discussed, highlighting 

parent needs and quality of services.

WORKSHOPS 


XI. 

Annual CPDD design and analysis workshop 

Chairs: Sterling McPherson and Susan Mikulich-Gilbertson 

Since the beginning of the HIV/AIDS epidemic, drug users have been at increased risk 

for HIV infection and transmission, both through risky injection drug practices and 

risky sexual behaviors. As the epidemic has evolved, drug users have faced increasing 

disparities related to HIV testing treatment, and retention in care— with 

correspondingly poorer clinical and psychosocial outcomes. Moreover, drug addiction 

can interfere with HIV treatment outcomes, both directly through biological processes 

and indirectly through difficulties with HIV disease management. With the goal of an 

AIDS-free generation, funding priorities now emphasize biomedical approaches. 

However, behavioral research remains critical to ensure that all individuals— no matter 

how difficult to reach— can derive the maximum benefits from new biomedical 

treatments to reduce the transmission of HIV and effectively manage HIV-associated 

comorbidities. This workshop highlights major advances from interdisciplinary 

research teams led by behavioral scientists. The presentations cover bio-behavioral 

approaches to identifying behavioral risks among high-risk groups, neurocognitive 

impacts on decision-making processes relevant to HIV risk, and multi-component 

interventions to reduce risk of HIV transmission and improve HIV-related outcomes. 

Our discussant will review the results of these studies in light of new NIH priorities for 

HIV/AIDS research among persons who use and abuse drugs. 

XII. 

Education in drug abuse 

Chairs: Michael Kuhar and Jack Stein 

How do you respond when a student, fellow, collaborator, visitor or layman wants to 

know more about drug abuse? Often laymen, faculty and trainees are exposed to a 

narrow area of training, but then may seek more information or even a broader 

overview of the field. It is to everyone’s advantage to expand their knowledge about 

drug abuse, and the availability of educational resources is very important. Education 

is central to prevention, treatment and research. It facilitates collaborative efforts and 

communication among colleagues. This workshop will describe what educational 

resources are available, and how to access them. The recent expansion of Internet 

resources can be overwhelming, but this workshop will describe them as well. It will 

cover online (and other) degree programs; the body of available knowledge and 

teaching; various online programs such as MOOCs (massive open online courses that 

can be taken anywhere at the learners convenience); and discovering NIDA’s research 

portfolio.


XIII. 

WORKSHOPS 

Regulatory and methodological considerations in the evaluation of 

drug dependence in the preclinical and clinical setting 

Chairs: Beatrice Setnik and Michael Klein 

Evaluating drug withdrawal effects is an integral component of dependence potential, 

which informs the overall safety, appropriate dosing, and scheduling of a drug. The 

methodological approaches to assess dependence continue to evolve and require 

careful evaluation of both preclinical and clinical data. Physical dependence can 

manifest from various drug classes including classes of drugs that are and are not 

associated with substance use disorder (e.g. beta blockers, corticosteroids). 

Preliminary approaches often include animal models to evaluate psychological 

dependence and the physical manifestation of withdrawal type symptoms. Translation 

of animal pharmacokinetics to human can be challenging and needs to be carefully 

evaluated to determine the translatability of animal to human data. In the clinical 

setting, evaluation of withdrawal requires characterization of a drug’s pharmacology to 

determine what type of symptoms may manifest upon abrupt discontinuation. Study 

populations must be carefully considered, particularly in patient populations that 

cannot be safely withdrawn from study drug. Clinical trials must determine what 

population, duration of maintenance and endpoints are relevant for a given drug. 

Commonly adverse events and drug-specific withdrawal scales are included to evaluate 

withdrawal symptoms, however other pharmacodynamics measures may also be 

considered. The administration of endpoints and safety monitoring requires also 

practical considerations in the context of larger patient trials, where confined stays 

may not be possible following abrupt discontinuation. This workshop will address the 

regulatory and methodological considerations that are rapidly evolving in this active 

area of research and will cover case examples of studies examining drug withdrawal 

and dependence.

Acknowledgements 

The following organizations and individuals have financially supported 

the work of the CPDD organization during the past year 

Apt Foundation 

George Bigelow, PhD, 

Johns Hopkins Behavioral 

Pharmacology 

Research Unit 

Alan Budney and 

Dartmouth College 

Cerecore 

Howard Chilcoat 

Theodore Cicero 

Sandra Comer 

William Dewey 

Linda Dwoskin 

Loretta Finnegan 

Charles Gorodetzky 

Sarah Heil & Andrew Goodwin IV 

Mr. Thomas C. Grissom 

Leonard Howell 

Lewis Katz School of Medicine 

at Temple University 

Dr. & Mrs. Donald Mess, Jr. 

Michigan State 

Mrs. Regina Hurley Nash 

Dr. John B. Neeld, Jr. 

NIDA (National Institute 

on Drug Abuse) 

Charles O’Keeffe 

James Sorensen 

UCLA Integrated Substance 

Abuse Programs 

University of Arkansas for 

Medical Sciences 

University of Kentucky 

T32 Training Grant 

Dr. Linda Dwoskin 

University of Miami, Miller 

School of Medicine 

Vince & Associates Clinical 

Research 

Washington University School 

of Medicine 

Marc J. Kaufman 

Funding for this conference was made possible (in part) by 

Grant Agreement # 5 R13 DA13192-12 from the 

National Institute on Drug Abuse 

The views expressed in written conference materials or publications and by speakers and 

moderators do not necessarily reflect the official policies of the Department of Health and 

Human Services; nor does mention of trade names, commercial practices, or organizations 

imply endorsement by the U.S. Government

CPDD 78th Annual Scientific Meeting Program

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?